Document:

Exhibit 10.8

 

WEATHERFORD INTERNATIONAL PLC

2019 EQUITY INCENTIVE PLAN

 

	1.	Purpose of the Plan

 

The Plan is intended
to advance the best interests of the Company, its Affiliates and its shareholders by providing those persons whose substantial
contributions are essential to the continued growth and profitability of the Company and its Affiliates with additional performance
incentives and an opportunity to obtain or increase their proprietary interest in the Company, thereby encouraging them to continue
in their Employment or affiliation with the Company or its Affiliates.

 

	2.	Definitions

 

The following capitalized
terms used in the Plan have the respective meanings set forth in this Section 2, unless the context clearly indicates otherwise.
The singular pronoun shall include the plural where the context so indicates.

 

(a)           Act : the Companies Act 2014 of Ireland, as amended.

 

(b)           Affiliate
: With respect to the Company, any Person directly or indirectly controlling, controlled by, or under common control with,
the Company or any other Person designated by the Committee in which the Company or an Affiliate has an interest. The Committee
shall have the authority to determine the time or times at which “Affiliate” status is determined within the foregoing
definition.

 

(c)           Applicable
Accounting Standards : Generally Accepted Accounting Principles in the United States, International Financial Reporting Standards
or such other accounting principles or standards as may apply to the Company’s financial statements under United States
federal securities laws from time to time.

 

(d)          Applicable
Laws : The requirements relating to the administration of equity-based and cash-based awards, as applicable, and the related
issuance of Shares under U.S. state corporate laws, U.S. federal and state and Irish or other non-U.S. corporate and securities
laws, the Code or other applicable tax laws, any stock exchange or quotation system on which the Shares are listed or quoted and
the applicable laws of any non-U.S. country or jurisdiction where Awards are, or will be, granted under the Plan.

 

(e)           Associate
: With respect to a specified Person, means:

 

(i)            any company, corporation, partnership, or other organization of which such specified Person is an officer or partner;

 

(ii)           any trust or other estate in which such specified Person has a substantial beneficial interest or as to which such specified
Person serves as trustee or in a similar fiduciary capacity;

 

(iii)          any
relative or spouse of such specified Person, or any relative of such spouse who has the same home as such specified Person, or
who is a director or officer of the Company or any of its Subsidiaries; and

 

(iv)          any
Person who is a director, officer, or partner of such specified Person or of any company (other than the Company or any wholly-owned
Subsidiary), corporation, partnership or other entity which is an Affiliate of such specified person.

 

     

     

    

 

(f)            Award
: An Option, Restricted Share, Restricted Share Unit, Share Appreciation Right, Other Share-Based Award or Performance-Based
Award granted pursuant to the Plan.

 

(g)           Award
Agreement : Any written agreement, contract, or other instrument or document evidencing the terms and conditions of an Award,
including through electronic medium.

 

(h)           Beneficial
Owner : A “beneficial owner”, as such term is defined in Rule 13d-3 under the Exchange Act provided that any Person
that has the right to acquire any of the Company’s outstanding securities entitled to vote generally in election of directors
at any time in the future, whether such right is contingent or absolute, pursuant to any agreement, arrangement or understanding
or upon exercise of conversion rights, warrants or options, or otherwise, shall be deemed the Beneficial Owner of such securities.

 

(i)            Benefit Plans : All employee benefit and compensation plans, agreements, arrangements, programs, policies, practices,
contracts or agreements of the Company and its Affiliates.

 

(j)            Board : The Board of Directors of the Company.

 

(k)           Change in Control : The date any event set forth in any one of the following paragraphs shall have occurred:

 

(i)            any
Person (other than Permitted Holders) is or becomes the Beneficial Owner, directly or indirectly, of 30% or more of either (A)
the then outstanding Shares of the Company (the “Outstanding Ordinary Shares”) or (B) the combined voting power
of the then outstanding voting securities of the Company entitled to vote generally in the election of directors (the “Outstanding
Voting Securities”), excluding any Person who becomes such a Beneficial Owner in connection with a transaction that
complies with clauses (A), (B) and (C) of paragraph (iii) below;

 

(ii)           individuals, who, as of the Effective Date, constitute the Board (the “Incumbent Board”) cease for any
reason to constitute at least a majority of the Board; provided, however, that any individual becoming a director subsequent to
the Effective Date whose election, or nomination for election by the Company’s shareholders, was approved by a vote of at
least 2/3rds of the Incumbent Board shall be considered as though such individual was a member of the Incumbent Board, but excluding,
for this purpose, any such individual whose initial assumption of office occurs as a result of an actual or threatened election
contest with respect to the election or removal of directors or any other actual or threatened solicitation of proxies or consents
by or on behalf of a Person other than the Board;

 

(iii)          the consummation of an acquisition, reorganization, reincorporation, redomestication, merger, amalgamation, consolidation,
plan or scheme of arrangement, exchange offer, business combination or similar transaction of the Company or any of its Subsidiaries
or the sale, transfer or other disposition of all or substantially all of the Company’s Assets (any of which, a “Corporate
Transaction”), unless, following such Corporate Transaction or series of related Corporate Transactions, as the case
may be, (A) all of the Persons who were the Beneficial Owners, respectively, of the Outstanding Ordinary Shares and Outstanding
Voting Securities immediately prior to such Corporate Transaction own or beneficially own, directly or indirectly, more than 50%
of, respectively, the Outstanding Ordinary Shares and the combined voting power of the Outstanding Voting Securities entitled to
vote generally in the election of directors (or other governing body), as the case may be, of the Entity resulting from such Corporate
Transaction (including, without limitation, an Entity (including any new parent Entity) which as a result of such transaction owns
the Company or all or substantially all of the Company’s Assets either directly or through one or more Subsidiaries or other
Entities) in substantially the same proportions as their ownership, immediately prior to such Corporate Transaction, of the Outstanding
Ordinary Shares and the Outstanding Voting Securities, as the case
may be, (B) no Person (other than Permitted Holders)(excluding any Entity resulting from such Corporate Transaction or any Benefit
Plan (or related trust) of the Company or such Entity resulting from such Corporate Transaction) beneficially owns, directly or
indirectly, 30% or more of, respectively, the then outstanding common shares of the Entity resulting from such Corporate Transaction
or the combined voting power of the then outstanding voting securities of such Entity except to the extent that such ownership
existed prior to the Corporate Transaction and (C) at least a majority of the members of the board of directors (or other governing
body) of the Entity resulting from such Corporate Transaction were members of the Incumbent Board at the time of the approval of
such Corporate Transaction; or

 

    	 	 	2

     

    

 

(iv)          approval or adoption by the shareholders of the Company of a plan or proposal which could result directly or indirectly
in the liquidation, transfer, sale or other disposal of all or substantially all of the Company’s Assets or the dissolution
of the Company, excluding any transaction that complies with clauses (A), (B) and (C) of paragraph (iii) above.

 

Notwithstanding the
foregoing, a transaction shall not constitute a Change in Control (i) if it is effected solely for the purpose of changing the
place of incorporation or formation, tax residency or form of organization of the ultimate parent entity of the Weatherford Group
(including where the Company is succeeded by an entity incorporated under the laws of another state, country or foreign government
for such purpose and whether or not the Company remains in existence following such transaction) and (ii) where all or substantially
all of the Person(s) who are the Beneficial Owners of the combined voting power of the Outstanding Voting Securities immediately
prior to such transaction will beneficially own, directly or indirectly, all or substantially all of the combined voting power
of the Outstanding Voting Securities of the ultimate parent entity resulting from such transaction in substantially the same proportions
as their ownership, immediately prior to such transaction, of such securities of the Company.

 

Notwithstanding the
foregoing, if a Change in Control constitutes a payment event with respect to any Award (or any portion of an Award) that provides
for the deferral of compensation that is subject to Section 409A, to the extent required to avoid the imposition of additional
taxes under Section 409A, the transaction or event described in this Section 2(k) with respect to such Award (or portion thereof)
shall only constitute a Change in Control for purposes of the payment timing of such Award if such transaction also constitutes
a “change in control event,” as defined in Treasury Regulation Section 1.409A-3(i)(5).

 

(l)            
Code : The U.S. Internal Revenue Code of 1986, as amended, or any successor thereto, and the rules and regulations
promulgated thereunder.

 

(m)          Committee
: The Compensation Committee of the Board (or a subcommittee thereof), or the delegate to which the Board or the Compensation
Committee has delegated its authority pursuant to Section 4(a) hereof, or such other committee of the Board to which the Board
has delegated power to act under or pursuant to the provisions of the Plan.

 

(n)           Company : Weatherford International plc, an Irish public limited company and any successor thereto.

 

(o)           Company Assets : Shall mean the assets (of any kind) owned by the Company, including, without limitation, the securities
of the Company’s Subsidiaries and any of the assets owned by the Company’s Subsidiaries.

 

(p)           Consultant: Any consultant or advisor if (a) the consultant or advisor renders bona fide service to the Company or
any Affiliate, (b) the services rendered by the consultant or advisor are not in connection with the offer or sale of a securities
in a capital-raising transaction and do not directly or indirectly promote or maintain a market for the Company's securities, and
(iii) the consultant or advisor is a natural person.

  

    	 	 	3

     

    

 

(q)           Director : A member of the Board.

 

(r)            Disability
: Unless otherwise provided in an Award Agreement or determined by the Committee, the Participant would qualify to receive
benefit payments under the long-term disability plan or policy, as it may be amended from time to time, of the Company or the
Affiliate to which the Participant provides Service, regardless of whether the Participant is covered by such plan or policy,
or the plan or policy of the Company, if an Affiliate does not maintain such a plan or policy. A Participant shall not be considered
to have incurred a Disability unless he or she furnishes proof of such impairment sufficient to satisfy the Committee in its discretion.
Notwithstanding the foregoing, for purposes of ISOs granted under the Plan, “Disability” means that the Participant
is disabled within the meaning of Section 22(e)(3) of the Code. Notwithstanding the foregoing, with respect to an Award that is
subject to Section 409A where the Award will be paid by reference to the Participant’s Disability, solely for purposes of
determining the timing of payment, no such event will constitute a Disability for purposes of the Plan or any Award Agreement
unless such event also constitutes a “disability” as defined under Section 409A.

 

(s)            Dividend
Equivalent Right : A right to receive the equivalent value of dividends paid on the Shares with respect to Shares underlying
Restricted Share Units or an Other Share-Based Award that is a Full Value Award prior to vesting of the Award, subject to the
additional requirements of Section 10(b) hereof. Such Dividend Equivalent Right shall be converted to cash or additional Shares,
or a combination of cash and Shares, by such formula and at such time and subject to such limitations as may be determined by
the Committee.

 

(t)            Effective
Date : The date immediately following the date that the Company emerges from bankruptcy.

 

(u)           Employee : A full-time or part-time employee of the Company or any Affiliate, including an officer or Director, who
is treated as an employee in the personnel records of the Company or Affiliate for the relevant period. Neither services as a Director
nor payment of a director’s fee by the Company or an Affiliate shall be sufficient to constitute “employment”
by the Company or an Affiliate.

 

(v)           Entity : Any corporation, partnership, association, joint-stock company, limited liability company, trust, unincorporated
organization or other business entity.

 

(w)           Exchange
Act : The U.S. Securities Exchange Act of 1934, as amended, or any successor thereto, and the rules and regulations promulgated
thereunder.

 

(x)            Fair
Market Value : On a given date, (i) if there should be a public market for the Shares on such date, the closing price of the Shares
as reported on such date on the principal national securities exchange on which such Shares are listed or admitted to trading,
or, if no sale occurred on such date, the first trading date immediately prior to such date during which a sale occurred; or (ii)
if the Shares are not listed or admitted on any national securities exchange but are regularly quoted on a national market or
other quotation system, the arithmetic mean of the per Share closing bid price and per Share closing asked price on such date
as quoted on such market or system, or, if no sale occurred on such date, then on the immediately preceding date on which sales
have been so reported or quoted; or (iii) if there should not be a public market for the Shares on such date, the Fair Market
Value shall be the value established by the Committee in good faith under a reasonable methodology and reasonable application
in compliance with Section 409A to the extent such determination is necessary for Awards under the Plan to comply with, or be
exempt from, Section 409A.

 

    	 	 	4

     

    

 

(y)           Full Value Awards : Any Award other than an (i) Option, (ii) Share Appreciation Right or (iii) other Award for which
the Participant pays (or the value or amount payable under the Award is reduced by) an amount equal to or exceeding the Fair Market
Value of the Shares, determined as of the date of grant.

 

(z)           ISO : An Option that is also an incentive stock option granted pursuant to Section 7(e) of the Plan.

 

(aa)         Option
: An option granted pursuant to Section 7 of the Plan.

 

(bb)        Option Price : The purchase price per Share of an Option, as determined pursuant to Section 7(b) of the Plan.

 

(cc)        
Other Share-Based Awards : Awards granted pursuant to Section 9 of the Plan.

 

(dd)         Participant : An Employee, Consultant, or Director who is selected by the Committee to participate in the Plan.

 

(ee)         Performance-Based Award : A Full-Value Award that vests, in whole or in part, based on the attainment of a Performance
Goal.

 

(ff)         
Performance Criteria : The criteria that the Committee selects for purposes of establishing the Performance Goal(s)
for a Participant during a Performance Period. The Performance Criteria that will be used to establish Performance Goals may include,
but are not limited to, one or more of the following: (i) consolidated earnings before or after taxes (including earnings before
interest, taxes, depreciation and amortization); (ii) net income; (iii) operating income; (iv) operating income margin; (v) gross
margin; (vi) earnings per Share; (vii) book value per Share; (viii) return on shareholders’ equity; (ix) expense management;
(x) return on invested capital; (xi) improvements in capital structure; (xii) profitability of an identifiable business unit or
product; (xiii) maintenance or improvement of profit margins or revenue; (xiv) Share price; (xv) market share; (xvi) revenues or
sales; (xvii) costs; (xviii) available cash flow; (xix) working capital; (xx) return on assets; (xxi) total shareholder return,
(xxii) productivity ratios, and (xxiii) economic value added. The Performance Criteria may be calculated in accordance with Applicable
Accounting Standards or on an adjusted basis.

 

(gg)         Performance
Goals : For a Performance Period, the goals established in writing by the Committee for the Performance Period based upon
the Performance Criteria. Depending on the Performance Criteria used to establish such Performance Goals, the Performance Goals
may be expressed in terms of overall Company performance, the performance of an Affiliate, the performance of a division or a
business unit of the Company or an Affiliate, or the performance of an individual or team. The Performance Goal established by
the Committee may also be based on a return or rates of return using any of the foregoing Performance Criteria and including a
return or rates of return based on revenue, earnings, capital, invested capital, cash, cash flow, assets, net assets, equity or
a combination or ratio therefrom. The Performance Goal established by the Committee may also be based on Performance Criteria,
which may be used to calculate a ratio or may be used as a cumulative or an absolute measure or as a measure of comparative performance
relative to a peer group of companies, an index, budget, prior period, or combination thereof, or other standard selected by the
Committee. Unless otherwise stated, such a Performance Goal need not be based upon an increase or positive result under a particular
business criterion and could include, for example, maintaining the status quo or limiting economic losses (measured, in each case,
by reference to specific business criteria). The Performance Goals may be measured either in absolute or relative terms. The Committee,
in its sole discretion, may provide that one or more adjustments shall be made to one or more of the Performance Goals.

 

    	 	 	5

     

    

 

(hh)         Performance
Period : One or more periods of time, which may be of varying and overlapping durations, as the Committee may select, over
which the attainment of one or more Performance Goals will be measured for the purpose of determining a Participant’s right
to, and the payment of, a Performance-Based Award.

 

(ii)           Permitted Holders : Capital Research and Management Company and its affiliates, on behalf of certain managed funds
and accounts, and Franklin Advisers, Inc., as investment manager on behalf of certain funds and accounts.

 

(jj)           Person : A "person" as such term is used for purposes of Section 3(a)(9) of the Exchange Act, as modified
and used in Sections 13(d) thereof, except that such term shall not include (i) the Company or any of its Affiliates, (ii) a trustee
or other fiduciary holding securities under a Benefit Plan, (iii) an underwriter temporarily holding securities pursuant to an
offering by the Company of such securities, or (iv) an Entity owned, directly or indirectly, by the shareholders of the Company
in the same proportions as their ownership of the Shares of the Company.

 

(kk)         Plan
: This Weatherford International plc 2019 Equity Incentive Plan, as from time to time amended and then in effect.

 

(ll)           Restricted Shares : Shares awarded to a Participant pursuant to Section 6 of the Plan that shall be subject to certain
restrictions and may be subject to risk of forfeiture.

 

(mm)       Restricted Share Unit : An Award granted pursuant to Section 5 of the Plan that shall be evidenced by a bookkeeping
entry representing the equivalent of one Share.

 

(nn)         Section 409A : U.S. Code Section 409A, as amended, or any successor thereto, and the rules and regulations promulgated
thereunder.

 

(oo)         Securities Act : The U.S. Securities Act of 1933, as amended, or any successor thereto, and the rules and regulations
promulgated thereunder.

 

(pp)         Service : Except as otherwise determined by the Committee in its sole discretion, a Participant’s Service terminates
when the Participant ceases to actively provide services to the Company or an Affiliate. The Committee shall determine which leaves
shall count toward Service and when Service terminates for all purposes under the Plan. Further, unless otherwise determined by
the Committee, a Participant’s Service shall not be deemed to have terminated merely because of a change in the capacity
in which the Participant provides Service to the Company or an Affiliate, or a transfer between entities (i.e., the Company or
any Affiliates), provided that there is no interruption or other termination of Service in connection with the Participant’s
change in capacity or transfer between entities (except as may be required to effect the change in capacity or transfer between
entities). For purposes of determining whether an Option is entitled to ISO status, an Employee’s Service shall be treated
as terminated 90 days after such Employee goes on leave, unless such Employee’s right to return to active work is guaranteed
by law or by a contract.

 

(qq)         Shares : Ordinary shares in the capital of the Company, nominal value $0.001 per ordinary share, and such other securities
of the Company that may be substituted for the Shares pursuant to Section 11 of the Plan.

 

(rr)          Share
Appreciation Right : A share appreciation right granted pursuant to Section 8 of the Plan.

 

(ss)         Subsidiary:
Any Affiliate which is a subsidiary of the Company within the meaning of Section 7 of the Act. For purposes of granting an ISO,
Subsidiary means any “subsidiary corporation” of the Company as defined in Section 424(f) of the Code. For purposes
of granting non-qualified Options, Stock Appreciation Rights or other “stock rights,” within the meaning of Section
409A, to a Participant that is a U.S. taxpayer, an entity may not be considered a Subsidiary if the Shares will not be treated
as “service recipient stock” of such entity under Section 409A.

 

    	 	 	6

     

    

 

(tt)           Substitute Award : An Award granted under the Plan in assumption of, or in substitution or exchange for, an outstanding
award previously granted by an entity directly or indirectly acquired by the Company or any Subsidiary or with which the Company
or any Subsidiary combines.

 

(uu)        Tax-Related
Items : Any U.S. federal, state, and/or local taxes and any taxes imposed by a jurisdiction outside of the United States (including,
without limitation, income tax, social insurance contributions, payment on account, employment tax obligations, stamp taxes and
any other taxes required by law to be withheld and any employer tax liability for which the Participant is liable).

 

(vv)        Weatherford
Group : The Company and its Subsidiaries.

 

	3.	Shares Subject to the Plan and Limitation on Issuable Shares

 

(a)           Number of Shares

 

Subject to Section
11, and as of the Effective Date, the total number of Shares which may be issued under the Plan is 4,075,000, and the maximum number
of Shares for which ISOs may be granted is 4,075,000. Except as provided below in Section 3(b) or 3(c), the number of Shares remaining
available for issuance shall be reduced by the relevant number of Shares for each Award (including Full Value Awards) granted under
the Plan. The Shares may consist, in whole or in part, of authorized and unissued Shares or treasury Shares or a combination thereof.

 

(b)           Shares Reissuable Under Plan

 

The following Shares
shall again be available for the grant of an Award pursuant to the Plan: (i) Shares that are not issued as a result of the termination,
cancellation, forfeiture, expiration or lapsing of any Award for any reason; (ii) Shares subject to a Full Value Award that are
not issued because the Award is settled in cash; (iii) Shares covered by a Full Value Award that are retained or are otherwise
not issued by the Company to the Participant in order to satisfy tax withholding obligations in connection with Full Value Awards.

 

(c)           Shares Not Reissuable Under Plan

 

Notwithstanding the
foregoing, the following Shares shall be counted against the maximum number of Shares available for issuance pursuant to Section
3(a) and shall not be returned to the Plan: (i) Shares subject to an Option or Share Appreciation Right that are retained or otherwise
not issued by the Company in order to satisfy tax withholding obligations in connection with Options or Share Appreciation Rights
or in payment of the exercise or purchase price of Options; (ii) Shares that are not issued or delivered as a result of the net-settlement
of an outstanding Option or Share Appreciation Right; or (iii) Shares that are repurchased or redeemed on the open market with
the proceeds of the exercise of an Option.

 

(d)           Shares Not Counted Against Share Pool Reserve

 

Notwithstanding anything
contained in Section 3 to the contrary, (i) Substitute Awards shall not reduce the overall limit on Shares available for grant
under the Plan; provided that Substitute Awards issued in connection with the assumption of, or in substitution for, outstanding
Options intended to qualify as ISOs shall reduce the aggregate number of Shares available for Awards of ISOs under the Plan; and
(ii) subject to any stock exchange requirements then applicable to the Company, available shares under a shareholder approved plan
of an entity directly or indirectly acquired by the Company or Subsidiary or with which the Company or Subsidiary combines (as
appropriately adjusted to reflect the acquisition or combination transaction) may be used for Awards under the Plan and shall not
reduce the number of Shares available for delivery under the Plan.

  

    	 	 	7

     

    

 

(e)          
Non-Employee Director Award Limit

 

Notwithstanding any
provision to the contrary in the Plan or in any policy of the Company regarding compensation payable to a non-Employee Director,
the sum of the grant date fair value (determined as of the grant date in accordance with Financial Accounting Standards Board Accounting
Standards Codification Topic 718, or any successor thereto) of all Awards payable in Shares and the maximum amount that may become
payable pursuant to all cash-based Awards that may be granted under the Plan to an individual as compensation for services as a
non-Employee Director, together with cash compensation paid to the non-Employee Director, shall not exceed $900,000 in any calendar
year.

 

(f)            Award
Limits for Employees and Consultants

 

The maximum number
of Shares that may be subject to Options or Share Appreciation Awards that are granted to any Employee or any Consultant during
any calendar year shall not exceed 400,000 Shares, subject to adjustment as provided in Section 11 hereof. The maximum amount with
respect to one or more Performance-Based Awards that may be granted to any Employee or any Consultant during any calendar year
shall not exceed $25,000,000 calculated based on the Fair Market Value of the number of Shares subject to the Performance-Based
Award on the date of grant.

 

	4.	Administration

 

(a)           Committee

 

The Plan shall be administered
by the Committee, which may delegate its duties and powers in whole or in part to any subcommittee thereof consisting solely of
at least two individuals who are intended to qualify as “Non-Employee Directors” within the meaning of Rule 16b-3 under
the Exchange Act and “independent directors” within the meaning of The New York Stock Exchange’s listed company
rules if such stock exchange rules are applicable to the Company at that time (or similar rules otherwise applicable to the Company,
if listed on a different stock exchange). Additionally, the Committee may delegate the authority to take any of the actions set
forth in Section 4(b), including the authority to grant Awards under the Plan to any Employee or group of Employees of the Company
or an Affiliate; provided that such delegation, including to grant Awards, is consistent with Applicable Laws and guidelines established
by the Committee from time to time. Notwithstanding the foregoing, the full Board, acting by a majority of its members in office,
shall conduct the general administration of the Plan (including the grant of Awards) with respect to all Awards granted to Non-Employee
Directors and for purposes of such Awards the term "Committee" as used in this Plan shall be deemed to refer to the Board.
In its sole discretion, the Board may at any time and from time to time exercise any and all rights and duties of the Committee
under the Plan, except with respect to matters which under Rule 16b-3 under the Exchange Act or The New York Stock Exchange’s
listed company rules, if such stock exchange rules are applicable to the Company at that time (or similar rules otherwise applicable
to the Company, if listed on a different stock exchange), are required to be determined in the sole discretion of the Committee.
The Committee may appoint such agents as it deems necessary or advisable for the proper administration of the Plan; provided, that
such appointment is consistent with Applicable Laws and any guidelines established by the Committee from time to time.

 

    	 	 	8

     

    

 

(b)          Authority
of Committee

 

The Committee has the
exclusive power, authority and discretion to:

 

(i)            Designate Participants to receive Awards;

 

(ii)           Determine
the type or types of Awards to be granted to each Participant;

 

(iii)          Determine the number of Awards to be granted and the number of Shares to which an Award will relate;

 

(iv)         Determine the terms and conditions of any Award granted pursuant to the Plan, including, without limitation, the Option
Price, grant price, or purchase price, Performance Criteria (or other objective/subjective goals (if any)), Performance Goals,
any restrictions or limitations on the Award, any schedule for lapse of forfeiture restrictions or restrictions on the exercisability
of an Award, vesting requirements, and accelerations or waivers thereof, and any provisions related to non-competition and recapture
of gain on an Award, based in each case on such considerations as the Committee in its sole discretion determines;

 

(v)          
Determine whether, to what extent, and pursuant to what circumstances (A) an Award may be settled in, or the exercise price
of an Award may be paid in, cash, Shares, other Awards, or other property, (B) the vesting, exercisability or forfeiture restrictions
applicable to an Award may be accelerated or waived, including, without limitation, in connection with the Participant’s
retirement or other termination or other event, or (C) an Award may be cancelled, forfeited, or surrendered;

 

(vi)          Prescribe the form of each Award Agreement, which need not be identical for each Participant and may vary for Participants
within and outside of the United States;

 

(vii)         Allot and issue any Shares which are to be allotted and issued upon the vesting or exercise of any Award;

 

(viii)        Decide all other matters that must be determined in connection with an Award;

 

(ix)          Establish, adopt, or revise any rules and regulations including adopting sub-plans to the Plan for the purposes of complying
with foreign laws and/or taking advantage of tax-favorable treatment for Awards granted to Participants outside the United States,
as it may deem necessary or advisable to administer the Plan;

 

(x)           Construe
and interpret the terms of, and any matter arising pursuant to, the Plan, or any Award Agreement;

 

(xi)          Correct
any defect or supply any omission or reconcile any inconsistency in the Plan in the manner and to the extent the Committee deems
necessary or desirable; and

 

(xii)         Make
all other decisions and determinations that may be required pursuant to the Plan or as the Committee deems necessary or advisable
to administer the Plan.

 

(c)           Decisions
Binding

 

Any decision of the
Committee or its delegate pursuant to Section 4(a) hereof shall lie within its sole and absolute discretion and shall be final,
conclusive and binding on all parties concerned (including, but not limited to, Participants and their beneficiaries or successors).

 

    	 	 	9

     

    

 

	5.	Terms and Conditions of Restricted Share Units

 

(a)           Restricted Share Units

 

The Committee is authorized to grant Restricted
Share Units to Participants in such amounts and subject to such terms and conditions not inconsistent with the Plan as the Committee
shall determine.

 

(b)           Vesting
Restrictions

 

The Committee shall
specify the date or dates on which the Restricted Share Units shall become fully vested and non-forfeitable, and may specify such
conditions to vesting, if any, as it deems appropriate. The vesting conditions, if any, may be based on, among other conditions,
a Participant’s continued Service or the attainment of Performance Goals.

 

(c)           Form and Timing of Payment

 

The Committee shall
specify the settlement date applicable to each grant of Restricted Share Units, which date shall not be earlier than the date or
dates on which the Restricted Share Units shall become fully vested and non-forfeitable, or such settlement date may be deferred
to any later date, subject to compliance with Section 409A, as applicable. On the settlement date, the Company shall, subject to
satisfaction of applicable Tax-Related Items (as further set forth in Section 20 hereof), deliver to the Participant one Share
for each Restricted Share Unit scheduled to be paid out on such date and not previously forfeited. Alternatively, settlement of
a Restricted Share Unit may be made in cash (in an amount reflecting the Fair Market Value of the Shares that otherwise would have
been issued) or any combination of cash and Shares, as determined by the Committee, in its sole discretion, in either case, less
applicable Tax-Related Items (as further set forth in Section 20 hereof). Until a Restricted Share Unit is settled, the number
of Restricted Share Units shall be subject to adjustment pursuant to Section 11 hereof.

 

(d)           Forfeiture

 

Except as otherwise
determined by the Committee at the time of the grant of the Award or thereafter, any Restricted Share Units that are not vested
as of the date of the Participant’s termination of Service shall be forfeited.

 

(e)           General
Creditors

 

A Participant who has
been granted Restricted Share Units shall have no rights other than those of a general creditor of the Company. Restricted Share
Units represent an unfunded and unsecured obligation of the Company, subject to the terms and conditions of the applicable Award
Agreement evidencing the grant of the Restricted Share Units.

 

	6.	Terms and Conditions of Restricted Share Awards

 

(a)           Grant of Restricted Shares

 

The Committee is authorized to grant Restricted
Shares to Participants selected by the Committee in such amounts and subject to such terms and conditions not inconsistent with
the Plan as the Committee shall determine.

 

(b)           Purchase
Price

 

At the time of the
grant of Restricted Shares, the Committee shall determine the price, if any, to be paid by the Participant for each Share subject
to the Award. The purchase price of Shares acquired pursuant to the Award shall be paid: (i) in cash at the time of purchase; (ii)
at the sole discretion of the Committee, by Service rendered or to be rendered to the Company or an Affiliate; or (iii) in any
other form of legal consideration that may be acceptable to the Committee in its sole discretion and in compliance with Applicable
Laws.

 

    	 	 	10

     

    

 

(c)           Issuance and Restrictions

 

Restricted Shares shall
be subject to such restrictions, if any, on transferability and other restrictions as the Committee may impose (including, without
limitation, limitations on the right to vote Restricted Shares or the right to receive dividends or repayment of capital on the
Restricted Shares). The restrictions, if any, may be based on, among other conditions, a Participant’s continued Service
or the attainment of Performance Goals. These restrictions, if any, may lapse separately or in combination at such times, pursuant
to such circumstances, in such installments, or otherwise, as the Committee determines at the time of the grant of the Award or
thereafter.

 

(d)           Dividends

 

Any dividends that
are distributed with respect to Restricted Shares shall be paid in accordance with the applicable Award Agreement, subject to the
provisions of Section 10(b)(ii) hereof.

 

(e)           Forfeiture

 

Except as otherwise
determined by the Committee at the time of the grant of the Award or thereafter, upon termination of Service during the applicable
restriction period, Restricted Shares that are at that time subject to restrictions shall be forfeited.

 

(f)            Certificates
for Restricted Shares

 

Restricted Shares granted
pursuant to the Plan may be evidenced in such manner as the Committee shall determine. If certificates representing Restricted
Shares are registered in the name of the Participant, certificates shall bear an appropriate legend referring to the terms, conditions,
and restrictions applicable to such Restricted Shares, and the Company may, at its discretion, retain physical possession of the
certificate until such time as all applicable restrictions lapse.

 

	7.	Terms and Conditions of Options

 

(a)           Option
Type

 

Options granted under
the Plan shall be, as determined by the Committee, non-qualified or ISOs, as evidenced by the related Award Agreements, and shall
be subject to the foregoing and the following terms and conditions and to such other terms and conditions, not inconsistent therewith,
as the Committee shall determine:

 

(b)           Option
Price

 

The Option Price per
Share shall be determined by the Committee, but shall not be less than the lower of (i) 100% of the Fair Market Value of a Share
on the date an Option is granted (other than in the case of Substitute Awards) and (ii) the nominal value of a Share.

 

(c)          
Exercisability

 

Options granted under
the Plan shall be exercisable at such time and upon such terms and conditions as may be determined by the Committee, but in no
event shall an Option be exercisable more than ten years after the date it is granted. The Committee shall specify the date or
dates on which the Options shall become fully vested, and may specify such conditions to vesting, if any, as it deems appropriate.
The vesting conditions, if any, may be based on, among other conditions, a Participant’s continued Service or the attainment
of Performance Goals.

 

    	 	 	11

     

    

 

(d)           Exercise
of Options

 

Except as otherwise
provided in the Plan or in an Award Agreement, an Option may be exercised for all, or from time to time any part, of the Shares
for which it is then exercisable. For purposes of Section 7 of the Plan, the exercise date of an Option shall be the later of the
date a notice of exercise is received by the Company or its designee or administrative agent in the form and manner satisfactory
to the Company and, if applicable, the date payment is received by the Company or its designee or administrative agent in accordance
with the following sentence. The purchase price for the Shares as to which an Option is exercised shall be paid to the Company
as designated by the Committee (including pursuant to any applicable Award Agreement), pursuant to one or more of the following
methods: (i) in cash or its equivalent (e.g., by personal check), (ii) if there is a public market for the Shares underlying the
Options at such time, through the delivery of irrevocable instructions to a broker to sell Shares obtained upon the exercise of
the Option and to deliver promptly to the Company an amount out of the proceeds of such sale equal to the aggregate Option Price
for the Shares being purchased, or (iii) any other method of payment authorized by the Committee. No fractional Shares will be
issued upon exercise of an Option, but instead the number of Shares will be rounded downward to the next whole Share.

 

(e)           ISOs

 

The Committee may grant
Options under the Plan that are intended to be ISOs. Such ISOs shall comply with the requirements of Section 422 of the Code. ISOs
shall be granted only to Participants who are employees of the Company and its Subsidiaries. No ISO may be granted to any Participant
who at the time of such grant, owns more than ten percent of the total combined voting power of all classes of stock of the Company
or of any Subsidiary, unless (i) the Option Price for such ISO is at least 110% of the Fair Market Value of a Share on the date
the ISO is granted and (ii) the date on which such ISO terminates is a date not later than the day preceding the fifth anniversary
of the date on which the ISO is granted. Any Participant who disposes of Shares acquired upon the exercise of an ISO either (A)
within two years after the date of grant of such ISO or (B) within one year after the transfer of such Shares to the Participant,
shall notify the Company of such disposition and of the amount realized upon such disposition. All Options granted under the Plan
are intended to be nonqualified options, unless the applicable Award Agreement expressly states that the Option is intended to
be an ISO. If an Option is intended to be an ISO, and if for any reason such Option (or portion thereof) shall not qualify as an
ISO, then, to the extent of such nonqualification, such Option (or portion thereof) shall be regarded as a nonqualified option
granted under the Plan; provided, that such Option (or portion thereof) otherwise complies with the Plan’s requirements relating
to nonqualified options. In no event shall any member of the Committee, the Company or any of its Affiliates (or their respective
employees, officers or directors) have any liability to any Participant (or any other Person) due to the failure of an Option to
qualify for any reason as an ISO.

 

(f)            Rights
with Respect to Shares

 

No Participant shall
have any rights to dividends or other rights of a shareholder with respect to Shares subject to an Option until the Participant
has given written notice of exercise of the Option, paid in full for such Shares and, if applicable, has satisfied any other conditions
imposed by the Committee pursuant to the Plan and applicable Award Agreement.

 

	8.	Terms and Conditions of Share Appreciation Rights

 

(a)           Grants

 

The Committee may grant
(i) a Share Appreciation Right independent of an Option or (ii) a Share Appreciation Right in connection with an Option, or a portion
thereof. A Share Appreciation Right granted pursuant to clause (ii) of the preceding sentence (A) may only be granted at the time
the related Option is granted, (B) shall cover the same number of Shares covered by an Option (or such lesser number of Shares
as the Committee may determine) and (C) shall be subject to the same terms and conditions as such Option except for such additional
limitations as are contemplated by this Section 8 (or such additional limitations as may be included in an Award Agreement). Payment
shall be made in Shares or cash, at the discretion of the Committee.

 

    	 	 	12

     

    

 

(b)          Terms

 

The exercise price
per Share of a Share Appreciation Right shall be an amount determined by the Committee but in no event shall such amount be less
than the Fair Market Value of a Share on the date the Share Appreciation Right is granted (other than in the case of Substitute
Awards); provided, that in the case of a Share Appreciation Right granted in conjunction with an Option, or a portion thereof,
the exercise price may not be less than the Option Price of the related Option. Each Share Appreciation Right granted independent
of an Option shall entitle a Participant upon exercise to a number of Shares equal to an amount that is (i) the excess of (A) the
opening price of the Shares on the exercise date of one Share (the “Opening Price”) over (B) the exercise price per
Share, multiplied by (ii) the number of Shares covered by the Share Appreciation Right; provided that if the Share Appreciation
Right is settled in Shares, such amount shall be divided by the Opening Price. Each Share Appreciation Right granted in conjunction
with an Option, or a portion thereof, shall entitle a Participant to surrender to the Company the unexercised Option, or any portion
thereof, and to receive from the Company in exchange therefore a number of Shares equal to an amount that is (i) the excess of
(A) the Opening Price over (B) the Option Price per Share, multiplied by (ii) the number of Shares covered by the Option, or portion
thereof, which is surrendered; provided, that if the Share Appreciation Right is settled in Shares, such amount shall be divided
by the Opening Price. Share Appreciation Rights may be exercised from time to time upon actual receipt by the Company or its designee
or administrative agent of written notice of exercise in the form and manner satisfactory to the Company stating the number of
Shares with respect to which the Share Appreciation Right is being exercised. The date a notice of exercise is received by the
Company shall be the exercise date. No fractional Shares will be issued in payment for Share Appreciation Rights, but instead the
number of Shares will be rounded downward to the next whole Share. The Committee shall specify the date or dates on which the Share
Appreciation Rights shall become fully vested, and may specify such conditions to vesting, if any, as it deems appropriate. The
vesting conditions, if any, may be based on, among other conditions, a Participant’s continued Service or the attainment
of Performance Goals.

 

(c)           Limitations

 

The Committee may impose,
in its discretion, such conditions regarding the exercisability of Share Appreciation Rights as it may deem fit, but in no event
shall a Share Appreciation Right be exercisable more than ten years after the date it is granted.

 

	9.	Other Share-Based Awards

 

(a)           Grants of Other Share-Based Awards and Performance-Based Awards

 

Subject to limitation
under Applicable Laws, the Committee is authorized under the Plan to grant Awards (other than Options, Restricted Share Units,
Restricted Shares and Share Appreciation Rights) to Employees, Consultants or Directors subject to the terms and conditions set
forth in this Section 9 and such other terms and conditions as may be specified by the Committee that are not inconsistent with
the provisions of the Plan and that, by their terms, involve or might involve the issuance of, consist of, or are denominated in,
payable in, valued in whole or in part by reference to, or otherwise relate to, Shares. The Committee may also grant Shares as
a bonus, or may grant other Awards in lieu of obligations of the Company or an Affiliate to pay cash or other property under the
Plan or other plans or compensatory arrangements. The terms and conditions applicable to such other Awards shall be determined
from time to time by the Committee and set forth in an applicable Award Agreement. The Committee may establish one or more separate
programs under the Plan for the purpose of issuing particular forms of Awards to one or more classes of Participants on such terms
and conditions as determined by the Committee from time to time.

 

    	 	 	13

     

    

 

(b)           Form of Payment

 

Payments with respect
to any Awards granted under Section 9 shall be made in cash or cash equivalent, in Shares or any combination of the foregoing,
as determined by the Committee.

 

(c)           Vesting Conditions

 

The Committee shall
specify the date or dates on which the Awards granted pursuant to this Section 9 shall become fully vested and nonforfeitable,
and may specify such conditions to vesting as it deems appropriate. The vesting conditions may be based on, among other vesting
conditions, a Participant’s continued Service or the attainment of Performance Goals.

 

(d)           Term

 

Except as otherwise
provided herein, the term of any Award granted pursuant to this Section 9 shall be set by the Committee in its discretion; provided,
that the term of any Award granted pursuant to this Section 9 shall not exceed 10 years.

 

	10.	Provisions Applicable to All Awards

 

(a)           Award
Agreement

 

Awards under the Plan
shall be evidenced by Award Agreements that set forth the terms, conditions and limitations for each Award, not inconsistent with
the Plan, which may include, without limitation, the term of an Award, the provisions applicable in the event the Participant’s
Service terminates, and the Company’s authority to unilaterally or bilaterally amend, modify, suspend, cancel or rescind
an Award.

 

(b)           Dividends
and Dividend Equivalent Rights

 

(i)            The
Committee in its sole discretion may provide a Participant as part of a Restricted Share Unit or Other Share-Based Award that
is a Full Value Award with Dividend Equivalent Rights, on such terms and conditions as may be determined by the Committee in its
sole discretion.

 

(ii)           Any Dividend Equivalent Rights provided in connection with an Award that is subject to vesting shall either (i) not be paid
or credited or (ii) be accumulated and subject to vesting restrictions applicable to the underlying Award. For Restricted Shares
subject to vesting, dividends shall be accumulated and subject to any restrictions and risk of forfeiture to which the underlying
Restricted Share is subject.

 

(c)           Limits
on Transfer

 

Each Award shall be
exercisable only by a Participant during the Participant’s lifetime, or, if permissible under Applicable Laws, by the Participant’s
legal guardian or representative. No Award may be assigned, alienated, pledged, attached, sold or otherwise transferred or encumbered
by a Participant other than by will or by the laws of descent and distribution and any such purported assignment, alienation, pledge,
attachment, sale, transfer or encumbrance shall be void and unenforceable against the Company or an Affiliate.

 

Notwithstanding the
foregoing, the Committee may, in its sole discretion, permit Awards (other than ISOs) to be transferred by a Participant, without
consideration, in connection with estate planning or charitable transfers, subject to compliance with Applicable Laws and such
rules as the Committee may adopt consistent with any applicable Award Agreement to preserve the purposes of the Plan; provided,
that the Participant gives the Committee advance written notice describing the terms and conditions of the proposed transfer and
the Committee notifies the Participant in writing that such a transfer would comply with the requirements of the Plan.

 

    	 	 	14

     

    

 

(d)           Minimum
Vesting

 

Awards granted under
the Plan may not vest or be settled, or become exercisable, prior to the one-year anniversary of the date of grant, except that
the Committee may provide that Awards vest or be settled, or become exercisable, prior to such date in the event of the Participant's
death or disability or in the event of a Change in Control. Notwithstanding the foregoing, up to 5% of the aggregate number of
Shares authorized for issuance under this Plan (as described in Section 3) may be issued pursuant to Awards subject to any or no
vesting conditions (including with regard to such one-year vesting limitation described in the preceding sentence), as the Committee
determines appropriate.

 

(e)           Paperless Administration

 

In the event that the
Company establishes, for itself or using the services of a third party, an automated system for the documentation, granting or
exercise of Awards, such as a system using an internet website, intranet or interactive voice response, then the paperless documentation,
granting or exercise of Awards by a Participant may be permitted through the use of such an automated system.

 

(f)            Nominal Value

 

Notwithstanding any
other provision in this Plan, no Share shall be allotted or issued pursuant to the exercise of vesting of an Award, or as an Award,
unless it is fully paid-up to at least its nominal value.

 

	11.	Adjustments Upon Certain Events

 

Notwithstanding any
other provisions in the Plan to the contrary, the following provisions shall apply to all Awards granted under the Plan:

 

(a)           Generally

 

In the event of any
increase, decrease or change in the number or characteristic of outstanding Shares (including to the price of the Shares) after
the Effective Date by reason of any reorganization, reclassification, recapitalization, merger, consolidation, spin-off, combination,
or transaction or exchange of Shares or other corporate exchange (including for these purposes, any Change in Control), or any
distribution to shareholders of Shares other than regular cash dividends, bonus issue, share split or any transaction similar to
the foregoing, the Committee shall make such substitution or adjustment, as it deems, in its sole discretion and without liability
to any person, to be equitable, as to (i) the number or kind of Shares or other securities issued or reserved for issuance pursuant
to the Plan or pursuant to outstanding Awards, (ii) the Option Price or exercise price of any Share Appreciation Right, (iii) the
number and kind of shares (or other securities or property) subject to outstanding Awards, and/or (iii) any other affected terms
of such Awards, including, without limitation, any affected Performance Criteria or Performance Goals. In the event of any change
in the outstanding Shares after the Effective Date by reason of any share split (forward or reverse) or any share dividend, all
adjustments described in the preceding sentence shall occur automatically in accordance with the ratio of the bonus issue, share
split or share dividend, unless otherwise determined by the Committee.

 

(b)           Change
in Control

 

The provisions of this Section 11(b) shall
apply in the event of a Change in Control.

 

    	 	 	15

     

    

 

(i)            Additional
Vesting of Time-Based Awards Notwithstanding Section 11(a) hereof, if a Change in Control occurs and a Participant’s
Awards that vest based solely on the Participant’s continued Service are not converted, assumed, substituted or replaced
by a successor or survivor corporation, or a parent or subsidiary thereof, then immediately prior to the Change in Control such
Awards shall become fully vested and, to the extent applicable, exercisable and all forfeiture restrictions and other conditions
or limitations on such Awards shall lapse. Where Awards described in the foregoing sentence are assumed or continued after a Change
in Control, the Committee may provide that one or more Awards will automatically accelerate upon an involuntary termination of
the Participant’s employment or service within a designated period following the effective date of such Change in Control.
Any such Award shall, accordingly, upon an involuntary termination of the Participant’s employment or service following
a Change in Control, become fully vested and, to the extent applicable, exercisable and all forfeiture restrictions on such Award
shall lapse. With respect to any ISOs, the portion of any ISO accelerated in connection with a Change in Control shall remain
exercisable as an ISO only to the extent the applicable $100,000 limitation is not exceeded. To the extent such U.S. dollar limitation
is exceeded, the accelerated portion of such Option shall not be exercisable as an ISO under the U.S. federal tax laws.

 

(ii)           Additional
Vesting of Performance-Based Awards With respect to Awards that vest based on the attainment of performance-based conditions,
in the Committee’s sole discretion, and on such terms and conditions as it deems appropriate, either by the terms of Award
Agreement or by action taken by the Committee in connection with the Change in Control, the Award shall vest (A) at the target
level, pro-rated to reflect the period the Participant was in Service during the performance period or (B) the actual performance
level attained, as determined on the most recent practicable date as of which performance may be measured prior to the date of
the Change in Control. Unless otherwise converted, assumed, substituted or replaced by a successor or survivor corporation, or
a parent or subsidiary thereof, any such Performance-Based Awards that have not either previously vested in accordance with the
terms of such Award or in accordance with this Section 11(b) (ii) shall terminate and cease to be outstanding as of the Change
in Control.

 

(iii)          Cancellation of Awards In connection with any Change in Control, the Committee may, in its sole discretion, but shall
not be obligated to, provide for cancellation of any one or more outstanding Awards and payment to the holders of such Awards that
are vested as of such cancellation (including, without limitation, any Awards that would vest in accordance with the terms of such
Award or in accordance with Section 11(b) (i) or (ii) hereof, as applicable), the value of such Awards, if any, as determined by
the Committee (which value, if applicable, may be based upon the price per Share received or to be received by other shareholders
of the Company in such event), including, without limitation, in the case of an outstanding Option or Share Appreciation Right,
a cash payment in an amount equal to the excess, if any, of the Fair Market Value (as of a date specified by the Committee) of
the Shares subject to such Option or Share Appreciation Right over the aggregate exercise price of such Option or Share Appreciation
Right (it being understood that, in such event, any Option or Share Appreciation Right having a per share exercise price equal
to, or in excess of, the Fair Market Value of a Share subject thereto may be canceled and terminated without any payment or consideration
therefor). Payments to holders pursuant to this Section 11(iii) above shall be made in cash or, in the sole discretion of the Committee,
in the form of such other consideration necessary for a Participant to receive property, cash, or securities (or combination thereof)
as such Participant would have been entitled to receive upon the occurrence of the transaction if the Participant had been, immediately
prior to such transaction, the holder of the number of Shares covered by the Award at such time (less any applicable exercise price).

 

(c)           Other
Requirements

 

Prior to any payment
or adjustment contemplated under this Section 11, the Committee may require a Participant to (i) represent and warrant as to the
unencumbered title to the Participant’s Awards; (ii) bear such Participant’s pro rata share of any post-closing indemnity
obligations, and be subject to the same post-closing purchase price adjustments, escrow terms, offset rights, holdback terms, and
similar conditions as the other holders of Shares, subject to any limitations or reductions as may be necessary to comply with
Section 409A; and (iii) deliver customary transfer documentation as reasonably determined by the Committee.

 

(d)           Fractional Shares

 

Any adjustment provided
under this Section 11 may provide for the elimination of any fractional share that might otherwise become subject to an Award.

 

    	 	 	16

     

    

 

	12.	No Right to Employment or Awards

 

The granting of an
Award under the Plan shall impose no obligation on the Company or any Affiliate to continue the employment or service of a Participant
and shall not lessen or affect the Company’s or Affiliate’s right to terminate the employment or service of such Participant.
No Participant or other Person shall have any claim to be granted any Award, and there is no obligation for uniformity of treatment
of Participants, or holders or beneficiaries of Awards. The terms and conditions of Awards and the Committee’s determinations
and interpretations with respect thereto need not be the same with respect to each Participant (whether or not such Participants
are similarly situated).

 

	13.	Successors and Assigns

 

The Plan shall be binding
on all successors and assigns of the Company and a Participant, including without limitation, the estate of such Participant and
the executor, administrator or trustee of such estate, or any receiver or trustee in bankruptcy or representative of the Participant’s
creditors.

 

	14.	Amendments or Termination

 

(a)           Amendment
and Termination of the Plan

 

The Board may amend,
alter, suspend, discontinue, cancel or terminate the Plan or any portion thereof at any time; provided; that no such amendment,
alteration, suspension, discontinuation or termination shall be made without shareholder approval, if at the time of such event,
shareholder approval is required under Applicable Law, if (i) it would materially increase the number of securities which may be
issued under the Plan or granted to any Participant (except for increases pursuant to Section 11 hereof), (ii) it materially expands
the types of Awards available under the Plan or materially expands the class of persons eligible to receive Awards under the Plan,
(iii) such approval is necessary to comply with Applicable Law, or (iv) the Committee determines that such approval is otherwise
required or advisable to facilitate compliance with Applicable Laws; provided; that, subject to Section 18 of the Plan or unless
required or advisable to facilitate compliance with Applicable Laws, as determined in the sole discretion of the Committee, any
such amendment, alteration, suspension, discontinuance or termination that would materially and adversely affect the rights of
any Participant or any holder of any Award theretofore granted shall not to that extent be effective without the consent of the
affected Participant.

 

(b)           Amendment
of Award Agreements

 

The Committee may,
to the extent consistent with the terms of any applicable Award Agreement, waive any conditions or rights under, amend any terms
of, or alter, suspend, discontinue, cancel or terminate, any Award theretofore granted or the associated Award Agreement, prospectively
or retroactively (including after a Participant’s termination of employment or service with the Company); provided; that,
subject to Section 18 of the Plan or unless required or advisable to facilitate compliance with Applicable Laws, as determined
in the sole discretion of the Committee, any such waiver, amendment, alteration, suspension, discontinuance, cancellation or termination
that would materially and adversely affect the rights of any Participant with respect to any Award theretofore granted shall not
to that extent be effective without the consent of the affected Participant.

 

    	 	 	17

     

    

 

(c)           No Repricing of Awards

 

Subject to Section
11 of the Plan, in no event shall the Committee or the Board take any action without approval of the shareholders of the Company
that would (i) reduce the exercise price of any Option or Share Appreciation Right, (ii) result in the cancellation of any outstanding
Option or Share Appreciation Right and replacement with a new Option or Share Appreciation Right with a lower exercise price or
with a cash payment or other Award at a time when the Option or Share Appreciation Right has a per Share exercise price that is
higher than the Fair Market Value of a Share on the date of the replacement or (iii) result in any other action that would be considered
a “repricing” for purposes of the shareholder approval rules of any stock exchange or inter-dealer quotation system
on which the securities of the Company are listed or quoted.

 

	15.	Choice of Law

 

The validity, construction
and effect of the Plan and any rules and regulations relating to the Plan shall be determined in accordance with applicable United
States federal law and the laws of the State of Texas, without regard to any conflict of laws principles, except to the extent
that the laws of Ireland mandatorily apply.

 

	16.	Severability

 

If any provision of
the Plan or the application of any provision hereof to any Person or circumstance is held to be invalid or unenforceable, the remainder
of the Plan and the application of such provision to any other Person or circumstance shall not be affected, and the provisions
so held to be unenforceable shall be reformed to the extent (and only to the extent) necessary to make it enforceable and valid.

 

	17.	Effectiveness and Term of the Plan

 

The Plan shall be effective
as of the Effective Date. The Plan shall terminate on the day before the tenth anniversary of the Effective Date and may be terminated
on any earlier date pursuant to Section 14 of the Plan. The applicable provisions shall continue in effect with respect to an Award
granted under the Plan for as long as such Award remains outstanding.

 

	18.	Section 409A

 

The Plan and all Awards
made hereunder shall be interpreted, construed and operated to reflect the intent of the Company that all aspects of the Plan and
the Awards shall be interpreted either to be exempt from the provisions of Section 409A or, to the extent subject to Section 409A,
comply with Section 409A. This Plan or an Award may be amended at any time, without the consent of any party, to avoid the application
of Section 409A in a particular circumstance or that is necessary or desirable to satisfy any of the requirements under Section
409A, but the Company shall not be under any obligation to make any such amendment. The exercisability of an Option shall not be
extended to the extent that such extension would subject the Participant to additional taxes under Section 409A. Notwithstanding
other provisions of the Plan or any Award Agreements thereunder, no Award shall be granted, deferred, accelerated, extended, paid
out or modified under this Plan in a manner that would be expected to result in the imposition of an additional tax under Section
409A upon a Participant. In the event that it is reasonably determined by the Committee that, as a result of Section 409A, payments
in respect of any Award under the Plan may not be made at the time contemplated by the terms of the Plan or the relevant Award
Agreement, as the case may be, without causing the Participant of such Award to be subject to taxation under Section 409A, the
Company will make such payment on the first day that would not result in the Participant incurring any tax liability under Section
409A. Anything contrary in this Plan notwithstanding, if an Award constitutes an item of deferred compensation subject to Section
409A and becomes payable by reason of a Participant’s termination of Service, it shall not be paid to the Participant unless
the Participant’s termination of Service constitutes a “separation from service” (within the meaning of Section
409A and any regulations or other guidance thereunder). In addition, no such payment or distribution shall be made to the Participant
prior to the earlier of (a) the expiration of the six month period measured from the date of the Participant’s separation
from service or (b) the date of the Participant’s death, if the Participant is deemed at the time of such separation from
service to be a “specified employee” (within the meaning of Section 409A) and to the extent such delayed commencement
is otherwise required in order to avoid a prohibited distribution under Section 409A. Except as provided in an Award Agreement,
all payments which had been delayed pursuant to the immediately preceding sentence shall be paid to the Participant in a lump sum
upon expiration of such six month period (or, if earlier, upon the Participant’s death).

 

    	 	 	18

     

    

 

	19.	Clawback/Recoupment Policy.

 

Notwithstanding anything
contained herein to the contrary, all Awards granted under the Plan shall be and remain subject to any incentive compensation clawback
or recoupment policy currently in effect or as may be adopted by the Board and, in each case, as may be amended from time to time.
No such policy adoption or amendment shall in any event require the prior consent of any Participant.

 

	20.	Tax-Related Items

 

The Company or any
Affiliate, as applicable, shall have the authority and the right to deduct or withhold, or to require a Participant to remit to
the Company, an amount sufficient to satisfy the obligation for Tax-Related Items with respect to any taxable or tax withholding
event concerning a Participant arising as a result of the Participant’s participation in the Plan or to take such other action
as may be necessary or appropriate in the opinion of the Company or an Affiliate, as applicable, to satisfy withholding obligations
for the payment of Tax-Related Items by one or a combination of the following: (a) withholding from the Participant’s wages
or other cash compensation; (b) withholding from the proceeds of sale of Shares underlying an Award, either through a voluntary
sale or a mandatory sale arranged by the Company on the Participant’s behalf, without need of further authorization; or (c)
in the Committee’s sole discretion, by withholding Shares otherwise issuable under an Award (or allowing the return of Shares)
sufficient, as determined by the Committee in its sole discretion, to satisfy such Tax-Related Items. Without limiting the foregoing,
the Company shall have no obligation to issue or deliver evidence of title for Shares subject to Awards granted hereunder to any
Participant or other Person until the Participant or such other Person has made arrangements acceptable to the Committee in its
sole discretion to satisfy the obligations for Tax-Related Items with respect to any taxable or tax withholding event concerning
the Participant or the Award or such other person arising as a result of an Award.

 

	21.	Government and Other Regulations

 

The obligation of the
Company to make payment of Awards in Shares or otherwise shall be subject to all Applicable Laws, and to such approvals by government
agencies, including government agencies in jurisdictions outside of the United States, in each case as may be required or as the
Company deems necessary or advisable. Without limiting the foregoing, the Company shall have no obligation to issue or deliver
evidence of title for Shares subject to Awards granted hereunder prior to: (i) obtaining any approvals from governmental agencies
that the Company determines are necessary or advisable, and (ii) completion of any registration or other qualification with respect
to the Shares under any Applicable Law or ruling of any governmental body that the Company determines to be necessary or advisable
or at a time when any such registration or qualification is not current, has been suspended or otherwise has ceased to be effective.
The inability or impracticability of the Company to obtain or maintain authority from any regulatory body having jurisdiction,
which authority is deemed by the Company’s counsel to be necessary to the lawful issuance and sale of any Shares hereunder,
shall relieve the Company of any liability in respect of the failure to issue or sell such Shares as to which such requisite authority
shall not have been obtained and shall constitute circumstances in which the Committee may determine to amend or cancel Awards
pertaining to such Shares, with or without consideration to the affected Participant. The Company shall be under no obligation
to register pursuant to the Securities Act any of the Shares delivered pursuant to the Plan. If the Shares delivered pursuant to
the Plan may in certain circumstances be exempt from registration pursuant to the Securities Act, the Company may restrict the
transfer of such Shares in such manner as it deems advisable to ensure the availability of any such exemption.

 

    	 	 	19

     

    

 

Notwithstanding any
provision of the Plan to the contrary, in order to comply with the Applicable Laws in countries other than Ireland or the U.S.
in which the Company or any of its Affiliates operates or has Employees or Consultants, the Committee, in its sole discretion,
shall have the power and authority to (i) determine which Affiliates shall be covered by the Plan; (ii) determine which Persons
employed outside the United States are eligible to participate in the Plan; (iii) amend or vary the terms and provisions of the
Plan and the terms and conditions of any Award granted to persons who reside or provide service outside Ireland or the United States;
(iv) establish sub-plans and modify exercise procedures and other terms and procedures to the extent such actions may be necessary
or advisable for legal or administrative reasons — any subplans and modifications to Plan terms and procedures established
under this Section 21 by the Committee shall be attached to the Plan document as appendices; and (v) take any action, before or
after an Award is made, that it deems advisable to obtain or comply with any necessary local government regulatory exemptions or
approvals; provided, that the Committee may not take any actions hereunder, and no Awards shall be granted, that would violate
the Exchange Act, the Code, any securities law or governing statute.

 

	22.	No Shareholders Rights

 

Except as otherwise
expressly provided herein, a Participant shall have none of the rights of a shareholder by virtue of holding or receiving an Award,
including no right to vote or receive dividends, until the Participant or its nominee/broker becomes the record owner of such Shares,
notwithstanding the exercise of an Option or Share Appreciation Right or vesting of any Award.

 

* * *

 

 

As adopted by the Board of Directors of
the Company on December 12, 2019 and effective as of the Effective Date.

  

    	 	 	20Exhibit 10.1

 

ARRANGEMENT
AGREEMENT

 

AMONG

 

AKERNA CORP.

 

AND

 

2732805
Ontario INC.

 

AND

 

ample organics
inc.

 

AND

 

john prentice,
solely in its capacity as shareholder representative

 

Dated as
of DECEMBER 18, 2019

 

     

     

    

 

TABLE OF CONTENTS

 

	Article 1 INTERPRETATION	
	1.1	 	Definitions	
	1.2	 	Interpretation Not Affected by Headings, etc.	18
	1.3	 	Number and Gender; Derivatives	19
	1.4	 	Date for Any Action	19
	1.5	 	Statute and Agreement References	19
	1.6	 	Currency	19
	1.7	 	Accounting Matters	19
	1.8	 	Interpretation Not Affected by Party Drafting	19
	1.9	 	Knowledge	19
	1.10	 	Disclosure in Writing	20
	1.11	 	Schedules	20
	Article 2 THE ARRANGEMENT	20
	2.1	 	Arrangement	20
	2.2	 	Akerna Approval	20
	2.3	 	Ample Approval	20
	2.4	 	Interim Order	21
	2.5	 	Akerna Shareholder Meeting	21
	2.6	 	Ample Shareholder Meeting	23
	2.7	 	Akerna Circular	24
	2.8	 	Ample Circular	25
	2.9	 	Final Order	26
	2.10	 	Court Proceedings	27
	2.11	 	U.S. Securities Law Matters	27
	2.12	 	Effective Date	28
	2.13	 	Closing	28
	2.14	 	Payment and Allocation of Up-front Consideration	28
	2.15	 	Ample Options and Warrants	29
	2.16	 	Satisfaction of Closing Indebtedness Amount and Transaction Expenses	30
	2.17	 	Indemnities and Directors’ and Officers’ Insurance	30
	2.18	 	Withholding Taxes	31
	2.19	 	Deferred Consideration	31
	2.20	 	Shareholder Representative	32
	2.21	 	Adjustments to Deemed Value Amount	34
	Article 3 COVENANTS	34
	3.1	 	Covenants of Ample Regarding the Conduct of Business	34
	3.2	 	Covenants of Akerna Regarding the Conduct of Business	38
	3.3	 	Covenants of Akerna Relating to the Exchangeable Shares	39

 

    - i -

     

    

 

	3.4	 	Covenants of Akerna Regarding Blue-Sky Laws	40
	3.5	 	Mutual Covenants Regarding the Arrangement	40
	3.6	 	Covenants of Akerna and Purchaser	41
	3.7	 	Covenants of Ample Regarding the Arrangement	45
	3.8	 	Covenants of Ample Regarding Non-Solicitation	48
	3.9	 	Mutual Covenants Regarding Regulatory Approvals	50
	3.10	 	Covenants Regarding Provision of Information; Access	51
	3.11	 	Section 85 Elections	51
	Article 4 REPRESENTATIONS AND WARRANTIES	51
	4.1	 	Representations and Warranties of Akerna and Purchaser	51
	4.2	 	Representations and Warranties of Ample	58
	Article 5 CONDITIONS PRECEDENT	70
	5.1	 	Mutual Conditions Precedent	70
	5.2	 	Additional Conditions to Obligations of Akerna and Purchaser	71
	5.3	 	Additional Conditions to Obligations of Ample	72
	5.4	 	Notice and Effect of Failure to Comply with Conditions	73
	5.5	 	Satisfaction of Conditions	74
	Article 6 INDEMNIFICATION	74
	6.1	 	Indemnification by Ample Shareholders	74
	6.2	 	Indemnification by Akerna and Purchaser	74
	6.3	 	Indemnification Claims	75
	6.4	 	Survival of Representations and Warranties	77
	6.5	 	Limitations	77
	6.6	 	Recourse to Escrowed Shares	79
	6.7	 	Satisfaction of Damages with Akerna Shares	80
	6.8	 	Exclusive Remedy	80
	6.9	 	Mitigation	80
	Article 7 AMENDMENT	81
	7.1	 	Amendment	81
	7.2	 	Amendment of Plan of Arrangement	81
	Article 8 TERMINATION AND AMENDMENT	82
	8.1	 	Termination	82
	Article 9 NOTICES	83
	9.1	 	Notices	83
	Article 10 GENERAL	85
	10.1	 	Assignment, Binding Effect and Entire Agreement	85
	10.2	 	Adjustments to Calculation	85
	10.3	 	Public Communications	85
	10.4	 	Costs	85
	10.5	 	No Liability	86

 

    - ii -

     

    

 

	10.6	 	Severability	86
	10.7	 	Further Assurances	86
	10.8	 	Time of Essence	86
	10.9	 	Applicable Laws and Enforcement	86
	10.10	 	Injunctive Relief	86
	10.11	 	Waiver	87
	10.12	 	Third Party Beneficiaries	87
	10.13	 	Counterparts, Execution	87

 

	SCHEDULES	 
	 	 
	Schedule “A” – Arrangement Resolution	 
	Schedule “B” – Plan of Arrangement	 
	Schedule “C” – Form of Exchangeable Share Support Agreement	 
	Schedule “D” – Form of Escrow Agreement	 
	Schedule “E” – Form of Voting and Exchange Trust Agreement	 
	Schedule “F” – Form of Rights Indenture	 
	Schedule “G” – Form of Ample Shareholder Support Agreement	 
	Schedule “H” – Form of Akerna Shareholder Support Agreement	 
	Schedule “I” – Exchangeable Share Provisions	 

 

    - iii -

     

    

 

ARRANGEMENT
AGREEMENT

 

THIS ARRANGEMENT
AGREEMENT is made as of December 18, 2019

 

AMONG:

 

AKERNA CORP., a company
existing under the laws of the State of Delaware (“Akerna”)

 

AND

 

2732805 ONTARIO INC., a
company existing under the laws of the Province of Ontario (“Purchaser”)

 

AND

 

AMPLE ORGANICS INC., a corporation
existing under the laws of the Province of Ontario (“Ample”)

 

AND

 

JOHN PRENTICE, an individual
resident in the Province of Ontario (hereinafter referred to as the “Shareholder Representative”)

 

WHEREAS:

 

		A.	Akerna through its wholly owned subsidiary, Purchaser, proposes to acquire all of the issued and
outstanding Ample Shares;

 

		B.	the Parties intend to carry out the transactions contemplated herein by way of an arrangement under
Section 182 of the OBCA; and

 

		C.	the Parties have entered into this Agreement to provide for the matters referred to in the foregoing
recitals and for other matters relating to such transaction.

 

NOW THEREFORE, in consideration of the
covenants and agreements herein contained and other good and valuable consideration (the receipt and sufficiency of which are hereby
acknowledged), the Parties hereto do hereby covenant and agree as follows:

 

Article
1

INTERPRETATION

 

		1.1	Definitions

 

In this Agreement, including the recitals
hereto, the following defined terms have the meanings hereinafter set forth:

 

“Acquisition Proposal”
means any offer, proposal or inquiry to Ample or, of which Ample is aware, to the Ample Shareholders from any Person, or group
of Persons Acting Jointly or in Concert, whether or not subject to due diligence or other conditions and whether made orally or
in writing, relating to:

 

		(a)	any direct or indirect sale, issuance or acquisition from Ample, an Ample Subsidiary or the Ample
Shareholders of shares or other equity interests (or securities convertible into or exercisable for such shares or interests) in
Ample or an Ample Subsidiary that, when taken together with the securities of Ample or an Ample Subsidiary held by the proposed
acquiror and any Person Acting Jointly or in Concert with such acquiror, represent: (i) 20% or more of the voting securities of
Ample or an Ample Subsidiary or rights or interests therein or thereto; or (ii) 20% or more of the consolidated revenue of Ample
or an Ample Subsidiary, taken as a whole; or 20% or more of the consolidated assets of Ample or an Ample Subsidiary, taken as a
whole;

 

     

     

    

 

		(b)	an amalgamation, arrangement, merger, business combination, consolidation or other similar transaction
involving Ample or an Ample Subsidiary;

 

		(c)	a take-over bid, tender offer, issuer bid, exchange offer, share exchange, recapitalization, liquidation,
dissolution, reorganization or other similar transaction involving Ample or an Ample Subsidiary; or

 

		(d)	any transactions or arrangements similar to or having the same effect or consequences as the foregoing,

 

except that the term Acquisition Proposal
shall exclude the Arrangement and the transactions contemplated by this Agreement;

 

“Acting Jointly or in Concert”
has the meaning ascribed thereto under Applicable Securities Laws of Canada;

 

“Affiliate” has the meaning
ascribed thereto under the Securities Act;

 

“Agreed Amount” means
part, but not all, of a Claimed Amount;

 

“Agreement”, “herein”,
“hereof”, “hereto”, “hereunder” and similar expressions mean and refer to this
arrangement agreement (including the schedules hereto) as supplemented, modified or amended, and not to any particular Article,
Section, Schedule or other portion hereof;

 

“Akerna Board” means the
board of directors of Akerna as it may be comprised from time to time, including any duly constituted and acting committee thereof;

 

“Akerna Bridge Loan” means
any loan provided by Akerna to Ample prior to the Effective Time on such terms and conditions as may be agreed between Akerna and
Ample, each acting reasonably;

 

“Akerna Circular” means
the notice of the Akerna Meeting and accompanying information circular of Akerna, together with all appendices, schedules and exhibits
thereto, to be sent by Akerna to the Akerna Shareholders in connection with the Akerna Meeting, as amended, supplemented or otherwise
modified;

 

“Akerna Disclosure Letter”
means the disclosure letter dated as of the date hereof from Akerna and Purchaser to Ample;

 

“Akerna Financial Statements”
has the meaning ascribed thereto in Section 4.1(m)(i);

 

“Akerna Fundamental Representations
and Warranties” means the representations of Akerna and Purchaser in Sections 4.1(a), 4.1(b), 4.1(d), 4.1(g), 4.1(p) and
4.1(t);

 

    - 2 -

     

    

 

“Akerna Information” means
the information contained in the files, reports, data, documents, agreements and other information relating to Akerna and each
Akerna Subsidiary, as provided by Akerna, Purchaser or their respective Representatives to Ample or its Representatives in connection
with the transactions contemplated hereby, in writing, including information contained in data rooms or provided in electronic
form;

 

“Akerna Material Adverse Change”
or “Akerna Material Adverse Effect” means any event, change, occurrence, effect or state of facts that, individually
or in the aggregate with other events, changes, occurrences, effects or states of facts is, or would reasonably be expected to
be, material and adverse to the business, operations, results of operations, capital, property, assets, liabilities, obligations
(whether absolute, accrued, conditional or otherwise) or condition (financial or otherwise) of Akerna and its Subsidiaries taken
as a whole, except any such event, change, occurrence, effect or state of facts resulting from or arising in connection with:

 

		(a)	any change or development generally affecting the industries in which Akerna and its Subsidiaries
operate;

 

		(b)	any change or development in global, national or regional political conditions (including any act
of terrorism or any outbreak of hostilities or war or any escalation or worsening thereof) or any natural disaster;

 

		(c)	any change in general economic, business or regulatory conditions or in global financial, credit,
currency or securities markets in Canada or the United States;

 

		(d)	any adoption, proposed implementation or change in Applicable Law or any interpretation thereof
by any Governmental Entity;

 

		(e)	any change in U.S. GAAP or changes in applicable regulatory accounting requirements applicable
to the industries in which it conducts business;

 

		(f)	changes or developments in or relating to currency exchange or interest rates;

 

		(g)	the negotiation, execution, announcement, performance or pendency of this Agreement or the consummation
of the transactions contemplated herein;

 

		(h)	actions or inactions expressly required by this Agreement or that are taken with the prior written
consent of Ample;

 

		(i)	any change in the market price or trading volume of any securities of Akerna (it being understood,
without limiting the applicability of subsections (a) through (h), that the causes underlying such changes in market price or trading
volume may be taken into account in determining whether an Akerna Material Adverse Effect has occurred), or any suspension of trading
in securities generally or on any securities exchange on which any securities of Akerna trade; or

 

		(j)	the failure, in and of itself, of Akerna to meet any internal or public projections, forecasts
or estimates of revenues, earnings or other financial operating metrics before, on or after the date of this Agreement (it being
understood, without limiting the applicability of subsections (a) through (h), that the causes underlying such failure may be taken
into account in determining whether an Akerna Material Adverse Effect has occurred),

 

    - 3 -

     

    

 

provided, however, that any such event,
change, occurrence, effect or state of facts referred to in subsections (a) to and including (f) above does not primarily relate
only to (or have the effect of primarily relating only to) Akerna and its Subsidiaries taken as a whole, or materially disproportionately
affect Akerna and its Subsidiaries, taken as a whole, compared to other companies operating in the business or industries in which
Akerna and its Subsidiaries operate; references in this Agreement to dollar amounts are not intended to be and shall not be deemed
to be illustrative or interpretative for purposes of determining whether an Akerna Material Adverse Effect has occurred. Notwithstanding
any other provision of this definition, no action of any kind taken by a Governmental Entity, nor the commencement by a Governmental
Entity of any Proceeding seeking a law or Order which would have the effect of making the Arrangement illegal or otherwise preventing
or prohibiting consummation of the Arrangement, will, in any such case, constitute an Akerna Material Adverse Effect;

 

“Akerna Meeting” means
the special meeting of the Akerna Shareholders, including any adjournment or postponement thereof, to be called and held in accordance
with this Agreement to consider, among other matters, the Akerna Shareholder Matters;

 

“Akerna Public Record”
means all information filed by Akerna with the U.S. Securities and Exchange Commission and made available to the public on the
Electronic Data Gathering, Analysis and Retrieval (EDGAR) system;

 

“Akerna Shareholder Approval”
shall mean the approval of the Akerna Shareholder Matters by the Akerna Shareholders;

 

“Akerna Shareholder Matters”
means the approval of (i) the issuance of such number of Akerna Shares as are required to be issued hereunder, (ii) the Arrangement
and (iii) such other matters required for the completion of the Arrangement in accordance with Applicable Laws;

 

“Akerna Shareholder Support Agreements”
means the voting support agreements, substantially in the form attached as Schedule “H” hereto, entered into between
Ample and the directors and officers of Akerna, in their capacity as holders of Akerna Shares;

 

“Akerna Shareholders”
means the holders of Akerna Shares;

 

“Akerna Shares” means
the shares of common stock in the authorized share capital of Akerna;

 

“Akerna Subsidiaries”
means the Purchaser and Callco and “Akerna Subsidiary” means any one of them;

 

“Akerna Transactions”
means the transactions described in the Akerna Disclosure Letter with the details of such transactions and materials relating thereto
being in all material respects the same as such details and materials that were disclosed to or provided to Ample prior to the
date hereof;

 

“Ample” means Ample Organics
Inc., a corporation existing under the OBCA, and where the context permits includes the Ample Subsidiaries;

 

“Ample Articles” means
the certificate and articles of amendment of Ample dated October 1, 2019;

 

“Ample Board” means the
board of directors of Ample as it may be comprised from time to time, including any duly constituted and acting committee thereof;

 

    - 4 -

     

    

 

“Ample Board Recommendation”
has the meaning ascribed thereto in Section 2.8(c);

 

“Ample Change in Recommendation”
has the meaning ascribed thereto in Section 8.1(a)(vi)(A);

 

“Ample Circular” means
the notice of the Ample Meeting and accompanying information circular of Ample, together with all appendices, schedules and exhibits
thereto, to be sent by Ample to the Ample Shareholders in connection with the Ample Meeting, as amended, supplemented or otherwise
modified;

 

“Ample Circular Disclosure”
means all information regarding Ample provided by Ample for inclusion in the Akerna Circular;

 

“Ample Common Shareholders”
means the holders of Ample Common Shares immediately prior to the Effective Time;

 

“Ample Common Shares”
means the Common Shares in the authorized capital of Ample;

 

“Ample Common Warrants”
means all outstanding and unexpired warrants to acquire Ample Common Shares;

 

“Ample Disclosure Letter”
means the disclosure letter dated as of the date hereof from Ample to Purchaser;

 

“Ample Financial Statements”
means the audited consolidated financial statements for the year ended December 31, 2017 and the year ended December 31, 2018,
including the notes thereto;

 

“Ample Fundamental Representations
and Warranties” means the representations of Ample in Sections 4.2(a), 4.2(b), 4.2(d), 4.2(e), 4.2(h), 4.2(q), 4.2(r),
4.2(s), 4.2(w), 4.2(z), 4.2(aa) and 4.2(dd);

 

“Ample Information” means
the information contained in the files, reports, data, documents, agreements and other information relating to Ample and each Ample
Subsidiary, as provided by Ample or its Representatives to Akerna, Purchaser or their Representatives in connection with the transactions
contemplated hereby, in writing, including information contained in data rooms or provided in electronic form;

 

“Ample Material Adverse Change”
or “Ample Material Adverse Effect” means any event, change, occurrence, effect or state of facts that, individually
or in the aggregate with other events, changes, occurrences, effects or states of facts is, or would reasonably be expected to
be, material and adverse to the business, operations, results of operations, capital, property, assets, liabilities, obligations
(whether absolute, accrued, conditional or otherwise) or condition (financial or otherwise) of Ample and its Subsidiaries taken
as a whole, except any such event, change, occurrence, effect or state of facts resulting from or arising in connection with:

 

		(a)	any change or development generally affecting the industries in which Ample and its Subsidiaries
operate;

 

		(b)	any change or development in global, national or regional political conditions (including any act
of terrorism or any outbreak of hostilities or war or any escalation or worsening thereof) or any natural disaster;

 

    - 5 -

     

    

 

		(c)	any change in general economic, business or regulatory conditions or in global financial, credit,
currency or securities markets in Canada or the United States;

 

		(d)	any adoption, proposed implementation or change in Applicable Law or any interpretation thereof
by any Governmental Entity;

 

		(e)	any change in IFRS or changes in applicable regulatory accounting requirements applicable to the
industries in which it conducts business;

 

		(f)	changes or developments in or relating to currency exchange or interest rates;

 

		(g)	the negotiation, execution, announcement, performance or pendency of this Agreement or the consummation
of the transactions contemplated herein;

 

		(h)	actions or inactions expressly required by this Agreement or that are taken with the prior written
consent of Akerna; or

 

		(i)	the failure, in and of itself, of Ample to meet any internal or public projections, forecasts or
estimates of revenues, earnings or other financial operating metrics before, on or after the date of this Agreement (it being understood,
without limiting the applicability of subsections (a) through (i), that the causes underlying such failure may be taken into account
in determining whether an Ample Material Adverse Effect has occurred);

 

provided, however, that any such event,
change, occurrence, effect or state of facts referred to in subsections (a) to and including (f) above does not primarily relate
only to (or have the effect of primarily relating only to) Ample and its Subsidiaries taken as a whole, or materially disproportionately
affect Ample and its Subsidiaries, taken as a whole, compared to other companies operating in the business or industries in which
Ample and its Subsidiaries operate; references in this Agreement to dollar amounts are not intended to be and shall not be deemed
to be illustrative or interpretative for purposes of determining whether an Ample Material Adverse Effect has occurred. Notwithstanding
any other provision of this definition, no action of any kind taken by a Governmental Entity, nor the commencement by a Governmental
Entity of any Proceeding seeking a law or Order which would have the effect of making the Arrangement illegal or otherwise preventing
or prohibiting consummation of the Arrangement, will, in any such case, constitute an Ample Material Adverse Effect;

 

“Ample Material Contract”
means in respect of Ample or any of its Subsidiaries, any Contract:

 

		(a)	that if terminated or modified or if it ceased to be in effect, would reasonably be expected to
have an Ample Material Adverse Effect;

 

		(b)	under which Ample or any of its Subsidiaries has directly or indirectly guaranteed any liabilities
or obligations of a third party in excess of $100,000 in the aggregate;

 

		(c)	that is a lease, sublease, license or right of way or occupancy agreement for real property which
is material to the business of Ample and its Subsidiaries, taken as a whole;

 

		(d)	that provides of the establishment of, investment in or formation of any partnership or joint venture
with an arm’s length Person in which the interest of Ample or any of its Subsidiaries exceeds book value of $100,000;

 

    - 6 -

     

    

 

		(e)	relating to indebtedness for borrowed money, whether incurred, assumed, guaranteed or secured by
any asset, with an outstanding principal amount in excess of $100,000;

 

		(f)	under which Ample or any of its Subsidiaries is obligated to make or expects to receive payments
in excess of $100,000 over the remaining term of the contract;

 

		(g)	that limits or restricts Ample or any of its affiliates from engaging in any line of business or
in any geographic area; or

 

		(h)	that is a collective bargaining agreement, a labour union contract or any other memorandum of understanding
or other agreement with a union;

 

“Ample Meeting” means
the special meeting of the Ample Shareholders, including any adjournment or postponement thereof, to be called and held in accordance
with this Agreement and the Interim Order to consider, among other matters, the Arrangement Resolution;

 

“Ample Options” means
the outstanding and unexpired stock options of Ample, whether or not vested, to acquire Ample Common Shares from treasury pursuant
to the Option Plan;

 

“Ample Preferred Shareholders”
means the holders of Ample Preferred Shares immediately prior to the Effective Time;

 

“Ample Preferred Shares”
means each issued and outstanding Class A Preferred Share in the capital of Ample, being all issued and outstanding Class A-1 Preferred
Shares, Class A-2 Preferred Shares and Class A-3 Preferred Shares;

 

“Ample Preferred Warrants”
means all outstanding and unexpired warrants to acquire Ample Preferred Shares;

 

“Ample Securities” means
collectively, the Ample Shares, Ample Options and Ample Warrants;

 

“Ample Shareholder Approval”
shall mean the approval of the Arrangement Resolution by the Ample Shareholders;

 

“Ample Shareholder Support Agreements”
means the voting support agreements, substantially in the form attached as Schedule “G” hereto, entered into between
Akerna and the Ample Supporting Securityholders, in their capacity as holders of Ample Securities;

 

“Ample Shareholders” means
collectively the Ample Common Shareholders and the Ample Preferred Shareholders;

 

“Ample Shares” means collectively
the Ample Common Shares and Ample Preferred Shares;

 

“Ample Subsidiaries” means
collectively Last Call Analytics Inc. and Ample Organics Australia PTY Ltd. and “Ample Subsidiary” means any one
of them;

 

“Ample Supporting Securityholders”
means each of the directors and officers of Ample and certain other holders of Ample Securities that enter into Ample Shareholder
Support Agreements;

 

“Ample Warrants” means
collectively the Ample Common Warrants and the Ample Preferred Warrants;

 

    - 7 -

     

    

 

“Applicable Laws” (in
the context that refers to one or more Persons) means any domestic or foreign, federal, state, provincial or local law (statutory,
common or otherwise, and including Applicable Securities Laws), constitution, treaty, convention, ordinance, code, rule, regulation,
order, injunction, judgment, decree, ruling or other similar requirement enacted, adopted, promulgated or applied by a Governmental
Entity, and any terms and conditions of any grant of approval, permission, authority or license of any Governmental Entity, that
is binding upon or applicable to such Person or Persons or its or their business, undertaking, property or securities and emanate
from a Person having jurisdiction over the Person or Persons or its or their business, undertaking, property or securities, as
the same may be amended from time to time prior to the Effective Date;

 

“Applicable Securities Laws”
means, collectively, and as the context may require: (a) the applicable securities legislation of each of the provinces and territories
of Canada, and the rules, regulations, instruments, orders and policies published and/or promulgated thereunder; (b) the polices
and rules of the NASDAQ; and (b) U.S. Securities Laws, as the foregoing may be amended from time to time prior to the Effective
Date;

 

“Arrangement” means the
arrangement under the provisions of Section 182 of the OBCA on the terms and conditions set forth in the Plan of Arrangement, as
supplemented, modified or amended in accordance with Article 8 of the Plan of Arrangement;

 

“Arrangement Resolution”
means the special resolution to approve the Arrangement to be considered at the Ample Meeting by the Ample Shareholders substantially
in the form attached as Schedule “A” hereto;

 

“Authorization” means,
with respect to any Person, any authorization, order, permit, approval, grant, licence, registration, consent, right, notification,
condition, franchise, privilege, certificate, judgment, writ, injunction, award, determination, direction, decision, decree, by-law,
rule or regulation, of, from or required by any Governmental Entity having jurisdiction over the Person;

 

“Business Day” means a
day on which banks are generally open for the transaction of commercial business in Toronto, Ontario, or Denver, Colorado but does
not in any event include a Saturday or Sunday or statutory holiday in Ontario or Colorado;

 

“Callco” means a direct
or indirect wholly-owned Subsidiary of Akerna to be incorporated under the laws of Ontario prior to the Effective Time;

 

“Claim” means any claim
by an Indemnified Party for indemnification in accordance with Article 6;

 

“Claim Notice” means written
notification containing:

 

		(a)	a description of Damages incurred or reasonably expected to be incurred by an Indemnified Party
and the Claimed Amount of such Damages; and

 

		(b)	a statement that an Indemnified Party is entitled to indemnification under Article 6 for such Damages
and a reasonable explanation of the basis therefor;

 

“Claimed Amount” means
the amount of any Damages incurred or reasonably expected to be incurred by an Indemnified Party in connection with a claim for
indemnification pursuant to Article 6;

 

“Closing Cash Amount”
means an amount equal to $7,500,000, minus the Closing Indebtedness Amount and the amount of the Transaction Expenses;

 

    - 8 -

     

    

 

“Closing Indebtedness Agreements”
means each of the following Contracts entered into by Ample:

 

		(a)	Loan promissory note dated December 14, 2018 issued by Ample to FirePower Gap Debt Limited Partnership;

 

		(b)	Share promissory note dated December 14, 2018 issued by Ample to FirePower Gap Debt Limited Partnership;

 

		(c)	Loan agreement dated as of October 1, 2019 between Ample (as debtor), Last Call Analytics Inc.
(as initial guarantor), Evergreen Gap Debt GP Inc. (as agent), Evergreen Gap Debt LP (as lender) and Firepower Gap Debt LP (as
lender); and

 

		(d)	Amended and restated loan agreement dated as of September 25, 2019 between Ample (as debtor), Last
Call Analytics Inc. (as guarantor), Ample Organics Australia PTY Ltd (as guarantor), Green Acre Capital Fund I LP (as lender) and
Osmington Capital Corporation (as lender);

 

“Closing Indebtedness Amount”
means an amount equal to the aggregate indebtedness (including the principal amount and any interest incurred thereon) of Ample
at the Effective Time pursuant to the Closing Indebtedness Agreements, the Akerna Bridge Loan (if any) and any indebtedness incurred
pursuant to Schedule 3.1(b)(xiv) of the Ample Disclosure Letter.

 

“Closing Shares” means
the Up-front Shares, less the Effective Time Shares, and less the Escrowed Shares;

 

“Competition Act” means
the Competition Act, R.S.C. 1985, c. C 34, as amended including regulations passed under the Competition Act;

 

“Confidentiality Agreement”
means the mutual non-disclosure agreement between Akerna and Ample dated July 29, 2019;

 

“Consideration” means
the Up-front Consideration, plus the Deferred Consideration;

 

“Consideration Shares”
means the Up-front Shares, plus the number of Exchangeable Shares to be issued in satisfaction of the Deferred Consideration pursuant
to the Arrangement;

 

“Contract” means any contract,
agreement, license, franchise, lease, arrangement, commitment, understanding or other right or obligation (written or oral) to
which a Party is a party or by which a Party is bound or to which any of their respective assets are subject;

 

“Controlling Party” has
the meaning ascribed thereto in Section 6.3(b);

 

“Court” means the Ontario
Superior Court of Justice;

 

“CVR” means a contingent
value right of Akerna issued pursuant to the Rights Indenture and entitling the holder thereof to a specified portion of the Deferred
Consideration, if any, on the Deferred Consideration Payment Date, which entitlement shall be evidenced by a certificate issued
by Akerna to each holder of a CVR;

 

    - 9 -

     

    

 

“Damages” means any and
all claims, debts, obligations and other liabilities (whether absolute, accrued, contingent, fixed or otherwise, or whether known
or unknown, or due to become due or otherwise), diminution in value, monetary damages, fines, fees, penalties, interest obligations,
deficiencies, losses and expenses (including amounts paid in settlement, interest, court costs, reasonable fees and expenses of
attorneys, accountants, financial advisors, investigators, and other experts, and other reasonable expenses of litigation, arbitration
or other dispute resolution procedures);

 

“Deemed Escrow Value”
has the meaning ascribed thereto in Section 6.6(a);

 

“Deemed Value Amount”
means an amount equal to $12.90;

 

“Deferred Consideration”
means $10,000,000, payable in Exchangeable Shares; provided that in the event the Recurring Revenue recognized during the Deferred
Consideration Period is less than $9,000,000, the Deferred Consideration amount of $10,000,000 shall be reduced by an amount equal
to the product of $6.67 multiplied by the difference between $9,000,000 and the amount of Recurring Revenue realized during the
Deferred Consideration Period (up to a maximum reduction of $10,000,000), as calculated in the Deferred Consideration Statement;

 

“Deferred Consideration Payment
Date” has the meaning ascribed thereto in Section 2.19(e);

 

“Deferred Consideration Period”
means the period of time beginning on the Effective Date, and ending on the date that is 12 months after the Effective Date;

 

“Deferred Consideration Statement”
means a statement prepared by Akerna setting forth in reasonable detail the:

 

		(a)	amount of Recurring Revenue;

 

		(b)	the amount Deferred Consideration payable to the holders of the CVRs; and

 

		(c)	the expected Deferred Consideration Payment Date;

 

“Depositary” means such
Person as Ample may appoint to act as depositary for the Ample Shares in relation to the Arrangement, with the approval of Akerna,
acting reasonably;

 

“Dispute” means the dispute
resulting if an Indemnifying Party in a response to any Claim Notice, disputes the liability of such Indemnifying Party for all
or part of a Claimed Amount;

 

“Dissent Rights” means
the rights of dissent granted in favour of registered Ample Shareholders in respect of the Arrangement described in the Plan of
Arrangement and the Interim Order;

 

“Economic Sanctions” has
the meaning ascribed thereto in subsection 4.1(v)(iii) and 4.2(ee)(iii);

 

“Effective Date” means
the date the Arrangement becomes effective pursuant to the OBCA;

 

“Effective Date Register”
has the meaning ascribed thereto in Section 2.20(i);

 

“Effective Time” means
the time at which the Arrangement becomes effective on the Effective Date pursuant to the OBCA;

 

    - 10 -

     

    

 

“Effective Time Shares”
means that number of Exchangeable Shares that is equal to ten percent (10%) of the total aggregate number of Up-front Shares that
are to be delivered by Akerna and Purchaser to the Ample Shareholders pursuant to the Arrangement Agreement;

 

“Eligible Holder” means
an Ample Shareholder that is: (a) a resident of Canada for the purposes of the Tax Act and not exempt from tax under Part I of
the Tax Act; or (b) a partnership, any member of which is a resident of Canada for the purposes of the Tax Act and not exempt from
tax under Part I of the Tax Act;

 

“Employee Plans” means
all health, welfare, supplemental unemployment benefit, bonus, profit sharing, option, stock appreciation, savings, insurance,
incentive, incentive compensation, deferred compensation, share purchase, share compensation, disability, pension or supplemental
retirement plans and other similar or material employee or director compensation or benefit plans, policies, trusts, funds, agreements
or arrangements for the benefit of directors or former directors of a Party or any of its Subsidiaries, or such Party or its Subsidiaries’
Employees or former Employees, which are maintained by, contributed to or binding upon a Party or any of its Subsidiaries or in
respect of which a Party or any of its Subsidiaries has any actual or potential liability, but excluding any statutory benefit
plans that any Party is required to participate in or comply with in accordance with Applicable Laws, including the Canada Pension
Plan and plans administered pursuant to applicable health, Tax, workplace safety insurance and employment insurance legislation;

 

“Employees” means, as
applicable, all of the employees of: (a) Ample or any Ample Subsidiary; and (b) Akerna or any Akerna Subsidiary, as at the Effective
Date;

 

“Employment Agreements” means
the separate employment agreements to be entered into between Ample and each of the Retained Personnel, in a form satisfactory
to Akerna and each of the Retained Personnel, in each case, acting reasonably;

 

“Environmental Law” means
all Applicable Laws relating to pollution or the protection or quality of the environment or to the release of hazardous substances
to the environment and all Authorizations issued pursuant to such laws;

 

“Escrow Agent” means Continental
Stock Transfer & Trust Company, Inc.;

 

“Escrow Agreement” means
the Escrow Agreement to be entered into among Akerna, the Purchaser, the Shareholder Representative and the Escrow Agent, in the
form or substantially in the form as set out in Schedule “D”;

 

“Escrowed Shares” means
that number of Exchangeable Shares that is equal to ten percent (10%) of the total aggregate number of Up-front Shares that are
to be delivered by Akerna and Purchaser to the Ample Shareholders pursuant to the Arrangement Agreement;

 

“Exchange Rate” means,
on any date of determination, the CAD/USD daily exchange rate quoted by the Bank of Canada three Business Days prior to such date;

 

“Exchange Ratio” means
0.0524 of an Akerna Share;

 

“Exchangeable Share Support Agreement”
means the agreement to be made between Akerna, Purchaser, Callco and the Shareholder Representative in the form or substantially
in the form as set out in Schedule “C”;

 

    - 11 -

     

    

 

“Exchangeable Shares”
means the redeemable preferred shares in the capital of Purchaser, having the rights, privileges, restrictions and conditions set
out in the Plan of Arrangement;

 

“Expected Claim Notice”
means a notice that, as a result of a legal proceeding instituted by or written claim made by a third party, an Indemnified Party
reasonably expects to incur Damages for which it is entitled to indemnification under Article 6;

 

“Final Order” means the
final order of the Court approving the Arrangement pursuant to subsection 182(5) of the OBCA, in a form acceptable to both Ample
and Akerna, each acting reasonably, as such order may be amended by the Court (with the consent of both Ample and Akerna, each
acting reasonably) at any time prior to the Effective Time or, if appealed, then, unless such appeal is withdrawn or denied, as
affirmed or as amended (provided that any such amendment is acceptable to both Ample and Akerna, each acting reasonably) on appeal;

 

“Governmental Entity”
means any:

 

		(a)	national, international, multinational, federal, provincial, state, regional, municipal, local
or other government or any governmental or public department, central bank, court, tribunal, arbitral body, commission, board,
bureau ministry or agency, domestic or foreign, including the Securities Authorities;

 

		(b)	any subdivision, agent, commission, board or authority of any of the foregoing; or

 

		(c)	any quasi-governmental or private body exercising any regulatory, expropriation or Taxing Authority
under or for the account of any of the foregoing;

 

“IFRS” means Canadian
generally accepted accounting principles for publicly accountable enterprises, being International Financial Reporting Standards
as adopted by the Canadian Accounting Standards Board effective for periods beginning on or after January 1, 2011;

 

“Indebtedness” means,
with respect to any Person, without duplication:

 

		(a)	indebtedness of such Person for borrowed money, secured or unsecured;

 

		(b)	every obligation of such Person evidenced by bonds, debentures, notes, derived obligations or other
similar instruments

 

		(c)	every obligation of such Person under purchase money mortgages, conditional sale agreements or
other similar instruments relating to purchased property or assets;

 

		(d)	every capitalized or non-consolidated lease obligation of such Person;

 

		(e)	every obligation of such Person under swaps (valued at the termination value thereof); and

 

		(f)	every obligation of the type referred to above of any other Person, the payment of which such Person
has guaranteed or for which such Person is otherwise responsible or liable;

 

“Indemnified Party”
has the meaning ascribed thereto in Section 6.3(a);

 

“Indemnifying Party”
has the meaning ascribed thereto in Section 6.3(a);

 

    - 12 -

     

    

 

“Intellectual Property”
means collectively, all rights in or affecting intellectual or industrial property or other proprietary rights existing in any
jurisdiction, including with respect to the following: (i) patents and applications therefor, and patents issuing thereon, including
continuations, divisionals, continuations-in-part, reissues, reexaminations, renewals and extensions, and the right to file other
or further applications and claim priority thereto; (ii) trademarks, service marks, trade names, service names, brand names and
trade dress rights, and all applications, registrations and renewals thereof; (iii) copyrights and registrations and applications
therefor, works of authorship, “moral” rights and mask work rights; (iv) domain names, uniform resource locators and
social media accounts or handles, including applications and registrations thereof; (v) telephone numbers; (vi) trade secrets;
and (vii) the right to file applications and obtain registrations for any of the foregoing, as applicable;

 

“Interim Order” means
an interim order of the Court concerning the Arrangement pursuant to the OBCA in a form acceptable to both Ample and Akerna, each
acting reasonably, containing declarations and directions with respect to the Arrangement and the holding of the Ample Meeting,
as such order may be affirmed, amended or modified by the Court;

 

“Investment Canada Act”
means the Investment Canada Act, R.S.C. 1985, c.28 (1st Supp.), as amended including regulations passed under
the Investment Canada Act;

 

“Liabilities” means any
and all debts, liabilities and obligations of any nature whatsoever, whether accrued or fixed, including those arising under any
law, Contract, Permit, license or other undertaking and as a result of any act or omission;

 

“Lien” means any lien,
mortgage, pledge, security interest, charge or encumbrance of any kind, whether voluntary or involuntary, (including any conditional
sale or other title retention agreement, any lease in the nature thereof, and any agreement to give any security interest but excluding
any present or future lease that is or would have been characterized as an operating lease under US GAAP or IFRS, as applicable
as in effect on the date hereof);

 

“Misrepresentation”, “material
change” and “material fact” have the meanings ascribed thereto under Applicable Securities Laws of Canada;

 

“NASDAQ” means the National
Association of Securities Dealers Automated Quotations exchange;

 

“Non-Controlling Party”
has the meaning ascribed thereto in Section 6.3(b);

 

“OBCA” means the Business
Corporations Act, R.S.O. 1900, c. B.16, as amended, including the regulations promulgated thereunder;

 

“Option Plan” means the
stock option plan of Ample, in effect as at the date hereof;

 

“Optionholders” means
the holders of Ample Options;

 

“Order” means all judicial,
arbitral, administrative, ministerial, departmental or regulatory judgments, injunctions, orders, decisions, rulings, determinations,
awards, or decrees of any Governmental Entity (in each case, whether temporary, preliminary or permanent);

 

“Out-of-Money Option”
means each Ample Option having an aggregate exercise price for any Ample Share in excess of the total value of all Up-front Consideration
that would be payable hereunder in respect of such Ample Share if such Ample Share were issued and outstanding at the Effective
Time;

 

    - 13 -

     

    

 

“Out-of-Money Warrant”
means each Ample Warrant having an aggregate exercise price for any Ample Share in excess of the total value of all Up-front Consideration
that would be payable hereunder in respect of such Ample Share if such Ample Share were issued and outstanding at the Effective
Time;

 

“Outside Date” means June
30, 2020 or such later date as may be agreed to in writing by Akerna and Ample;

 

“Parties” means, collectively,
the parties to this Agreement, and “Party” means any one of them;

 

“Paying Agent” means Continental
Stock Transfer & Trust Company, Inc.;

 

“Payout Letters” has the
meaning ascribed thereto in Section 2.16(a);

 

“Permit” means any license,
permit, certificate, franchise, consent, order, grant, easement, covenant, approval, classification, registration or other authorization
of and from any Person, including any Governmental Entity;

 

“Permitted Liens” means:

 

		(a)	Liens for taxes, assessments and governmental charges, the payment of which is not yet due and
payable or which are being contested in good faith by, as applicable: (i) Ample or an Ample Subsidiary and by appropriate proceedings
promptly initiated and diligently conducted, and a reserve or other appropriate provision, if any, as shall be required by US GAAP
or IFRS, as applicable shall have been made therefor in the books of account of the applicable Person; and (ii) Akerna or an Akerna
Subsidiary and by appropriate proceedings promptly initiated and diligently conducted, and a reserve or other appropriate provision,
if any, as shall be required by US GAAP or IFRS, as applicable shall have been made therefor in the books of account of the applicable
Person;

 

		(b)	Liens imposed by law, such as carrier’s, warehousemen’s, mechanic’s, materialmen’s and other similar
Liens securing obligations (other than Indebtedness for borrowed money) that are not due or delinquent or that are being contested
in good faith and by appropriate proceedings promptly initiated and diligently conducted, and a reserve or other appropriate provision,
if any, as shall be required by US GAAP or IFRS, as applicable shall have been made therefor in the books of account of the applicable
Person;

 

		(c)	Liens securing purchase money Indebtedness or of purchase money mortgages and any other Lien on
equipment acquired, leased or held with a fair market value less than or equal to $100,000, on an aggregate basis at any time (including
equipment held as lessee under a capital lease) in the ordinary course of business to secure the purchase price of or rental payments
with respect to such equipment or to secure Indebtedness incurred for the purpose of financing the acquisition (including acquisition
as lessee under capital leases), construction or improvement of any such equipment to be subject to such Liens existing on any
such equipment at the time of such acquisition, or extensions, renewals or replacements of any of the foregoing for the same or
a lesser amount, provided that (x) no such Lien shall extend to or cover any equipment other than the equipment being acquired,
constructed or improved, and no such extension, renewal or replacement shall extend to or cover any property not theretofore subject
to the Lien being extended, renewed or replaced; and (y) the principal amount of the Indebtedness secured by any such Lien, or
any extension, renewal or replacement thereof, shall not exceed the greater of the fair market value or the cost of the property
so held or acquired;

 

    - 14 -

     

    

 

		(d)	deposits and pledges of cash or securities securing (i) the performance of bids, tenders, leases,
contracts (other than for the payment of money) or statutory obligations that arise in the ordinary course of business or (ii)
obligations on surety or appeal or performance bonds, including those to support or secure reclamation in accordance with Applicable
Laws that are incurred or arise in the ordinary course of business or (iii) obligations incurred in the ordinary course of business
that do not involve the incurrence of Indebtedness and, in each case, only to the extent such deposits or pledges secure obligations
that are not past due or that are being contested in good faith and by appropriate proceedings promptly initiated and diligently
conducted, and a reserve or other appropriate provision, if any, as shall be required by US GAAP or IFRS, as applicable shall have
been made therefor in the books of account of the applicable Person;

 

		(e)	pledges, deposits and Liens in connection with workers’ compensation, employment insurance and
other similar legislation and deposits securing liability to insurance carriers under insurance or self-insurance arrangements
to the extent required by law;

 

		(f)	rights of set-off or bankers’ Liens upon deposits of cash or broker’s Liens upon securities in
favour of financial institutions, banks or other depositary institutions;

 

		(g)	survey exceptions, title defects, easements, zoning restrictions and similar encumbrances on real
property and minor irregularities in the title thereto that do not (i) secure obligations for the payment of money; or (ii) materially
adversely impair the value of such property or its use by Ample or any Ample Subsidiary in the normal conduct of their business;

 

		(h)	Liens given in the ordinary course of business to a public utility or any municipality or governmental
or other public authority when required by such utility or municipality or governmental or other authority in connection with the
operations of Ample or any Ample Subsidiary;

 

		(i)	with respect to Liens set forth in subsection (c), replacement liens in respect of any refinancing
or the replacement of the underlying Indebtedness provided such refinancing or replacement does not increase the then-outstanding
principal balance of such Indebtedness being refinanced or replaced;

 

		(j)	Liens which could not be reasonably expected to cause an Ample Material Adverse Effect or Akerna
Material Adverse Effect, arising or potentially arising under statutory provisions (other than Environmental Laws) which have not
at the time been filed or registered in accordance with Applicable Laws or of which written notice has not been duly given in accordance
with Applicable Laws or which, although filed or registered, relate to obligations that are not due or delinquent or that are being
contested in good faith and by appropriate proceedings promptly initiated and diligently conducted, and a reserve or other appropriate
provision, if any, as shall be required by US GAAP or IFRS, as applicable shall have been made therefor in the books of account
of the applicable Person;

 

		(k)	the right reserved to or vested in any government or Governmental Entity by any statutory provision
or by the terms of any lease, production sharing contract, licence, franchise, grant or permit of, to terminate any such lease,
license, franchise, grant or permit, or to require annual or other payments as a condition to the continuance thereof; and

 

		(l)	Liens arising from the right of distress enjoyed by landlords or Liens otherwise granted to landlords,
in either case, to secure the payment of arrears of rent in respect of leased properties.

 

    - 15 -

     

    

 

“Person” includes any
individual, firm, partnership, joint venture, venture capital fund, association, trust, trustee, executor, administrator, legal
personal representative, estate group, body corporate, corporation, unincorporated association or organization, Governmental Entity,
syndicate or other entity, whether or not having legal status;

 

“Plan of Arrangement”
means the plan of arrangement set forth in Schedule “B” to this Agreement, as such plan of arrangement may be amended
or supplemented from time to time in accordance with the terms thereof and hereof;

 

“Proceeding” means any
suit, claim, action, charge, complaint, litigation, arbitration, proceeding (including any civil, criminal, administrative, investigative
or appellate proceeding), hearing, audit, examination or investigation commenced, brought, conducted or heard by or before, any
court or other Governmental Entity;

 

“Purchaser” means 2732805
Ontario Inc., a company existing under the laws of the Province of Ontario;

 

“Purchaser Circular Disclosure”
means all information regarding Purchaser and Akerna provided by Purchaser and Akerna for inclusion in the Ample Circular;

 

“Purchaser Indemnified Person”
has the meaning ascribed thereto in Section 6.1;

 

“Recurring Revenue” means
all recurring revenue that is derived from or that is associated with license revenue from Ample’s core seed-to-sale, AmpleCentral
and “Last Call Analytics” products;

 

“Regulatory Approvals”
means, collectively, the following: (a) acceptance of the NASDAQ; (b) the Final Order; and (c) such other sanctions, rulings, consents,
orders, exemptions, permits and other approvals (including the lapse, without objection, of a prescribed time under any Applicable
Laws that states that a transaction may be implemented if a prescribed time lapses following the giving of notice without an objection
being made) of Governmental Entities required in connection with the Plan of Arrangement except for those sanctions, rulings, consents,
orders, exemptions, permits and other approvals, the failure of which to obtain individually or in the aggregate, would not reasonably
be expected to have an Akerna Material Adverse Effect, taken as a whole, or an Ample Material Adverse Effect, taken as a whole
(either before or after giving effect to the Arrangement) or would not materially impede or delay the completion of the Arrangement;

 

“Replacement Option”
means an option or right to purchase Akerna Shares granted by Akerna in replacement of Ample Options on the basis set forth in
subsection 2.15;

 

“Representatives” means,
with respect to any Person and its Subsidiaries, collectively, the officers, directors, employees, consultants, advisors (including
financial advisors and legal counsel), representatives, agents or other parties acting on its behalf;

 

“Retained Personnel” means
John Prentice, Evan McEwen and Tom Ritchie.

 

“Rights Indenture” means
the rights indenture to be entered into between Akerna, Purchaser, the Shareholder Representative and a trust company acceptable
to Ample and Purchaser, as rights agent, providing for the creation and issuance of the CVRs, in the form or substantially in the
form attached as Schedule “F”;

 

    - 16 -

     

    

 

“Securities Act” means
the Securities Act (Ontario) and the rules, regulations and published policies made thereunder;

 

“Securities Authorities”
means, collectively, the securities commissions or similar securities regulatory authorities in each of the provinces of Canada;

 

“Shareholder Representative”
means John Prentice;

 

“Significant Shareholder”
has the meaning ascribed thereto in Section 4.2(i);

 

“Special Voting Share”
means the special voting share in the capital of Akerna to be issued by Akerna and deposited with the trustee appointed under the
Voting and Exchange Trust Agreement, which, at any time entitles the holder of record to that number of votes at meetings of holders
of Akerna Shares equal to the number of Exchangeable Shares outstanding at such time (excluding any Exchangeable Shares held by
Akerna or any Affiliate);

 

“Subsidiary” has the meaning
ascribed thereto in the Securities Act, which for certainty shall include any indirect subsidiaries;

 

“Tax” or “Taxes”
means any and all taxes, duties, fees, excises, premiums, assessments, imposts, levies and other charges or assessments of any
kind whatsoever however denominated, including any interest, penalties or other additions that may become payable in respect thereof,
imposed by any Taxing Authority, whether computed on a separate, consolidated, unitary, combined or other basis, which taxes will
include, without limiting the generality of the foregoing, all income or profits taxes (including, but not limited to, federal
income taxes and provincial income taxes), payroll and employee withholding taxes, employment insurance premiums, unemployment
insurance, social insurance taxes, Canada Pension Plan contributions, sales and use taxes (including goods and services and provincial
sales taxes), value added taxes, excise taxes, fuel taxes, franchise taxes, gross receipts taxes, carbon taxes, capital taxes,
production taxes, recapture, withholding taxes, employee health taxes, surtaxes, customs, import and export taxes, business license
taxes, occupation taxes, real and personal property taxes, stamp taxes, environmental taxes, transfer taxes, workers compensation
and other governmental charges, and other obligations of the same or of a similar nature to any of the foregoing, which Ample or
any Ample Subsidiary is required to pay, withhold, remit or collect;

 

“Tax Act” means the Income
Tax Act, R.S.C. 1985, c. 1 (5th Supp.), as amended, including the regulations promulgated thereunder;

 

“Tax Returns” means all
reports, estimates, elections, notices, filings, designations, forms, declarations of estimated tax, information statements and
returns relating to, or required to be supplied to any Taxing Authority in connection with, any Taxes (including any attached schedules,
estimated tax returns, withholding tax returns, and information returns and reports);

 

“Taxing Authority” means
any Governmental Entity responsible for the imposition of any Tax (domestic or foreign);

 

“Third Party Action” means
any suit or proceeding by a Person other than a Party for which indemnification may be sought by an Indemnified Party pursuant
to Article 6;

 

“Third Party Beneficiaries”
has the meaning ascribed thereto in Section 10.12;

 

    - 17 -

     

    

 

“Transaction Expenses”
means all legal, advisory, accounting fees and expenses of Ample arising as a result of the Arrangement that are incurred prior
to, and remain unpaid as of, the Effective Time;

 

“United States” means
the United States of America, its territories and possessions, any state of the United States, and the District of Columbia;

 

“Up-front Consideration”
means the Up-front Shares to be issued and the Closing Cash Amount to be delivered by Akerna and Purchaser at the Effective Time
in accordance with this Agreement;

 

“Up-front Share Consideration
Amount” means an amount equal to $42,500,000, plus the aggregate exercise prices of all Replacement Options to be granted
in exchange for Ample Options (other than Out-of-Money Options) pursuant to the Arrangement and Ample Warrants (other than Out-of-Money
Warrants);

 

“Up-front Shares” means
an aggregate number of Exchangeable Shares that is equal to the Up-front Share Consideration Amount, divided by the Deemed Value
Amount, less (i) the aggregate number of Exchangeable Shares and/or Akerna Shares that the Optionholders would be entitled to receive
exclusively as a result of the exercise immediately following the Effective Time of all Replacement Options granted in exchange
for Ample Options (other than Out-of-Money Options) pursuant to the Arrangement, and less (ii) the aggregate number of Exchangeable
Shares and/or Akerna Shares that the Warrantholders would be entitled to receive exclusively as a result of the exercise of all
Ample Warrants (other than Out-of-Money Warrants) immediately following to the Effective Time;

 

“U.S. Exchange Act” means
the United States Exchange Act of 1934, as amended and the rules and regulations promulgated thereunder;

 

“U.S. GAAP” means generally
accepted accounting principles in the United States of America in effect from time to time;

 

“U.S. Securities Act”
means the United States Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder;

 

“U.S. Securities Laws”
means the U.S. Securities Act, the U.S. Exchange Act and applicable state securities legislation of the United States and all rules,
regulations and orders promulgated thereunder, as amended from time to time; and

 

“Voting and Exchange Trust Agreement”
means an agreement to be made between Akerna, Purchaser, Callco, the Shareholder Representative and the trustee to be chosen by
Akerna to act as trustee under the Voting and Exchange Trust Agreement, substantially in the form attached hereto as Schedule “E”;
and

 

“Warrantholders” means
holders of Ample Warrants.

 

		1.2	Interpretation Not Affected by Headings, etc.

 

The division of this Agreement into Articles,
Sections, subsections and other portions and the insertion of headings are for convenience of reference only and will not affect
the construction or interpretation hereof. Unless otherwise indicated, all references to an “Article”, “Section”
or “subsections” followed by a number and/or a letter refer to the specified Article, Section or subsections of this
Agreement.

 

    - 18 -

     

    

 

		1.3	Number and Gender; Derivatives

 

Unless the context otherwise requires,
in this Agreement, words importing the singular number include the plural and vice versa, and words importing the use of
any gender include all genders. If a word is defined in this Agreement a grammatical derivative of that word will have a corresponding
meaning. The words “include”, “includes” and “including” shall be deemed to be followed by the words
“without limitation”.

 

		1.4	Date for Any Action

 

If any date on which any action is required
to be taken hereunder by any of the Parties is not a Business Day, such action is required to be taken on the next succeeding day
which is a Business Day.

 

		1.5	Statute and Agreement References

 

Any reference in this Agreement to any
statute or any Section thereof will, unless otherwise expressly stated, be deemed to be a reference to such statute or Section
as amended, restated or re-enacted from time to time. References to any agreement or document will be to such agreement or document
(together with all appendices, schedules and exhibits thereto), as it may have been or may hereafter be amended, supplemented,
replaced or restated from time to time.

 

		1.6	Currency

 

All sums of money that are referred to
in this Agreement are expressed in lawful money of Canada unless otherwise noted.

 

		1.7	Accounting Matters

 

Unless otherwise stated, all accounting
terms used in this Agreement in respect of: (a) Akerna shall have the meanings attributable thereto under U.S. GAAP and all determinations
of an accounting nature in respect of Akerna required to be made shall be made in accordance with U.S. GAAP consistently applied;
and (b) Ample shall have the meanings attributable thereto under IFRS and all determinations of an accounting nature in respect
of Ample required to be made shall be made in accordance with IFRS consistently applied.

 

		1.8	Interpretation Not Affected by Party Drafting

 

The Parties hereto acknowledge that their
respective legal counsel have reviewed and participated in settling the terms of this Agreement, and the Parties agree that any
rule of construction to the effect that any ambiguity is to be resolved against the drafting party will not be applicable in the
interpretation of this Agreement.

 

		1.9	Knowledge

 

Where any representation or warranty is
expressly qualified by reference to the knowledge of a Party, it is deemed to refer to the actual knowledge of the Executive Officers
of Akerna or Ample, as the case may be, after reasonable inquiry. For purposes of this Section 1.9, “Executive Officers”
(a) in the case of the Akerna, means Jessica Billingsley, Ray Thompson and Ruth Ann Kraemer; and (b) in the case of Ample, means
John Prentice and Peter Slater.

 

    - 19 -

     

    

 

		1.10	Disclosure in Writing

 

References herein to disclosure in writing
shall, in the case of disclosure to Purchaser be references exclusively to the Ample Disclosure Letter or this Agreement.

 

		1.11	Schedules

 

The following schedules attached hereto
are incorporated into and form an integral part of this Agreement:

 

Schedule “A” – Arrangement
Resolution

Schedule “B” – Plan
of Arrangement

Schedule “C” – Form
of Exchangeable Share Support Agreement

Schedule “D” – Form of Escrow Agreement

Schedule “E” – Form
of Voting and Exchange Trust Agreement

Schedule “F” – Form
of Rights Indenture

Schedule “G” – Form
of Ample Shareholder Support Agreement

Schedule “H” – Form
of Akerna Shareholder Support Agreement

Schedule “I” – Exchangeable
Share Provisions

 

Article
2

THE ARRANGEMENT

 

		2.1	Arrangement

 

Ample and Akerna agree that the Arrangement
will be implemented in accordance with the terms and subject to the conditions contained in this Agreement and the Plan of Arrangement.
In the event of any conflict between the terms of this Agreement and the Plan of Arrangement, the Plan of Arrangement shall govern.

 

		2.2	Akerna Approval

 

Akerna represents and warrants to Ample
that the Akerna Board has unanimously determined that:

 

		(a)	the Arrangement and entry into this Agreement are, as of the date of this Agreement, in the best
interests of Akerna; and

 

		(b)	it will unanimously recommend that the Akerna Shareholders vote in favour of the Akerna Shareholder
Matters.

 

		2.3	Ample Approval

 

Ample represents and warrants to Akerna
and Purchaser that the Ample Board has unanimously determined that:

 

		(a)	the Arrangement is fair to the Ample Shareholders (other than Akerna) from a financial point of
view;

 

		(b)	the Arrangement and entry into this Agreement are, as of the date of this Agreement, in the best
interests of Ample; and

 

		(c)	subject to Section 3.8(e), it will unanimously recommend that the Ample Shareholders vote in favour
of the Arrangement Resolution.

 

    - 20 -

     

    

 

		2.4	Interim Order

 

As soon as reasonably practicable following
the execution of this Agreement, but in any event no later than February 20, 2020, Ample shall apply to the Court in a manner acceptable
to Akerna, acting reasonably, pursuant to the OBCA and prepare, file and diligently pursue an application to the Court of the Interim
Order, which shall provide, among other things:

 

		(a)	for the class of Persons to whom notice is to be provided in respect of the Arrangement and the
Ample Meeting and for the manner in which such notice is to be provided;

 

		(b)	that the requisite approval for the Arrangement Resolution shall be 66 2/3% of the votes cast on
the Arrangement Resolution by Ample Shareholders present in person or represented by proxy at the Ample Meeting voting together
as a single class, together with the affirmative vote of the holders holding not less than a majority of the Ample Preferred Shares;

 

		(c)	that it is the intention of Akerna and Purchaser to rely upon Section 3(a)(10) of the U.S. Securities
Act in connection with the offer and sale of Consideration Shares and Akerna Shares to be issued pursuant to the exchange of Exchangeable
Shares, in each case in accordance with the Arrangement, based on the Court’s approval of the Arrangement, which approval
through the issuance of the Final Order will constitute its determination of the fairness of the Arrangement;

 

		(d)	that the Ample Meeting may be adjourned or postponed from time to time by the Ample Board subject
to the terms of this Agreement without the need for additional approval of the Court;

 

		(e)	that the record date for Ample Shareholders entitled to notice of and to vote at the Ample Meeting
will not change in respect of any adjournment(s) or postponements of the Ample Meeting;

 

		(f)	that, in all other respects, other than as ordered by the Court, the terms, conditions and restrictions
of the constating documents of Ample, including quorum requirements and other matters, shall apply in respect of the Ample Meeting;

 

		(g)	for the grant of the Dissent Rights to registered holders of Ample Shares as set forth in the Plan
of Arrangement;

 

		(h)	for the notice requirements with respect to the presentation of the application to the Court for
the Final Order; and

 

		(i)	for such other matters as Akerna may reasonably require, subject to obtaining the prior consent
of Ample, such consent not to be unreasonably withheld, conditioned or delayed.

 

    - 21 -

     

    

 

		2.5	Akerna Shareholder Meeting

 

Subject to the terms of this Agreement
and receipt of the Interim Order, Akerna shall:

 

		(a)	convene and conduct the Akerna Meeting in accordance with its constating documents and Applicable
Laws, as soon as reasonably practicable, and in any event on or before February 26, 2020;

 

		(b)	in consultation with Ample, fix and publish a record date for the purposes of determining Akerna
Shareholders entitled to receive notice of and vote at the Akerna Meeting and give notice to Ample of the Akerna Meeting;

 

		(c)	allow Ample’s Representatives and counsel to attend the Akerna Meeting;

 

		(d)	not adjourn, postpone or cancel (or propose or permit the adjournment, postponement or cancellation
of) the Akerna Meeting without Ample’s prior written consent (such consent not be unreasonably withheld, conditioned or delayed),
except:

 

		(i)	as required for quorum purposes (in which case the meeting shall be adjourned and not cancelled),
by Applicable Law or by a Governmental Entity or by valid Akerna Shareholder action (which action is not solicited or proposed
by Akerna or the Akerna Board); or

 

		(ii)	as otherwise expressly permitted under this Agreement;

 

		(e)	provide Ample with copies of or access to information regarding the Akerna Meeting generated by
any dealer or proxy solicitation firm engaged by Akerna, as requested from time to time by Ample;

 

		(f)	use commercially reasonable efforts to solicit proxies in favour of the Akerna Shareholder Matters;

 

		(g)	promptly advise Ample, at such times as Ample may reasonably request, as to the aggregate tally
of the proxies received by Akerna in respect of the Akerna Shareholder Matters;

 

		(h)	unless otherwise agreed to in writing by Ample or this Agreement is terminated in accordance with
its terms or except as required by Applicable Law or by a Governmental Entity, Akerna shall continue to take all steps reasonably
necessary to hold the Akerna Meeting and to cause the Akerna Shareholder Matters to be voted on at such meeting and shall not propose
to adjourn or postpone the Ample Meeting other than as contemplated by Section 2.5(d); and

 

		(i)	not change the record date for the Akerna Shareholders entitled to vote at the Akerna Meeting in
connection with any adjournment or postponement of the Akerna Meeting unless required by Applicable Law or with the written consent
of Ample, such consent not to be unreasonably withheld, conditioned or delayed.

 

    - 22 -

     

    

 

		2.6	Ample Shareholder Meeting

 

Subject to the terms of this Agreement
and receipt of the Interim Order, Ample shall:

 

		(a)	convene and conduct the Ample Meeting in accordance with its constating documents, the Interim
Order and Applicable Laws, as soon as reasonably practicable, and in any event on or before February 26, 2020;

 

		(b)	in consultation with Akerna, fix and publish a record date for the purposes of determining Ample
Shareholders entitled to receive notice of and vote at the Ample Meeting and give notice to Akerna of the Ample Meeting;

 

		(c)	allow Akerna’s Representatives and counsel to attend the Ample Meeting;

 

		(d)	not adjourn, postpone or cancel (or propose or permit the adjournment, postponement or cancellation
of) the Ample Meeting without Akerna’s prior written consent (such consent not be unreasonably withheld, conditioned or delayed),
except:

 

		(i)	as required for quorum purposes (in which case the meeting shall be adjourned and not cancelled),
by Applicable Law or by a Governmental Entity or by valid Ample Shareholder action (which action is not solicited or proposed by
Ample or the Ample Board); or

 

		(ii)	as otherwise expressly permitted under this Agreement;

 

		(e)	provide Akerna with copies of or access to information regarding the Ample Meeting generated by
any dealer or proxy solicitation firm engaged by Ample, as requested from time to time by Akerna;

 

		(f)	use commercially reasonable efforts to solicit proxies in favour of the Arrangement Resolution;

 

		(g)	promptly advise Akerna, at such times as Akerna may reasonably request, as to the aggregate tally
of the proxies received by Ample in respect of the Arrangement Resolution;

 

		(h)	promptly advise Akerna of any written communication from any Ample Shareholder in opposition to
the Arrangement, written notice of dissent, purported exercise or withdrawal of Dissent Rights, and written communications sent
by or on behalf of Ample to any Ample Shareholder exercising or purporting to exercise Dissent Rights;

 

		(i)	not make any payment or settlement offer, or agree to any payment or settlement prior to the Effective
Time with respect to Dissent Rights without the prior written consent of Akerna;

 

		(j)	notwithstanding the receipt of an Acquisition Proposal or an Ample Change in Recommendation, unless
otherwise agreed to in writing by Akerna or this Agreement is terminated in accordance with its terms or except as required by
Applicable Law or by a Governmental Entity, Ample shall continue to take all steps reasonably necessary to hold the Ample Meeting
and to cause the Arrangement Resolution to be voted on at such meeting and shall not propose to adjourn or postpone the Ample Meeting
other than as contemplated by Section 2.6(d); and

 

		(k)	not change the record date for the Ample Shareholders entitled to vote at the Ample Meeting in
connection with any adjournment or postponement of the Ample Meeting unless required by Applicable Law or with the written consent
of Akerna, such consent not to be unreasonably withheld, conditioned or delayed.

 

    - 23 -

     

    

 

		2.7	Akerna Circular

 

		(a)	Akerna shall as soon as reasonably practicable following the date of this Agreement (but taking
into account the need for Ample to provide the Ample Circular Disclosure) prepare and complete, in consultation with Ample, the
Akerna Circular together with any other documents required by Applicable Laws in connection with the Akerna Meeting and the Akerna
Shareholder Matters, and Akerna shall, after receipt of Ample of the Interim Order, cause the Akerna Circular and such other documents
to be sent to each Akerna Shareholder (if applicable) and any other Person as required by Applicable Laws, in each case so as to
permit the Akerna Meeting to be held by the date specified in Section 2.5(a).

 

		(b)	On the date of mailing thereof, Akerna shall ensure that the Akerna Circular complies in all material
respects with all Applicable Laws and shall contain sufficient detail to permit Akerna Shareholders to form a reasoned judgment
concerning the matters to be placed before them at the Akerna Meeting, and, without limiting the generality of the foregoing, shall
ensure that the Akerna Circular will not contain any misrepresentation (except that Akerna shall not be responsible for the accuracy
of any Ample Circular Disclosure).

 

		(c)	The Akerna Circular shall contain the unanimous recommendation of the Akerna Board to Akerna Shareholders
that they vote in favour of the Akerna Shareholder Matters.

 

		(d)	Ample shall provide to Akerna in writing the Ample Circular Disclosure to be included by Akerna
in the Akerna Circular not less than ten Business Days before the mailing date of the Akerna Circular and shall ensure that at
the time of the mailing, such information does not contain any misrepresentation and complies in all material respects with Applicable
Laws.

 

		(e)	Ample hereby indemnifies and saves harmless Akerna, its Subsidiaries and their respective Representatives
from and against any and all liabilities, claims, demands, losses, costs, damages and expenses to which Akerna, any Subsidiary
or any of their respective Representatives may be subject or may suffer as a result of, or arising from, any misrepresentation
or alleged misrepresentation contained in the Ample Circular Disclosure included in the Akerna Circular that was provided by Ample
in writing for inclusion in the Akerna Circular pursuant to Section 2.7(d), including as a result of any order made, or any inquiry,
investigation or proceeding instituted by any Securities Authority or other Governmental Entity based on such a misrepresentation
or alleged misrepresentation.

 

		(f)	Ample and its legal counsel shall be given a reasonable opportunity to review and comment on drafts
of the Akerna Circular and related documents prior to the Akerna Circular being printed and mailed to the Akerna Shareholders,
and reasonable consideration shall be given to any comments made by Ample and its legal counsel, provided that all information
relating solely to Ample and its Affiliates included in the Akerna Circular shall be in form and content approved in writing by
Ample, acting reasonably. Akerna shall provide Ample with final copies of the Akerna Circular prior to the mailing to Akerna Shareholders.

 

    - 24 -

     

    

 

		(g)	Each Party shall promptly notify the other Party if it becomes aware that the Akerna Circular contains
a misrepresentation or otherwise requires an amendment or supplement and the Parties shall co-operate in the preparation of any
amendment or supplement to the Akerna Circular as required or appropriate and Akerna shall promptly mail or otherwise publicly
disseminate (if required under Applicable Law) any amendment or supplement to the Akerna Circular to the Akerna Shareholders.

 

		2.8	Ample Circular

 

		(a)	Ample shall as soon as reasonably practicable following the date of this Agreement (but taking
into account the need for Akerna to provide the Purchaser Circular Disclosure) prepare and complete, in consultation with Akerna,
the Ample Circular together with any other documents required by Applicable Laws in connection with the Ample Meeting and the Arrangement,
and Ample shall, after obtaining the Interim Order, cause the Ample Circular and such other documents to be sent to each Ample
Shareholder (if applicable) and any other Person as required by the Interim Order and Applicable Laws, in each case so as to permit
the Ample Meeting to be held by the date specified in Section 2.6(a).

 

		(b)	On the date of mailing thereof, Ample shall ensure that the Ample Circular complies in all material
respects with all Applicable Laws and the Interim Order and shall contain sufficient detail to permit Ample Shareholders to form
a reasoned judgment concerning the matters to be placed before them at the Ample Meeting, and, without limiting the generality
of the foregoing, shall ensure that the Ample Circular will not contain any misrepresentation (except that Ample shall not be responsible
for the accuracy of any Purchaser Circular Disclosure). The Ample Circular shall also contain such information as may be required
to allow Akerna and Purchaser to rely upon the exemption from registration provided under Section 3(a)(10) of the U.S. Securities
Act with respect to the offer and sale of the Consideration Shares and the Akerna Shares to be issued pursuant to the exchange
of the Exchangeable Shares, in each case pursuant to the Arrangement.

 

		(c)	Subject to Section 3.8(e) and any Ample Change in Recommendation, the Ample Circular shall: (i)
state that the Ample Board has unanimously determined that the Arrangement is fair to the Ample Shareholders and that the Arrangement
and entry into this Agreement are in the best interests of Ample; and (ii) contain the unanimous recommendation of the Ample Board
to Ample Shareholders that they vote in favour of the Arrangement Resolution (the “Ample Board Recommendation”).

 

		(d)	Akerna shall provide to Ample in writing the Purchaser Circular Disclosure to be included by Ample
in the Ample Circular not less than ten Business Days before the mailing date of the Ample Circular and shall ensure that at the
time of the mailing, such information does not contain any misrepresentation and complies in all material respects with Applicable
Laws.

 

		(e)	Akerna hereby indemnifies and saves harmless Ample, its Subsidiaries and their respective Representatives
from and against any and all liabilities, claims, demands, losses, costs, damages and expenses to which Ample, any Subsidiary or
any of their respective Representatives may be subject or may suffer as a result of, or arising from, any misrepresentation or
alleged misrepresentation contained in the Purchaser Circular Disclosure included in the Ample Circular that was provided by Akerna
in writing for inclusion in the Ample Circular pursuant to Section 2.8(d), including as a result of any order made, or any inquiry,
investigation or proceeding instituted by any Securities Authority or other Governmental Entity based on such a misrepresentation
or alleged misrepresentation.

 

    - 25 -

     

    

 

		(f)	At the reasonable request of Akerna from time to time, Ample shall, or shall direct its registrar
and transfer agent to, provide Akerna with a list (in both written and electronic form) of: (i) the registered Ample Shareholders,
together with their addresses and respective holdings of Ample Shares; and (ii) the names and addresses and holdings of all Persons
having rights issued by Ample to acquire Ample Shares. Ample shall from time to time require that its registrar and transfer agent
furnish Akerna with such additional information, including updated or additional lists of Ample Shareholders and lists of holdings
and other assistance as Akerna may reasonably request.

 

		(g)	Akerna and its legal counsel shall be given a reasonable opportunity to review and comment on drafts
of the Ample Circular and related documents prior to the Ample Circular being printed and mailed to the Ample Shareholders, and
reasonable consideration shall be given to any comments made by Akerna and its legal counsel, provided that all information relating
solely to Akerna and its Affiliates included in the Ample Circular shall be in form and content approved in writing by Akerna,
acting reasonably. Ample shall provide Akerna with final copies of the Ample Circular prior to the mailing to Ample Shareholders.

 

		(h)	Each Party shall promptly notify the other Party if it becomes aware that the Ample Circular contains
a misrepresentation or otherwise requires an amendment or supplement and the Parties shall co-operate in the preparation of any
amendment or supplement to the Ample Circular as required or appropriate and Ample shall promptly mail or otherwise publicly disseminate
(if required under Applicable Law) any amendment or supplement to the Ample Circular to the Ample Shareholders.

 

		2.9	Final Order

 

If: (a) the Interim Order is obtained;
and (b) the Arrangement Resolution is passed at the Ample Meeting by Ample Shareholders as provided for in the Interim Order and
as required by Applicable Law, subject to the terms of this Agreement, Ample shall take all steps necessary or desirable to submit
the Arrangement to the Court and diligently pursue an application for the Final Order pursuant to the OBCA as soon as reasonably
practicable, but in any event not later than three Business Days after the Ample Shareholder Approval is obtained.

 

    - 26 -

     

    

 

		2.10	Court Proceedings

 

Subject to the terms of this Agreement,
Akerna shall cooperate with and assist Ample in seeking the Interim Order and the Final Order, including by providing to Ample,
on a timely basis, any information reasonably required to be supplied by Akerna in connection therewith. Ample shall provide Akerna’s
legal counsel with reasonable opportunity to review and comment upon drafts of all material to be filed with the Court in connection
with the Arrangement, and will give reasonable consideration to all such comments. Subject to Applicable Law, Ample shall not file
any material with the Court in connection with the Arrangement or serve any such material, and shall not agree to modify or amend
materials so filed or served, except as contemplated by this Section 2.10 or with Akerna’s prior written consent, such consent
not to be unreasonably withheld, conditioned or delayed; provided that, nothing herein shall require Akerna to agree or
consent to any increase in or variation in the form of Consideration or other modification or amendment to such filed or served
materials that expands or increases Akerna’s obligations, or diminishes or limits Akerna’s rights, set forth in any
such filed or served materials or under this Agreement or the Arrangement. Ample shall also provide to Akerna’s legal counsel
on a timely basis, copies of any notice of appearance, evidence or other Court documents served on Ample in respect of the application
for the Interim Order or the Final Order or any appeal therefrom and of any notice, whether written or oral, received by Ample
indicating any intention to oppose the granting of the Interim Order or the Final Order or to appeal the Interim Order or the Final
Order. Ample shall ensure that all materials filed with the Court in connection with the Arrangement are consistent with the terms
of this Agreement and the Plan of Arrangement. In addition, Ample shall not object to Akerna’s legal counsel making such
submissions on the hearing of the motion for the Interim Order and the application for the Final Order as such counsel considers
appropriate, provided that Ample is advised of the nature of any submissions prior to the hearing and such submissions are consistent
in all material respects with this Agreement and the Plan of Arrangement. Ample shall also oppose any proposal from any party that
the Final Order contain any provision inconsistent with this Agreement, and, if at any time after the issuance of the Final Order
and prior to the Effective Date, Ample is required by the terms of the Final Order or by Applicable Law to return to Court with
respect to the Final Order, it shall do so after notice to, and in consultation and cooperation with, Akerna.

 

		2.11	U.S. Securities Law Matters

 

The Parties agree that the Arrangement
will be carried out with the intention that all Consideration Shares and Akerna Shares to be issued pursuant to the exchange of
Exchangeable Shares, in each case issued under the Arrangement, will be offered and sold by Akerna and Purchaser, whether in the
United States, Canada or any other country, in reliance on the exemption from the registration requirements of the U.S. Securities
Act provided by section 3(a)(10) thereunder. In order to ensure the availability of the exemption under section 3(a)(10) of the
U.S. Securities Act and to facilitate Akerna’s compliance with other U.S. Securities Laws, the Parties agree that the Arrangement
will be carried out on the following basis:

 

		(a)	the Court will be asked to approve the procedural and substantive fairness of the terms and conditions
of the Arrangement;

 

		(b)	prior to the issuance of the Interim Order, the Court will be advised of the intention of Akerna
and Purchaser to rely on the exemption provided by Section 3(a)(10) of the U.S. Securities Act with respect to the issuance of
Consideration Shares and Akerna Shares to be issued pursuant to the exchange of Exchangeable Shares, in each case pursuant to the
Arrangement, based on the Court’s approval of the Arrangement;

 

		(c)	prior to the issuance of the Interim Order, Ample will file with the Court a draft copy of the
proposed text of the Ample Circular together with any other documents required by Applicable Law in connection with the Ample Meeting;

 

		(d)	the Court will be advised that its approval of the Arrangement will be relied upon as a determination
that the Court has satisfied itself as to the procedural and substantive fairness of the terms and conditions of the Arrangement
to all Persons who are entitled to receive Consideration Shares and Akerna Shares to be issued pursuant to the exchange of Exchangeable
Shares, in each case pursuant to the Arrangement;

 

    - 27 -

     

    

 

		(e)	Ample will ensure that each Ample Shareholder and any other Person entitled to receive Consideration
Shares and Akerna Shares to be issued pursuant to the exchange of Exchangeable Shares, in each case pursuant to the Arrangement,
will be given adequate and appropriate notice advising them of their right to attend the hearing of the Court to approve the procedural
and substantive fairness of the terms and conditions of the Arrangement and providing them with sufficient information necessary
for them to exercise that right;

 

		(f)	the Final Order will expressly state that the Arrangement is approved by the Court as being procedurally
and substantively fair to all Persons entitled to receive Consideration Shares and Akerna Shares to be issued pursuant to the exchange
of Exchangeable Shares, in each case pursuant to the Arrangement;

 

		(g)	the Interim Order will specify that each Person entitled to receive Consideration Shares and Akerna
Shares to be issued pursuant to the exchange of Exchangeable Shares, in each case pursuant to the Arrangement, will have the right
to appear before the Court at the hearing of the Court to give approval of the Arrangement;

 

		(h)	the Court will hold a hearing before approving the fairness of the terms and conditions of the
Arrangement and issuing the Final Order; and

 

		(i)	all Consideration Shares and Akerna Shares to be issued pursuant to the exchange of Exchangeable
Shares, in each case issued to Persons in the United States, will be registered or qualified under the securities laws of each
state, territory or possession of the United States in which any Person receiving such securities is located, unless an exemption
from such state securities law registration or qualification requirements is available. In addition, the issuer of any Consideration
Shares or Akerna Shares to be issued pursuant to the exchange of Exchangeable Shares, in each case issued to a Person in any state,
territory or possession of the United States, shall comply with any issuer broker-dealer registration requirement applicable in
that state, territory or possession, unless an exemption from such issuer broker-dealer registration requirement is available.

 

		2.12	Effective Date

 

The Arrangement shall become effective
at the Effective Time on the Effective Date. The certificate of arrangement shall be conclusive evidence that the Arrangement has
become effective as of the Effective Time. The Parties shall use their commercially reasonable efforts to cause the Effective Date
to occur on or about February 28, 2020 or as soon thereafter as reasonably practicable and, in any event, by the Outside Date.

 

		2.13	Closing

 

The closing of the Arrangement will take
place at the offices of legal counsel to Ample, or at such other location as may be agreed upon by the Parties.

 

		2.14	Payment and Allocation of Up-front Consideration

 

		(a)	Akerna and Purchaser will, following receipt by Ample of the Final Order and prior to the Effective
Time, deposit in escrow with the Depositary (the terms and conditions of such escrow to be satisfactory to the Parties, acting
reasonably) the Effective Time Shares, sufficient funds to satisfy the Closing Cash Amount and CVRs evidencing Akerna’s and
Purchaser’s obligations with respect to the Deferred Consideration.

 

    - 28 -

     

    

 

		(b)	Akerna and Purchaser will, following receipt by Ample of the Final Order and at or prior to the
Effective Time, deposit in escrow with the Escrow Agent (the terms and conditions of such escrow to be satisfactory to the Parties,
acting reasonably) the Closing Shares to be held in escrow and distributed in accordance with the terms of this Agreement and the
Escrow Agreement.

 

		(c)	Akerna and Purchaser will, following receipt by Ample of the Final Order and at or prior to the
Effective Time, deposit in escrow with the Escrow Agent (the terms and conditions of such escrow to be satisfactory to the Parties,
acting reasonably) the Escrowed Shares to be held in escrow and distributed in accordance with the terms of this Agreement and
the Escrow Agreement.

 

		(d)	The entitlement of each Ample Shareholder to the Up-front Consideration (or any portion thereof)
shall be as prescribed by the Ample Articles, as determined by the Shareholder Representative acting reasonably and with reference
to the Effective Date Register.

 

		(e)	In no event shall Purchaser be required to issue a fractional Exchangeable Share. Where the aggregate
number of Exchangeable Shares to be issued as Up-front Consideration under the Arrangement would result in a fraction of an Exchangeable
Share being issuable, the number of Exchangeable Shares to be issued shall be rounded to the nearest whole Exchangeable Share (with
fractions equal to or greater than 0.5 being rounded up and fractions less than 0.5 being rounded down).

 

		2.15	Ample Options and Warrants

 

		(a)	Subject to Applicable Laws and to the receipt of the approval of NASDAQ:

 

		(i)	Each Ample Warrant outstanding at the Effective Time shall be continued on the same terms and conditions
as were applicable immediately prior to the Effective Time;

 

		(ii)	Each Ample Option outstanding at the Effective Time (whether vested or unvested) will be exchanged
for a Replacement Option to acquire, on the same terms and conditions as were applicable under such Ample Option immediately prior
to the Effective Time, such number of Akerna Shares as is equal to (A) that number of Ample Shares that were issuable upon exercise
of such Ample Option immediately prior to the Effective Time, multiplied by (B) the Exchange Ratio, rounded down to the nearest
whole number of Akerna Shares, at an exercise price per Akerna Share equal to the greater of the quotient determined by dividing
(X) the exercise price per Ample Share at which such Ample Option was exercisable immediately prior to the Effective Time, by (Y)
the Exchange Ratio, rounded up to the nearest whole cent, and such minimum amount that meets the requirements of paragraph 7(1.4)(c)
of the Tax Act.

 

		(b)	Pursuant to the terms of the Ample Options, Ample may facilitate the acceleration of the vesting
of any unvested Ample Options subject to accelerated vesting on a change of control of Ample as may be necessary or desirable to
allow all Optionholders to exercise their respective Ample Options for the purpose of participating in the Arrangement.

 

    - 29 -

     

    

 

		2.16	Satisfaction of Closing Indebtedness Amount and Transaction
Expenses

 

		(a)	Ample will, following receipt by Ample of the Final Order and prior to the Effective Time, provide
or cause to be provided to Akerna and Purchaser payout letters (the “Payout Letters”) with respect to the Closing
Indebtedness Amount, and will make arrangements reasonably satisfactory to the Akerna and Purchaser (i) for all lenders and creditors
entitled to repayment of any portion of the Closing Indebtedness Amount to provide to Akerna and the Purchaser recordable form
lien releases and other documents reasonably requested simultaneously with or promptly following the Effective Time to evidence
repayment, extinguishment and discharge of such portion of the Closing Indebtedness Amount, and (ii) to terminate effective as
of the Effective Time all obligations Ample and its Subsidiaries under the credit agreements, guarantees, security agreements and
other financial instruments and documents relating to such portion of the Closing Indebtedness Amount.

 

		(b)	At the Effective Time, Akerna and Purchaser shall satisfy and pay the Closing Indebtedness Amount
on behalf of each applicable debtor by paying directly to the applicable lenders and creditors in immediately available funds all
amounts owing in respect of the Closing Indebtedness Amount, if any, in each case, as directed pursuant to the Payout Letters.

 

		(c)	At the Effective Time, Akerna and Purchaser shall pay and satisfy all Transaction Expenses on behalf
of Ample by paying directly to the appropriate Persons set forth on Schedule 2.16(c) of the Ample Disclosure Letter in immediately
available funds all amounts owing in respect of the Transaction Expenses, in each case as set out on Schedule 2.16(c) of the Ample
Disclosure Letter.

 

		2.17	Indemnities and Directors’ and Officers’ Insurance

 

		(a)	Akerna and Purchaser agree that: (i) after the Effective Time, Ample and any successor to Ample
will not take any action to terminate or materially adversely affect indemnities provided or available to or in favour of past
and present officers and directors of Ample and the Ample Subsidiaries pursuant to the provisions of the articles, by-laws or other
constating documents of Ample or any Ample Subsidiary, applicable corporate legislation and any written indemnity agreements which
have been entered into between Ample and past and present officers and directors of Ample and the Ample Subsidiaries effective
on or prior to the date hereof (the forms of which were provided in the Ample Information); and (ii) immediately prior to the Effective
Time, Akerna will make arrangements satisfactory to the Ample Board, acting reasonably, to secure the obligations under such written
indemnity agreements.

 

		(b)	Prior to the Effective Date, Ample will secure “run-off” directors’ and officers’ liability
insurance for the current and former directors and officers of Ample and the Ample Subsidiaries, covering claims made or reported
within six years after the Effective Date, which has a scope and coverage substantially similar in scope and coverage to that provided
pursuant to Ample’s current directors and officers insurance policy, including coverage for any claims arising from completion
of the Arrangement and related transactions, and Purchaser will not take any action, or cause Ample to take any action, to adversely
affect or terminate such directors’ and officers’ liability insurance.

 

    - 30 -

     

    

 

		2.18	Withholding Taxes

 

Akerna, Purchaser, Ample, Callco and the
Depositary, as applicable, shall be entitled to deduct and withhold, or direct Akerna, Purchaser, Ample, Callco or the Depositary
to deduct and withhold on their behalf, from any consideration otherwise payable or otherwise deliverable to any Ample Shareholders
under the Plan of Arrangement such amounts as Akerna, Purchaser, Ample, Callco or the Depositary, as applicable, are required or
reasonably believe to be required to deduct and withhold from such consideration under any provision of any Applicable Law in respect
of Taxes. Any such amounts will be deducted, withheld and remitted from the consideration payable pursuant to the Plan of Arrangement
and shall be treated for all purposes under this Agreement as having been paid to Ample Shareholders in respect of which such deduction,
withholding and remittance was made.

 

		2.19	Deferred Consideration

 

		(a)	Not later than 45 calendar days after the Deferred Consideration Period, Akerna shall deliver to
the Shareholder Representative the Deferred Consideration Statement. The Deferred Consideration Statement shall be prepared in
accordance with U.S. GAAP applied consistently with Ample’s past practices (to the extent such past practices are consistent
with U.S. GAAP).

 

		(b)	The Deferred Consideration Statement shall be accompanied by all relevant backup materials, in
detail reasonably acceptable to the Shareholder Representative and such other material reasonably requested by the Shareholder
Representative, and a statement setting forth the amount, if any, of Deferred Consideration payable to holders of the CVRs.

 

		(c)	The Shareholder Representative shall have 20 Business Days to accept or dispute the Deferred Consideration
Statement by providing written notice of such acceptance or dispute to Akerna. In the event that Akerna does not receive any written
notice of acceptance or dispute of the Deferred Consideration Statement from the Shareholder Representative by the expiry of such
20 Business Day period, the Shareholder Representative will be deemed to have accepted the Deferred Consideration Statement for
and on behalf of all holders of CVRs. Notwithstanding the foregoing, the period for the Shareholder Representative to accept or
dispute the Deferred Consideration Statement shall be extended by such number of days as is equal to the period from: (i) the date
the Shareholder Representative requests other material as contemplated under Section 2.19(b); and (ii) the date all such material
is delivered to the Shareholder Representative.

 

		(d)	In the event the Shareholder Representative disputes the Deferred Consideration Statement, the
Shareholder Representative shall provide Akerna the nature and basis of such dispute, and Akerna and the Shareholder Representative
shall use their commercially reasonable efforts to reach agreement on the disputed amounts in order to determine the amount of
the Deferred Consideration payable, if any. If Akerna and the Shareholder Representative are unable to resolve the dispute within
15 Business Days, then any remaining items in dispute shall be submitted to an independent firm of professional accountants selected
by Akerna and the Shareholder Representative, and if the Parties fail to or refuse to mutually select a firm within a further five
Business Days after written request therefor by Akerna or the Shareholder Representative, as applicable, such independent firm
shall be KPMG LLP. All determinations and calculations pursuant to this subsection 2.19(d) shall consider only those Deferred Consideration
Statement calculations on which the Parties have disagreed, shall be in writing, and shall be delivered to Akerna and the Shareholder
Representative as promptly as practicable. The determination of the independent firm of professional accountants shall be binding
and conclusive upon all Parties and will not be subject to appeal, absent manifest error. The fees and expenses of the independent
firm of professional accountants shall be for the account of Akerna up to a maximum amount equal to $60,000; provided that all
such fees and expenses in excess of such amount shall be shared equally by the Shareholder Representative on the one hand, and
Akerna and Purchaser on the other hand.

 

    - 31 -

     

    

 

		(e)	If Deferred Consideration is payable in accordance with the Deferred Consideration Statement, then
Akerna or Purchaser shall promptly (and in any case within five Business Days of the acceptance or final determination of the Deferred
Consideration Statement) (the “Deferred Consideration Payment Date”) deliver to the Paying Agent such number of
Exchangeable Shares as is equal to the quotient obtained by dividing: (i) the dollar value of the Deferred Consideration payable,
by (ii) the 20 day volume weighted average price of the Akerna Shares (converted to Canadian dollars from US dollars using the
Exchange Rate as of the Deferred Consideration Payment Date) as quoted on the NASDAQ on the last trading day immediately preceding
the issuance of such Exchangeable Shares, to be held and released by the Paying Agent to the holders of CVRs in accordance with
the terms of the Rights Indenture.

 

		(f)	No certificates or other entitlements to fractional Exchangeable Shares shall be issued to any
holder of CVRs, and each holder of a CVR otherwise entitled to a fractional interest in an Exchangeable Share will receive the
nearest whole number of Exchangeable Shares (with fractions equal to or greater than 0.5 being rounded up and fractions less than
0.5 being rounded down).

 

		(g)	Akerna covenants and agrees that following the Effective Time and until the expiration of the Deferred
Consideration Period, Akerna shall cause Ample to make commercially reasonable efforts to preserve and expand the Recurring Revenue
recognized by Ample during the Deferred Consideration Period, and Akerna shall not take, or permit Ample to take, any action or
series of actions with respect to the business and affairs of Ample that are intended to lower or otherwise frustrate the Ample
Shareholders’ entitlement to receive all or any portion of the Deferred Consideration.

 

		2.20	Shareholder Representative

 

		(a)	In order to efficiently administer the transactions contemplated by this Agreement, the Plan of
Arrangement, the Escrow Agreement and the Rights Indenture, including: (i) the final determination of the Deferred Consideration
and the allocation of the Consideration among the Ample Shareholders in accordance with the Ample Articles; (ii) the exercise on
behalf of the Ample Shareholders of any voting rights, consent rights and/or the right to direct any votes with respect to the
Special Voting Share, in each case, attaching to Up-front Shares during such time as any such Up-front Shares are held in escrow
pursuant to the Escrow Agreement; (iii) the determination from time to time while the Up-front Shares (or any of them) are held
in escrow pursuant to this Escrow Agreement, of the number (if any) of Up-front Shares in respect of which each Ample Shareholder
shall be entitled to provide instructions with respect to the exercise of any voting rights (including any right to direct the
voting of the Special Voting Share) or consent right; (iv) the waiver of any condition to the obligations of Ample or the Ample
Shareholders to consummate the transactions contemplated hereby; and (v) the defense and/or settlement of any claims for which
the Ample Shareholder may be required to indemnify Akerna or Purchaser pursuant to this Agreement, the Shareholder Representative,
by virtue of the entering into of this Agreement by the Parties, is hereby appointed as the true, exclusive and lawful representative,
attorney-in-fact and agent for each Ample Shareholder in connection with this Agreement and the Plan of Arrangement.

 

    - 32 -

     

    

 

		(b)	The Shareholder Representative is hereby authorized to make all decisions, take all actions or
do any and all thing necessary relating to: (i) the final determination of the Deferred Consideration and the allocation of the
Consideration among the Ample Shareholders in accordance with the Ample Articles; (ii) the exercise on behalf of the Ample Shareholders
of any voting rights, consent rights and/or the right to direct any votes with respect to the Special Voting Share, in each case,
attaching to Up-front Shares during such time as any such Up-front Shares are held in escrow pursuant to the Escrow Agreement;
(iii) the determination from time to time while the Up-front Shares (or any of them) are held in escrow pursuant to this Escrow
Agreement, of the number (if any) of Up-front Shares in respect of which each Ample Shareholder shall be entitled to provide instructions
with respect to the exercise of any voting rights (including any right to direct the voting of the Special Voting Share) or consent
right; (iv) the waiver of any condition to the obligations of Ample or the Ample Shareholders to consummate the transactions contemplated
hereby; (v) the defense and/or settlement of any claims for which the Ample Shareholder may be required to indemnify Akerna or
Purchaser pursuant to this Agreement; and (vi) any and all additional actions contemplated to be taken by the Shareholder Representative
on behalf of the Ample Shareholders (or any of them) pursuant to this Agreement, the Plan of Arrangement, the Escrow Agreement
or the Rights Indenture.

 

		(c)	Akerna and Purchaser shall be able to rely conclusively on the instructions and decision of the
Shareholder Representative as to any decision or act of the Shareholder Representative taken in accordance with this Agreement,
the Plan of Arrangement, the Escrow Agreement or the Rights Indenture and no party shall have any cause of action against Akerna
or Purchaser for any action taken in reliance upon the instructions or decisions of the Shareholder Representative.

 

		(d)	No Ample Shareholder shall have any cause of action against the Shareholder Representative for
any action taken, decision made or instruction given by the Shareholder Representative in accordance with this Agreement, the Plan
of Arrangement, the Escrow Agreement or the Rights Indenture, except for fraud or wilful breach by the Shareholder Representative
of this Agreement, the Plan of Arrangement, the Escrow Agreement or the Rights Indenture. The Shareholder Representative shall
not be liable to any Ample Shareholder for any action taken or omitted to be taken by them in connection with this Agreement, the
Plan of Arrangement, the Escrow Agreement or the Rights Indenture in good faith and in the exercise of their reasonable judgment.

 

    - 33 -

     

    

 

		(e)	The provisions of this Section 2.20 are independent and severable, are irrevocable and coupled
with an interest and shall be enforceable notwithstanding any rights or remedies that any Ample Shareholder may have in connection
with the transactions contemplated by this Agreement, the Plan of Arrangement, the Escrow Agreement or the Rights Indenture.

 

		(f)	Remedies available at law for any breach of this Section 2.20 are inadequate, therefore, Akerna,
Purchaser and the Shareholder Representative shall be entitled to temporary and permanent injunctive relief without the necessity
of proving damages if either of them brings an action to enforce the provisions of this Section 2.20.

 

		(g)	The provisions of this Section 2.20 shall be binding upon the executors, heirs, legal representative,
personal representatives, successors and permitted assigns of each Ample Shareholder, and any references in this Agreement to an
Ample Shareholder or Ample Shareholders shall mean and include the successors to the Ample Shareholder’s rights hereunder, whether
pursuant to testamentary disposition, the laws of dissent and distribution or otherwise.

 

		(h)	Notwithstanding any other provision of this Agreement, the appointment of the Shareholder Representative
shall be subject to and conditional upon receipt of the Ample Shareholder Approval and the approval by the Court of the Arrangement
pursuant to the Interim Order and the Final Order.

 

		(i)	Ample hereby covenants and agrees that on or prior to the Effective Date, Ample shall furnish to
the Shareholder Representative a certified copy of the true and complete shareholder register of Ample as of the Effective Date
(the “Effective Date Register”).

 

		2.21	Adjustments to Deemed Value Amount

 

Notwithstanding anything in this Agreement
to the contrary, if, between the date of this Agreement and the Effective Time, the issued and outstanding Akerna Shares shall
have been changed into a different number of shares by reason of any split or consolidation of the issued and outstanding Akerna
Shares, then, it being acknowledged by the Parties that the Deemed Value amount set forth herein is intended to reflect the deemed
value of one Akerna Share on the Effective Date for the purpose of determining the number of Up-front Shares issuable hereunder,
the Deemed Value Amount shall be appropriately adjusted to provide to Ample Shareholders the same economic effect as contemplated
by this Agreement and the Arrangement prior to such action and as so adjusted shall, from and after the date of such event, be
the Deemed Value Amount for all purposes hereunder.

 

Article
3

COVENANTS

 

		3.1	Covenants of Ample Regarding the Conduct of Business

 

Ample covenants and agrees that, during
the period from the date of this Agreement until the earlier of the Effective Time and the time that this Agreement is terminated
in accordance with its terms, except as required or permitted by this Agreement, as required by Applicable Law, Governmental Entity
or existing Contract or unless Akerna and Purchaser otherwise agree in writing (such agreement not to be unreasonably withheld,
conditioned or delayed):

 

		(a)	other than as set out in Schedule 3.1(a) of the Ample Disclosure Letter, Ample shall and shall
cause each of its Subsidiaries to: (i) in all material respects conduct the business of Ample and its Subsidiaries (taken as a
whole) only in, and not take any action except in, the ordinary course of business consistent with past practice; and (ii) use
commercially reasonable efforts to preserve intact the present business organization, goodwill, business relationships and assets
of Ample and its Subsidiaries (taken as a whole) and to keep available the services of their officers and employees as a group;

 

    - 34 -

     

    

 

		(b)	without limiting the generality of Section 3.1(a), Ample shall not, and shall cause each of its
Subsidiaries not to, during the period from the date of this Agreement until the earlier of the Effective Time and the time that
this Agreement is terminated in accordance with its terms, directly or indirectly:

 

		(i)	amend or propose to amend its articles, notice of articles or other constating documents, including
partnership agreements of its Subsidiaries;

 

		(ii)	declare, set aside or pay any dividend or other distribution (whether in cash, securities or property
or any combination thereof) in respect of any Ample Shares;

 

		(iii)	other than as set out in Schedule 3.1(b) of the Ample Disclosure Letter, issue, sell, grant, award,
pledge, dispose of or otherwise encumber or agree to issue, sell, grant, award, pledge, dispose of or otherwise encumber any Ample
Shares or other equity or voting interests or any options, stock appreciation rights, warrants, calls, conversion or exchange privileges
or rights of any kind to acquire (whether on exchange, exercise, conversion or otherwise) any Ample Shares or other equity or voting
interests or other securities or any shares of its Subsidiaries;

 

		(iv)	split, combine or reclassify any outstanding Ample Shares or the securities of any of its Subsidiaries;

 

		(v)	redeem, purchase or otherwise acquire or offer to purchase or otherwise acquire Ample Shares or
other securities of Ample or any securities of its Subsidiaries;

 

		(vi)	amend the terms of any securities of Ample or any of its Subsidiaries;

 

		(vii)	adopt or propose a plan of liquidation or resolutions providing for the liquidation or dissolution
of Ample or any of its Subsidiaries;

 

		(viii)	reorganize, amalgamate or merge Ample or its Subsidiaries with any other Person;

 

		(ix)	sell, pledge, lease, dispose of, mortgage, licence, encumber or otherwise transfer or agree to
sell, pledge, lease, dispose of, mortgage, licence, encumber or otherwise transfer any assets of Ample or any of its Subsidiaries
or any interest in any assets of Ample or any of its Subsidiaries, except in the ordinary course of business consistent with past
practice and subject to a maximum (in terms of value of such assets or interests therein) of $100,000 (whether individually or
in the aggregate);

 

		(x)	acquire (by merger, consolidation, acquisition of stock or assets or otherwise) or agree to acquire,
directly or indirectly, in one transaction or in a series of related transactions, any Person, or make any investment or agree
to make any investment, directly or indirectly, in one transaction or in a series of related transactions, either by purchase of
shares or securities, contributions of capital (other than to wholly-owned Subsidiaries), property transfer or purchase of any
property or assets of any other Person, other than pursuant to acquisitions in the ordinary course of business consistent with
past practice that do not have a purchase or subscription price greater than $100,000 in the aggregate (including any assumed indebtedness);

 

    - 35 -

     

    

 

		(xi)	incur any capital expenditures or enter into any agreement obligating Ample or its Subsidiaries
to provide for future capital expenditures other than budgeted capital expenditures that (A) have been approved by the Ample Board
prior to the date of this Agreement; or (B) do not exceed $100,000 in the aggregate;

 

		(xii)	make any changes in financial accounting methods, principles, policies or practices, except as
required, in each case, by IFRS or by Applicable Laws;

 

		(xiii)	reduce the stated capital of the shares of Ample or any of its Subsidiaries;

 

		(xiv)	other than as set out in Schedule 3.1(b) of the Ample Disclosure Letter or in respect of pre-existing
indebtedness of any Person acquired by Ample in acquisitions permitted by Section 3.1(b)(x) or capital expenditures permitted by
Section 3.1(b)(xi), incur, create, assume or otherwise become liable for any indebtedness for borrowed money or any other material
liability or obligation or issue any debt securities, or guarantee, endorse or otherwise become responsible for, the obligations
of any other Person or make any loans or advances;

 

		(xv)	pay, discharge, settle, satisfy, compromise, waive, assign or release any claims, rights, liabilities
or obligations (including any litigation, proceeding or investigation by any Governmental Entity) other than:

 

		(A)	the payment, discharge or satisfaction, in the ordinary course of business, of liabilities reflected
or reserved against in Ample’s financial statements (or in those of any of its Subsidiaries) or incurred in the ordinary
course of business; or

 

		(B)	payment of any fees related to the Arrangement;

 

		(xvi)	other than as set out in Schedule 3.1(b) of the Ample Disclosure Letter, amend or modify in any
material respect or terminate or waive any material right under any Ample Material Contract or enter into any contract or agreement
that would be an Ample Material Contract if in effect on the date hereof;

 

		(xvii)	enter into or terminate any interest rate, currency, equity or commodity swaps, hedges, derivatives,
forward sales contracts or other financial instruments or like transaction, other than in the ordinary course of business consistent
with past practice;

 

		(xviii)	materially change the business carried on by Ample and its Subsidiaries, as a whole;

 

    - 36 -

     

    

 

		(xix)	other than as set out in Schedule 3.1(b) of the Ample Disclosure Letter: (A) grant, accelerate,
or increase any severance, change of control or termination pay to (or amend any existing arrangement relating to the foregoing
with) any director, officer or employee of Ample or any of its Subsidiaries; (B) grant, accelerate, or increase any payment, award
(equity or otherwise) or other benefits payable to, or for the benefit of, any director, officer or employee of Ample or any of
its Subsidiaries; (C) increase the coverage, contributions, funding requirements or benefits available under any benefit plan or
create any new plan which would be considered to be a benefit plan once created; (D) increase compensation (in any form), bonus
levels or other benefits payable to any director, officer, employee or consultant of Ample or any of its Subsidiaries or grant
any general increase in the rate of wages, salaries, bonuses or other remuneration, except in the ordinary course of business consistent
with past practice; (E) make any material determination under any Employee Plan that is not in the ordinary course of business
consistent with past practice; or (F) take or propose any action to effect any of the foregoing;

 

		(xx)	make any bonus or profit sharing distribution or similar payment of any kind;

 

		(xxi)	terminate the employment of any officer, except for cause; or

 

		(xxii)	take any action or fail to take any action which action or failure to act would reasonably be expected
to cause any Governmental Entities to institute proceedings for the suspension of, or the revocation or limitation of rights under,
any material authorizations necessary to conduct its businesses as now conducted, and use its commercially reasonable efforts to
maintain such authorizations;

 

		(c)	Ample shall use all commercially reasonable efforts to cause its current insurance (or re-insurance)
policies maintained by Ample or any of its Subsidiaries not to be cancelled or terminated or any of the coverage thereunder to
lapse, unless simultaneously with such termination, cancellation or lapse, replacement policies underwritten by insurance and reinsurance
companies of nationally recognized standing providing coverage equal to or greater than the coverage under the cancelled, terminated
or lapsed policies for substantially similar premiums are in full force and effect; provided that neither Ample nor any of its
Subsidiaries shall obtain or renew any insurance (or re-insurance) policy for a term exceeding 12 months;

 

		(d)	Ample and each of its Subsidiaries shall:

 

		(i)	not take any action inconsistent with past practice relating to the filing of any Tax Return or
the withholding, collecting, remitting and payment of any Tax, except as may be required by Applicable Laws;

 

		(ii)	not amend any Tax Return or change any of its methods of reporting income, deductions or accounting
for income Tax purposes from those employed in the preparation of its income tax return for the taxation year ended December 31,
2018, except as may be required by Applicable Laws;

 

    - 37 -

     

    

 

		(iii)	not make or revoke any material election relating to Taxes, other than any election that has yet
to be made in respect of any event or circumstance occurring prior to the date of the Agreement;

 

		(iv)	not enter into any Tax sharing, Tax allocation, Tax related waiver or Tax indemnification agreement;

 

		(v)	not settle (or offer to settle) any Tax claim, audit, proceeding or re-assessment that would reasonably
be expected to be material to Ample and its Subsidiaries, taken as a whole; and

 

		(vi)	keep Akerna reasonably informed, on a current basis, of any events, discussions, notices or changes
with respect to any Tax investigation (other than ordinary course communications which could not reasonably be expected to be material
to Ample and its Subsidiaries, taken as a whole); and

 

		(e)	Ample shall not authorize, agree to, propose, enter into or modify any contract, agreement, commitment
or arrangement, to do any of the matters prohibited by the other subsections of this Section 3.1 or resolve to do so.

 

		3.2	Covenants of Akerna Regarding the Conduct of Business

 

Akerna covenants and agrees that during
the period from the date of this Agreement until the earlier of the Effective Time and the time that this Agreement is terminated
in accordance with its terms, except as required or permitted by this Agreement, as required by Applicable Law, Governmental Entity
or existing Contract or unless Ample shall otherwise agree in writing (such agreement not to be unreasonably withheld, conditioned
or delayed):

 

		(a)	Akerna shall and shall cause each of its Subsidiaries to: (i) in all material respects conduct
the business of Akerna and its Subsidiaries (taken as a whole) only in, and not take any action except in, the ordinary course
of business consistent with past practice and in connection with the Akerna Transactions; and (ii) use commercially reasonable
efforts to preserve intact the present business organization, goodwill, business relationships and assets of Akerna and its Subsidiaries
(taken as a whole) and to keep available the services of their officers and employees as a group;

 

		(b)	without limiting the generality of Section 3.2(a), Akerna shall not, directly or indirectly:

 

		(i)	amend or propose to amend its articles, by-laws or other constating documents, other than to effect
a split or consolidation of the issued and outstanding Akerna Shares;

 

		(ii)	declare, set aside or pay any dividend or other distribution (whether in cash, securities or property
or any combination thereof) in respect of any Akerna Shares;

 

		(iii)	issue, sell, grant, award or pledge or agree to issue, sell, grant, award or pledge any Akerna
Shares or securities convertible into or exchangeable for Akerna Shares, other than in connection with the Arrangement and the
Akerna Transactions, Akerna Shares issuable pursuant to the terms of outstanding options and other convertible securities of Akerna,
securities granted or issued pursuant to Akerna’s equity compensation plans in the ordinary course of business and consistent
with past practice and Akerna Shares issued as part of the purchase price in connection with the acquisition of shares or assets
of another business by Akerna, directly or indirectly, by merger or otherwise;

 

    - 38 -

     

    

 

		(iv)	redeem, purchase or otherwise acquire or offer to purchase or otherwise acquire Akerna Shares or
other securities of Akerna, other than ordinary course purchases of Akerna Shares made in the public markets and at then prevailing
market price;

 

		(v)	adopt or propose a plan of liquidation or resolutions providing for the liquidation or dissolution
of Akerna;

 

		(vi)	other than in connection with the Akerna Transactions, merge Akerna with any other Person that
is not a wholly-owned Subsidiary of Akerna;

 

		(vii)	sell, pledge, lease, dispose of, mortgage, licence, encumber or otherwise transfer or agree to
sell, pledge, lease, dispose of, mortgage, licence, encumber or otherwise transfer all or substantially all of the assets of Akerna
and its Subsidiaries (on a consolidated basis);

 

		(viii)	reduce the stated capital of the shares of Akerna;

 

		(ix)	materially change the business carried on by Akerna and its Subsidiaries, taken as a whole;

 

		(x)	take any action or fail to take any action which action or failure to act would reasonably be expected
to cause any Governmental Entities to institute proceedings for the suspension of, or the revocation or limitation of rights under,
any material authorizations necessary to conduct its businesses as now conducted, and use its commercially reasonable efforts to
maintain such authorizations; or

 

		(xi)	take any action or series of actions that cause or would reasonably be expected to cause the Akerna
Shares to cease being traded on the NASDAQ; and

 

		(c)	Akerna shall not authorize, agree to, propose, enter into or modify any contract, agreement, commitment
or arrangement, to do any of the matters prohibited by the other subsections of this Section 3.2 or resolve to do so.

 

		3.3	Covenants of Akerna Relating to the Exchangeable Shares

 

Akerna shall and, where appropriate, shall
cause Purchaser to:

 

		(a)	create the Exchangeable Shares and the Special Voting Share prior to the Effective Time in a manner
reasonably acceptable to Ample and consistent with the Exchangeable Share Provisions attached hereto as Schedule “I”;

 

		(b)	prior to the Effective Time, incorporate and organize Callco under the laws of Ontario;

 

    - 39 -

     

    

 

		(c)	at the Effective Time, execute and deliver and cause Purchaser and Callco to execute and deliver
the Exchangeable Share Support Agreement and the Voting and Exchange Trust Agreement, as applicable;

 

		(d)	at the Effective Time, deliver the Special Voting Share in accordance with the Voting and Exchange
Trust Agreement;

 

		(e)	ensure that Purchaser is and continues to be at all relevant times a taxable Canadian corporation
within the meaning of the Tax Act;

 

		(f)	apply for and use commercially reasonable efforts to obtain conditional approval of the listing
and posting for trading on the NASDAQ of the Akerna Shares issuable pursuant to the exchange of the Exchangeable Shares;

 

		(g)	not take any action which could reasonably be expected to prevent the exchange of Ample Shares
for consideration that includes Exchangeable Shares under the Arrangement by Eligible Holders who make and file a valid tax election
under subsection 85(1) or (2) of the Tax Act as described and on the terms set forth in the Plan of Arrangement from being treated
as a tax-deferred transaction for purposes of the Tax Act if such holders are otherwise eligible for such treatment; and

 

		(h)	do all things necessary (as further described in the Exchangeable Share Support Agreement and the
Exchangeable Share terms contained in Purchaser’s articles of incorporation) to permit the exchange of the Exchangeable Shares
for Akerna Shares.

 

		3.4	Covenants of Akerna Regarding Blue-Sky Laws

 

Akerna shall use its commercially reasonable
efforts ensure that the Exchangeable Shares, and the Akerna Shares to be issued pursuant to the exchange of the Exchangeable Shares,
in each case to be issued pursuant to the Arrangement shall, at the Effective Time, either be registered or qualified under all
applicable U.S. Securities Laws, or exempt from such registration and qualification requirements.

 

		3.5	Mutual Covenants Regarding the Arrangement

 

Each of the Parties covenants and agrees
that, subject to the terms and conditions of this Agreement, during that period from the date of this Agreement until the earlier
of the Effective Time and the time that this Agreement is terminated in accordance with its terms:

 

		(a)	it shall use its commercially reasonable efforts to, and shall cause its Subsidiaries to use all
commercially reasonable efforts to, satisfy (or cause the satisfaction of) the conditions precedent to its obligations hereunder
as set forth in Article 5 to the extent the same is within its control and to take, or cause to be taken, all other action and
to do, or cause to be done, all other things necessary, proper or advisable under all Applicable Laws to complete the Arrangement,
including using its commercially reasonable efforts to promptly: (i) obtain all necessary and material waivers, consents and approvals
required to be obtained by it from parties to any Contracts; (ii) obtain all necessary and material Authorizations as are required
to be obtained by it or any of its Subsidiaries under Applicable Laws; (iii) fulfill all conditions and satisfy all provisions
of this Agreement and the Arrangement; and (iv) co-operate with the other Party in connection with the performance by it and its
Subsidiaries of their obligations hereunder;

 

    - 40 -

     

    

 

		(b)	it shall not take any action, shall refrain from taking any action, and shall not permit any action
to be taken or not taken, which is inconsistent with this Agreement or which would reasonably be expected to, individually or in
the aggregate, materially impede or materially delay the consummation of the Arrangement or the other transactions contemplated
herein;

 

		(c)	it shall use commercially reasonable efforts to: (i) defend all lawsuits or other legal, regulatory
or other proceedings against itself or any of its Subsidiaries challenging or affecting this Agreement or the consummation of the
transactions contemplated hereby; (ii) appeal, overturn or have lifted or rescinded any injunction or restraining order or other
order, including orders, relating to itself or any of its Subsidiaries which may materially adversely affect the ability of the
Parties to consummate the Arrangement; and (iii) appeal or overturn or otherwise have lifted or rendered non-applicable in respect
of the Arrangement, any Applicable Law that makes consummation of the Arrangement illegal or otherwise prohibits or enjoins Ample
or Akerna from consummating the Arrangement; and

 

		(d)	it shall carry out the terms of the Interim Order and Final Order applicable to it and use commercially
reasonable efforts to comply promptly with all requirements which Applicable Laws may impose on it or its Subsidiaries or Affiliates
with respect to the transactions contemplated hereby.

 

Each Party will use its commercially reasonable
efforts to cooperate with the other in connection with the performance by the other of their obligations under this Section 3.5
and this Agreement including continuing to provide reasonable access to information and to maintain ongoing communications as between
officers of each Party, subject in all cases to the Confidentiality Agreement.

 

		3.6	Covenants of Akerna and Purchaser

 

Subject to the other provisions of this
Agreement, Akerna and Purchaser jointly covenant and agree that, from the date of this Agreement until the Effective Date or termination
of this Agreement, except with the prior written consent of Ample (such consent not to be unreasonably withheld, conditioned or
delayed), and except as otherwise expressly permitted or specifically contemplated by this Agreement (including the Plan of Arrangement)
or required by Applicable Laws, they will:

 

		(a)	provide Ample and its legal counsel with reasonable opportunity to review and comment upon drafts
of all Purchaser Circular Disclosure and will give reasonable consideration to the comments of Ample and its counsel with respect
to any information to be included in such material and any other matters contained therein and ensure that the Purchaser Circular
Disclosure provided by it expressly for inclusion in the Ample Circular does not, at the time of the mailing of the Ample Circular,
contain any misrepresentation;

 

		(b)	use its commercially reasonable efforts to take all such steps as are necessary to set the record
date for the Akerna Meeting as a date not later than January 27, 2020;

 

		(c)	subject to the terms of this Agreement, use their commercially reasonable efforts take all such
steps as are necessary to convene and hold the Akerna Meeting in accordance with Applicable Laws not later than February 26, 2020
for the purpose of considering the Akerna Shareholder Matters and, unless this Agreement will have been terminated in accordance
with subsection 8.1(a), Akerna will not cancel the Akerna Meeting or fail to put the Akerna Shareholder Matters before the Akerna
Shareholders for their consideration without Ample’s prior written consent, other than as may be required under Applicable
Laws; and Akerna will not propose to adjourn or postpone the Akerna Meeting without the prior consent of Ample except as required
by Applicable Laws or by a Governmental Entity and except as required under subsections 2.5(d) or 5.45.4(b); and Akerna shall,
if requested by Ample (acting reasonably), adjourn the Akerna Meeting one or more times for the purposes of obtaining any required
quorum or attempting to obtain the requisite approval of the Akerna Shareholder Matters;

 

    - 41 -

     

    

 

		(d)	subject to compliance by Ample with its obligations set forth in subsection 3.7(i), as soon as
practicable after the execution and delivery of this Agreement, prepare the Akerna Circular together with any other documents required
by Applicable Laws in connection with the Akerna Meeting required to be filed or prepared by Akerna and, subject to subsection
3.7(i), as soon as practicable after the execution and delivery of this Agreement, Akerna shall, unless otherwise agreed by Ample,
cause the Akerna Circular and other documentation required in connection with the Akerna Meeting to be sent to the Akerna Shareholders
and be filed as required by Applicable Laws;

 

		(e)	provide Ample and its legal counsel a reasonable opportunity to review and comment on drafts of
the Akerna Circular and other documents to be sent to the Akerna Shareholders in connection with the Akerna Meeting, and will give
reasonable consideration to any comments made by Ample and their counsel, provided that all information included in the Akerna
Circular and any other documents to be sent to the Akerna Shareholders in connection with the Akerna Meeting relating to Ample
will be in form and content satisfactory to Ample, acting reasonably;

 

		(f)	ensure that the Akerna Circular (other than any Ample Circular Disclosure included in the Akerna
Circular that was provided to Akerna by, or approved by, Ample expressly for inclusion in the Akerna Circular) complies with Applicable
Laws and, without limiting the generality of the foregoing, that the Akerna Circular will not contain a misrepresentation and provides
the Akerna Shareholders with information in sufficient detail to permit them to form a reasoned judgment concerning the Akerna
Shareholder Matters and will include: (i) the unanimous determination of the Akerna Board that voting in favour of the Akerna Shareholder
Matters is in the best interests of Akerna and the unanimous recommendation that the Akerna Shareholders vote in favour of the
Akerna Shareholder Matters; (ii) a statement that each director and officer of Akerna intends to vote all of such Person’s Akerna
Shares (including any Akerna Shares issued upon exercise or exchange of any securities convertible or exercisable into Akerna Shares)
in favour of the Akerna Shareholder Matters; and (iii) any other disclosure required under Applicable Securities Laws that is required
to be included in the Akerna Circular;

 

		(g)	ensure that all Purchaser Circular Disclosure included in the Ample Circular that was provided
to Ample by or approved by Akerna or Purchaser complies with Applicable Laws;

 

    - 42 -

     

    

 

		(h)	indemnify and save harmless Ample and its directors and officers from and against any and all liabilities,
claims, demands, losses, costs, damages and expenses (excluding any loss of profits or consequential damages) to which Ample or
its directors and officers may be subject or which Ample or its directors or officers may suffer, whether under the provisions
of any statute or otherwise, in any way caused by, or arising, directly or indirectly, from or in consequence of:

 

		(i)	any misrepresentation or alleged misrepresentation contained in: (A) the Akerna Circular (other
than in respect of Ample Circular Disclosure); (B) in any Purchaser Circular Disclosure included in the Ample Circular that was
provided to Ample by, or approved by, Akerna or Purchaser expressly for inclusion in the Ample Circular; or (C) any material filed
by Akerna in connection with the transactions contemplated by this Agreement in compliance or intended compliance with any Applicable
Laws;

 

		(ii)	any order made or any inquiry, investigation or proceeding by any securities commission or other
competent authority based upon any Misrepresentation or alleged Misrepresentation contained in: (A) the Akerna Circular (other
than in respect of Ample Circular Disclosure); (B) the Purchaser Circular Disclosure included in the Ample Circular that was provided
to Ample by, or approved by, Akerna or Purchaser expressly for inclusion in the Ample Circular; or (C) in any material filed by
or on behalf of Akerna or Purchaser in compliance or intended compliance with Applicable Securities Laws; and

 

		(iii)	Akerna or Purchaser not complying with any requirement of Applicable Laws in connection with the
transactions contemplated in this Agreement,

 

except that Akerna and/or Purchaser
will not be liable in any such case to the extent that any such liabilities, claims, demands, losses, costs, damages and expenses
arise out of:

 

		(iv)	any information contained in the Ample Circular other than the Purchaser Circular Disclosure included
in the Ample Circular that was provided to Ample by, or approved by, Akerna or Purchaser expressly for inclusion in the Ample Circular;

 

		(v)	any Ample Circular Disclosure included in the Akerna Circular that was provided to Akerna by, or
approved by, Ample expressly for inclusion in the Akerna Circular;

 

		(vi)	or the negligence of Ample or the non-compliance by Ample with any requirement of Applicable Laws
in connection with the transactions contemplated by this Agreement;

 

		(i)	provide notice to Ample of the Akerna Meeting and allow Ample’s Representatives to attend
the Akerna Meeting;

 

		(j)	except for proxies and other non-substantive communications with Akerna Shareholders and communications
that Akerna is required to keep confidential pursuant to Applicable Law, furnish promptly to Ample or their counsel: (i) a copy
of each notice, report, schedule or other document delivered, filed or received by Akerna from securityholders or Governmental
Entities in connection with the Arrangement or the Akerna Meeting; (ii) any filings under Applicable Laws in connection with the
transactions contemplated hereby; and (iii) any dealings with stock exchanges, regulatory agencies or other governmental authorities
in connection with the transactions contemplated hereby;

 

		(k)	solicit proxies to be voted at the Akerna Meeting in favour of the Akerna Shareholder Matters;

 

    - 43 -

     

    

 

		(l)	promptly advise Ample of the number or amount of Ample Shares for which Akerna receives notices
of dissent or written objections to the Akerna Shareholder Matters and provide Ample with copies of such notices and written objections
and subject to Applicable Laws;

 

		(m)	promptly inform Ample of any requests or comments made by Securities Authorities in connection
with the Akerna Circular and any other required filings under Applicable Laws; and each of the Parties will cooperate with the
other and will diligently do all such acts and things as may be necessary in the manner contemplated in the context of the preparation
of the Akerna Circular and any other required filings under Applicable Laws and use its commercially reasonable efforts to resolve
all requests or comments made by Securities Authorities with respect to the Akerna Circular and any other required filings under
Applicable Laws as promptly as practicable after receipt thereof;

 

		(n)	advise Ample, as Ample may request, and on a daily basis on each of the last five Business Days
prior to the proxy cut-off date for the Akerna Meeting, as to the aggregate tally of the proxies received by Akerna in respect
of the Akerna Shareholder Matters and any other matters to be considered at the Akerna Meeting, and provide Ample with copies of
any materials, or grant access to information regarding the Akerna Meeting, generated by any proxy solicitation firm;

 

		(o)	keep Ample informed as to discussions between Akerna and any Person holding not less than 10% of
the voting rights attached to all of the Akerna Shares with respect to the Akerna Shareholder Matters;

 

		(p)	take or cause to be taken all corporate action to allot and reserve for issuance the Exchangeable
Shares to be issued in exchange for the Ample Shares, and the Akerna Shares to be issued in exchange for the Exchangeable Shares;

 

		(q)	take or cause to be taken all corporate action to maintain the listing of the Akerna Shares on
the NASDAQ;

 

		(r)	take or cause to be taken all corporate action to enter into the Rights Indenture and to create
and issue the CVRs to each former holder of Ample Shares at the Effective Time;

 

		(s)	take or cause to be taken all corporate action, as reasonably requested by Ample or its counsel,
to assist Ample in diligently pursuing the application to the Court for the Final Order; and

 

		(t)	make all necessary filings and applications under Applicable Laws, including Applicable Securities
Laws, required to be made on the part of Akerna and Purchaser in connection with the transactions contemplated herein, including,
without limitation, for all Regulatory Approvals, and shall take all commercially reasonable action necessary to be in compliance
with such Applicable Laws.

 

    - 44 -

     

    

 

		3.7	Covenants of Ample Regarding the Arrangement

 

Subject to the other provisions of this
Agreement, Ample covenants and agrees that, from the date of this Agreement until the Effective Date or termination of this Agreement,
except with the prior written consent of Akerna and Purchaser (such consent not to be unreasonably withheld, conditioned or delayed),
and except as otherwise expressly permitted or specifically contemplated by this Agreement (including the Plan of Arrangement)
or required by Applicable Laws, it will:

 

		(a)	provide Akerna and Purchaser and their legal counsel with reasonable opportunity to review and
comment upon drafts of all materials to be filed with the Court in connection with the Arrangement, including by providing on a
timely basis a description of any information required to be supplied by Akerna and Purchaser for inclusion in such material, prior
to the service and filing of such material, and will give reasonable consideration to the comments of Akerna and Purchaser and
their counsel with respect to any information to be included in such material and any other matters contained therein;

 

		(b)	ensure that all material filed with the Court in connection with the Arrangement is consistent
in all material respects with the terms of this Agreement and the Plan of Arrangement;

 

		(c)	not object to legal counsel to Akerna and Purchaser making such submissions on the application
for the Interim Order and the application for the Final Order as such counsel considers appropriate (acting reasonably), provided
such submissions are in all material respects consistent with this Agreement and the Plan of Arrangement;

 

		(d)	use its commercially reasonable efforts to take all such steps as are necessary to set the record
date for the Ample Meeting as a date not later than January 27, 2020;

 

		(e)	subject to the terms of this Agreement and in accordance and compliance with the Interim Order,
use its commercially reasonable efforts to take all such steps as are necessary to convene and hold the Ample Meeting in accordance
with the Interim Order and Applicable Laws not later than February 26, 2020 for the purpose of considering the Arrangement Resolution
and, unless this Agreement will have been terminated in accordance with subsection 8.1(a), Ample will not cancel the Ample Meeting
or fail to put the Arrangement Resolution before the Ample Shareholders for their consideration without Akerna and Purchaser’s
prior written consent, other than as may be required under the Interim Order or Applicable Laws and Ample will not propose to adjourn
or postpone the Ample Meeting without the prior consent of Akerna and Purchaser except as required by Applicable Laws or by a Governmental
Entity and except as required under subsections 2.6(d) or 5.4(b); and Ample shall, if requested by Akerna and Purchaser (each acting
reasonably), adjourn the Ample Meeting one or more times for the purposes of obtaining any required quorum or attempting to obtain
the requisite approval of the Arrangement Resolution;

 

		(f)	subject to compliance by Akerna and Purchaser with their obligations set forth in subsection 3.6(g)
as soon as practicable after the execution and delivery of this Agreement, prepare the Ample Circular together with any other documents
required by Applicable Laws in connection with the Ample Meeting required to be filed or prepared by Ample and, subject to subsection
3.6(g), as soon as practicable after the execution and delivery of this Agreement, Ample shall, unless otherwise agreed by Akerna
and Purchaser, cause the Ample Circular and other documentation required in connection with the Ample Meeting to be sent to the
Ample Shareholders and be filed as required by the Interim Order and Applicable Laws;

 

    - 45 -

     

    

 

		(g)	provide Akerna and Purchaser and their legal counsel a reasonable opportunity to review and comment
on drafts of the Ample Circular and other documents to be sent to the Ample Shareholders in connection with the Ample Meeting or
the Arrangement, and will give reasonable consideration to any comments made by Akerna and Purchaser and their counsel, provided
that all information included in the Ample Circular and any other documents to be sent to the Ample Shareholders in connection
with the Ample Meeting or the Arrangement relating to Akerna and Purchaser will be in form and content satisfactory to Akerna and
Purchaser, each acting reasonably;

 

		(h)	ensure that the Ample Circular (other than any Purchaser Circular Disclosure included in the Ample
Circular that was provided to Ample by, or approved by, Akerna or Purchaser expressly for inclusion in the Ample Circular) complies
with Applicable Laws and, without limiting the generality of the foregoing, that the Ample Circular will not contain a misrepresentation
and provides the Ample Shareholders with information in sufficient detail to permit them to form a reasoned judgment concerning
the matters before them and will include: (i) the unanimous determination of the Ample Board that the Arrangement is in the best
interests of Ample, is fair to the Ample Shareholders, and the unanimous recommendation that the Ample Shareholders vote in favour
of the Arrangement Resolution; (ii) a statement that each director and officer of Ample intends to vote all of such Person’s Ample
Shares (including any Ample Shares issued upon exercise or exchange of any Ample Options or Ample Warrants) in favour of the Arrangement
Resolution; and (iii) any other disclosure required under Applicable Securities Laws that is required to be included in the Ample
Circular;

 

		(i)	ensure that all Ample Circular Disclosure included in the Akerna Circular that was provided to
Akerna by or approved by Ample complies with Applicable Laws;

 

		(j)	indemnify and save harmless Akerna and Purchaser and their respective directors and officers from
and against any and all liabilities, claims, demands, losses, costs, damages and expenses (excluding any loss of profits or consequential
damages) to which Akerna, Purchaser or their respective directors and officers may be subject or which Akerna, Purchaser or their
respective directors or officers may suffer, whether under the provisions of any statute or otherwise, in any way caused by, or
arising, directly or indirectly, from or in consequence of:

 

		(i)	any misrepresentation or alleged misrepresentation contained in: (A) the Ample Circular (other
than in respect of the Purchaser Circular Disclosure); (B) in any Ample Circular Disclosure included in the Akerna Circular that
was provided to Akerna by, or approved by, Ample expressly for inclusion in the Akerna Circular; or (C) any material filed by Ample
in connection with the transactions contemplated by this Agreement in compliance or intended compliance with any Applicable Laws;

 

		(ii)	any order made or any inquiry, investigation or proceeding by any securities commission or other
competent authority based upon any Misrepresentation or alleged Misrepresentation contained in: (A) the Ample Circular (other than
in respect of the Purchaser Circular Disclosure); (B) the Ample Circular Disclosure included in the Akerna Circular that was provided
to Akerna by, or approved by, Ample expressly for inclusion in the Akerna Circular; or (C) in any material filed by or on behalf
of Ample in compliance or intended compliance with Applicable Securities Laws; and

 

    - 46 -

     

    

 

		(iii)	Ample not complying with any requirement of Applicable Laws in connection with the transactions
contemplated in this Agreement,

 

except that Ample will not be liable
in any such case to the extent that any such liabilities, claims, demands, losses, costs, damages and expenses arise out of:

 

		(iv)	any information contained in the Akerna Circular other than Ample Circular Disclosure included
in the Akerna Circular that was provided to Akerna by, or approved by, Ample expressly for inclusion in the Akerna Circular;

 

		(v)	any Purchaser Circular Disclosure included in the Ample Circular that was provided to Ample by,
or approved by, Akerna or Purchaser expressly for inclusion in the Ample Circular;

 

		(vi)	or the negligence of Akerna or Purchaser or the non-compliance by Akerna or Purchaser with any
requirement of Applicable Laws in connection with the transactions contemplated by this Agreement;

 

		(k)	provide notice to Akerna and Purchaser of the Ample Meeting and allow Akerna’s and Purchaser’s
Representatives to attend the Ample Meeting;

 

		(l)	except for proxies and other non-substantive communications with the holders of Ample securityholders
and communications that Ample is required to keep confidential pursuant to Applicable Law, furnish promptly to Akerna and Purchaser
or their counsel: (i) a copy of each notice, report, schedule or other document delivered, filed or received by Ample from securityholders
or Governmental Entities in connection with the Arrangement or the Ample Meeting; (ii) any filings under Applicable Laws in connection
with the transactions contemplated hereby; and (iii) any dealings with stock exchanges, regulatory agencies or other governmental
authorities in connection with the transactions contemplated hereby;

 

		(m)	solicit proxies to be voted at the Ample Meeting in favour of matters to be considered at the Ample
Meeting, including the Arrangement Resolution;

 

		(n)	promptly advise Akerna and Purchaser of the number or amount of Ample Shares for which Ample receives
notices of dissent or written objections to the Arrangement and provide Akerna and Purchaser with copies of such notices and written
objections and subject to Applicable Laws, will provide Akerna and Purchaser with an opportunity to review and comment upon any
written communications proposed to be sent by or on behalf of Ample to any Ample Shareholder exercising or purporting to exercise
Dissent Rights in relation to the Arrangement Resolution and reasonable consideration will be given to any comments made by Akerna
and Purchaser and their counsel prior to sending any such written communications; provided that, Ample will not settle any
claims with respect to Dissent Rights without the prior written consent of Akerna and Purchaser (such consent not to be unreasonably
withheld, conditioned or delayed);

 

		(o)	promptly inform Akerna and Purchaser of any requests or comments made by Securities Authorities
in connection with the Ample Circular and any other required filings under Applicable Laws; and each of the Parties will cooperate
with the other and will diligently do all such acts and things as may be necessary in the manner contemplated in the context of
the preparation of the Ample Circular and any other required filings under Applicable Laws and use its commercially reasonable
efforts to resolve all requests or comments made by Securities Authorities with respect to the Ample Circular and any other required
filings under Applicable Laws as promptly as practicable after receipt thereof;

 

    - 47 -

     

    

 

		(p)	advise Akerna and Purchaser, as Akerna and Purchaser may request, and on a daily basis on each
of the last five Business Days prior to the proxy cut-off date for the Ample Meeting, as to the aggregate tally of the proxies
received by Ample in respect of the Arrangement Resolution and any other matters to be considered at the Ample Meeting, and provide
Akerna and Purchaser with copies of any materials, or grant access to information regarding the Ample Meeting, generated by any
proxy solicitation firm;

 

		(q)	subject to obtaining such approvals as are required by the Interim Order, proceed with and diligently
pursue the application to the Court for the Final Order;

 

		(r)	provide Akerna and Purchaser’s legal counsel, on a timely basis, with copies of any notice and
evidence served on Ample or its legal counsel in respect of the application for the Final Order or any appeal therefrom;

 

		(s)	keep Akerna and Purchaser informed as to discussions with all Significant Shareholders;

 

		(t)	make all necessary filings and applications under Applicable Laws, including Applicable Securities
Laws, required to be made on the part of Ample in connection with the transactions contemplated herein, including, without limitation,
for all Regulatory Approvals, and will take all actions necessary to be in compliance with such Applicable Laws;

 

		(u)	use its commercially reasonable efforts to obtain resignations and mutual releases (in a form satisfactory
to Akerna), to be effective at the Effective Time, from all directors of Ample on or prior to the Effective Time;

 

		(v)	use its commercially reasonable efforts to obtain Employment Agreements, to be effective at the
Effective Time, from all of the Retained Personnel on or prior to the Effective Time; and

 

		3.8	Covenants of Ample Regarding Non-Solicitation

 

		(a)	Except as otherwise expressly provided in this Section 3.8, Ample shall not, directly or indirectly
through any Representative:

 

		(i)	solicit, assist, initiate, knowingly encourage or otherwise facilitate (including by way of furnishing
confidential information or entering into any form of agreement, arrangement or understanding) any inquiry, proposal or offer that
constitutes or may reasonably be expected to constitute or lead to an Acquisition Proposal;

 

		(ii)	enter into, engage in, continue or otherwise participate in any discussions or negotiations with
any Person (other than Akerna and its Subsidiaries or affiliates) in respect of any inquiry, proposal or offer that constitutes
or may reasonably be expected to lead to an Acquisition Proposal, it being acknowledged and agreed that, provided Ample is then
in compliance with its obligations under this Section 3.8, Ample may: (A) advise a Person who has submitted a written Acquisition
Proposal of the restrictions in this Agreement; or (B) advise a Person who has submitted a written Acquisition Proposal that their
Acquisition Proposal does not constitute a superior proposal;

 

    - 48 -

     

    

 

		(iii)	accept, approve, endorse or recommend, or publicly propose to accept, approve, endorse or recommend,
or take no position or remain neutral with respect to, any publicly announced or publicly proposed Acquisition Proposal (it being
understood that publicly taking no position or a neutral position with respect to any Acquisition Proposal for a period of no more
than three Business Days following the formal announcement of such Acquisition Proposal will not be considered to be in violation
of this Section 3.8(a)(iii) provided the Ample Board has rejected such Acquisition Proposal and affirmed the Ample Board Recommendation
before the end of such three Business Day period);

 

		(iv)	approve, recommend or enter into (other than a confidentiality agreement permitted by and in accordance
with this Section 3.8) or publicly propose to enter into any agreement to accept, recommend, approve or enter into any agreement
in respect of an Acquisition Proposal; or

 

		(v)	withdraw, amend, modify or qualify, or publicly propose or state an intention to withdraw, amend,
modify or qualify, the Ample Board Recommendation.

 

		(b)	Ample shall, and shall cause its Subsidiaries and Representatives to immediately cease and terminate,
and cause to be ceased and terminated, any solicitation, encouragement, discussion or negotiations commenced prior to the date
of this Agreement with any Person (other than Akerna) with respect to any inquiry, proposal or offer that constitutes, or may reasonably
be expected to constitute or lead to, an Acquisition Proposal and, in connection therewith, Ample will discontinue access to and
disclosure of its and its Subsidiaries’ confidential information (and not allow access to or disclosure of any such confidential
information, or any data room, virtual or otherwise) and shall as soon as possible request, and exercise all rights it has (or
cause its Subsidiaries to exercise any rights that they have) to require the return or destruction of all confidential information
regarding Ample and its Subsidiaries previously provided in connection therewith to any Person other than Akerna to the extent
such information has not already been returned or destroyed.

 

		(c)	Ample shall as soon as practicable, and in any event, within 24 hours, notify Akerna (orally at
first and then in writing) if it receives or otherwise becomes aware of any proposal or offer that constitutes or may reasonably
be expected to constitute or lead to an Acquisition Proposal, of such Acquisition Proposal, inquiry, proposal or offer, including
the identity of the Person making such Acquisition Proposal, inquiry, proposal or offer and the material terms and conditions thereof
and copies of all material or substantive documents received in respect of, from or on behalf of any such Person. Ample shall keep
Akerna promptly and fully informed of the status of developments and discussions and negotiations with respect to such Acquisition
Proposal, proposal or offer, including any material changes, modifications or other amendments thereto.

 

		(d)	Ample will ensure that the Representatives retained by it are aware of the provisions of this Section
3.8 and will be responsible for any breach of this Section 3.8 by any of them.

 

    - 49 -

     

    

 

		(e)	Nothing contained in this Agreement shall prohibit the Ample Board from withdrawing, modifying,
qualifying or changing its recommendation to the Ample Shareholders in respect of the transactions contemplated herein prior to
the approval of the Arrangement by such Ample Shareholders, if the Ample Board determines, in good faith (after consultation with
its financial advisors and after receiving advice of outside counsel), that the failure to make such withdrawal, modification,
qualification or change would be inconsistent with its fiduciary duties under Applicable Laws; provided that: (i) prior to making
any such withdrawal, modification, qualification or change of recommendation, Ample shall give Akerna not less than 48 hours’
notice of its intention thereof; and (ii) the foregoing shall not relieve Ample from its obligation to proceed to call and hold
the Ample Meeting (provided that, except as required under Applicable Laws, Ample shall be relieved from any obligation to actively
solicit proxies in favour of the Arrangement in such circumstances), except in circumstances where this Agreement is terminated
in accordance with the terms hereof.

 

		(f)	Nothing in this Section 3.8 shall prohibit Ample or its Representatives from complying with Part
2 Division 3 of Multilateral Instrument 62-104 Take-Over Bids and Issuer Bids and similar provisions under Applicable Securities
Laws relating to the provision of directors circulars in respect of an Acquisition Proposal.

 

		3.9	Mutual Covenants Regarding Regulatory Approvals

 

		(a)	Each Party, as applicable to that Party, covenants and agrees with respect to obtaining all Regulatory
Approvals that, subject to the terms and conditions of this Agreement, until the earlier of the Effective Time and the date on
which this Agreement is terminated in accordance with its terms:

 

		(i)	each Party shall use its commercially reasonable efforts to obtain all Regulatory Approvals and
co-operate with the other Party in connection with all Regulatory Approvals sought by the other Party and shall use its commercially
reasonable efforts to effect all necessary registrations, filings and submissions of information required by Governmental Entities
relating to the Arrangement or this Agreement;

 

		(ii)	each Party shall use commercially reasonable efforts to respond promptly to any request or notice
from any Governmental Entity requiring that Party to supply additional information that is relevant to the review of the transactions
contemplated by this Agreement in respect of obtaining or concluding the Regulatory Approvals sought by either Party and each Party
shall co-operate with the other Party and shall furnish to the other Party such information and assistance as a Party may reasonably
request in connection with preparing any submission or responding to such notice from a Governmental Entity;

 

		(iii)	subject to compliance with Applicable Laws, each Party shall permit the other Party an opportunity
to review in advance any proposed substantive applications, notices, filings, submissions, undertakings, correspondence and communications
(including responses to requests for information and inquiries from any Governmental Entity) in respect of obtaining or concluding
the Regulatory Approvals and shall provide the other Party with a reasonable opportunity to comment thereon and agree to consider
those comments in good faith and each Party shall provide the other Party with any substantive applications, notices, filings,
submissions, undertakings or other substantive correspondence provided to a Governmental Entity or any substantive communications
received from a Governmental Entity, in respect of obtaining or concluding the Regulatory Approvals; and

 

    - 50 -

     

    

 

		(iv)	subject to compliance with Applicable Laws, each Party shall keep the other Party reasonably informed
on a timely basis of the status of discussions relating to obtaining or concluding the Regulatory Approvals sought by each such
Party and, for certainty, no Party shall participate in any substantive meeting (whether in person, by telephone or otherwise)
with a Governmental Entity in respect of obtaining or concluding the required Regulatory Approvals unless it advises the other
Party in advance and gives such other Party an opportunity to attend.

 

		3.10	Covenants Regarding Provision of Information; Access

 

From and after the date
hereof, until the Effective Time or termination of this Agreement, Ample, to the extent it is not restricted from doing so pursuant
to confidentiality or other restrictions (in which circumstances it will use its commercially reasonable efforts to obtain a waiver
thereof) shall provide Akerna and Purchaser and their Representatives access, upon reasonable notice, during normal business hours
and at such other time or times as Akerna and Purchaser may reasonably request, to its and each Ample Subsidiary’s premises, books,
contracts, records, computer systems, properties, Employees and management personnel and shall furnish promptly to Akerna and Purchaser
all information concerning its and each Ample Subsidiary’s business, properties and personnel as Akerna and Purchaser may reasonably
request, which information shall remain subject to the Confidentiality Agreement, including for the purposes to permit Akerna and
Purchaser to be in a position to expeditiously and efficiently integrate the operations of Ample and to provide an orderly transition
of control immediately upon but not prior to the Effective Time. The Parties shall use all commercially reasonable efforts to ensure
that they take no actions, through the exchange of confidential information or otherwise, in breach of the Competition Act or any
other applicable competition laws, and notwithstanding anything contained in this Agreement, neither Akerna nor Purchaser shall
control or materially influence Ample until following the Effective Time.

 

		3.11	Section 85 Elections

 

Where an Eligible Holder desires to so
elect, Purchaser shall make a joint election with such Ample Shareholder in respect of its disposition of its Ample Shares pursuant
to Section 85 of the Tax Act (and any similar provision of any applicable provincial Tax legislation) in accordance with the procedures
and within the time limits set out in the Plan of Arrangement. The agreed amount under such joint elections shall be determined
by each such Ample Shareholder in his or her sole discretion within the limits set out in the Tax Act.

 

Article
4

REPRESENTATIONS AND
WARRANTIES

 

		4.1	Representations and Warranties of Akerna and Purchaser

 

Each of Akerna and Purchaser jointly and
severally hereby represents and warrants to and in favour of Ample and acknowledges that Ample is relying upon such representations
and warranties in connection with the matters contemplated by this Agreement and the consummation of the Arrangement:

 

    - 51 -

     

    

 

		(a)	Organization, Status and Qualification. Each of Akerna and Purchaser is duly formed and
is validly subsisting, under the laws of its jurisdiction of formation and has the requisite power and authority to own, lease
and operate its respective properties and assets and to conduct its business as now owned and conducted. Each of Akerna and Purchaser
is duly qualified to carry on business in each jurisdiction in which its assets and properties, owned, leased, licensed or otherwise
held, or the nature of its activities makes such qualification necessary, except where the failure to be so qualified will not,
individually or in the aggregate, have an Akerna Material Adverse Effect.

 

		(b)	Authorization. Each of Akerna and Purchaser has all necessary corporate power and authority
and has taken all necessary corporate action to authorize the execution and delivery of this Agreement and the Contracts, agreements
and instruments required by this Agreement to be delivered by it and the performance of its obligations hereunder and thereunder
(subject to approval of the Akerna Board of the Akerna Circular and matters relating to and to be approved at the Akerna Meeting).

 

		(c)	Enforceability. This Agreement has been duly executed and delivered by each of Akerna and
Purchaser and (assuming due execution and delivery by Ample) is a legal, valid and binding obligation of Akerna and Purchaser enforceable
against each of Akerna and Purchaser in accordance with its terms, except that enforcement may be limited by bankruptcy, insolvency,
fraudulent transfer, reorganization, moratorium and other Applicable Laws of general application relating to or affecting the rights
of creditors generally and that equitable remedies, including specific performance, may be granted only in the discretion of a
court of competent jurisdiction. Each of the Contracts, agreements and instruments required by this Agreement to be delivered by
each of Akerna and Purchaser will, at the Effective Time, have been duly executed and delivered by each of Akerna and Purchaser
and (assuming due execution and delivery by the other parties thereto) will at the Effective Time be enforceable against each of
Akerna and Purchaser in accordance with its terms, except that enforcement may be limited by bankruptcy, insolvency, fraudulent
transfer, reorganization moratorium and other Applicable Laws of general application relating or affecting the rights of creditors
generally and that equitable remedies, including specific performance, may be granted only in the discretion of a court of competent
jurisdiction.

 

		(d)	No Violations. Other than as permitted or contemplated under this Agreement, none of the
execution and delivery of this Agreement by Akerna and Purchaser, the consummation by Akerna and Purchaser of the Arrangement or
any of the transactions contemplated by this Agreement or compliance by Akerna and Purchaser with any of the provisions hereof
will:

 

		(i)	violate, conflict with, or result in a breach of any provision of, require any consent, approval
or notice under, or constitute a default (or an event which with or without notice or lapse of time or both, would constitute a
default) under any of the terms, conditions or provisions of their respective constating or governing documents;

 

		(ii)	allow any Person to exercise any rights, require any consent or notice under or other action by
any Person, or cause or permit the termination, cancellation, acceleration or other change of any right or obligation or the loss
of any benefit to which Akerna or Purchaser is entitled (including by triggering any rights of first refusal or first offer or
other restrictions or limitations) under any Contract to which it is a party, except as would not reasonably be expected to have,
individually or in the aggregate, an Akerna Material Adverse Effect or impede the consummation of the Arrangement; or

 

    - 52 -

     

    

 

		(iii)	subject to obtaining the Regulatory Approvals and Akerna Shareholder Approval, violate any Applicable
Laws.

 

Other than in
connection with obtaining any required Regulatory Approvals, compliance with any Applicable Laws, stock exchange rules and policies,
the Interim Order and the Final Order, no Authorization of, or other action by or in respect of, or filing, recording, registering
or publication with, or notification to, any Governmental Entity is necessary on the part of Akerna or Purchaser for the consummation
by Akerna and Purchaser of their obligations in connection with the Arrangement under this Agreement or for the completion of the
Arrangement, except for such Authorizations and filings as to which the failure to obtain or make would not materially impede or
delay the ability of Akerna or Purchaser to consummate the Arrangement.

 

		(e)	Compliance with Applicable Laws; No Orders. Akerna and each Akerna Subsidiary has complied
with all Applicable Laws in all material respects and is not in violation of any Applicable Laws in any material respect except
where the failure to so comply would not reasonably be expected to have an Akerna Material Adverse Effect.

 

		(f)	Regulatory Approvals. As at the date of this Agreement, there are no Regulatory Approvals
required to be obtained by Akerna or any Akerna Subsidiary in connection with this Agreement or the Arrangement other than the
acceptance of the NASDAQ.

 

		(g)	Capitalization.

 

		(i)	Akerna is authorized to issue (i) 5,000,000 shares of preferred stock, par value USD$0.0001, of
which none are issued and outstanding as at the date hereof; and (ii) 75,000,000 shares of common stock, par value USD$0.0001,
of which 10,958,656 shares are outstanding as at the date hereof. Prior to the Effective Time, Akerna will reserve for issuance
the Akerna Shares to be issued upon exchange of the Exchangeable Shares.

 

		(ii)	As of the date hereof, (A) the authorized capital of the Purchaser consists of an unlimited number
of common shares (the “Purchaser Shares”), and no other shares, and (B) all of the outstanding Purchaser Shares
are owned, directly or indirectly, by Akerna.

 

		(iii)	Upon completion of the Arrangement, (A) all of the shares in the capital of the Purchaser other
than the Exchangeable Shares required to be issued by the Purchaser hereunder will be owned, legally and beneficially, by Akerna,
and (B) each of the Exchangeable Shares required to be issued by the Purchaser hereunder shall be, as and when required to be issued
hereunder, validly issued, fully paid and non-assessable.

 

    - 53 -

     

    

 

		(iv)	The total aggregate number of Akerna Shares that Akerna may be required to issue upon the exchange
of all Exchangeable Shares issuable hereunder (including in respect of the Deferred Consideration) will at the Effective Time have
been duly authorized and reserved for issuance and will, on such exchange, be validly issued, fully paid and non-assessable.

 

		(h)	Bankruptcy. Neither Akerna nor any Akerna Subsidiary is an insolvent Person within the meaning
of the Bankruptcy and Insolvency Act (Canada) or any other Applicable Law regarding bankruptcy, insolvency or creditor’s
rights generally and nor have any such entity made an assignment in favour of its creditors or a proposal in bankruptcy to its
creditors or any class thereof, and no petition for a receiving order has been presented in respect of it. Neither Akerna nor any
Akerna Subsidiary has initiated proceedings with respect to a compromise or arrangement with its creditors or for its winding up,
liquidation or dissolution. No receiver or interim receiver has been appointed in respect of Akerna or any Akerna Subsidiary or
any of the assets of Akerna and no execution or distress has been levied on any of the assets or Akerna, nor have proceedings been
commenced in connection with any of the foregoing.

 

		(i)	Registrant Status and Stock Exchange Compliance. Akerna is an SEC registrant. There is no
Order delisting, suspending or cease trading any securities of Akerna. The Akerna Shares are listed and posted for trading on the
NASDAQ, and are not listed or quoted on any market other than the NASDAQ, and Akerna is in compliance in all material respects
with the applicable listing and corporate governance rules and regulations of the NASDAQ. No Securities Authority, other competent
authority or stock exchange in Canada or the United States has issued any order which is currently outstanding preventing or suspending
trading in any securities of Akerna, no such proceeding is, to the knowledge of Akerna, pending, contemplated or threatened and
neither Akerna or any Akerna Subsidiaries is in material default of any requirement of any Applicable Laws.

 

		(j)	U.S. Securities Law Matters.

 

		(i)	The Akerna Shares are registered pursuant to Section 12(b) of the U.S. Exchange Act and Akerna
is in compliance with its reporting obligation pursuant to Section 13 of the U.S. Exchange Act.

 

		(ii)	Other than the Akerna Shares, Akerna does not have, nor is it required to have, any class of securities
registered under the U.S. Exchange Act, nor is Akerna subject to any reporting obligation (whether active or suspended) pursuant
to section 15(d) of the U.S. Exchange Act.

 

		(iii)	Akerna is not an investment company registered or required to be registered under the Investment
Company Act of 1940, as amended.

 

		(k)	WTO Investor. Akerna is a “WTO investor” within the meaning of the Investment
Canada Act.

 

		(l)	Reports. Akerna has timely filed true and correct copies of documents that Akerna is required
to file under U.S. Securities Laws, other than such documents that the failure to file would, individually or in the aggregate,
not have an Akerna Material Adverse Effect.

 

    - 54 -

     

    

 

		(m)	Financial Statements.

 

		(i)	The audited consolidated financial statements for Akerna as of and for each of the fiscal years
ended on June 30, 2018 and June 30, 2019 (the “Akerna Financial Statements”) including the notes thereto and
the interim consolidated financial statements for the three month period ended September 30, 2019 including the notes thereto have
been, and all financial statements of Akerna which are publicly disseminated by Akerna in respect of any subsequent periods prior
to the Effective Date will be, prepared in accordance with U.S. GAAP applied on a basis consistent with prior periods and all Applicable
Laws and present fairly, in all material respects, the assets, liabilities (whether accrued, absolute, contingent or otherwise),
consolidated financial position and results of operations of Akerna and its Subsidiaries as of the respective dates thereof and
its results of operations and cash flows for the respective periods covered thereby (except as may be indicated expressly in the
notes thereto)

 

		(ii)	As of the date of this Agreement, none of the Akerna, any of its Subsidiaries or, to Akerna’s knowledge,
any director, officer, auditor, accountant or representative of Akerna or any of its Subsidiaries has received or otherwise obtained
knowledge of any complaint, allegation, assertion or claim that Akerna or any of its Subsidiaries has engaged in questionable accounting
or auditing practices or any expression of concern from its employees regarding questionable accounting or auditing matters.

 

		(n)	Litigation. To the knowledge of Akerna, there are no investigations by Governmental Entities,
actions, suits or proceedings in progress, pending or threatened against Akerna or any of its Subsidiaries, which if successful,
would reasonably be expected to have an Akerna Material Adverse Effect or would significantly impede the ability of Akerna to consummate
the Arrangement.

 

		(o)	Undisclosed Liabilities. There are no liabilities or obligations of Akerna or Purchaser
of any kind whatsoever, whether accrued, contingent, absolute, determined, determinable or otherwise, other than liabilities or
obligations: (i) disclosed in Akerna’s audited consolidated financial statements as at June 30, 2019; (ii) incurred in the ordinary
course of business since June 30, 2019; (iii) incurred in connection with this Agreement or the Akerna Transactions; or (iv) that
would not be reasonably expected to have, individually or in the aggregate, an Akerna Material Adverse Effect.

 

		(p)	Intellectual Property. Except as would not be reasonably expected to have, individually
or in the aggregate, an Akerna Material Adverse Effect: (i) Akerna and its Subsidiaries, as applicable, own or possess, or have
a licence to or otherwise have the right to use, all Intellectual Property which is material and necessary for the conduct of its
business as presently conducted; and (ii) to the knowledge of Akerna, neither Akerna nor any of its subsidiaries is infringing
on any intellectual property right of any third party.

 

		(q)	Sufficient Funds. Akerna has sufficient funds available to satisfy the aggregate cash consideration
payable under the terms of the Plan of Arrangement.

 

		(r)	Public Disclosure. The information and statements set forth in the Akerna Public Record
were true, correct and complete, and did not contain any misrepresentation, as of the date of such information or statement.

 

    - 55 -

     

    

 

		(s)	No Material Change. Since the date of the Akerna Financial Statements, other than as disclosed
in the Akerna Public Record:

 

		(i)	there has not been any Akerna Material Adverse Change (on a consolidated basis) and as of the date
of this Agreement, there have been no material facts, transactions, events or occurrences which, to the knowledge of Akerna, would
reasonably be expected to have an Akerna Material Adverse Effect (on a consolidated basis);

 

		(ii)	Akerna and its Subsidiaries have not issued, sold, transferred, disposed of, acquired, redeemed,
granted options or rights to purchase, rights of first refusal or subscription rights, or sold any securities of Akerna or its
Subsidiaries (or securities convertible into or exchangeable for Akerna Shares) or permitted any reclassifications of any securities
of Akerna or any of its Subsidiaries;

 

		(iii)	Akerna and its Subsidiaries have not amended or modified their constating documents;

 

		(iv)	Akerna and its Subsidiaries have not declared, paid or otherwise set aside for payment any non-cash
dividend or other non-cash distribution with respect to the Akerna Shares or any other equity securities;

 

		(v)	Akerna and its Subsidiaries have not merged or consolidated with, or acquired all or substantially
all the assets of, or otherwise acquired, any business, business organization or division thereof, or any other Person;

 

		(vi)	no liability or obligation of any nature (whether absolute, accrued, contingent or otherwise) which
has had, or is reasonably likely to have, individually or in the aggregate, an Akerna Material Adverse Effect has been incurred;

 

		(vii)	there has not been any material change to the accounting practices used by Akerna and its Subsidiaries;

 

		(viii)	there has not been any satisfaction or settlement of any material claims or material liabilities,
other than the settlement of claims or liabilities in the ordinary course of business; and

 

		(ix)	Akerna and its Subsidiaries have conducted their business only in the ordinary and normal course
consistent with past practice, except for the transactions contemplated by this Agreement and the Akerna Transactions.

 

		(t)	Taxes. Akerna and its Subsidiaries have timely filed all material Tax Returns required to
be filed in all applicable jurisdictions and such Tax Returns are, in all material respects, true, complete and correct, and have
been prepared and filed in all material respects in accordance with Applicable Laws. Akerna and its Subsidiaries have made and
remitted all material amounts of required deductions or withholdings of Taxes, and have paid all Taxes payable by Akerna and any
of its Subsidiaries as and when due and payable.

 

    - 56 -

     

    

 

		(u)	Corporate Records. The corporate records and minute books, books of account and other records
of Akerna and each Akerna Subsidiary have (whether of a financial or accounting nature or otherwise) been maintained in accordance
with, in all material respects, all Applicable Laws and prudent business practice and are complete and accurate in all material
respects. Copies of the constating documents of Akerna and each Akerna Subsidiary, together with all amendments to date, which
are included in the Akerna Information, are accurate and complete in all material respects and have not been amended or superseded.

 

		(v)	Anti-Corruption.

 

		(i)	Neither Akerna or Purchaser has, directly or indirectly: (A) made, offered or authorized any contribution,
payment, promise, advantage or gift of funds or property to any official, employee or agent of any governmental agency, authority
or instrumentality of any jurisdiction or any official of any public international organization; or (B) made any contribution to
any candidate for public office, in either case where either the payment or the purpose of such contribution, payment, promise,
advantage or gift would violate, or was or would be prohibited under, Applicable Laws, including the principles described in the
Convention on Combating Bribery of Foreign Public Officials in International Business Transactions and the Convention’s Commentaries,
the U.S. Foreign Corrupt Practices Act of 1977, as amended, the Corruption of Foreign Public Officials Act (Canada)
or the Proceeds of Crime (Money Laundering) and Terrorist Financing Act (Canada) or the rules and regulations promulgated
thereunder.

 

		(ii)	No action, suit or proceeding by or before any court or Governmental Entity or any arbitrator involving
Akerna or Purchaser is pending or threatened under any applicable financial recordkeeping and reporting requirements and under
all applicable money laundering laws and statutes and the rules and regulations thereunder and any related or similar rules, regulations
or guidelines, issued, administered or enforced by any Governmental Entity, whether in Canada, the United States or other jurisdictions.

 

		(iii)	None of Akerna, Purchaser, nor any director, officer, agent, employee or any other Person acting
on behalf of Akerna or Purchaser, has been or is the subject of any sanctions administered by the Office of Foreign Assets Control
of the U.S. Treasury Department (in this subsection subsection 4.1(v)(iii), “OFAC”) (including but not limited
to the designation as a “specially designated national or blocked person” thereunder), the Government of Canada, Her
Majesty’s Treasury, the European Union or any other relevant sanctions authority; and neither Akerna nor Purchaser is in violation
of any of the economic sanctions of the United States administered by OFAC or economic sanctions of any other relevant sanctions
authority or any law or executive order relating thereto (in this subsection 4.1(o), the “Economic Sanctions”)
or is conducting business with any Person subject to any Economic Sanctions (a “Sanctioned Person”); and neither
Akerna nor Purchaser nor any of their affiliates are owned by or affiliated with a Sanctioned Person.

 

		(w)	Freely Tradeable Shares. The Exchangeable Shares, and the Akerna Shares to be issued pursuant
to the exchange of the Exchangeable Shares, in each case to be issued pursuant to the Arrangement, shall be registered or qualified
for distribution, or exempt from or not subject to any requirement for registration or qualification for distribution, under Applicable
Securities Laws. Such securities shall not be “restricted securities” within the meaning of Rule 144 under the U.S. Securities
Act or under any other U.S. federal or state securities laws.

 

    - 57 -

     

    

 

		(x)	Non-Reliance. Ample acknowledges that none of Akerna,
Purchaser, any Akerna Subsidiary, nor any Akerna Shareholder makes any representation or warranty with respect to Akerna, Purchaser,
any Akerna Subsidiary or the Arrangement other than those expressly set forth in this Section 4.1 or any other agreement or instrument
entered into by Akerna, Purchaser or Callco pursuant to this Agreement, and Ample has not relied on any statement of any Person
in entering into this Agreement other than such express representations and warranties.

 

		4.2	Representations and Warranties of Ample

 

Ample hereby represents and warrants to
and in favour of Akerna and Purchaser as follows and acknowledges that Akerna and Purchaser are relying on these representations
and warranties in connection with the matters contemplated by this Agreement and the consummation of the Arrangement:

 

		(a)	Organization, Status and Qualification. Each of Ample and each Ample Subsidiary is a corporation
duly incorporated, amalgamated or continued, or organized, as the case may be, and is validly subsisting, under the laws of the
jurisdiction of its formation and has the requisite power and authority to own, lease and operate its respective properties and
assets and to conduct its business as now owned and conducted. Each of Ample and each Ample Subsidiary is duly qualified to carry
on business in each jurisdiction in which its assets and properties, owned, leased, licensed or otherwise held, or the nature of
its activities makes such qualification necessary, except where the failure to be so qualified will not, individually or in the
aggregate, have an Ample Material Adverse Effect.

 

		(b)	Authorization. Ample has all necessary corporate power and authority and has taken all necessary
corporate action to authorize the execution and delivery of this Agreement and the Contracts, agreements and instruments required
by this Agreement to be delivered by it and the performance of its obligations hereunder and thereunder (subject to approval of
the Ample Board of the Ample Circular and matters relating to and to be approved at the Ample Meeting).

 

		(c)	Enforceability. This Agreement has been duly executed and delivered by Ample and (assuming
due execution and delivery by Akerna and Purchaser) is a legal, valid and binding obligation of Ample enforceable against it in
accordance with its terms, except that enforcement may be limited by bankruptcy, insolvency, fraudulent transfer, reorganization,
moratorium and other Applicable Laws of general application relating to or affecting the rights of creditors generally and that
equitable remedies, including specific performance, may be granted only in the discretion of a court of competent jurisdiction.
Each of the Contracts, agreements and instruments required by this Agreement to be delivered by it will, at the Effective Time,
have been duly executed and delivered by it and (assuming due execution and delivery by the other parties thereto) will at the
Effective Time be enforceable against it in accordance with its terms, except that enforcement may be limited by bankruptcy, insolvency,
fraudulent transfer, reorganization moratorium and other Applicable Laws of general application relating or affecting the rights
of creditors generally and that equitable remedies, including specific performance, may be granted only in the discretion of a
court of competent jurisdiction.

 

    - 58 -

     

    

 

		(d)	No Violations. Other than as permitted or contemplated under this Agreement and subject
to obtaining the consents and delivery of the notices set forth in Schedule 4.2(d) of the Ample Disclosure Letter, none of the
execution and delivery of this Agreement by Ample, the consummation by Ample of the Arrangement or any of the transactions contemplated
by this Agreement or compliance by Ample with any of the provisions hereof will:

 

		(i)	violate, conflict with, or result in a breach of any provision of, require any consent, approval
or notice under, or constitute a default (or an event which with or without notice or lapse of time or both, would constitute a
default) under any of the terms, conditions or provisions of its constating or governing documents;

 

		(ii)	allow any Person to exercise any rights, or constitute a default under, or cause or permit the
termination, cancellation, acceleration or other change of any right or obligation or the loss of any benefit to which Ample is
entitled (including by triggering any rights of first refusal or first offer or other restrictions or limitations) under any Ample
Material Contract;

 

		(iii)	subject to obtaining the Regulatory Approvals and the Ample Shareholder Approval in respect of
the Arrangement, violate any Applicable Laws; and

 

		(iv)	result in any restriction on Ample or any Ample Subsidiary from engaging in its business, as now
conduced, or from competing with any Person or in any geographical area and does not and will not trigger or cause to arise any
rights of any Person under any contract or arrangement to restrict Ample or any Ample Subsidiary from engaging in its business,
as now conducted.

 

Other than in connection with obtaining
any required Regulatory Approvals, compliance with any Applicable Laws, stock exchange rules and policies, the Interim Order and
the Final Order, no Authorization of, or other action by or in respect of, or filing, recording, registering or publication with,
or notification to, any Governmental Entity is necessary on the part of Ample for the consummation by Ample of its obligations
in connection with the Arrangement under this Agreement or for the completion of the Arrangement, except for such Authorizations
and filings as to which the failure to obtain or make would not materially impede or delay the ability of Ample to consummate the
Arrangement.

 

		(e)	Subsidiaries. Other than as disclosed in Schedule 4.2(e) of the Ample Disclosure Letter
and the Ample Subsidiaries, Ample does not have any material Subsidiaries or own, directly or indirectly, any shares, partnership
interest, limited liability company interest or joint venture interest in, or any security issued by, any other Person. All of
the issued and outstanding equity interests of Ample’s Subsidiaries are owned beneficially and of record by Ample and are fully
paid and non-assessable.

 

		(f)	Compliance with Applicable Laws; No Orders. Ample and each Ample Subsidiary has complied
with all Applicable Laws in all material respects and is not in violation of any Applicable Laws in any material respect except
where the failure to so comply would not reasonably be expected to have an Ample Material Adverse Effect.

 

    - 59 -

     

    

 

		(g)	Regulatory Approvals. As at the date of this Agreement, there are no Regulatory Approvals
required to be obtained by Ample or the Ample Subsidiaries in connection with this Agreement or the Arrangement other than the
Interim Order and the Final Order.

 

		(h)	Authorized and Issued Capital. The authorized capital of Ample consists of an unlimited
number of Ample Common Shares and 5,304,000 Ample Preferred Shares. As of the date of this Agreement, there are issued and outstanding
37,447,622 Ample Common Shares and 4,061,358 Ample Preferred Shares and no other shares are issued and outstanding. Other than:
(i) Ample Options to acquire up to 1,309,750 Ample Common Shares; (ii) Ample Common Warrants to acquire up to 2,217,161 Ample Common
Shares; and (iii) Ample Preferred Warrants to acquire up to 312,000 Ample Preferred Shares, there are no options, warrants or other
rights, plans, agreements or commitments of any nature whatsoever requiring the issuance, sale or transfer by Ample of any securities
of Ample (including Ample Shares) or any securities convertible into, or exchangeable or exercisable for, or otherwise evidencing
a right to acquire, any securities of Ample (including Ample Shares). All outstanding Ample Shares and Ample Preferred Shares have
been duly authorized and validly issued, are fully paid and non-assessable and are not subject to, nor were they issued in violation
of, any pre-emptive rights. Other than the Ample Shares and Ample Preferred Shares, there are no securities of Ample outstanding
which have the right to vote generally with the shareholders of Ample on any matter.

 

		(i)	Significant Shareholders. Other than as set out in Schedule 4.2(i) of the Disclosure Letter,
to the knowledge of Ample, no Person beneficially owns, directly or indirectly, or exercises control or direction over, Ample Shares
representing more than 10% of the issued and outstanding Ample Shares (each, a “Significant Shareholder”).

 

		(j)	Bankruptcy. Neither Ample nor any Ample Subsidiary is an insolvent Person within the meaning
of the Bankruptcy and Insolvency Act (Canada) or any other Applicable Law regarding bankruptcy, insolvency or creditor’s
rights generally and nor have any such entity made an assignment in favour of its creditors or a proposal in bankruptcy to its
creditors or any class thereof, and no petition for a receiving order has been presented in respect of it. Neither Ample nor any
Ample Subsidiary has initiated proceedings with respect to a compromise or arrangement with its creditors or for its winding up,
liquidation or dissolution. No receiver or interim receiver has been appointed in respect of Ample or any Ample Subsidiary or any
of the assets of Ample and no execution or distress has been levied on any of the assets of Ample, nor have proceedings been commenced
in connection with any of the foregoing.

 

		(k)	Securities Laws Matters. No Securities Authority, other competent authority or stock exchange
in Canada or the United States has issued any order which is currently outstanding preventing or suspending trading in any securities
of Ample, no such proceeding is, to the knowledge of Ample, pending, contemplated or threatened and neither Ample or Ample Subsidiaries
is in material default of any requirement of any Applicable Laws.

 

		(l)	U.S. Securities Law Matters.

 

		(i)	There is no class of securities of Ample which is registered pursuant to Section 12 of the U.S.
Exchange Act, nor is Ample subject to any reporting obligation (whether active or suspended) pursuant to section 15(d) of the U.S.
Exchange Act. Ample is not, and has never been, subject to any requirement to register any class of its equity securities pursuant
to Section 12(g) of the U.S. Exchange Act.

 

    - 60 -

     

    

 

		(ii)	Ample is not an investment company registered or required to be registered under the U.S. Investment
Company Act of 1940.

 

		(iii)	Ample is not, has not previously been and on the Effective Date will not be a “shell company”
(as defined in Rule 405 under the U.S. Securities Act).

 

		(m)	Financial Statements.

 

		(i)	The Ample Financial Statements fairly present, in accordance with IFRS, consistently applied, the
financial position and condition of Ample at the dates thereof and the results of the operations of Ample for the periods then
ended and reflect, in accordance with IFRS, consistently applied, all material assets, liabilities or obligations (absolute, accrued,
contingent or otherwise) of Ample, as at the dates thereof.

 

		(ii)	Neither Ample nor, to Ample’s knowledge, any director, officer, Employee, auditor, accountant or
representative of Ample, has received or otherwise had or obtained knowledge of any material complaint, allegation, assertion,
expression of concern or claim from any source, whether written or oral, regarding the accounting, internal accounting controls
or auditing practices, procedures, methodologies or methods of Ample or the Ample Subsidiaries, including any material complaint,
allegation, assertion, expression of concern or claim from any source that Ample has engaged in questionable accounting or auditing
practices, which has not been resolved to the satisfaction of the Ample Board.

 

		(n)	Litigation. To the knowledge of Ample, there are no investigations by Governmental Entities,
actions, suits or proceedings in progress, pending or threatened against Ample or any of its Subsidiaries, which if successful,
would reasonably be expected to have an Ample Material Adverse Effect or would significantly impede the ability of Ample to consummate
the Arrangement.

 

		(o)	Undisclosed Liabilities. Other than as disclosed in Schedule 4.2(o) of the Ample Disclosure
Letter, there are no liabilities or obligations of Ample of any kind whatsoever whether accrued, contingent, absolute, determined,
determinable or otherwise, other than liabilities or obligations: (i) disclosed in Ample’s audited consolidated financial statements
as at December 31, 2018; (ii) incurred in the ordinary course of business since December 31, 2018; (iii) incurred in connection
with this Agreement; or (iv) that would not be reasonably expected to have, individually or in the aggregate, an Ample Material
Adverse Effect.

 

		(p)	No Restrictions on Business. Other than as disclosed in Schedule 4.2(p) of the Ample Disclosure
Letter, neither Ample nor any Ample Subsidiary is a party to or bound or affected by any commitment, agreement, judgment, injunction,
order, decree or document binding upon Ample or such Ample Subsidiary that has or could reasonably be expected to have the effect
of prohibiting, restricting or impairing its business, or individually or in the aggregate, having an Ample Material Adverse Effect
or containing any covenant expressly prohibiting, restricting or limiting its freedom or ability to: (i) compete in any line of
business or geographic region; (ii) transfer or move any of the assets or operations; (iii) conduct any business practice of Ample
or such Ample Subsidiary as now conducted; or (iv) effect any acquisition of property by Ample or such Ample Subsidiary (including
following the transactions contemplated by this Agreement).

 

    - 61 -

     

    

 

		(q)	Real Property.

 

		(i)	Except as would not be reasonably expected to have, individually or in the aggregate, an Ample
Material Adverse Effect: (A) Ample and the Ample Subsidiaries, as applicable, have valid, good and marketable title to all of the
real or immovable property owned by them (the “Ample Owned Properties”) free and clear of any Liens, except for
Permitted Liens; and (B) there are no outstanding options or rights of first refusal to purchase the Ample Owned Properties or
any portion thereof or interest therein.

 

		(ii)	Except as would not be reasonably expected to have, individually or in the aggregate, an Ample
Material Adverse Effect: (A) each lease or sublease for real and immovable property leased or subleased by Ample or any Ample Subsidiaries
creates a good and valid leasehold estate in the premises thereby demised and is in full force and effect; (B) none of Ample or
any Ample Subsidiaries is in breach of, or default under, such lease or sublease and no event has occurred which, with notice,
lapse of time or both, would constitute such a breach or default by Ample or any Ample Subsidiaries or permit termination, modification
or acceleration by any third party thereunder; and (C) to the knowledge of Ample, no third party has repudiated or has the right
to terminate or repudiate any such lease or sublease (except for the normal exercise of remedies in connection with a default thereunder
or any termination rights set forth in the lease or sublease) or any provision thereof.

 

		(r)	Personal Property. Ample and its Subsidiaries have valid, good and marketable title to all
personal property owned by them, except as would not, individually or in the aggregate, be reasonably expected to have an Ample
Material Adverse Effect.

 

		(s)	Intellectual Property. Except as would not be reasonably expected to have, individually
or in the aggregate, an Ample Material Adverse Effect: (i) Ample and its Subsidiaries, as applicable, own or possess, or have a
licence to or otherwise have the right to use, all Intellectual Property which is material and necessary for the conduct of its
business as presently conducted (collectively, the “Ample Intellectual Property Rights”); (ii) to the knowledge
of Ample, all such Ample Intellectual Property Rights that are owned by Ample and its Subsidiaries are valid and enforceable subject
only to any limitation under bankruptcy, insolvency or other Applicable Laws affecting the enforcement of creditors’ rights generally
and the discretion that a court may exercise in the granting of equitable remedies such as specific performance and injunction
and does not infringe in any material way upon the rights of others; and (iii) to the knowledge of Ample, no third party is infringing
upon the Ample Intellectual Property Rights owned or licensed by Ample or its Subsidiaries.

 

    - 62 -

     

    

 

		(t)	Employment Matters.

 

		(i)	No Ample Employee has any agreement as to length of notice or severance payment required to terminate
his or her employment other than such as results from Applicable Law from the employment of an employee without an agreement as
to notice or severance.

 

		(ii)	Other than as set out in Schedule 4.2(t)(ii) of the Ample Disclosure Letter and except as provided
in this Agreement, there are no change of control payments, golden parachutes, severance payments, retention payments, Contracts
or other agreements with current or former Ample Employees providing for cash or other compensation or benefits upon the consummation
of, or relating to, the Arrangement, including a change of control of Ample or any of its Subsidiaries.

 

		(iii)	Ample and its Subsidiaries are in material compliance with all terms and conditions of employment
and all Applicable Laws respecting employment, including pay equity, wages, hours of work, overtime, vacation, human rights and
work safety and health.

 

		(iv)	There are no charges pending under applicable occupational health and safety legislation. Ample
has complied in all material respects with any orders issued under applicable occupational health and safety legislation and there
are no appeals of any orders under applicable occupational health and safety legislation currently outstanding.

 

		(v)	There are no material Ample Employee related claims, complaints, investigations or orders under
all Applicable Laws respecting employment now pending or, to the knowledge of Ample, threatened against Ample and its Subsidiaries
by or before any Governmental Entity as of the date of this Agreement and, as of the date of this Agreement, no such claims, complaints,
investigations or orders could reasonably be expected to have an Ample Material Adverse Effect.

 

		(vi)	None of Ample or its Subsidiaries is: (A) a party to any collective bargaining agreement with respect
to any Ample Employees or any contract with any employee association; or (B) is subject to any application for certification or,
to the knowledge of Ample, threatened or apparent union-organizing campaigns for employees not covered under a collective bargaining
agreement and no trade union, council of trade unions, employee bargaining agency or affiliated bargaining agent holds bargaining
rights with respect to any employees of Ample by way of certification, voluntary recognition or succession rights. There is no
labour strike, dispute, work slowdown or stoppage pending or involving, or to the knowledge of Ample threatened against Ample or
any of its Subsidiaries.

 

		(u)	Material Contracts and Other Contracts. True and correct copies of all Ample Material Contracts
entered into by Ample and the Ample Subsidiaries have been included in the Ample Information and:

 

		(i)	such Ample Material Contracts are valid and binding obligations of Ample or the applicable Ample
Subsidiary, and Ample has no reason to believe that such Ample Material Contracts are not, valid and binding obligations of each
other party thereto;

 

    - 63 -

     

    

 

		(ii)	neither Ample nor, to the knowledge of Ample, any of the other parties thereto (including any Ample
Subsidiary), is in breach or violation of, or default under (in each case, with or without notice or lapse of time or both) any
such Ample Material Contract and Ample has not received or given any notice of a default under any such Ample Material Contract
which remains uncured; and

 

		(iii)	to the knowledge of Ample, there exists no state of facts which after notice or lapse of time or
both would constitute a default or breach of any Ample Material Contract or entitle any party to terminate, accelerate, modify
or cause a default under, or trigger any pre-emptive rights or rights of first refusal under, any such Ample Material Contracts.

 

		(v)	No Material Change. Since the date of the latest Ample Financial Statements:

 

		(i)	there has not been any Ample Material Adverse Change (on a consolidated basis) and as of the date
of this Agreement, there have been no material facts, transactions, events or occurrences which, to the knowledge of Ample, would
reasonably be expected to have an Ample Material Adverse Effect (on a consolidated basis);

 

		(ii)	other than as set out in Schedule 4.2(v) of the Ample Disclosure Letter, Ample and its Subsidiaries
have not issued, sold, transferred, disposed of, acquired, redeemed, granted options or rights to purchase, rights of first refusal
or subscription rights, or sold any securities of Ample or its Subsidiaries (or securities convertible into or exchangeable for
Ample Shares) or permitted any reclassifications of any securities of Ample or any of its Subsidiaries;

 

		(iii)	other than as set out in Schedule 4.2(v) of the Ample Disclosure Letter, Ample and its Subsidiaries
have not amended or modified their constating documents;

 

		(iv)	Ample and its Subsidiaries have not declared, paid or otherwise set aside for payment any non-cash
dividend or other non-cash distribution with respect to the Ample Shares or any other equity securities;

 

		(v)	Ample and its Subsidiaries have not merged or consolidated with, or acquired all or substantially
all the assets of, or otherwise acquired, any business, business organization or division thereof, or any other Person;

 

		(vi)	other than as set out in Schedule 4.2(v) of the Ample Disclosure Letter, there has not been any
material increase in the salary, bonus or other remuneration payable by Ample or any of its Subsidiaries to any of their respective
directors, officers, employees or consultants, and there has not been any amendment or modification to the vesting or exercisability
schedule or criteria, including any acceleration, right to accelerate or acceleration event or other entitlement under any stock
option, deferred compensation or other compensation award or any grant to such director, officer, employee or consultant of any
increase in severance or termination pay or any increase or modification of any bonus, pension, insurance or benefit arrangement
made to, for or with any of such directors, officers, employees or consultants;

 

    - 64 -

     

    

 

		(vii)	no liability or obligation of any nature (whether absolute, accrued, contingent or otherwise) which
has had, or is reasonably likely to have, individually or in the aggregate, an Ample Material Adverse Effect has been incurred;

 

		(viii)	there has not been any material change to the accounting practices used by Ample and its Subsidiaries;

 

		(ix)	other than as set out in Schedule 4.2(v) of the Ample Disclosure Letter, there has not been any
entering into, or any amendment of, any Ample Material Contract other than in the ordinary course of business consistent with past
practice;

 

		(x)	there has not been any satisfaction or settlement of any material claims or material liabilities,
other than the settlement of claims or liabilities in the ordinary course of business; and

 

		(xi)	Ample and its Subsidiaries have conducted their business only in the ordinary and normal course
consistent with past practice, except for the transactions contemplated by this Agreement.

 

		(w)	Taxes.

 

		(i)	Ample and its Subsidiaries have timely filed, all material Tax Returns prior to the date hereof,
other than those which have been administratively waived, and all such Tax Returns are true, complete and correct and are in accordance
with Applicable Laws in all material respects;

 

		(ii)	Ample and its Subsidiaries have paid on a timely basis all Taxes and all assessments and reassessments
of Taxes due on or before the date hereof, other than Taxes which are being or have been contested in good faith and for which
adequate accruals have been provided in the Ample Financial Statements. Ample and its Subsidiaries have provided adequate accruals
in accordance with IFRS in the most recent Ample Financial Statements for any Taxes of Ample and each of its Subsidiaries for the
period covered by such financial statements that have not been paid whether or not shown as being due in any Tax Returns. Since
the date of the most recent Ample Financial Statements, no material liability in respect of Taxes not reflected in such financial
statements or otherwise provided for has been assessed, proposed to be assessed, incurred or accrued, other than in the ordinary
course of business;

 

		(iii)	Ample and its Subsidiaries have duly and timely withheld, or caused to be withheld, all material
amounts of Taxes required by Applicable Laws to be withheld by it (including Taxes and other amounts required to be withheld by
it in respect of any amount paid or credited or deemed to be paid or credited by it to or for the account of any Person, including
any present or former employees, officers or directors and any Persons who are non-residents of Canada for the purpose of the Tax
Act) and duly and timely remitted, or caused to be remitted, to the appropriate Taxing Authority such Taxes required by Applicable
Laws to be remitted by it;

 

    - 65 -

     

    

 

		(iv)	Ample and its Subsidiaries have duly and timely collected, or caused to be collected, all material
amounts of sales or transfer taxes, including goods and services, harmonized sales and provincial or territorial sales taxes, required
by Applicable Laws to be collected by it and duly and timely remitted to the appropriate Taxing Authority any such amounts required
by Applicable Laws to be remitted by it;

 

		(v)	there are no audits or investigations in progress, or to the knowledge of Ample, pending or threatened
by any Governmental Entity with respect to Taxes against Ample or any Ample Subsidiary or any of the assets of Ample or any Ample
Subsidiary; and to the knowledge of Ample, no deficiencies, litigation, proposed adjustments or matters in controversy with respect
to any amount of Taxes of Ample or any Ample Subsidiary have been asserted or have been raised by any Governmental Entity which
remain unresolved at the date hereof, except, in each case, as are being contested in good faith and for which adequate accruals
have been provided in the Ample Financial Statements;

 

		(vi)	there are no currently effective elections, agreements or waivers extending the statutory period
or providing for an extension of time with respect to the assessment or reassessment of any amount of Taxes of, or the filing of
any Tax Return or any payment of any amount of Taxes by, Ample or any Ample Subsidiary;

 

		(vii)	Ample is, and has been since incorporation, a “taxable Canadian corporation” as defined
in the Tax Act;

 

		(viii)	there are no circumstances existing which could result in additional Taxes owing as a result of
the application of section 17, subsection 18(4), section 78, section 79, sections 80 to 80.04 or section 245 of the Tax Act to
each of Ample and the Ample Subsidiaries;

 

		(ix)	there are no Liens for Taxes upon any of the assets of Ample or any of its Subsidiaries; and

 

		(x)	Ample has not either directly or indirectly transferred any property to or supplied any services
to or acquired any property or services from a Person with whom it was not dealing at arm’s length (for the purposes of the Tax
Act) for consideration other than consideration equal to the fair market value of the property or services at the time of the transfer,
supply or acquisition of the property or services.

 

		(x)	Corporate Records. Other than as set out in Schedule 4.2(x) of the Ample Disclosure Letter,
the corporate records and minute books, books of account and other records of Ample and each Ample Subsidiary have (whether of
a financial or accounting nature or otherwise) been maintained in accordance with, in all material respects, all Applicable Laws
and prudent business practice and are complete and accurate in all material respects. Copies of the constating documents of Ample
and each Ample Subsidiary, together with all amendments to date, which are included in the Ample Information, are accurate and
complete in all material respects and have not been amended or superseded.

 

    - 66 -

     

    

 

		(y)	Insurance. Policies of insurance are in force naming Ample as an insured that adequately
cover all risks as are customarily covered by businesses in the industry in which Ample operates and Ample and its Subsidiaries
are in compliance in all material respects with all requirements with respect to such policies. All such policies shall remain
in force and effect (subject to taking into account insurance market conditions and offerings and industry practices) and shall
not be cancelled or otherwise terminated as a result of the Arrangement. To the knowledge of Ample, each material insurance policy
currently in effect that insures the physical properties, business, operations and assets of Ample and its Subsidiaries is valid
and binding and in full force and effect and there is no material claim pending under any such policies as to which coverage has
been questioned, denied or disputed. There is no material claim pending under any insurance policy of Ample or any Subsidiary that
has been denied, rejected, questioned, or disputed by any insurer or as to which any insurer has made any reservation of rights
or refused to cover all or any material portion of such claims.

 

		(z)	Employee Plans.

 

		(i)	Except as would not be reasonably expected to have, individually or in the aggregate, an Ample
Material Adverse Effect, all of the Employee Plans are and have been established, registered, qualified and administered in accordance
with all Applicable Laws and in accordance with their terms, the terms of the material documents that support such Employee Plans
and the terms of agreements between Ample and its Subsidiaries and Ample Employees (present and former) who are members of, or
beneficiaries under, the Employee Plans. To the knowledge of Ample, no fact or circumstance exists which could adversely affect
the registered status of any such Employee Plan. Neither Ample nor, to the knowledge of Ample, any of its agents or delegates,
has breached any fiduciary obligation with respect to the administration or investment of any Employee Plan.

 

		(ii)	Except as would not be reasonably expected to have, individually or in the aggregate, an Ample
Material Adverse Effect: (A) all current obligations of Ample regarding the Employee Plans have been satisfied; and (B) all contributions,
premiums or Taxes required to be made or paid by Ample by Applicable Laws or under the terms of each Employee Plan have been made
in a timely fashion in accordance with Applicable Laws and the terms of the applicable Employee Plan.

 

		(iii)	There are no material pension or retirement income plans of Ample.

 

		(iv)	To the knowledge of Ample, no Employee Plan is subject to any pending investigation, examination,
action, claim (including claims for Taxes, interest, penalties or fines) or any other proceeding initiated by any Person (other
than routine claims for benefits) which, if adversely determined, would be reasonably expected to have, individually or in the
aggregate, an Ample Material Adverse Effect and, to the knowledge of Ample, there exists no state of facts which could reasonably
be expected to give rise to any such investigation, examination, action, claim or other proceeding.

 

    - 67 -

     

    

 

		(v)	Other than as set out in Schedule 4.2(z)(v) of the Ample Disclosure Letter and except as provided
in this Agreement, the execution, delivery and performance of this Agreement and the consummation of the Arrangement will not:
(A) result in any material payment (including bonus, golden parachutes, retirement, severance, unemployment compensation or other
benefit or enhanced benefit) becoming due or payable to any of the Ample Employees (present or former); (B) materially increase
the compensation or benefits otherwise payable to any Ample Employee (present or former); or (C) result in the acceleration of
the time of payment or vesting of any material benefits or entitlements otherwise available pursuant to any Employee Plan.

 

		(vi)	None of the Employee Plans provide for retiree or post-termination benefits or for benefits to
retired or terminated employees or to the beneficiaries or dependants of retired or terminated employees.

 

		(vii)	All current obligations of Ample regarding the Employee Plans have been satisfied, and all contributions,
premiums or Taxes required to be made or paid by Ample by Applicable Laws or under the terms of each Employee Plan have been made
in a timely fashion in accordance with Applicable Laws and the terms of the applicable Employee Plan.

 

		(aa)	Environmental Matters. Except as would not be reasonably expected to have, individually
or in the aggregate, an Ample Material Adverse Effect: (i) no written notice, order, complaint or penalty has been received by
Ample or any of its Subsidiaries alleging that Ample or any of its Subsidiaries is in violation of, or has any liability or potential
liability under, any Environmental Laws and there are no judicial, administrative or other actions, suits or proceedings pending
or, to the knowledge of Ample, threatened against Ample or any of its Subsidiaries which alleges a violation of, or any liability
or potential liability under, any Environmental Laws; (ii) Ample and each of its Subsidiaries has all environmental permits necessary
for the operation of their respective businesses and to comply with all Environmental Laws; and (iii) the operations of Ample and
each of its Subsidiaries are in compliance with Environmental Laws.

 

		(bb)	No Dividends. Since December 31, 2018, Ample has not declared, paid or resolved to declare
or pay any dividends or distributions.

 

		(cc)	Related Party Transactions. No officer, director or Employee of Ample, or any Affiliate
of such officer, director or Employee: (i) is a party to any contract or transaction with Ample (other than for legal services
and services as Employees, officers or directors); (ii) has any ownership interest in any property, real or personal or mixed,
tangible or intangible, used by Ample or any Ample Subsidiary in its business; or (iii) is indebted to Ample or any Ample Subsidiary.

 

		(dd)	Brokers. Other than as set out in Schedule 4.2(dd) of the Ample Disclosure Letter, no broker,
finder or investment banker is entitled to any brokerage, finder’s or other fee or commission from, or to the reimbursement of
any of its expenses by, Ample in connection with this Agreement or the Arrangement.

 

    - 68 -

     

    

 

		(ee)	Anti-Corruption.

 

		(i)	Neither Ample nor any Ample Subsidiary has, directly or indirectly: (A) made, offered or authorized
any contribution, payment, promise, advantage or gift of funds or property to any official, employee or agent of any governmental
agency, authority or instrumentality of any jurisdiction or any official of any public international organization; or (B) made
any contribution to any candidate for public office, in either case where either the payment or the purpose of such contribution,
payment, promise, advantage or gift would violate, or was or would be prohibited under, Applicable Laws, including the principles
described in the Convention on Combating Bribery of Foreign Public Officials in International Business Transactions and the Convention’s
Commentaries, the U.S. Foreign Corrupt Practices Act of 1977, as amended, the Corruption of Foreign Public Officials
Act (Canada) or the Proceeds of Crime (Money Laundering) and Terrorist Financing Act (Canada) or the rules and regulations
promulgated thereunder.

 

		(ii)	No action, suit or proceeding by or before any court or Governmental Entity or any arbitrator involving
Ample or any Ample Subsidiary is pending or threatened under any applicable financial recordkeeping and reporting requirements
and under all applicable money laundering laws and statutes and the rules and regulations thereunder and any related or similar
rules, regulations or guidelines, issued, administered or enforced by any Governmental Entity, whether in Canada or other jurisdictions.

 

		(iii)	None of Ample, any Ample Subsidiary, nor any director, officer, agent, Employee or any other Person
acting on behalf of Ample, or any Ample Subsidiary has been or is the subject of any sanctions administered by the Office of Foreign
Assets Control of the U.S. Treasury Department (in this subsection 4.2(ee)(iii) only, “OFAC”) (including but not
limited to the designation as a “specially designated national or blocked person” thereunder), the Government of Canada,
Her Majesty’s Treasury, the European Union or any other relevant sanctions authority; and none of Ample or any Ample Subsidiary
is in violation of any of the economic sanctions of the United States administered by OFAC or economic sanctions of any other relevant
sanctions authority or any law or executive order relating thereto (in this subsection 4.2(ee)(iii) only, the “Economic
Sanctions”) or is conducting business with any Person subject to any Economic Sanctions.

 

		(ff)	Equity Monetization Plans. There are no outstanding stock appreciation rights, phantom equity,
profit sharing plan or similar rights, agreements, arrangements or commitments payable to any Employee and which are based upon
the revenue, value, income or any other attribute of Ample or any Ample Subsidiary.

 

		(gg)	Rights Plans. Ample does not have any similar type of shareholder rights plan. Ample will
not adopt any shareholder rights plan or any other similar form of plan, agreement, Contract or instrument that will trigger any
rights to acquire Ample Shares or other securities of Ample or any Ample Subsidiary upon the entering into of this Agreement or
in connection with the Arrangement.

 

    - 69 -

     

    

 

		(hh)	Place of Principal Offices. None of Ample or any Ample Subsidiary is incorporated or formed
in the United States, is not organized under the laws of the United States and does not have its principal office within the United
States.

 

		(ii)	Investment Company. None of Ample or any Ample Subsidiary is registered or required to be
registered as an “investment company” pursuant to the United States Investment Company Act of 1940, as amended.

 

		(jj)	Shareholder Agreements. Other than as set out in Schedule 4.2(jj) and existing agreements
with Akerna, there are no shareholders agreements, registration rights agreements, voting trusts, proxies or similar agreements,
arrangements, or commitments to which Ample is a party or, to the knowledge of Ample, with respect to any shares or other equity
interests of Ample or any other Contract relating to disposition, voting or dividends with respect of any equity securities of
Ample.

 

		(kk)	Competition Act. Ample, together with its affiliates, as such term is defined under the
Competition Act, neither have assets in Canada with an aggregate value in excess of $96,000,000 nor aggregate gross revenues from
sales in, from or into Canada in excess of $96,000,000, as determined in accordance with the Competition Act.

 

		(ll)	Disclosure. The representations and warranties set forth in this Section 4.2 do not contain
any untrue statement of a material fact or omit to state a material fact which is necessary in order to make the statements contained
in those representations and warranties, taken as a whole, not misleading in any material respect.

 

		(mm)	Non-Reliance. Each of Akerna and Purchaser acknowledge
that none of Ample, any Ample Subsidiary, nor any Ample Shareholder makes any representation or warranty with respect to Ample,
any Ample Subsidiary or the Arrangement other than those expressly set forth in this Section 4.2 or any other agreement or instrument
entered into by Ample pursuant to this Agreement, and each of Akerna and Purchaser have not relied on any statement of any Person
in entering into this Agreement other than such express representations and warranties.

 

Article
5

CONDITIONS PRECEDENT

 

		5.1	Mutual Conditions Precedent

 

The respective obligations of the Parties
to complete the Arrangement are subject to the satisfaction or mutual waiver, on or before the Effective Date or such other time
specified, of the following conditions:

 

		(a)	the Interim Order will have been granted in form and substance satisfactory to Akerna, Purchaser
and Ample, acting reasonably, and such order will not have been set aside or modified in a manner unacceptable to Akerna, Purchaser
and Ample, each acting reasonably, on appeal or otherwise;

 

		(b)	the Arrangement Resolution will have been passed by the Ample Shareholders by the Outside Date
in accordance with the Interim Order;

 

    - 70 -

     

    

 

		(c)	the Akerna Shareholder Matters will have been passed by the Akerna Shareholders by the Outside
Date;

 

		(d)	the Final Order will have been granted by the Outside Date in form and substance satisfactory to
Akerna, Purchaser and Ample, acting reasonably, and such order will not have been set aside or modified in a manner unacceptable
to Akerna, Purchaser and Ample, each acting reasonably, on appeal or otherwise;

 

		(e)	no Governmental Entity shall have enacted, issued, promulgated, enforced or entered any order or
law which is then in effect and has the effect of making the Arrangement illegal or otherwise preventing or prohibiting consummation
of the Arrangement;

 

		(f)	all Regulatory Approvals will have been obtained on terms and conditions satisfactory to each of
Akerna, Purchaser and Ample, each acting reasonably;

 

		(g)	the Akerna Shares to be issued upon the exchange of Exchangeable Shares shall, subject to customary
conditions, have been approved for listing on the NASDAQ; and

 

		(h)	the Exchangeable Shares, and the Akerna Shares to be issued pursuant to the exchange of the Exchangeable
Shares, in each case to be issued pursuant to the Arrangement, shall be exempt from the registration requirements of the U.S. Securities
Act pursuant to Section 3(a)(10) thereof.

 

		5.2	Additional Conditions to Obligations of Akerna and Purchaser

 

The obligation of Akerna and Purchaser
to complete the Arrangement is subject to the fulfillment of each of the following conditions precedent on or before the Effective
Time (each of which is for the exclusive benefit of Akerna and Purchaser and may be waived by Akerna and Purchaser, in whole or
in part at any time, each in its sole discretion, without prejudice to any other rights which Akerna may have):

 

		(a)	the representations and warranties of Ample set forth in this Agreement will be: (i) for the representations
and warranties qualified as to materiality, true and correct in all respects; and (ii) for all other representations and warranties,
true and correct in all material respects, as of the date of this Agreement and as of the Effective Date as if made on and as of
such date (except to the extent such representations and warranties speak as of an earlier date, the accuracy of which will be
determined as of that specified date), except where the failure of such representations and warranties to be true and correct,
individually or in the aggregate, would not or would not be reasonably expected to have an Ample Material Adverse Effect or materially
impede completion of the Arrangement, and Ample will have provided to Akerna and Purchaser a certificate of two senior officers
or authorized signatories certifying such accuracy;

 

		(b)	Ample will have complied in all material respects with its covenants herein, and Ample will have
provided to Akerna and Purchaser a certificate of two senior officers or authorized signatories certifying compliance with such
covenants;

 

		(c)	there shall be no action or proceeding (whether by a Governmental Entity or any other Person) pending
or threatened in any jurisdiction to:

 

    - 71 -

     

    

 

		(i)	cease trade, enjoin or prohibit or impose any limitations, damages or conditions on, Akerna’s ability
to acquire, hold or exercise full rights of ownership over, any Ample Shares, including the right to vote the Ample Shares;

 

		(ii)	impose terms or conditions on the completion of the Arrangement or on the ownership or operation
by Akerna of the business or assets of Akerna, Ample and any Ample Subsidiaries, affiliates and related entities; or

 

		(iii)	prevent or materially delay the consummation of the Arrangement;

 

		(d)	between the date hereof and the Effective Time, there will not have occurred any Ample Material
Adverse Effect;

 

		(e)	the Shareholder Representative shall have duly executed and delivered copies of each of the Escrow
Agreement and the Rights Indenture;

 

		(f)	on the date hereof, Akerna and Purchaser shall have received the Ample Shareholder Support Agreements
duly executed by each of the directors and officers of Ample;

 

		(g)	as of the Effective Time, the Ample Supporting Securityholders shall not have breached their obligations
or covenants under the Ample Shareholder Support Agreements in any material respect; and

 

		(h)	Ample Shareholders have not validly exercised and not withdrawn Dissent Rights with respect to
more than 5% of the Ample Shares then outstanding.

 

		5.3	Additional Conditions to Obligations of Ample

 

The obligation of Ample to complete the
Arrangement is subject to the fulfillment of each of the following conditions precedent on or before the Effective Time (each of
which is for the exclusive benefit of Ample and may be waived by Ample, in whole or in part at any time, in its sole discretion,
without prejudice to any other rights which Ample may have):

 

		(a)	Akerna and the Purchaser shall have delivered the Up-front Consideration and CVRs in accordance
with Section 2.14;

 

		(b)	the representations and warranties of Akerna and Purchaser set forth in this Agreement will be:
(i) for the representations and warranties qualified as to materiality, true and correct in all respects; and (ii) for all other
representations and warranties, true and correct in all material respects, as of the date of this Agreement and as of the Effective
Date as if made on and as of such date (except to the extent such representations and warranties speak as of an earlier date, the
accuracy of which will be determined as of that specified date), except where the failure of such representations and warranties
to be true and correct, individually or in the aggregate, would not or would not be reasonably expected to have a material adverse
effect on the ability of Purchaser to complete the Arrangement or materially impede completion of the Arrangement, and Akerna and
Purchaser will have provided to Ample a certificate of two senior officers or authorized signatories certifying such accuracy;

 

    - 72 -

     

    

 

		(c)	Akerna and Purchaser will have complied in all material respects with its covenants herein, and
Akerna and Purchaser will have provided to Ample a certificate of two senior officers or authorized signatories certifying compliance
with such covenants; and

 

		(d)	between the date hereof and the Effective Time, there will not have occurred any Akerna Material
Adverse Effect;

 

		(e)	on the date hereof, Ample shall have received the Akerna Shareholder Support Agreements duly executed
by each of the directors and officers of Akerna;

 

		(f)	Akerna shall have delivered copies of each of the Exchangeable Share Support Agreement, the Voting
and Exchange Trust Agreement, the Escrow Agreement and the Rights Indenture, in each case, duly executed by each party thereto
other than the Shareholder Representative; and

 

		(g)	as of the Effective Time, the directors and officers of Akerna shall not have breached their obligations
or covenants under the Akerna Shareholder Support Agreements in any material respect.

 

		5.4	Notice and Effect of Failure to Comply with Conditions

 

		(a)	Each Party shall give prompt notice to the other Parties of the occurrence, or failure to occur,
at any time from the date hereof to the Effective Date of any event or state of facts which occurrence or failure would, or would
be likely to: (i) cause any of the representations or warranties of any Party contained herein to be untrue or inaccurate in any
material respect; or (ii) result in the failure to comply with or satisfy any covenant, condition or agreement to be complied with
or satisfied by any Party hereunder; provided that, that no such notification will affect the representations or warranties
of the Parties or the conditions to the obligations of the Parties hereunder.

 

		(b)	If any of the conditions precedents set forth in Sections 5.1, 5.2 or 5.3 hereof shall not be complied
with or waived by the Party or Parties for whose benefit such conditions are provided on or before the date required for the performance
thereof, then a Party for whose benefit the condition precedent is provided may, in addition to any other remedies they may have
at law or equity, rescind and terminate this Agreement provided that the Party intending to rely thereon has delivered a written
notice to the other Parties, specifying in reasonable detail all breaches of covenants, representations and warranties or other
matters which the Party delivering such notice is asserting as the basis for the non-fulfillment of the applicable condition or
the availability of a termination right, as the case may be. If any such notice is delivered, provided that a Party is proceeding
diligently to cure any such matter capable of being cured, and that has not occurred as a result of a willful breach, to the satisfaction
of the other Parties, acting reasonably, no Party may terminate this Agreement if such matter capable of being cured has been cured
to the satisfaction of the Parties seeking termination of this Agreement, acting reasonably, prior to the expiration of a period
of five Business Days from the date of receipt of such notice (provided that no such cure period shall extend beyond the Outside
Date and no such cure period shall be provided for a breach which by its nature cannot be cured). More than one such notice may
be delivered by a Party. If a Party seeking termination of this Agreement hereunder delivers a notice of such termination within
five Business Days of the scheduled date of the Akerna Meeting or Ample Meeting, as applicable, unless the Parties agree otherwise
and subject to compliance with Applicable Law, the respective Party shall postpone or adjourn its shareholders’ meeting to
the earlier of: (i) the date that is ten Business Days from receipt of the termination notice; and (ii) five Business Days prior
to the Outside Date.

 

    - 73 -

     

    

 

		5.5	Satisfaction of Conditions

 

The conditions set out in this Article
5 are conclusively deemed to have been satisfied, waived or released at the Effective Time. For certainty, and notwithstanding
the terms of any escrow arrangement entered into between the Parties and the Depositary other than the Escrow Agreement, all funds
and CVRs held in escrow by the Depositary pursuant to Section 2.14(a) hereof shall be released from escrow at the Effective Time
without any further act or formality required on the part of any Person, and the Exchangeable Shares deposited with the Escrow
Agent will be held and released at the times and in accordance with the terms and conditions of the Escrow Agreement.

 

Article
6

INDEMNIFICATION

 

		6.1	Indemnification by Ample Shareholders

 

From and after the Effective Time, the
Ample Shareholders shall, jointly and severally indemnify Akerna and Purchaser (each a “Purchaser Indemnified Person”)
in respect of, and hold each Purchaser Indemnified Person harmless against any and all Damages incurred or suffered by such Purchaser
Indemnified Person resulting from, relating to or constituting:

 

		(a)	any breach or inaccuracy, as of the date of this Agreement or as of the Effective Date, of any
representation or warranty of Ample contained in this Agreement or any other agreement or instrument furnished by Ample to Akerna
pursuant to this Agreement; or

 

		(b)	any failure to perform any covenant or agreement of Ample contained in this Agreement or any other
agreement or instrument furnished by Ample to Akerna pursuant to this Agreement.

 

		6.2	Indemnification by Akerna and Purchaser

 

From and after the Effective Time, Akerna
and Purchaser shall, jointly and severally indemnify each Ample Shareholder (each an “Ample Indemnified Person”)
in respect of, and hold it harmless against any and all Damages incurred or suffered by any Ample Shareholder resulting from, relating
to or constituting:

 

		(a)	any breach or inaccuracy, as of the date of this Agreement or as of the Effective Date, of any
representation or warranty of Akerna or Purchaser contained in this Agreement or any other agreement or instrument furnished by
Akerna or Purchaser to Ample pursuant to this Agreement; or

 

		(a)	any failure to perform any covenant or agreement of Akerna or Purchaser contained in this Agreement
or any other agreement or instrument furnished by Akerna or Purchaser to Ample pursuant to this Agreement.

 

    - 74 -

     

    

 

		6.3	Indemnification Claims

 

		(a)	A Party that may be entitled to make a Claim for indemnification under this Agreement (the “Indemnified
Party”) shall provide a Claim Notice to the other Party or Parties (the “Indemnifying Party”) promptly
upon the Indemnified Party becoming aware of the Claim and in no event later than the relevant date, if any, specified in Section
6.4. Each Claim Notice shall describe in reasonable detail (to the extent then known to the Indemnified Party) the facts constituting
the basis for such Claim, the amount of the claimed Damages, and whether such Claim arises in respect of a Third Party Action or
whether such Claim does not so arise. No delay or failure on the part of an Indemnified Party in so delivering a Claim Notice shall
relieve any Indemnifying Party of any liability or obligation hereunder except to the extent of any damage or liability caused
by or arising out of such delay or failure.

 

		(b)	Within 15 Business Days after delivery of a Claim Notice respecting a Third Party Action, the Indemnifying
Party may, upon written notice thereof to the Indemnified Party, assume control of the defense of such Third Party Action with
counsel reasonably satisfactory to the Indemnified Party; provided that: (i) the Indemnifying Party may only assume control of
such defense if: (A) they acknowledge in writing to the Indemnified Party that any damages, fines, costs or other liabilities that
may be assessed against the Indemnified Party in connection with such Third Party Action constitute Damages for which such Indemnified
Party shall be indemnified pursuant to this Article 6; and (B) the ad damnum in such Third Party Action, taken together with the
estimated costs of defense thereof and the Claimed Amount with respect to any unresolved claims for indemnification then pending,
is less than or equal to the value of the unused portion of the maximum liability each applicable Indemnifying Party is liable
for as contemplated hereunder; and (ii) an Indemnifying Party may not assume control of the defense of any Third Party Action involving
Taxes or criminal liability or in which equitable relief is sought against an Indemnifying Party. If the Indemnifying Party does
not, or is not permitted under the terms of this Agreement to, so assume control of the defense of a Third Party Action, the Indemnified
Party shall control such defense. The Party which is not controlling the defense of the Third Party Action (the “Non-Controlling
Party”) may participate in such defense at its own expense. The party controlling the defence of the Third Party Action
(the “Controlling Party”) Party shall keep the Non-Controlling Party advised of the status of such Third Party
Action and the defense thereof and shall consider in good faith recommendations made by the Non-Controlling Party with respect
thereto. The Non-Controlling Party shall furnish the Controlling Party with such information as it may have with respect to such
Third Party Action (including copies of any summons, complaint or other pleading which may have been served on such party and any
written claim, demand, invoice, billing or other document evidencing or asserting the same) and shall otherwise cooperate with
and assist the Controlling Party in the defense of such Third Party Action. The Indemnifying Party shall not agree to any settlement
of, or the entry of any judgment arising from, any Third Party Action without the prior written consent of the Indemnified Party,
which shall not be unreasonably withheld, conditioned or delayed; provided that the consent of the Indemnified Party shall not
be required if the Indemnifying Party, agrees in writing to pay any amounts payable pursuant to such settlement or judgment and
such settlement or judgment includes a complete release of the Indemnified Party from further liability and has no other adverse
effect on the Indemnified Party. Except as provided in subsection 6.3(d) below, the Indemnified Party shall not agree to any settlement
of, or the entry of any judgment arising from, any such Third Party Action without the prior written consent of the Indemnifying
Party, which shall not be unreasonably withheld, conditioned or delayed.

 

    - 75 -

     

    

 

		(c)	Within 15 Business Days after delivery of a Claim Notice, an Indemnifying Party shall deliver to
each Indemnified Party a written response in which the Indemnifying Party, shall: (i) agree that the Indemnified Party is entitled
to receive all of the Claimed Amount; (ii) agree that the Indemnified Party is entitled to receive an Agreed Amount; or (iii) dispute
that the Indemnified Party is entitled to receive any of the Claimed Amount. The Indemnifying Party may contest the payment of
all or a portion of the Claimed Amount only based upon a good faith belief that all or such portion of the Claimed Amount does
not constitute Damages for which the Indemnified Party is entitled to indemnification under this Article 6. If no written response
is delivered by the Indemnifying Party within such 15 Business Day period, the Indemnifying Party shall be deemed to have agreed
that all of the Claimed Amount is owed to the Indemnified Party. Acceptance by the Indemnified Party of partial payment of any
Claimed Amount shall be without prejudice to the Indemnified Party’s right to claim the balance of any such Claimed Amount.

 

		(d)	During the 20 Business Day period following the delivery of a written response from the Indemnifying
Party that reflects a Dispute, the Indemnifying Party and Indemnified Party shall use good faith efforts to resolve the Dispute.
If the Dispute is not resolved within such 20 Business Day period, any party may commence an action to resolve such Dispute in
a court of competent jurisdiction in the Province of Ontario in accordance with this Agreement. If the Indemnified Party is seeking
to enforce the Claim that is the subject of the Dispute pursuant to the Escrow Agreement, the Indemnifying Party and Indemnified
Party shall deliver to the Escrow Agent, promptly following the resolution of the Dispute (whether by mutual agreement, arbitration,
judicial decision or otherwise), a written notice executed by both the Indemnifying Party and Indemnified Party instructing the
Escrow Agent as to what (if any) portion of the Escrowed Shares shall be distributed to the Indemnified Party (which notice shall
be consistent with the terms of the resolution of the Dispute).

 

		(e)	Notwithstanding the other provision of this Section 6.3, if a third party asserts (other than by
means of a lawsuit or a tax reassessment) that the Indemnified Party is liable to such third party for a monetary or other obligation
which may constitute or result in Damages for which the Indemnified Party may be entitled to indemnification pursuant to this Article
6, and the Indemnified Party reasonably determines that it has a valid business reason to fulfill such obligation, then: (i) the
Indemnified Party shall be entitled to satisfy such obligation, without prior notice to or consent from the Indemnifying Party;
(ii) the Indemnified Party may subsequently make a claim for indemnification in accordance with this Article 6; (iii) the Indemnified
Party shall be reimbursed, in accordance with this Article 6, for any such Damages for which it is entitled to indemnification
(subject to the right of the Indemnifying Party to dispute the Indemnified Party’s entitlement to indemnification, or the amount
for which it is entitled to indemnification, under the terms of this Article 6).

 

		(f)	The Shareholder Representative shall have full power and authority on behalf of each Ample Shareholder,
to take any and all actions on behalf of, execute any and all instrument on behalf of, and execute or waive any and all rights
of, the Ample Shareholders under this Article 6. The Shareholder Representative shall have no liability to any Ample Shareholders
for any action taken or omitted on behalf of the Ample Shareholders pursuant to this Article 6.

 

    - 76 -

     

    

 

		6.4	Survival of Representations and Warranties

 

		(a)	Unless otherwise specified in this Section 6.4(a) or elsewhere in this Agreement, the representations
and warranties contained in this Agreement shall survive the Effective Date and the consummation of the transactions contemplated
hereby and shall continue in full force and effect in accordance with their terms until the date that is 12 months from the Effective
Date.

 

		(b)	If an Indemnified Party delivers to an Indemnifying Party, before expiration of a representation,
warranty, covenant or agreement, a Claim Notice or an Expected Claim Notice based upon a breach of such representation, warranty,
covenant or agreement, then the applicable representation, warranty, covenant or agreement shall survive until, but only for the
purposes of, the resolution of the matter covered by such notice. If the legal proceeding or written claim with respect to which
an Expected Claim Notice has been given is definitively withdrawn or resolved in favour of the Indemnified Party, then the Indemnified
Party shall promptly so notify the Indemnifying Party. The rights to indemnification set forth in this Article 6 shall not be affected
by: (i) any investigation conducted by or on behalf of the Indemnified Party or any knowledge acquired (or capable of being acquired)
by the Indemnified Party whether before or after the date of this Agreement or the Effective Date with respect to the inaccuracy
or noncompliance with any representation, warranty, covenant or obligation which is the subject of indemnification hereunder; or
(ii) any waiver by the Indemnified Party of any closing condition relating to the accuracy of representations and warranties or
the performance of or compliance with agreements and covenants.

 

		6.5	Limitations

 

		(a)	With respect to Claims for Damages arising under Section 6.1 or 6.2, no Ample Shareholders, on
one hand, and neither of Akerna nor the Purchaser, on the other hand, shall be liable for any such Damages until the aggregate
amount of all such Damages for which such Party(ies) may be liable, exceeds $350,000 (at which point the applicable Indemnifying
Party(ies) shall become liable for all Damages under Section 6.1 or 6.2, as applicable, from first dollar, and in excess of such
amount); provided that the limitation set forth in this sentence shall not apply to claims based on: (i) fraud; or (ii)
any claim pursuant to an Akerna Fundamental Representation and Warranty or an Ample Fundamental Representation and Warranty, (iii)
any failure of Akerna to satisfy its obligations with respect to the Deferred Consideration under Section 2.19 or the Rights Indenture,
or (iv) any Ample Shareholder’s entitlement following the Effective Time to receive Akerna Shares in exchange for Exchangeable
Shares held by such Ample Shareholder or any alleged breach of the Voting and Exchange Trust Agreement, the Exchangeable Share
Support Agreement or the rights and entitlements of any holder of Exchangeable Shares under the articles of incorporation of Purchaser.

 

		(b)	Except for Claims based on fraud, the total aggregate liability of the Ample Shareholders for all
Claims shall not exceed the aggregate value of the Escrowed Shares.

 

    - 77 -

     

    

 

		(c)	The total liability of the Ample Shareholders for all Claims (inclusive of Claims based on fraud)
shall not exceed the aggregate value of the Escrowed Shares and the Closing Shares.

 

		(d)	The recovery of Escrowed Shares and Closing Shares pursuant to Section 6.6 shall be the exclusive
means for a Purchaser Indemnified Person to collect Damages for which it is entitled to indemnification under this Article 6 from
the Ample Shareholders.

 

		(e)	Except for Claims based on (i) fraud, (ii) with respect to any failure of Akerna to satisfy its
obligations with respect to the Deferred Consideration under Section 2.19 or the Rights Indenture, or (iii) any Ample Shareholder’s
entitlement following the Effective Time to receive Akerna Shares in exchange for Exchangeable Shares held by such Ample Shareholder
or any alleged breach of the Voting and Exchange Trust Agreement, the Exchangeable Share Support Agreement or the rights and entitlements
of any holder of Exchangeable Shares under the articles of incorporation of Purchaser, the total liability of Akerna and Purchaser
shall not exceed the amount determined by multiplying the aggregate number of Escrowed Shares by the Deemed Value Amount.

 

		(f)	The total liability of Akerna and Purchaser for all Claims (inclusive of Claims based on fraud),
except for Claims based on (i) any failure of Akerna to satisfy its obligations with respect to the Deferred Consideration under
Section 2.19 or the Rights Indenture, or (ii) any Ample Shareholder’s entitlement following the Effective Time to receive
Akerna Shares in exchange for Exchangeable Shares held by such Ample Shareholder or any alleged breach of the Voting and Exchange
Trust Agreement, the Exchangeable Share Support Agreement or the rights and entitlements of any holder of Exchangeable Shares under
the articles of incorporation of Purchaser, shall not exceed the amount determined by multiplying the aggregate number of Escrowed
Shares and Closing Shares by the Deemed Value Amount.

 

		(g)	An Indemnifying Party shall have no liability to an Indemnified Party for any punitive or exemplary
damages except in connection with a Third Party Action.

 

		(h)	An Indemnifying Party shall have no liability to an Indemnified Party hereunder for any Damages
that arise as a result of any proposed or actual promulgation or change of any Applicable Laws which occurs after the Effective
Date, whether or not the same takes effect retroactively.

 

		(i)	An Indemnifying Party shall not have duplicate liability to an Indemnified Party hereunder by virtue
of more than one representation, warranty or covenant relating to the same matter or thing.

 

		(j)	No Ample Shareholder shall have any right of contribution against Ample with respect to any breach
by Ample of any of its representations, warranties, covenants or agreements.

 

		(k)	Any payments made to a Party pursuant to this Article 6 or pursuant to the Escrow Agreement shall
be treated as an adjustment to the Consideration for tax purposes to the extent permitted by Applicable Law.

 

    - 78 -

     

    

 

		(l)	Where any payment is made under this Agreement pursuant to an indemnity, compensation or reimbursement
provision, or in respect of any Claim Notice, and the sum is subject to a charge to Taxes in the hands of the recipient (other
than Taxes attributable to a payment being properly treated as an adjustment to the Consideration) the sum payable shall be increased
to such sum as will ensure that after payment of such Taxes (and after giving credit for any relief available to the recipient
in respect of the matter giving rise to the payment) the recipient shall be left with a sum equal to the sum that would have been
received in the absence of such a charge to Taxes.

 

		6.6	Recourse to Escrowed Shares

 

		(a)	Except with respect to Claims based on fraud, recovery of Escrowed Shares pursuant to this Section
6.6(a) shall be the exclusive means for a Purchaser Indemnified Person to collect any Damages for which it is entitled to indemnification
under this Article 6 from the Ample Shareholders. During the term of the Escrow Agreement (exclusive of any extension thereof past
its regular term which occurs solely as a result of a Claim being made thereunder, other than with respect to such Claim), if the
Ample Shareholders (or any of them) are determined to owe a Claim amount under this Article 6, then the amount due to any Purchaser
Indemnified Person shall be made by the delivery of Escrowed Shares to each applicable Purchaser Indemnified Person pursuant to
the Escrow Agreement. The Parties hereby agree that the number of Escrowed Shares that shall be released from escrow in satisfaction
of any liability for Damages that a Purchaser Indemnified Person is entitled to recover from an Ample Shareholder in connection
with any claim for indemnification under this Article 6 shall, subject to the other limitations on liability set forth in this
Article 6, be equal to the amount of Damages that such Purchaser Indemnified Person is entitled to recover from such Ample Shareholder,
divided by the 20 day volume weighted average price of the Akerna Shares (converted to Canadian dollars from US dollars using the
Exchange Rate as of the last trading day immediately preceding the date on which such Claim is Determined) as quoted on the NASDAQ
on the last trading day immediately preceding the date on which such Claim is Determined (the “Deemed Escrow Value”).
A Claim shall be deemed to be “Determined” for the purposes of this Section 6.6(a), (a) in the case of any
Third Party Action which the Shareholder Representative, on behalf of the Ample Shareholders (or any of them), elected to defend,
by any settlement agreement between the Shareholder Representative and the applicable Persons asserting such Third Party Action,
or otherwise by order of a court, tribunal or arbitrator of competent jurisdiction; or (b) in the case of all other Claims for
indemnification, by written acknowledgement of liability by the Shareholder Representative, on behalf of the Ample Shareholders
(or any of them), by settlement agreement between the Shareholder Representative and the applicable Purchaser Indemnified Person(s),
or otherwise by order of a court, tribunal or arbitrator of competent jurisdiction.

 

		(b)	With respect to Claims based on fraud, if the aggregated Deemed Escrow Value of the Escrowed Shares
that are then available to be claimed against pursuant to the Escrow Agreement is insufficient to satisfy any Ample Shareholder’s
liability for Damages in respecting of fraud, then during the term of the Escrow Agreement (exclusive of any extension thereof
past its regular term which occurs solely as a result of a Claim being made thereunder, other than with respect to such Claim),
the amount due to the applicable Purchaser Indemnified Persons that cannot be satisfied out of the Escrowed Shares shall be made
by the delivery to the applicable Purchaser Indemnified Persons of Closing Shares that then remain in escrow and available to be
claimed against pursuant to the Escrow Agreement. The Parties hereby agree that the number of Closing Shares that shall be released
from escrow in satisfaction of any liability for Damages based on fraud that a Purchaser Indemnified Person is entitled to recover
from an Ample Shareholder in connection with any claim for indemnification under this Article 6 shall, subject to all other limitations
on liability set forth in this Article 6, be equal to the amount of Damages that such Purchaser Indemnified Person is entitled
to recover from such Ample Shareholder (minus the amount of any such Damages recovered against the Escrowed Shares), divided by
the applicable Deemed Escrow Value.

 

    - 79 -

     

    

 

		6.7	Satisfaction of Damages with Akerna Shares

 

If Akerna and Purchaser (or either
of them) are determined to owe a Claim amount under this Article 6, then the amount due to any Ample Indemnified Person may, in
the sole discretion of Akerna and the Purchaser, be made by the issuance of additional Akerna Shares to such Ample Indemnified
Person. The Parties hereby agree that the number of additional Akerna Shares to be issued in satisfaction of any liability for
Damages that an Ample Indemnified Person is entitled to recover from Akerna and/or Purchaser in connection with any claim for indemnification
under this Article 6 shall, subject to the other limitations on liability set forth in this Article 6, be equal to the amount of
Damages that such Ample Indemnified Person is entitled to recover from Akerna and/or Purchaser, divided by the 20 day volume weighted
average price of the Akerna Shares (converted to Canadian dollars from US dollars using the Exchange Rate as of the last trading
day immediately preceding the date on which such Claim is Determined) as quoted on the NASDAQ on the last trading day immediately
preceding the date on which such Claim is Determined. A Claim shall be deemed to be “Determined” for the purposes
of this Section 6.7, (a) in the case of any Third Party Action which Akerna and/or Purchaser elected to defend, by any settlement
agreement between Akerna and/or Purchaser and the applicable Persons asserting such Third Party Action, or otherwise by order of
a court, tribunal or arbitrator of competent jurisdiction; or (b) in the case of all other Claims for indemnification, by written
acknowledgement of liability by Akerna and/or Purchaser, by settlement agreement between Akerna and/or Purchaser and the applicable
Ample Indemnified Person(s), or otherwise by order of a court, tribunal or arbitrator of competent jurisdiction.

 

		6.8	Exclusive Remedy

 

Following the Effective Date,
no Party may make any claim for Damages in respect of this Agreement, including for certainty, in respect of the Arrangement and
each other transaction contemplated hereby, or in respect of any breach hereof, against any other Party except by making a Claim
pursuant to and in accordance with this Article 6. The indemnities provided for in Sections 6.1 and 6.2 shall constitute the only
remedy of Akerna, Purchaser and the Shareholder Representative (on behalf of the Ample Shareholders) against any Party for any
inaccuracy in or breach of any representation, warranty, covenant or agreement of such Party contained in this Agreement and each
of the Parties hereto expressly waives and renounces any other remedies whatsoever, whether at law or in equity, which it would
otherwise be entitled to as against a Party.

 

		6.9	Mitigation

 

Nothing in this Article 6 shall eliminate
or reduce an Indemnified Party’s obligation to mitigation Damage as required by Applicable Laws.

 

    - 80 -

     

    

 

Article
7

AMENDMENT

 

		7.1	Amendment

 

This Agreement may at any time and from
time to time before or after the holding of the Ample Meeting be amended by written agreement of the Parties without, subject to
Applicable Laws, further notice to or authorization on the part of the Ample Shareholders and any such amendment may, without limitation:

 

		(a)	change the time for performance of any of the obligations or acts of the Parties;

 

		(b)	waive any inaccuracies or modify any representation or warranty contained herein or in any document
delivered pursuant hereto;

 

		(c)	waive compliance with or modify any of the covenants herein contained and waive or modify performance
of any of the obligations of the Parties; or

 

		(d)	waive compliance with or modify any other conditions precedent contained herein,

 

provided that no such amendment reduces
or materially adversely affects the consideration to be received by Ample Shareholders without approval by the affected Ample Shareholders
given in the same manner as required for the approval of the Arrangement or as may be ordered by the Court.

 

		7.2	Amendment of Plan of Arrangement

 

		(a)	Ample, Akerna and Purchaser reserve the right to amend, modify and/or supplement the Plan of Arrangement
at any time and from time to time prior to the Effective Time by written agreement of the Parties, provided that any amendment,
modification or supplement must be contained in a written document which is: (i) filed with the Court and, if made following the
Ample Meeting, approved by the Court; and (ii) communicated to Ample Shareholders in the manner required by the Court (if so required).

 

		(b)	Other than as may be required under the Interim Order, any amendment, modification or supplement
to the Plan of Arrangement may be proposed by Ample, Akerna and Purchaser (if consented to by all of the Parties, each acting reasonably)
at any time prior to or at the Ample Meeting with or without any other prior notice or communication and, if so proposed and accepted,
in the manner contemplated and to the extent required by this Agreement, by the Ample Shareholders, shall become part of the Plan
of Arrangement for all purposes.

 

		(c)	Any amendment, modification or supplement to the Plan of Arrangement which is approved or directed
by the Court following the Ample Meeting shall be effective only: (i) if it is consented to by Ample, Akerna and Purchaser (each
acting reasonably); and (ii) is not adverse to the financial interests of any former holder of Ample Shares and, if required by
the Court or Applicable Laws, it is consented to by the Ample Shareholders.

 

		(d)	Any amendment, modification or supplement to this Plan of Arrangement which is approved or directed
by the Court following the Effective Time shall be effective only if it is consented to in writing by Purchaser, Akerna and Ample,
and provided that it concerns a matter which, in the reasonable opinion of each of Purchaser, Akerna and Ample, is of an administrative
nature required to better give effect to the implementation of this Plan of Arrangement and is not adverse to the financial interests
of any former holder of Ample Shares, Ample Options or Ample Warrants.

 

    - 81 -

     

    

 

Article
8

TERMINATION AND AMENDMENT

 

		8.1	Termination

 

		(a)	This Agreement may be terminated at any time prior to the Effective Date:

 

		(i)	by mutual written consent of the Parties;

 

		(ii)	by either Akerna and Purchaser or Ample, if the Arrangement Resolution shall have failed to receive
the Ample Shareholder Approval at the Ample Meeting (including any adjournment or postponement thereof) in accordance with the
Interim Order;

 

		(iii)	by either Akerna and Purchaser or Ample, if the Akerna Shareholder Matters shall have failed to
receive the Akerna Shareholder Approval at the Akerna Meeting (including any adjournment or postponement thereof);

 

		(iv)	by either Akerna and Purchaser or Ample, if the Effective Time shall not have occurred on or prior
to the Outside Date, except that the right to terminate this Agreement under this subsection 8.1(a)(iii) shall not be available
to any Party whose failure to fulfill any of its obligations has been the cause of, or resulted in, the failure of the Effective
Time to occur by such date;

 

		(v)	as provided in Section 5.4; provided that the Party seeking termination is not then in breach
of this Agreement so as to cause any of the conditions set forth in Sections 5.1, 5.2 and 5.3, as applicable, not to be satisfied;

 

		(vi)	by Akerna if:

 

		(A)	prior to the Effective Time: (1) the Ample Board or any committee thereof: (i) fails to recommend
or withdraws, amends, modifies or qualifies, in a manner adverse to Akerna or fails to reaffirm (without qualification) the Ample
Board Recommendation, or its recommendation of the Arrangement within five Business Days (and in any case prior to the Ample Meeting)
after having been requested in writing by Akerna to do so (acting reasonably); or (ii) takes no position or a neutral position
with respect to an Acquisition Proposal for more than five Business Days after the public announcement of such Acquisition Proposal;
or (2) the Ample Board or a committee thereof shall have resolved or proposed to take any of the foregoing actions ((1) or (2)
each a “Ample Change in Recommendations”); or (3) Ample shall have breached Section 3.8 in any material respect;

 

    - 82 -

     

    

 

		(B)	a breach of any representation or warranty or failure to perform any covenant or agreement on the
part of Ample set forth in this Agreement shall have occurred that would cause the conditions set forth in Section 5.2(a) or Section
5.2(b) not to be satisfied, and such conditions are incapable of being satisfied by the Outside Date, as reasonably determined
by Akerna and provided that Akerna is not then in breach of this Agreement so as to cause any condition in Section 5.3(a) or Section
5.3(c) not to be satisfied; or

 

		(C)	there has occurred an Ample Material Adverse Effect which is not capable of being cured on or before
the Outside Date; and

 

		(vii)	by Ample if:

 

		(A)	a breach of any representation or warranty or failure to perform any covenant or agreement on the
part of Akerna or Purchaser set forth in this Agreement shall have occurred that would cause the conditions set forth in Section
5.3(a) or Section 5.3(c) not to be satisfied, and such conditions are incapable of being satisfied by the Outside Date, as reasonably
determined by Ample and provided that Ample is not then in breach of this Agreement so as to cause any condition in Section 5.2(a)
or Section 5.2(b) not to be satisfied; or

 

		(B)	there has occurred an Akerna Material Adverse Effect which is not capable of being cured on or
before the Outside Date;

 

		(b)	The Party desiring to terminate this Agreement pursuant to this Section 8.1 shall deliver written
notice of such termination to the other Parties, specifying in reasonable detail the basis for such Party’s exercise of its termination
right.

 

		(c)	If this Agreement is terminated in accordance with the foregoing provisions of this Section 8.1,
this Agreement will forthwith become void and no Party will have any further liability or obligation to the other Parties hereunder
except as provided this subsection 8.1(b), subsection 3.6(h), subsection 3.7(j), Section 10.1, Section 10.5, Section 10.9, Section
10.10 and Section 10.12, which will survive such termination. Notwithstanding the foregoing, nothing contained in this subsection
8.1(c) shall relieve any Party from liability for any fraud or wilful or intentional breach of any provision of this Agreement.

 

Article
9

NOTICES

 

		9.1	Notices

 

All notices that may or are required to
be given pursuant to any provision of this Agreement are to be given or made in writing and delivered by personal delivery or delivery
by recognized commercial courier, sent by email (with confirmation of transmission) or delivered by registered mail (return receipt
requested, postage prepaid), addressed as follows:

 

	 	(a)	in the case of Akerna to: 

 

Akerna Corp.

1601 Arapahoe Street

Denver, CO 80202

	Attention:	Scott Sozio, President
	Email:	scott.sozio@akerna.com

 

    - 83 -

     

    

 

with a copy to:

 

Dentons Canada LLP

15th Floor, Bankers Court, 850 –
2nd Street S.W.

Calgary, Alberta T2P 0R8

	Attention:	Courtney Burton
	Email:	courtney.burton@dentons.com

 

	 	(b)	in the case of Purchaser, to:

 

2732805 Ontario Inc.

c/o Akerna Corp.

1601 Arapahoe Street

Denver, CO 80202

	Attention:	Scott Sozio, President
	Email:	scott.sozio@akerna.com

 

	 	(c)	in the case of Ample, to:

 

Ample Organics Inc.

629 Eastern Avenue, Building B

Toronto, Ontario M4M 1E4

	Attention:	John Prentice
	Email:	john.prentice@ampleorganics.com

 

with a copy to:

 

Dentons Canada LLP

77 King Street West, Suite 400

Toronto-Dominion Centre

Toronto, Ontario M5K 0A1

 

	Attention:	Eric Foster
	Email:	eric.foster@dentons.com

 

	 	(d)	in the case of the Shareholder Representative, to:

 

John Prentice

629 Eastern Avenue, Building B

Toronto, Ontario M4M 1E4

	Email:	john.prentice@ampleorganics.com

 

or at such other address or email of which
the addressee may from time to time may notify the addressor. Any notice shall be deemed to have been validly and effectively given
and received (a) if sent by personal delivery or by courier on the date of actual receipt by the receiving party; (b) if sent by
email on the date of transmission if a Business Day or if not a Business Day or after 5:00 p.m. (Eastern Standard Time) on
the date of transmission, on the next following Business Day; or (c) if sent by certified or registered mail (postage prepaid)
on the date indicated in the return receipt.

 

    - 84 -

     

    

 

Article
10

GENERAL

 

		10.1	Assignment, Binding Effect and Entire Agreement

 

		(a)	Except as expressly permitted by the terms hereof, neither this Agreement nor any of the rights,
interests or obligations hereunder will be assigned by any of the Parties hereto without the prior written consent of the other
Parties hereto. The above notwithstanding, Akerna and/or Purchaser may assign all or any part of its rights or obligations under
this Agreement and any agreements ancillary hereto to one or more of Akerna’s or Purchaser’s Affiliates, and provided further
that if such assignment takes place, Akerna will continue to be fully liable as primary obligor, on a joint and several basis with
any such entity, to Ample or the Ample Shareholders, as applicable, for any default in performance by the assignee of any of Akerna’s
or Purchaser’s obligations hereunder.

 

		(b)	This Agreement will be binding on and will inure to the benefit of the Parties and their respective
successors and permitted assigns.

 

		(c)	This Agreement (including the schedules attached hereto), the Akerna Disclosure Letter and the
Ample Disclosure Letter constitute the entire agreement with respect to the subject matter hereof, and supersede all other prior
agreements and understandings, both written and oral, between the Parties with respect to the subject matter hereof and thereof.

 

		10.2	Adjustments to Calculation

 

Notwithstanding anything in this Agreement
to the contrary, in respect of each calculation hereunder based upon the 20 day volume weighted average price of the Akerna Shares
as quoted on the NASDAQ, if during the referenced 20 day period there shall be any split or consolidation of the issued and outstanding
Akerna Shares, then such calculation shall be appropriately adjusted to take into account for the purposes of such calculation,
only the portion of such 20 day period following the completion of such split or consolidation.

 

		10.3	Public Communications

 

Each Party agrees to consult with the other
Parties prior to issuing, or permitting any of its directors, officers, employees or agents to issue, any press releases or otherwise
make public statements with respect to this Agreement or the Arrangement. Without limiting the generality of the foregoing, no
Party will issue any press release regarding the Arrangement, this Agreement or any transaction relating to this Agreement without
first providing a draft of such press release to the other Parties and reasonable opportunity for comment and obtaining their consent
to issue (which consent will not be unreasonably withheld, conditioned or delayed); provided, however, that the foregoing will
be subject to each Party’s overriding obligation to make any such disclosure required in accordance with Applicable Laws. If such
disclosure is required and the other Party has not reviewed or commented on or consented to the disclosure, the Party making such
disclosure will use all commercially reasonable efforts to give prior oral or written notice to the other Party, and if such prior
notice is not possible, to give such notice promptly following such disclosure.

 

		10.4	Costs

 

Except as otherwise expressly provided
for herein, all fees, costs and expenses incurred in connection with this Agreement and the transactions contemplated hereby will
be paid by the Party incurring such cost or expense, whether or not the Arrangement is completed.

 

    - 85 -

     

    

 

		10.5	No Liability

 

No director or officer of Akerna shall
have any personal liability whatsoever to Ample under this Agreement, or any other document delivered in connection with the transaction
contemplated hereby on behalf of Akerna. No director or officer of Ample shall have any personal liability whatsoever to Akerna
under this Agreement, or any other document delivered in connection with the transactions contemplated hereby on behalf of Ample.

 

		10.6	Severability

 

If any one or more of the provisions or
parts thereof contained in this Agreement should be or become invalid, illegal or unenforceable in any respect, the remaining provisions
or parts thereof contained herein will be and will be conclusively deemed to be severable therefrom and the validity, legality
or enforceability of such remaining provisions or parts thereof will not in any way be affected or impaired by the severance of
the provisions or parts thereof severed. Upon such determination that any term or other provision is invalid, illegal or incapable
of being enforced, the Parties will negotiate in good faith to modify this Agreement so as to effect the original intent of the
Parties as closely as possible in an acceptable manner to the end that the transactions contemplated hereby are fulfilled to the
fullest extent possible.

 

		10.7	Further Assurances

 

Each Party hereto will, from time to time
and at all times hereafter, at the request of the another Party hereto, but without further consideration, do all such further
acts, and execute and deliver all such further documents and instruments and provide all such further assurances as may be reasonably
required in order to fully perform and carry out the terms and intent hereof.

 

		10.8	Time of Essence

 

Time will be of the essence of this Agreement.

 

		10.9	Applicable Laws and Enforcement

 

This Agreement will be governed, including
as to validity, interpretation and effect, by the laws of the Province of Ontario and the laws of Canada applicable therein, and
will be construed and treated in all respects as an Ontario contract. Each of the Parties hereby irrevocably attorns to the non-exclusive
jurisdiction of the Courts of the Province of Ontario in respect of all matters arising under and in relation to this Agreement
and the Arrangement. Each Party hereby waives any right to trial by jury in any action, proceeding or counterclaim (whether based
on contract, tort or otherwise) arising out of or relating to this Agreement or the transactions contemplated hereby or the actions
of the Parties in the negotiation, administration, performance and enforcement of this Agreement.

 

		10.10	Injunctive Relief

 

The Parties agree that irreparable harm
would occur for which money damages would not be an adequate remedy at law in the event that any of the provisions of this Agreement
were not performed in accordance with their specific terms or were otherwise breached. It is accordingly agreed that the Parties
will be entitled to equitable remedies, including specific performance, a restraining order and interlocutory, preliminary and
permanent injunctive relief and other equitable relief to prevent breaches of this Agreement, any requirement for the securing
or posting of any bond in connection with the obtaining of any such injunctive or other equitable relief hereby being waived. Such
remedies will not be the exclusive remedies for any breach of this Agreement but will be in addition to all other remedies available
at law or equity to each of the Parties.

 

    - 86 -

     

    

 

		10.11	Waiver

 

Any Party may, on its own behalf only:
(a) extend the time for the performance of any of the obligations or acts of another Party; (b) waive compliance with another Party’s
agreements or the fulfillment of any conditions to its own obligations contained herein; or (c) waive inaccuracies in another Party’s
representations or warranties contained herein or in any document delivered by such other Party; provided, however, that any such
extension or waiver (with respect only to the Party delivering such extension or waiver) will be valid only if set forth in an
instrument in writing signed on behalf of such Party and, unless otherwise provided in the written waiver, will be limited to the
specific breach or condition waived.

 

		10.12	Third Party Beneficiaries

 

Except as provided in subsection 3.6(h)
and subsection 3.7(j), and except for the rights of the Ample Shareholders to receive the Consideration for their Ample Shares
pursuant to the Arrangement following the Effective Time, which rights are hereby acknowledged and agreed by Akerna and Purchaser
to be for the benefit of, and enforceable by, the Third Party Beneficiaries or the Ample Shareholders (as applicable), or on their
behalf, this Agreement is not intended to confer any rights or remedies upon any Person other than the Parties to this Agreement.
The provisions of subsection 3.6(h) are intended for the benefit of all present and former directors and officers of Ample, as
and to the extent applicable in accordance with their terms, and shall be enforceable by each of such Persons and his or her heirs,
executors, administrators and other legal representatives, and the provisions of subsection 3.7(j) are intended for the benefit
of all present and former directors and officers of Akerna and Purchaser, as and to the extent applicable in accordance with their
terms, and shall be enforceable by each of such Persons and his or her heirs, executors, administrators and other legal representatives
(collectively, the “Third Party Beneficiaries”), and each of Akerna, Purchaser and Ample, as applicable, shall
hold the rights and benefits of subsection 3.6(h) and subsection 3.7(j) in trust for and on behalf of the Third Party Beneficiaries
and each of Akerna, Purchaser and Ample hereby accepts such trust and agrees to hold the benefit of and enforce performance of
such covenants on behalf of the Third Party Beneficiaries, and in addition to, and not in substitution for, any other rights that
the Third Party Beneficiaries may have by contract or otherwise.

 

		10.13	Counterparts, Execution

 

This Agreement may be executed in two or
more counterparts, each of which will be deemed to be an original but all of which together will constitute one and the same instrument.
The Parties will be entitled to rely upon delivery of an executed facsimile or similar executed electronic copy of this Agreement,
and such facsimile or similar executed electronic copy will be legally effective to create a valid and binding agreement between
the Parties.

 

[Remainder of page left blank intentionally
– signatures follow]

 

    - 87 -

     

    

 

Each of Parties has caused this Agreement
to be executed as of the date first written above by their respective officers thereunto duly authorized.

 

	2732805 ONTARIO INC.	 	AKERNA CORP.
	 	 	 
	Per:	 	 	Per:	 
	 	Name:	 	 	Name: 
	 	Title:	 	 	Title: 

 

Signature Page – Arrangement Agreement

 

     

     

    

 

	 	AMPLE ORGANICS INC.
	 	 
	 	Per:	 
	 	 	Name:
	 	 	Title:
	 	 	 
	 	 	 
	 	 	JOHN PRENTICE

 

Signature Page – Arrangement Agreement

 

     

     

    

   

SCHEDULE “A”

Arrangement Resolution 

 

		1.	The arrangement (the “Arrangement”)
under Section 182 of the Business Corporations Act (Ontario) (the “OBCA”) involving Ample Organics Inc.
(“Ample”), pursuant to the arrangement agreement between Ample, Akerna Corp., 2732805 Ontario Inc. and John
Prentice dated December 18, 2019, as it may be modified, supplemented or amended from time to time in accordance with its terms
(the “Arrangement Agreement”), as more particularly described and set forth in the information circular of
Ample dated [●] (the “Circular”), and all transactions contemplated
thereby, are hereby authorized, approved and adopted.

 

		2.	The plan of arrangement of Ample, as it has been or may
be modified, supplemented or amended in accordance with the Arrangement Agreement and its terms (the “Plan of Arrangement”),
the full text of which is set out as [Appendix ●] to the Circular, is hereby
authorized, approved and adopted.

 

		3.	The: (i) Arrangement Agreement and all the transactions
contemplated thereby; (ii) actions of the directors of Ample in approving the Arrangement and the Arrangement Agreement; and (iii)
actions of the directors and officers of Ample in executing and delivering the Arrangement Agreement and any modifications, supplements
or amendments thereto, and causing the performance by Ample of its obligations thereunder, are hereby ratified, authorized and
approved.

 

		4.	The Corporation is hereby authorized to apply for a final
order from the Ontario Superior Court of Justice (Commercial List) (the “Court”) to approve the Arrangement
on the terms set forth in the Arrangement Agreement and the Plan of Arrangement.

 

		5.	Notwithstanding that this resolution has been passed (and
the Arrangement adopted) by the holders of [Common Shares and Class A Preferred Shares of Ample] (collectively, the “Shareholders”)
or that the Arrangement has been approved by the Court, the directors of Ample are hereby authorized and empowered, at their discretion
and without further notice to or approval of Shareholders: (i) to amend, modify or supplement the Arrangement Agreement or the
Plan of Arrangement to the extent permitted by their terms; and (ii) subject to the terms of the Arrangement Agreement, not to
proceed with the Arrangement and any related transactions.

 

		6.	Any officer or director of Ample is hereby authorized and
directed for and on behalf of Ample to execute, under corporate seal or otherwise, and to deliver or cause to be delivered, for
filing with the Director under the OBCA, articles of arrangement and such other documents as are necessary or desirable to the
Director to give effect to the Arrangement and the Plan of Arrangement and the transactions contemplated thereby in accordance
with the Arrangement Agreement, such determination to be conclusively evidenced by the execution and delivery of such articles
of arrangement and any such other documents.

 

		7.	Any officer or director of Ample is hereby authorized and
directed, for and on behalf of Ample, to execute or cause to be executed and to deliver or cause to be delivered, all such other
documents and instruments and to perform or cause to be performed all such other acts and things as, in such person’s opinion,
may be necessary or desirable to give full force and effect to the foregoing resolutions and the matters authorized thereby, such
determination to be conclusively evidenced by the execution and delivery of any such other document or instrument or the doing
of any such other act or thing.

 

    A-1

     

    

 

SCHEDULE “B”  

PLAN OF ARRANGEMENT

UNDER SECTION 182 OF THE

BUSINESS CORPORATIONS ACT (ONTARIO)

 

ARTICLE
1

INTERPRETATION

 

		1.1	Definitions

 

In this Plan of Arrangement,
unless the context otherwise requires, the following words and terms shall have the meaning hereinafter set out:

 

“Affected Person” has
the meaning set forth in Section 6.3;

 

“Affiliate” has the
meaning ascribed thereto under the Securities Act;

 

“Akerna” means Akerna
Corp., a corporation existing under the laws of Delaware;

 

“Akerna Bridge Loan”
means any loan provided by Akerna to Ample prior to the Effective Time on such terms and conditions as may be agreed between Akerna
and Ample, each acting reasonably;

 

“Akerna Control Transaction”
has the meaning set forth in the Exchangeable Share Provisions;

 

“Akerna Shares” means
the shares of common stock in the authorized share capital of Akerna;

 

“Ample” means Ample
Organics Inc., a corporation existing under the laws of the Province of Ontario;

 

“Ample Articles” means
the certificate and articles of amendment of Ample dated October 1, 2019;

 

“Ample Common Shares”
means the common shares in the authorized capital of Ample;

 

“Ample Common Warrants”
means all outstanding and unexpired warrants to acquire Ample Common Shares;

 

“Ample Meeting” means
the special meeting of the Ample Shareholders, including any adjournment or postponement thereof, to be called and held in accordance
with the Arrangement Agreement and the Interim Order to consider, among other matters, the Arrangement Resolution;

 

“Ample Options” means
the outstanding stock options of Ample, whether or not vested, to acquire Ample Common Shares from treasury pursuant to the Option
Plan;

 

“Ample Preferred Shares”
means each issued and outstanding series of Class A Preferred Shares in the capital of Ample, being the Class A-1 Preferred Shares,
Class A-2 Preferred Shares and Class A-3 Preferred Shares;

 

“Ample Preferred Warrants”
means all outstanding and unexpired warrants to acquire Ample Preferred Shares;

 

“Ample Shareholders”
means the holders of Ample Shares immediately prior to the Effective Time;

 

“Ample Shareholders Agreement”
means that certain second amended and restated unanimous shareholders’ agreement dated June 25, 2018, as amended, respecting
the business and affairs of Ample;

 

“Ample Shares” means
the Ample Common Shares and the Ample Preferred Shares;

 

    B-1

     

    

 

“Ample Voting Agreement”
means the voting trust agreement between John Prentice (as voting trustee), Ample and certain Ample Shareholders dated July 13,
2017;

 

“Ample Warrants” means
collectively the Ample Common Warrants and the Ample Preferred Warrants;

 

“Applicable Laws” (in
the context that refers to one or more Persons) means any domestic or foreign, federal, state, provincial or local law (statutory,
common or otherwise, and including Applicable Securities Laws), constitution, treaty, convention, ordinance, code, rule, regulation,
order, injunction, judgment, decree, ruling or other similar requirement enacted, adopted, promulgated or applied by a Governmental
Entity, and any terms and conditions of any grant of approval, permission, authority or license of any Governmental Entity, that
is binding upon or applicable to such Person or Persons or its or their business, undertaking, property or securities and emanate
from a Person having jurisdiction over the Person or Persons or its or their business, undertaking, property or securities, as
the same may be amended from time to time prior to the Effective Date;

 

“Applicable Securities Laws”
means, collectively, and as the context may require: (a) the applicable securities legislation of each of the provinces and territories
of Canada, and the rules, regulations, instruments, orders and policies published and/or promulgated thereunder; (b) the polices
and rules of the NASDAQ; and (b) U.S. Securities Laws, as the foregoing may be amended from time to time prior to the Effective
Date;

 

“Arrangement” means
the arrangement under the OBCA on the terms and subject to the conditions set out in this Plan of Arrangement, subject to any amendments
or variations to this Plan of Arrangement made in accordance with the terms of this Plan of Arrangement and the Arrangement Agreement
or made at the direction of the Court in the Final Order;

 

“Arrangement Agreement”
means the arrangement agreement dated December 18, 2019 to which this Plan of Arrangement is attached as Schedule “C”,
and all schedules annexed thereto, as the same may be amended, supplemented or otherwise modified from time to time in accordance
with the terms thereof;

 

“Arrangement Resolution”
means the special resolution of the Ample Shareholders approving the Arrangement which is to be considered at the Ample Meeting,
substantially in the form of Schedule “B” to the Arrangement Agreement;

 

“Articles of Arrangement”
means the articles of arrangement in respect of the Arrangement required under subsection 183(1) of the OBCA to be filed with the
Director after the Final Order has been granted, giving effect to the Arrangement, which shall include this Plan of Arrangement
and otherwise be in form and content satisfactory to the Parties, each acting reasonably;

 

“Automatic Exchange Right”
has the meaning set forth in the Voting and Exchange Trust Agreement;

 

“Broker” has the meaning
set forth in Section 6.3(a);

 

“Business Day” means
any day, other than a Saturday, a Sunday or a statutory or civic holiday in the Province of Ontario or in the State of Colorado;

 

“Callco” means a direct
or indirect wholly-owned Subsidiary of Akerna to be incorporated under the laws of the Province of Ontario prior to the Effective
Time;

 

“Certificate of Arrangement”
means the certificate of arrangement to be issued by the Director pursuant to subsection 183(2) of the OBCA in respect of the Articles
of Arrangement;

 

“Change of Law” means
any amendment to the Tax Act and other applicable provincial income tax laws that permits a resident of Canada for the purposes
of the Tax Act who holds Exchangeable Shares as capital property and deals at arm’s length with Akerna and Purchaser (all
for the purposes of the Tax Act and other applicable provincial income tax laws), to exchange their Exchangeable Shares for Akerna
Shares on a basis that will not require such holders to recognize any gain or loss or any actual or deemed dividend in respect
of such exchange for the purposes of the Tax Act or applicable provincial income tax laws;

 

    B-2

     

    

 

“Change of Law Call Date”
has the meaning ascribed thereto in Section 7.3(b);

 

“Change of Law Call Purchase Price”
has the meaning ascribed thereto in Section 7.3(a);

 

“Change of Law Call Right”
has the meaning ascribed thereto in Section 7.3(a);

 

“Closing Cash Amount”
means an amount equal to $7,500,000, minus the Closing Indebtedness Amount and the amount of the Transaction Expenses;

 

“Closing Indebtedness Agreements”
has the meaning ascribed thereto in the Arrangement Agreement;

 

“Closing Indebtedness Amount”
means an amount equal to the aggregate indebtedness of Ample at the Effective Time pursuant to the Closing Indebtedness Agreements
and the Akerna Bridge Loan (if any);

 

“Closing Shares” means
the Up-front Shares, less the Effective Time Shares, and less the Escrowed Shares;

 

“Consideration” means
the Up-front Consideration, plus the Deferred Consideration;

 

“Court” means the Ontario
Superior Court of Justice;

 

“CVR” means a contingent
value right of Akerna issued pursuant to the Rights Indenture and entitling the holder thereof to the Deferred Consideration, if
any, on the Deferred Consideration Payment Date;

 

“Deemed Value Amount”
means an amount equal to $12.90;

 

“Deferred Consideration”
means $10,000,000, payable in Exchangeable Shares; provided that in the event the Recurring Revenue realized during the Deferred
Consideration Period is less than $9,000,000, the Deferred Consideration amount of $10,000,000 shall be reduced by an amount equal
to the product of $6.67 multiplied by the difference between $9,000,000 and the amount of Recurring Revenue realized during the
Deferred Consideration Period (up to a maximum reduction of $10,000,000), as calculated in the Deferred Consideration Statement;

 

“Deferred Consideration Payment
Date” has the meaning ascribed thereto in Section 2.19(e) of the Arrangement Agreement;

 

“Deferred Consideration Period”
means the period of time beginning on the Effective Date, and ending on the date that is 12 months after the Effective Date;

 

“Deferred Consideration Statement”
means a statement prepared by Akerna setting forth in reasonable detail the:

 

		(a)	amount of Recurring Revenue;

 

		(b)	the amount Deferred Consideration payable to the holders of the CVRs; and

 

		(c)	the expected Deferred Consideration Payment Date;

 

    B-3

     

    

 

“Depositary” means any
Person that Ample may appoint to act as depositary for the Ample Shares in relation to the Arrangement, with the approval of Akerna,
acting reasonably;

 

“Director” means the
Director appointed under section 278 of the OBCA;

 

“Dissent Rights” has
the meaning set forth in Section 5.1(a);

 

“Dissent Shares” means
Ample Shares held by a Dissenting Shareholder and in respect of which the Dissenting Shareholder has validly exercised Dissent
Rights and which Dissent Rights remain valid immediately prior to the Effective Time;

 

“Dissenting Shareholder”
means a registered Ample Shareholder who has duly exercised a Dissent Right and has not withdrawn or been deemed to have withdrawn
such exercise of Dissent Rights, but only in respect of Ample Shares in respect of which Dissent Rights are validly exercised by
such Ample Shareholder;

 

“Effective Date” means
the date shown on the Certificate of Arrangement;

 

“Effective Date Register”
means the true and complete shareholder register of Ample as of the Effective Date delivered by Ample pursuant to the Arrangement
Agreement;

 

“Effective Time” means
the time at which the Arrangement becomes effective on the Effective Date pursuant to the OBCA;

 

“Effective Time Shares”
means that number of Exchangeable Shares that is equal to ten percent (10%) of the total aggregate number of Up-front Shares that
are to be delivered by Akerna and Purchaser to the Ample Shareholders pursuant to the Arrangement Agreement;

 

“Eligible Holder” means
an Ample Shareholder that is: (a) a resident of Canada for the purposes of the Tax Act and not exempt from tax under Part I of
the Tax Act; or (b) a partnership, any member of which is a resident of Canada for the purposes of the Tax Act and not exempt from
tax under Part I of the Tax Act;

 

“Escrow Agent” means
Continental Stock Transfer & Trust Company, Inc.;

 

“Escrow Agreement” means
the Escrow Agreement to be entered into among Akerna, the Purchaser, the Shareholder Representative and the Escrow Agent, in the
form substantially in the form as set out in Schedule “E” to the Arrangement Agreement;

 

“Escrowed
Shares” means [●] Exchangeable Shares, which number of Exchangeable Shares is equal to ten percent (10%) of the
total aggregate number of Up-front Shares that are to be delivered by Akerna and Purchaser to the Ample Shareholders pursuant
to the Arrangement Agreement;

 

“Exchange Rate” means,
on any date of determination, the CAD/USD daily exchange rate quoted by the Bank of Canada three (3) Business Days prior to such
date;

 

“Exchange Ratio” means
0.0524 of an Akerna Share;

 

“Exchangeable Share Consideration”
has the meaning set forth in the Exchangeable Share Provisions;

 

“Exchangeable Share Price”
has the meaning set forth in the Exchangeable Share Provisions;

 

“Exchangeable Share Provisions”
means the rights, privileges, restrictions and conditions attaching to the Exchangeable Shares, which rights, privileges, restrictions
and conditions shall be in substantially the form set out in Annex “A” to this Plan of Arrangement;

 

    B-4

     

    

 

“Exchangeable Share Support Agreement”
means an agreement to be made between Akerna, Purchaser and Callco substantially in the form of Schedule “D” to the
Arrangement Agreement, as the same may be amended, supplemented or otherwise modified from time to time in accordance with the
terms thereof;

 

“Exchangeable Share Voting Event”
has the meaning set forth in the Exchangeable Share Provisions;

 

“Exchangeable Shares”
means the redeemable preferred shares in the capital of Purchaser, having the rights, privileges, restrictions and conditions set
forth the Exchangeable Share Provisions;

 

“Exempt Exchangeable Share Voting
Event” has the meaning set forth in the Exchangeable Share Provisions;

 

“Final Order” means
the final order of the Court approving the Arrangement pursuant to subsection 182(5) of the OBCA, in a form acceptable to both
Ample and Akerna, each acting reasonably, as such order may be amended by the Court (with the consent of both Ample and Akerna,
each acting reasonably) at any time prior to the Effective Time or, if appealed, then, unless such appeal is withdrawn or denied,
as affirmed or as amended (provided that any such amendment is acceptable to both Ample and Akerna, each acting reasonably) on
appeal;

 

“Governmental Entity”
means any:

 

		(a)	national, international, multinational, federal, provincial, state, regional, municipal, local
or other government or any governmental or public department, central bank, court, tribunal, arbitral body, commission, board,
bureau ministry or agency, domestic or foreign, including the Securities Authorities;

 

		(b)	any subdivision, agent, commission, board or authority of any of the foregoing; or

 

		(c)	any quasi-governmental or private body exercising any regulatory, expropriation or Taxing Authority
under or for the account of any of the foregoing;

 

“Interim Order” means
an interim order of the Court concerning the Arrangement pursuant to the OBCA in a form acceptable to both Ample and Akerna, each
acting reasonably, containing declarations and directions with respect to the Arrangement and the holding of the Ample Meeting,
as such order may be affirmed, amended or modified by the Court;

 

“Letter of Transmittal”
means the letter of transmittal to be delivered by Ample to each Ample Shareholder as at the date for use in connection with the
Arrangement providing for, among other things, delivery of the certificates representing such Ample Shareholder’s Ample Shares
to the Depositary;

 

“Liens” means any hypothecs,
mortgages, pledges, assignments, liens, charges, security interests, encumbrances and adverse rights or claims, other third party
interest or encumbrance of any kind, whether contingent or absolute, and any agreement, option, right or privilege (whether by
Applicable Laws, contract or otherwise) capable of becoming any of the foregoing;

 

“Liquidation Amount”
has the meaning set forth in the Exchangeable Share Provisions;

 

“Liquidation Call Purchase Price”
has the meaning set forth in Section 7.1(a);

 

“Liquidation Call Right”
has the meaning set forth in Section 7.1(a);

 

“Liquidation Date” has
the meaning set forth in the Exchangeable Share Provisions;

 

“NASDAQ” means the National
Association of Securities Dealers Automated Quotations exchange;

 

    B-5

     

    

 

“OBCA” means the Business
Corporations Act, R.S.O. 1990, c. B.16, as amended, including the regulations promulgated thereunder;

 

“Option Plan” means
the stock option plan of Ample, in effect as at the date hereof;

 

“Optionholders” means
the holders of Ample Options;

 

“Out-of-Money Option”
means each Ample Option having an aggregate exercise price for any Ample Share(s) in excess of the total value of all Up-front
Consideration that would be payable hereunder in respect of such Ample Share if such Ample Share were issued and outstanding at
the Effective Time;

 

“Out-of-Money Warrant”
means each Ample Warrant having an aggregate exercise price for any Ample Share(s) in excess of the total value of all Up-front
Consideration that would be payable hereunder in respect of such Ample Share if such Ample Share were issued and outstanding at
the Effective Time;

 

“Parties” means, collectively,
the parties to the Arrangement Agreement, and “Party” means any one of them;

 

“Person” includes any
individual, firm, partnership, joint venture, venture capital fund, association, trust, trustee, executor, administrator, legal
personal representative, estate group, body corporate, corporation, unincorporated association or organization, Governmental Entity,
syndicate or other entity, whether or not having legal status;

 

“Plan of Arrangement”
means this plan of arrangement and any amendments or variations hereto made in accordance with Section 7.2 of the Arrangement Agreement
and this plan of arrangement or upon the direction of the Court in the Final Order;

 

“Purchaser” means 2732805
Ontario Inc., a company existing under the laws of the Province of Ontario;

 

“Recurring Revenue”
means all recurring revenue that is derived from or that is associated with license revenue from Ample’s core seed-to-sale,
AmpleCentral and “Last Call Analytics” products;

 

“Redemption Call Purchase Price”
has the meaning set forth in Section 7.2(a);

 

“Redemption Call Right”
has the meaning set forth in Section 7.2(a);

 

“Redemption Date” has
the meaning set forth in the Exchangeable Share Provisions;

 

“Replacement Options”
has the meaning set forth in the Arrangement Agreement;

 

“Retraction Call Right”
has the meaning set forth in the Exchangeable Share Provisions;

 

“Rights Agent” means
the rights agent appointed pursuant to the Rights Indenture;

 

“Rights Indenture” means
the rights indenture to be entered into between Akerna, Purchaser, the Shareholder Representative and a trust company acceptable
to Ample and Purchaser, as rights agent, providing for the creation and issuance of the CVRs, in the form or substantially in the
form attached as Schedule “G” to the Arrangement Agreement;

 

“Securities Act” means
the Securities Act (Ontario) and the rules, regulations and published policies made thereunder;

 

“Securities Authorities”
means, collectively, the securities commissions or similar securities regulatory authorities in each of the provinces of Canada;

 

    B-6

     

    

 

“Shareholder Representative”
means John Prentice;

 

“Special Voting Share”
means the special voting share in the capital of Akerna to be issued by Akerna and deposited with the Trustee in accordance with
the Voting and Exchange Trust Agreement, which, at any time entitles the holder of record to that number of votes at meetings of
holders of Akerna Shares equal to the number of Exchangeable Shares outstanding at such time (excluding any Exchangeable Shares
held by Akerna or any Affiliate);

 

“Subsidiary” has the
meaning ascribed thereto in the Securities Act, which for certainty shall include any indirect subsidiaries;

 

“Tax Act” means the
Income Tax Act, R.S.C. 1985, c. 1 (5th Supp.), as amended, including the regulations promulgated thereunder;

 

“Taxing Authority” means
any Governmental Entity responsible for the imposition of any tax (domestic or foreign);

 

“Transaction Expenses”
means all legal, advisory, accounting fees and expenses of Ample arising as a result of the Arrangement that are incurred prior
to, and remain unpaid as of, the Effective Time;

 

“Transfer Agent” has
the meaning set forth in the Exchangeable Share Provisions;

 

“Trustee” means the
trustee to be chosen by Akerna and Ample, acting reasonably, to act as trustee under the Voting and Exchange Trust Agreement and
any successor trustee appointed under the Voting and Exchange Trust Agreement;

 

“U.S. Exchange Act”
means the United States Exchange Act of 1934, as amended and the rules and regulations promulgated thereunder;

 

“U.S. Securities Act”
means the United States Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder;

 

“U.S. Securities Laws”
means the U.S. Securities Act, the U.S. Exchange Act and applicable state securities legislation of the United States and all rules,
regulations and orders promulgated thereunder, as amended from time to time;

 

“Up-front Consideration”
means the Up-front Shares to be issued and the Closing Cash Amount to be delivered by Akerna and Purchaser at the Effective Time
in accordance with the Arrangement Agreement;

 

“Up-front Consideration Amount”
means an amount equal to $42,500,000, plus the aggregate exercise prices of all Replacement Options to be granted in exchange for
Ample Options (other than Out-of-Money Options) pursuant to the Arrangement and Ample Warrants (other than Out-of-Money Warrants);

 

“Up-front Shares” means
an aggregate number of Exchangeable Shares that is equal to the Up-front Consideration Amount, divided by the Deemed Value Amount,
less (i) the aggregate number of Exchangeable Shares and/or Akerna Shares that the Optionholders would be entitled to receive exclusively
as a result of the exercise immediately following the Effective Time of all Replacement Options granted in exchange for Ample Options
(other than Out-of-Money Options) pursuant to the Arrangement, and less (ii) the aggregate number of Exchangeable Shares and/or
Akerna Shares that the Warrantholders would be entitled to receive exclusively as a result of the exercise of all Ample Warrants
(other than Out-of-Money Warrants) immediately following to the Effective Time;

 

“Voting and Exchange Trust Agreement”
means an agreement to be made between Ample, Purchaser, Callco and the Trustee in connection with this Plan of Arrangement substantially
in the form attached as Schedule “G” to the Arrangement Agreement;

 

“Warrantholders” means
holder of Ample Warrants; and

 

“Withholding Obligation”
has the meaning set forth in Section 6.3.

 

    B-7

     

    

 

		1.2	Interpretation Not Affected by Headings

 

The division of this
Plan of Arrangement into Articles and Sections and the insertion of headings are for convenience of reference only and shall not
affect in any way the meaning or interpretation of this Plan of Arrangement. Unless the contrary intention appears, references
in this Plan of Arrangement to an Article, Section or Annex by number or letter or both refer to the Article, Section or Annex,
respectively, bearing that designation in this Plan of Arrangement.

 

		1.3	Date for any Action

 

If the date on or by
which any action is required or permitted to be taken hereunder is not a Business Day, such action shall be required or permitted
to be taken on the next succeeding day which is a Business Day.

 

		1.4	Number and Gender; Derivatives

 

In this Plan of Arrangement,
unless the contrary intention appears, words importing the singular include the plural and vice versa, and words importing gender
include all genders. If a word is defined in this Plan of Arrangement a grammatical derivative of that word will have a corresponding
meaning. The words “include”, “includes” and “including” shall be deemed to be followed by
the words “without limitation”.

 

		1.5	References to Persons and Statutes

 

A reference to a Person
includes any successor to that Person. A reference to any statute includes all regulations made pursuant to such statute and the
provisions of any statute or regulation which amends, supplements or supersedes any such statute or regulation.

 

		1.6	Currency

 

Unless otherwise stated,
all references in this Plan of Arrangement to sums of money are expressed in lawful money of Canada and “$” refers
to Canadian dollars.

 

		1.7	Time

 

Time shall be of the
essence in every matter or action contemplated hereunder. All times expressed herein or in the Letter of Transmittal refer to the
local time of Ample (being the time in Toronto, Ontario) unless otherwise stipulated herein or therein.

 

		1.8	Annexes

 

The following annex
is attached to this Plan of Arrangement and is incorporated by reference into this Plan of Arrangement and forms a part hereof:

 

Annex “A”
– Exchangeable Share Provisions

 

    B-8

     

    

 

ARTICLE
2

SHAREHOLDER REPRESENTATIVE

 

		2.1	Shareholder Representative

 

		(i)	In order to efficiently administer the transactions contemplated by this Plan of Arrangement, the
Arrangement Agreement, the Escrow Agreement and the Rights Indenture, including: (i) the final determination of the Deferred Consideration
and the allocation of the Consideration among the Ample Shareholders in accordance with the terms of this Plan of Arrangement,
the Arrangement Agreement and the Ample Articles; (ii) the exercise on behalf of the Ample Shareholders of any voting rights, consent
rights and/or the right to direct any votes with respect to the Special Voting Share, in each case, attaching to Up-front Shares
during such time as any such Up-front Shares are held in escrow pursuant to the Escrow Agreement; (iii) the determination from
time to time while the Up-front Shares (or any of them) are held in escrow pursuant to this Escrow Agreement, of the number (if
any) of Up-front Shares in respect of which each Ample Shareholder shall be entitled to provide instructions with respect to the
exercise of any voting rights (including any right to direct the voting of the Special Voting Share) or consent right; (iv) the
waiver of any condition to the obligations of Ample or the Ample Shareholders to consummate the transactions contemplated hereby;
and (v) the defense and/or settlement of any claims for which the Ample Shareholder may be required to indemnify Akerna or Purchaser
pursuant to the Arrangement Agreement, the Shareholder Representative is hereby appointed as the true, exclusive and lawful representative,
attorney-in-fact and agent for each Ample Shareholder in accordance with, and to the extent provided for, in the Arrangement Agreement
and this Plan of Arrangement.

 

		(ii)	The Shareholder Representative is hereby authorized to make all decisions, take all actions or
do any and all thing necessary relating to: (i) the final determination of the Deferred Consideration and the allocation of the
Consideration among the Ample Shareholders in accordance with the terms of this Plan of Arrangement, the Arrangement Agreement
and the Ample Articles; (ii) the exercise on behalf of the Ample Shareholders of any voting rights, consent rights and/or the right
to direct any votes with respect to the Special Voting Share, in each case, attaching to Up-front Shares during such time as any
such Up-front Shares are held in escrow pursuant to the Escrow Agreement, (iii) the determination from time to time while the Up-front
Shares (or any of them) are held in escrow pursuant to this Escrow Agreement, of the number (if any) of Up-front Shares in respect
of which each Ample Shareholder shall be entitled to provide instructions with respect to the exercise of any voting rights (including
any right to direct the voting of the Special Voting Share) or consent right; (iv) the waiver of any condition to the obligations
of Ample or the Ample Shareholders to consummate the transactions contemplated hereby; (v) the defense and/or settlement of any
claims for which the Ample Shareholder may be required to indemnify Akerna or Purchaser pursuant to the Arrangement Agreement;
and (vi) any and all additional actions contemplated to be taken by the Shareholder Representative on behalf of the Ample Shareholders
(or any of them) pursuant to the Arrangement Agreement, this Plan of Arrangement, the Escrow Agreement or the Rights Indenture.

 

    B-9

     

    

 

		(iii)	Akerna and Purchaser shall be able to rely conclusively on the instructions and decision of the
Shareholder Representative as to any decision or act of the Shareholder Representative taken in accordance with the Arrangement
Agreement, this Plan of Arrangement, the Escrow Agreement or the Rights Indenture and no Party shall have any cause of action against
Akerna or Purchaser for any action taken in reliance upon the instructions or decisions of the Shareholder Representative.

 

		(iv)	No Ample Shareholder shall have any cause of action against the Shareholder Representative for
any action taken, decision made or instruction given by the Shareholder Representative in accordance with the Arrangement Agreement,
this Plan of Arrangement, the Escrow Agreement or the Rights Indenture, except for fraud or wilful breach by the Shareholder Representative
of the Arrangement Agreement, this Plan of Arrangement, the Escrow Agreement or the Rights Indenture. The Shareholder Representative
shall not be liable to any Ample Shareholder for any action taken or omitted to be taken by them in connection with the Arrangement
Agreement, this Plan of Arrangement, the Escrow Agreement or the Rights Indenture in good faith and in the exercise of their reasonable
judgment.

 

ARTICLE
3

EFFECT OF ARRANGEMENT

 

		3.1	Arrangement Agreement

 

This Plan of Arrangement
is made pursuant to and subject to the provisions of the Arrangement Agreement. If there is any conflict or inconsistency between
the provisions of this Plan of Arrangement and the provisions of the Arrangement Agreement regarding the Arrangement, the provisions
of this Plan of Arrangement shall govern. This Plan of Arrangement constitutes an arrangement for the purposes of the OBCA.

 

		3.2	Binding Effect

 

		(a)	At the Effective Time, this Plan of Arrangement will become effective and shall be binding upon
Akerna, Purchaser, Callco, Ample, the Depositary, the Trustee, the Rights Agent, the Escrow Agent, all registered and beneficial
Ample Shareholders, including Dissenting Shareholders, the Optionholders and the Warrantholders, in each case without any further
authorization, act or formality on the part of the Court, except as expressly provided herein.

 

		(b)	The Articles of Arrangement shall be filed with the Director with the purpose and intent that none
of the provisions of this Plan of Arrangement shall become effective unless all of the provisions of this Plan of Arrangement become
effective. The Certificate of Arrangement shall be conclusive evidence that this Plan of Arrangement has become effective and that
each of the provisions of Section 4.1 has become effective in the sequence set out therein.

 

		(c)	Other than as expressly provided for herein, no portion of this Plan of Arrangement shall take
effect with respect to any Party or Person until the Effective Time.

 

    B-10

     

    

 

ARTICLE
4

ARRANGEMENT

 

		4.1	Arrangement

 

Commencing at the Effective
Time, each of the following events shall occur and shall be deemed to occur consecutively in the following order, except where
noted, without any further authorization, act or formality:

 

		(a)	the Ample Shareholders Agreement and the Ample Voting Agreement shall each be deemed to be terminated
and of no further force or effect;

 

		(b)	each Ample Shareholder (other than Dissenting Shareholders) shall be deemed to have irrevocably
appointed the Shareholder Representative to act on its behalf in accordance with Section 2.1, and to have authorized the Shareholder
Representative to enter into the Escrow Agreement and the Rights Indenture on behalf of such Ample Shareholder and, upon the execution
and delivery of the Escrow Agreement and the Rights Indenture, the Escrow Agreement and the Rights Indenture shall each be binding
upon each Ample Shareholder (other than Dissenting Shareholders) as if it had been entered into by each such Ample Shareholder
directly;

 

		(c)	each Dissent Share shall, as of the Effective Time, be deemed to be transferred and assigned by
such Dissenting Shareholder, without any further act of formality on its part, to Purchaser (free and clear of all Liens) in accordance
with, and for the consideration contemplated in, ARTICLE 5 and:

 

		(i)	the registered holder thereof shall cease to be, and shall be deemed to cease to be, the registered
holder of each such Dissent Share and the name of such registered holder shall be, and shall be deemed to be, removed from the
central securities register maintained by or on behalf of Ample in respect of each such Dissent Share, and at such time each Dissenting
Shareholder will have the rights set out in Section 5.1;

 

		(ii)	the registered holder thereof shall be deemed to have executed and delivered all consents, releases,
assignments and waivers, statutory or otherwise, required to transfer and assign each such Dissent Share; and

 

		(iii)	Purchaser shall be and shall be deemed to be the holder of all of the outstanding Dissent Shares
and the central securities register of Purchaser shall be, and shall be deemed to be, revised accordingly;

 

		(d)	each Ample Share (other than any Ample Share held by Akerna, Purchaser or any of their respective
Affiliates and any Dissent Share) shall be transferred and assigned, without any further act or formality on its part, to Purchaser
(free and clear of all Liens) in exchange for the Up-front Consideration, which shall, subject Section 4.4, be delivered pursuant
to Section 6.1, and:

 

		(i)	the registered holder thereof shall cease to be, and shall be deemed to cease to be, the registered
holder of each such Ample Share and the name of such registered holder shall be, and shall be deemed to be, removed from the central
securities register maintained by or on behalf of Ample;

 

		(ii)	the registered holder thereof shall be deemed to have executed and delivered all consents, releases,
assignments and waivers, statutory or otherwise, required to transfer and assign each such Ample Share; and

 

    B-11

     

    

 

		(iii)	Purchaser shall be and shall be deemed to be the holder of all of the outstanding Ample Shares
and the central securities register maintained by or on behalf of Ample shall be, and shall be deemed to be, revised accordingly;
and

 

		(e)	concurrently with the preceding step: (i) Akerna, Callco, Purchaser and the Shareholder Representative
shall execute the Exchangeable Share Support Agreement; and (ii) Akerna, Purchaser, Callco, the Trustee and the Shareholder Representative
shall execute the Voting and Exchange Trust Agreement;

 

it being expressly provided that the events
provided for in this Section 4.1 will be deemed to occur on the Effective Date, notwithstanding that certain procedures related
thereto may not be completed until after the Effective Date.

 

		4.2	Tax Election

 

Each beneficial owner
of Ample Shares who is an Eligible Holder shall be entitled to make an income tax election pursuant to subsection 85(1) of the
Tax Act, or subsection 85(2) of the Tax Act if such beneficial owner is a partnership (and in each case, where applicable, the
analogous provisions of provincial income tax law), with respect to the transfer of its Ample Shares to Purchaser and the receipt
of Consideration in respect thereof by providing two (2) signed copies of the necessary prescribed election form(s) (or equivalent
information through an alternative document or platform, at Akerna’s discretion) to the Depositary within sixty (60) days
following the Effective Date, duly completed with the details of the number of Ample Shares transferred and the applicable agreed
amounts for the purposes of such elections. Thereafter, subject to the election forms being correct and complete and complying
with the provisions of the Tax Act (and applicable provincial income tax law), the forms will be signed by Purchaser and returned
to such former beneficial owner of Ample Shares within sixty (60) days after the receipt thereof by the Depositary for filing with
the Canada Revenue Agency (or the applicable provincial Taxing Authority) by such former beneficial owner. Purchaser will not be
responsible for the proper completion of any election form and, except for Purchaser’s obligation to return (within sixty
(60) days after the receipt thereof by the Depositary) duly completed election forms which are received by the Depositary within
sixty (60) days of the Effective Date, Purchaser will not be responsible for any taxes, interest or penalties resulting from the
failure by a former beneficial owner of Ample Shares to properly complete or file the election forms in the form and manner and
within the time prescribed by the Tax Act (or any applicable provincial legislation).

 

		4.3	Entitlement to Cash Consideration

 

In any case where the
aggregate cash consideration payable to a particular Ample Shareholder under the Arrangement would, but for this provision, include
a fraction of a cent, the consideration payable shall be rounded down to the nearest whole cent.

 

		4.4	No Fractional Shares

 

In no event shall Akerna
or Purchaser be required to issue a fractional Akerna Share or a fractional Exchangeable Share. Where the aggregate number of Exchangeable
Shares to be issued pursuant to the Arrangement (or Akerna Shares exchangeable for Exchangeable Shares) would result in a fraction
of an Akerna Share or an Exchangeable Share being issuable, the number of Akerna Shares or Exchangeable Shares, as the case may
be, to be issued shall be rounded to the nearest whole Akerna Share or Exchangeable Share, as the case may be (with fractions equal
to or greater than 0.5 being rounded up and fractions less than 0.5 being rounded down).

 

    B-12

     

    

 

ARTICLE
5

DISSENT RIGHTS

 

		5.1	Dissent Rights

 

		(a)	In connection with the Arrangement, each registered Ample Shareholder may exercise rights of dissent
(“Dissent Rights”) with respect to the Ample Shares held by such Ample Shareholder pursuant to section 185 of
the OBCA, as modified by the Interim Order and this Section 5.1; provided that, notwithstanding subsection 185(6) of the OBCA,
the written objection to the Arrangement Resolution referred to in subsection 185(6) of the OBCA must be received by Ample not
later than 5:00 p.m. (Toronto time) two (2) Business Days immediately preceding the date of the Ample Meeting. Dissenting Shareholders
who:

 

		(i)	are ultimately entitled to be paid fair value for their Dissent Shares: (1) shall be deemed to
not to have participated in the transactions in ARTICLE 4 (other than Section 4.1(c)); (2) shall be deemed to have transferred
and assigned such Dissent Shares (free and clear of all Liens) to Purchaser in accordance with Section 4.1(c); (3) will be entitled
to be paid the fair value of such Dissent Shares by Purchaser, which fair value, notwithstanding anything to the contrary contained
in the OBCA, shall be determined as of the close of business on the day before the Arrangement Resolution was adopted at the Ample
Meeting; and (4) will not be entitled to any other payment or consideration, including any payment that would be payable under
the Arrangement had such holders not exercised their Dissent Rights in respect of such Ample Shares; or

 

		(ii)	are ultimately not entitled, for any reason, to be paid by Purchaser fair value for their Dissent
Shares, shall not be reinstated as a holder of Ample Shares and shall be deemed to have participated in the Arrangement in respect
of those Ample Shares on the same basis as a non-Dissenting Shareholder who did not deposit with the Depositary a duly completed
and executed Letter of Transmittal and shall be entitled to receive only the Consideration set forth in Section 4.1(d), notwithstanding
the provisions of section 185 of the OBCA.

 

		(b)	In no event shall Purchaser, Akerna, Ample or any other Person be required to recognize a Dissenting
Shareholder as a registered or beneficial owner of Ample Shares or any interest therein (other than the rights set out in this
Section 5.1) at or after the Effective Time, and at the Effective Time the names of such Dissenting Shareholders shall be deleted
from the central securities register maintained by or on behalf of Ample as at the Effective Time.

 

		(c)	For greater certainty, in addition to any other restrictions in the Interim Order or in section
185 of the OBCA, any Person who has voted in favour of the Arrangement Resolution shall not be entitled to dissent with respect
to the Arrangement. In addition, a Dissenting Shareholder may only exercise Dissent Rights in respect of all, and not less than
all, of its Ample Shares.

 

ARTICLE
6

EXCHANGE OF CERTIFICATES AND DELIVERY OF CONSIDERATION

 

		6.1	Certificates and Payments

 

		(a)	Following receipt of the Final Order and prior to the Effective Time, Akerna or Purchaser shall
deposit in escrow with the Depositary (the terms and conditions of such escrow to be satisfactory to the Parties, each acting reasonably)
the Effective Time Shares, sufficient funds to satisfy the aggregate Closing Cash Amount and CVRs evidencing Akerna’s and
Purchaser’s obligations with respect to the Deferred Consideration, in each case to the Ample Shareholders (other than Dissenting
Shareholders), which Closing Cash Amount, Effective Time Shares and CVRs shall be held by the Depositary as agent for and nominee
of such former Ample Shareholders for distribution to such former Ample Shareholders in accordance with the terms of the Arrangement
Agreement and the provisions of this ARTICLE 6.

 

    B-13

     

    

 

		(b)	Following receipt of the Final Order and at or prior to the Effective Time, Akerna or Purchaser
shall deposit in escrow with the Escrow Agent (the terms and conditions of such escrow to be satisfactory to the Parties, each
acting reasonably) the Closing Shares to be held in escrow and distributed in accordance with the terms of the Arrangement Agreement
and the Escrow Agreement.

 

		(c)	Following receipt of the Final Order and at or prior to the Effective Time, Akerna or Purchaser
shall deposit in escrow with the Escrow Agent (the terms and conditions of such escrow to be satisfactory to the Parties, each
acting reasonably) the Escrowed Shares to be held in escrow and distributed in accordance with the terms of the Arrangement Agreement
and the Escrow Agreement.

 

		(d)	At the Effective Time, Akerna or Purchaser shall deliver the Special Voting Share to the Trustee
in accordance with the Voting and Exchange Trust Agreement.

 

		(e)	Upon surrender to the Depositary for cancellation of a certificate or certificates which immediately
prior to the Effective Time represented outstanding Ample Shares that were transferred pursuant to Section 4.1(d), together with
a duly completed and executed Letter of Transmittal and any such additional documents and instruments as the Depositary may reasonably
require or as would have been required to effect such transfer under applicable securities transfer legislation, the OBCA and the
Ample Articles after giving effect to Section 4.1(c), the former registered holder of the Ample Shares represented by such surrendered
certificate (other than Dissenting Shareholders) shall be entitled to receive in exchange therefor, and the Depositary shall deliver
to each Ample Shareholder in accordance with the Arrangement Agreement and the written instructions of the Shareholder Representative,
the Up-front Consideration and CVRs that each Ample Shareholder has the right to receive under the Arrangement at the Effective
Time for such Ample Shares, less any amounts withheld pursuant to Section 6.3, and any certificate so surrendered shall forthwith
be cancelled.

 

		(f)	From and after the Effective Time and until surrendered for cancellation as contemplated by this
ARTICLE 6, each certificate that immediately prior to the Effective Time represented one or more Ample Shares (other than Ample
Shares held by Akerna, Purchaser or any of their respective Affiliates) shall be deemed at all times to represent only the right
to receive in exchange therefor the Up-front Consideration that the holder of such certificate is entitled to receive in accordance
with Section 4.1 and this ARTICLE 6, less any amounts withheld pursuant to Section 6.3.

 

		(g)	The entitlement of each Ample Shareholder to the Consideration (or any portion thereof) shall be
as prescribed by the Ample Articles, as determined by the Shareholder Representative acting reasonably and with reference to the
Effective Date Register. In accordance with the Ample Articles and in furtherance of the foregoing sentence, the Consideration
(or any portion thereof) shall be allocated as and when it is payable to the Ample Shareholders without regard for, and without
taking into account, any portion of the Consideration that has not yet been paid to the Ample Shareholders at such time and/or
which remains subject to any escrow. For the purposes of allocating the Consideration (or any portion thereof) as and when it is
due and payable to the Ample Shareholders, (i) the fair market value of each Exchangeable Share or Akerna Share released from escrow
pursuant to the Escrow Agreement shall be equal to the five (5) day volume weighted average price of an Akerna Share (converted
to Canadian dollars from US dollars using the Exchange Rate as of the date that such Exchangeable Share and/or Akerna Share is
released from escrow in accordance with the Escrow Agreement) as quoted on the NASDAQ on the last trading day immediately preceding
the date that such Exchangeable Share and/or Akerna Share is released from escrow in accordance with the Escrow Agreement; and
(ii) the fair market value of each Exchangeable Share issued in respect of the Deferred Consideration shall be equal to the five
(5) day volume weighted average price of an Akerna Share (converted to Canadian dollars from US dollars using the Exchange Rate
as of the Deferred Consideration Payment Date) as quoted on the NASDAQ on the last trading day immediately preceding the Deferred
Consideration Payment Date.

 

    B-14

     

    

 

		6.2	Lost Certificates

 

In the event any certificate
which immediately prior to the Effective Time represented one or more outstanding Ample Shares that were transferred pursuant to
Section 4.1(c) was lost, stolen or destroyed, upon the making of an affidavit of that fact by the Person claiming such certificate
to be lost, stolen or destroyed, the Depositary will issue in exchange for such lost, stolen or destroyed certificate, the Consideration
deliverable in accordance with such holder’s duly completed and executed Letter of Transmittal. When authorizing such payment
in exchange for any lost, stolen or destroyed certificate, the Person to whom such cash is to be delivered shall, as a condition
precedent to the delivery of such Consideration, give a bond satisfactory to Akerna and the Depositary (each acting reasonably)
in such sum as Akerna may direct, or otherwise indemnify Akerna, Purchaser and Ample in a manner satisfactory to Akerna, Purchaser
and Ample, each acting reasonably, against any claim that may be made against Akerna, Purchaser or Ample with respect to the certificate
alleged to have been lost, stolen or destroyed.

 

		6.3	Withholding Rights

 

Akerna, Purchaser,
Callco, Ample, the Depositary, the Escrow Agent or the Trustee shall be entitled to deduct and withhold, or direct Akerna, Purchaser,
Callco, Ample, the Depositary, the Escrow Agent, the Trustee or the Rights Agent to deduct and withhold on their behalf, from any
amount payable to any Person under this Plan of Arrangement (an “Affected Person”), such amounts as Akerna,
Purchaser, Callco, Ample, the Depositary, the Escrow Agent, the Trustee or the Rights Agent determines, each acting reasonably,
are required or permitted to be deducted and withheld with respect to such payment under the Tax Act, the United States Internal
Revenue Code or any provision of any other Applicable Laws (a “Withholding Obligation”). To the extent that
amounts are so deducted and withheld, such deducted and withheld amounts shall be treated for all purposes hereof as having been
paid to the Affected Person in respect of which such deduction and withholding was made. Akerna, Purchaser, Callco, Ample, the
Depositary, the Escrow Agent, the Trustee and the Rights Agent shall also have the right to:

 

		(a)	deduct, withhold and sell, or direct Akerna, Purchaser, Callco, Ample, the Depositary, the Escrow
Agent, the Trustee or the Rights Agent to deduct, withhold and sell on their behalf, on their own account or through a broker (a
“Broker”), and on behalf of any Affected Person; or

 

		(b)	require the Affected Person to irrevocably direct the sale through a Broker and irrevocably direct
the Broker pay the proceeds of such sale to Akerna, Purchaser, Callco, Ample, the Depositary, the Escrow Agent or the Trustee as
appropriate (and, in the absence of such irrevocable direction, the Affected Person shall be deemed to have provided such irrevocable
direction),

 

such number of Exchangeable Shares (or
the Akerna Shares exchanged therefor) delivered or deliverable to such Affected Person pursuant to this Plan of Arrangement or
the Exchangeable Share Provisions as is necessary to produce sale proceeds (after deducting commissions payable to the Broker and
other costs and expenses) sufficient to fund any Withholding Obligations. Any Exchangeable Shares to be sold in accordance with
this Section 6.3 shall first be exchanged for Akerna Shares in accordance with their terms and the Akerna Shares delivered in respect
of such shares shall be sold. Any such sale of Akerna Shares shall be affected on a public market and as soon as practicable following
the Effective Date. None of Akerna, Purchaser, Callco, Ample, the Depositary, the Escrow Agent, the Trustee, the Rights Agent or
the Broker will be liable for any loss arising out of any sale of such Akerna Shares, including any loss relating to the manner
or timing of such sales, the prices at which the Akerna Shares are sold or otherwise.

 

    B-15

     

    

 

		6.4	Distributions with respect to Unsurrendered Share Certificates

 

No dividend or other
distribution declared or made after the Effective Time with respect to Exchangeable Shares with a record date after the Effective
Time shall be delivered to the holder of any unsurrendered certificate that, immediately prior to the Effective Time, represented
outstanding Ample Shares unless and until the holder of such certificate shall have complied with the provisions of Section 6.1
or Section 6.2. Subject to Applicable Laws and to Section 6.3, at the time of such compliance, there shall, in addition to the
delivery of Consideration to which such holder is thereby entitled, be delivered to such holder, without interest, the amount of
the dividend or other distribution with a record date after the Effective Time theretofore paid with respect to such Exchangeable
Shares.

 

		6.5	Limitation and Proscription

 

To the extent that
a former Ample Shareholder shall not have complied with the provisions of Section 6.1 or Section 6.2 on or before the date that
is six (6) years after the Effective Date (the “final proscription date”), then the Consideration that such
former Ample Shareholder was entitled to receive shall be automatically cancelled without any repayment of capital in respect thereof
and the Consideration to which such former Ample Shareholder was entitled, shall be delivered to Akerna or Purchaser, as applicable,
by the Depositary and the Exchangeable Shares forming part of the Consideration shall be deemed to be cancelled, and the interest
of the former Ample Shareholder in such Exchangeable Shares (and any dividend or other distribution referred to in Section 6.4)
to which it was entitled shall be terminated as of such final proscription date, and the certificates formerly representing Ample
Shares shall cease to represent a right or claim of any kind or nature as of such final proscription date. Any payment made by
way of cheque by the Depositary pursuant to this Plan of Arrangement that has not been deposited or has been returned to the Depositary
or that otherwise remains unclaimed, in each case, on or before the final proscription date shall cease to represent a right or
claim of any kind or nature and the right of any Ample Shareholder to receive the Consideration for Ample Shares pursuant to this
Plan of Arrangement shall terminate and be deemed to be surrendered and forfeited to Purchaser.

 

		6.6	No Liens

 

Any exchange or transfer
of Ample Shares pursuant to this Plan of Arrangement shall be free and clear of any Liens or other claims of third parties of any
kind.

 

		6.7	Ample Options and Warrants

 

		(a)	Subject to Applicable Laws and to the receipt of the approval of NASDAQ:

 

		(i)	Each Ample Warrant outstanding at the Effective Time shall be continued on the same terms and conditions
as were applicable immediately prior to the Effective Time;

 

    B-16

     

    

 

		(ii)	Each Ample Option outstanding at the Effective Time (whether vested or unvested) shall be exchanged
for a Replacement Option to acquire, on the same terms and conditions as were applicable under such Ample Option immediately prior
to the Effective Time, such number of Akerna Shares as is equal to (A) that number of Ample Shares that were issuable upon the
exercise of such Ample Option immediately prior to the Effective Time, multiplied by (B) the Exchange Ratio, rounded down to the
nearest whole number of Akerna Shares, at an exercise price per Akerna Share equal to the greater of the quotient determined by
dividing (X) the exercise price per Ample Share at which such Ample Option was exercisable immediately prior to the Effective Time,
by (Y) the Exchange Ratio, rounded up to the nearest whole cent, and such minimum amount that meets the requirements of paragraph
7(1.4)(c) of the Tax Act.

 

		(b)	Pursuant to the terms of the Ample Options, Ample may facilitate the acceleration of the vesting
of any unvested Ample Options subject to accelerated vesting on a change of control of Ample as may be necessary or desirable to
allow all Optionholders to exercise their respective Ample Options for the purpose of participating in the Arrangement.

 

		6.8	Paramountcy

 

From and after the
Effective Time: (i) this Plan of Arrangement shall take precedence and priority over any and all Ample Shares issued prior to the
Effective Time; (ii) the rights and obligations of the registered holders of Ample Shares (other than Akerna, Purchaser or any
of their respective Affiliates), and of Ample, Akerna, Purchaser, the Depositary, the Escrow Agent, the Trustee, the Rights Agent
and any transfer agent or other depositary in relation thereto, shall be solely as provided for in this Plan of Arrangement and
the Arrangement Agreement; and (iii) all actions, causes of action, claims or proceedings (actual or contingent and whether or
not previously asserted) based on or in any way relating to any Ample Shares shall be deemed to have been settled, compromised,
released and determined without liability except as set forth herein.

 

ARTICLE
7

CERTAIN RIGHTS OF AKERNA AND CALLCO TO ACQUIRE EXCHANGEABLE SHARES

 

		7.1	Liquidation Call Right

 

In addition to the
rights contained in the Exchangeable Share Provisions (including, without limitation, the Retraction Call Right), Akerna and Callco
shall have the following rights in respect of the Exchangeable Shares:

 

		(a)	Subject to the proviso in Section 7.1(b) that Callco shall only be entitled to exercise the Liquidation
Call Right with respect to those Exchangeable Shares, if any, in respect of which Akerna has not exercised the Liquidation Call
Right, Akerna and Callco shall each have the overriding right (the “Liquidation Call Right”), in the event of
and notwithstanding the proposed liquidation, dissolution or winding-up of Purchaser or any other distribution of the assets of
Purchaser among its shareholders for the purpose of winding up its affairs, pursuant to Section 5 of the Exchangeable Share Provisions,
and subject to the sale and purchase contemplated by the Automatic Exchange Right, to purchase from all but not less than all of
the holders of the Exchangeable Shares (other than any holder of Exchangeable Shares which is Akerna or any of its Affiliates)
on the Liquidation Date all but not less than all of the Exchangeable Shares held by each such holder upon payment by Akerna or
Callco, as the case may be, to each such holder of the Exchangeable Share Price (payable in the form of the Exchangeable Share
Consideration) applicable on the last Business Day prior to the Liquidation Date (the “Liquidation Call Purchase Price”)
in accordance with Section 7.1(c). In the event of the exercise of the Liquidation Call Right by Akerna or Callco, as the case
may be, each such holder of Exchangeable Shares (other than Akerna and its Affiliates) shall be obligated to sell all of the Exchangeable
Shares held by the holder to Akerna or Callco, as the case may be, on the Liquidation Date upon payment by Akerna or Callco, as
the case may be, to such holder of the Liquidation Call Purchase Price (payable in the form of Exchangeable Share Consideration)
for each such share, and Purchaser shall have no obligation to pay any Liquidation Amount to the holders of such shares so purchased.

 

    B-17

     

    

 

		(b)	Callco shall only be entitled to exercise the Liquidation Call Right with respect to those Exchangeable
Shares, if any, in respect of which Akerna has not exercised the Liquidation Call Right. To exercise the Liquidation Call Right,
Akerna or Callco must notify the Transfer Agent, as agent for the holders of the Exchangeable Shares, and Purchaser of its intention
to exercise such right: (i) in the case of a voluntary liquidation, dissolution or winding-up of Purchaser or any other voluntary
distribution of the assets of Purchaser among its shareholders for the purpose of winding up its affairs, at least thirty (30)
days before the Liquidation Date; or (ii) in the case of an involuntary liquidation, dissolution or winding-up of Purchaser or
any other involuntary distribution of the assets of Purchaser among its shareholders for the purpose of winding up its affairs,
at least five (5) Business Days before the Liquidation Date. The Transfer Agent will notify the holders of the Exchangeable Shares
as to whether or not Akerna and/or Callco has exercised the Liquidation Call Right forthwith after the expiry of the period during
which Akerna or Callco may exercise the Liquidation Call Right. If Akerna and/or Callco exercises the Liquidation Call Right, then
on the Liquidation Date, Akerna and/or Callco, as the case may be, will purchase and the holders of the Exchangeable Shares (other
than any holder of Exchangeable Shares which is Akerna or any of its Affiliates) will sell, all of the Exchangeable Shares held
by such holders on such date for a price per share equal to the Liquidation Call Purchase Price (payable in the form of Exchangeable
Share Consideration).

 

		(c)	For the purposes of completing the purchase and sale of the Exchangeable Shares pursuant to the
exercise of the Liquidation Call Right, Akerna and/or Callco, as the case may be, shall deposit or cause to be deposited with the
Transfer Agent, on or before the Liquidation Date, the Exchangeable Share Consideration representing the aggregate Liquidation
Call Purchase Price for all holders of the Exchangeable Shares (other than Akerna and its Affiliates), less any amounts withheld
pursuant to Section 6.3. Provided that such Exchangeable Share Consideration has been so deposited with the Transfer Agent, the
holders of the Exchangeable Shares (other than Akerna and its Affiliates) shall cease to be holders of the Exchangeable Shares
on and after the Liquidation Date and, from and after such date, shall not be entitled to exercise any of the rights of holders
in respect thereof (including, without limitation, any rights under the Voting and Exchange Trust Agreement) other than the right
to receive their proportionate part of the aggregate Liquidation Call Purchase Price, without interest, upon presentation and surrender
by the holder of certificates representing the Exchangeable Shares held by such holder and the holder shall on and after the Liquidation
Date be considered and deemed for all purposes to be the holder of the Akerna Shares which such holder is entitled to receive.
Upon surrender to the Transfer Agent of a certificate or certificates representing Exchangeable Shares, together with such other
documents and instruments as may be required to effect a transfer of Exchangeable Shares under the OBCA and the articles of Purchaser,
as applicable, and such additional documents, instruments and payments as the Transfer Agent may reasonably require, the holder
of such surrendered certificate or certificates shall be entitled to receive, in exchange therefor, and the Transfer Agent on behalf
of Akerna and/or Callco, as the case may be, shall deliver to such holder the Exchangeable Share Consideration such holder is entitled
to receive. If neither Akerna nor Callco exercises the Liquidation Call Right in the manner described above, each holder of Exchangeable
Shares will be entitled to receive, on the Liquidation Date, the Liquidation Amount otherwise payable by Purchaser in respect of
the Exchangeable Shares held by such holder in connection with the liquidation, dissolution or winding-up of Purchaser or any distribution
of the assets of Purchaser among its shareholders for the purpose of winding up its affairs pursuant to Section 5 of the Exchangeable
Share Provisions.

 

    B-18

     

    

 

		7.2	Redemption Call Right

 

In addition to the
rights contained in the Exchangeable Share Provisions (including, without limitation, the Retraction Call Right), Akerna and Callco
shall have the following rights in respect of the Exchangeable Shares:

 

		(a)	Subject to the proviso in Section 7.2(b) that Callco shall only be entitled to exercise the Redemption
Call Right with respect to those Exchangeable Shares, if any, in respect of which Akerna has not exercised the Redemption Call
Right, and notwithstanding the proposed redemption of the Exchangeable Shares by Purchaser pursuant to Section 7 of the Exchangeable
Share Provisions, Akerna and Callco shall each have the overriding right (the “Redemption Call Right”) to purchase
from all but not less than all of the holders of the Exchangeable Shares (other than any holder of Exchangeable Shares which is
Akerna or any of its Affiliates) on the Redemption Date all but not less than all of the Exchangeable Shares held by each such
holder upon payment by Akerna or Callco, as the case may be, to each such holder of the Exchangeable Share Price (payable in the
form of the Exchangeable Share Consideration) applicable on the last Business Day prior to the Redemption Date (the “Redemption
Call Purchase Price”) in accordance with Section 7.2(c). In the event of the exercise of the Redemption Call Right by
Akerna or Callco, as the case may be, each such holder of Exchangeable Shares shall be obligated to sell all of the Exchangeable
Shares held by the holder to Akerna or Callco, as the case may be, on the Redemption Date upon payment by Akerna or Callco, as
the case may be, to such holder of the Redemption Call Purchase Price (payable in the form of Exchangeable Share Consideration),
and Purchaser shall have no obligation to redeem, or to pay the Redemption Price (as defined in the Exchangeable Share Provisions)
in respect of, such shares so purchased.

 

		(b)	Callco shall only be entitled to exercise the Redemption Call Right with respect to those Exchangeable
Shares, if any, in respect of which Akerna has not exercised the Redemption Call Right. To exercise the Redemption Call Right,
Akerna or Callco must notify the Transfer Agent, as agent for the holders of the Exchangeable Shares, and Purchaser of its intention
to exercise such right: (i) in the case of a redemption occurring as a result of an Akerna Control Transaction, an Exchangeable
Share Voting Event or an Exempt Exchangeable Share Voting Event, on or before the Redemption Date; and (ii) in any other case,
at least thirty (30) days before the Redemption Date. The Transfer Agent will notify the holders of the Exchangeable Shares as
to whether or not Akerna and/or Callco has exercised the Redemption Call Right forthwith after the expiry of the period during
which Akerna or Callco may exercise the Redemption Call Right. If Akerna and/or Callco exercises the Redemption Call Right, Akerna
and/or Callco, as the case may be, will purchase and the holders of the Exchangeable Shares (other than any holder of Exchangeable
Shares which is Akerna or any of its Affiliates) will sell, on the Redemption Date, all of the Exchangeable Shares held by such
holders on such date for a price per share equal to the Redemption Call Purchase Price (payable in the form of Exchangeable Share
Consideration).

 

		(c)	For the purposes of completing the purchase and sale of the Exchangeable Shares pursuant to the
exercise of the Redemption Call Right, Akerna and/or Callco, as the case may be, shall deposit or cause to be deposited with the
Transfer Agent, on or before the Redemption Date, the Exchangeable Share Consideration representing the aggregate Redemption Call
Purchase Price less any amounts withheld pursuant to Section 6.3. Provided that such Exchangeable Share Consideration has been
so deposited with the Transfer Agent, the holders of the Exchangeable Shares (other than Akerna and its Affiliates) shall cease
to be holders of the Exchangeable Shares on and after the Redemption Date and, from and after such date, shall not be entitled
to exercise any of the rights of holders in respect thereof (including, without limitation, any rights under the Voting and Exchange
Trust Agreement) other than the right to receive their proportionate part of the aggregate Redemption Call Purchase Price, without
interest, upon presentation and surrender by the holder of certificates representing the Exchangeable Shares held by such holder
and the holder shall on and after the Redemption Date be considered and deemed for all purposes to be the holder of the Akerna
Shares which such holder is entitled to receive. Upon surrender to the Transfer Agent of a certificate or certificates representing
Exchangeable Shares, together with such other documents and instruments as may be required to effect a transfer of Exchangeable
Shares under the OBCA and the articles of Purchaser, as applicable, and such additional documents, instruments and payments as
the Transfer Agent may reasonably require, the holder of such surrendered certificate or certificates shall be entitled to receive,
in exchange therefor, and the Transfer Agent on behalf of Akerna and/or Callco, as the case may be, shall deliver to such holder
the Exchangeable Share Consideration such holder is entitled to receive. If neither Akerna nor Callco exercises the Redemption
Call Right in the manner described above, each holder of Exchangeable Shares will be entitled to receive, on the Redemption Date,
the Redemption Price otherwise payable by Callco in respect of the Exchangeable Shares held by such holder in connection with the
redemption of the Exchangeable Shares pursuant to Section 7 of the Exchangeable Share Provisions.

 

    B-19

     

    

 

		7.3	Change of Law Call Right

 

In addition to the
rights contained in the Exchangeable Share Provisions (including, without limitation, the Retraction Call Right), Akerna and Callco
shall have the following rights in respect of the Exchangeable Shares:

 

		(a)	Subject to the proviso in Section 7.3(b) that Callco shall only be entitled to exercise the Change
of Law Call Right with respect to those Exchangeable Shares, if any, in respect of which Akerna has not exercised the Change of
Law Call Right, Akerna and Callco shall each have the overriding right (the “Change of Law Call Right”), in
the event of a Change of Law, to purchase from all but not less than all of the holders of the Exchangeable Shares (other than
any holder of Exchangeable Shares which is Akerna or any of its Affiliates) on the Change of Law Call Date all but not less than
all of the Exchangeable Shares held by each such holder upon payment by Akerna or Callco, as the case may be, to each such holder
of the Exchangeable Share Price (payable in the form of the Exchangeable Share Consideration) applicable on the last Business Day
prior to the Change of Law Call Date (the “Change of Law Call Purchase Price”) in accordance with Section 7.3(c).
In the event of the exercise of the Change of Law Call Right by Akerna or Callco, as the case may be, each such holder of Exchangeable
Shares shall be obligated to sell all of the Exchangeable Shares held by the holder to Akerna or Callco, as the case may be, on
the Change of Law Call Date upon payment by Akerna or Callco, as the case may be, to such holder of the Change of Law Call Purchase
Price (payable in the form of Exchangeable Share Consideration).

 

		(b)	Callco shall only be entitled to exercise the Change of Law Call Right with respect to those Exchangeable
Shares, if any, in respect of which Akerna has not exercised the Change of Law Call Right. To exercise the Change of Law Call Right,
Akerna or Callco must notify the Transfer Agent, as agent for the holders of the Exchangeable Shares, and Callco of its intention
to exercise such right at least thirty (30) days before the date (the “Change of Law Call Date”) on which Akerna
or Callco, as the case may be, shall acquire the Exchangeable Shares pursuant to the exercise of the Change of Law Call Right.
The Transfer Agent will notify the holders of the Exchangeable Shares as to whether or not Akerna and/or Callco has exercised the
Change of Law Call Right forthwith after receiving notice of such exercise from Akerna and/or Callco. If Akerna and/or Callco exercises
the Change of Law Call Right, Akerna and/or Callco, as the case may be, will purchase and the holders of the Exchangeable Shares
(other than any holder of Exchangeable Shares which is Akerna or any of its Affiliates) will sell, on the Change of Law Call Date,
all of the Exchangeable Shares held by such holders on such date for a price per share equal to the Change of Law Call Purchase
Price (payable in the form of Exchangeable Share Consideration).

 

    B-20

     

    

 

		(c)	For the purposes of completing the purchase and sale of the Exchangeable Shares pursuant to the
exercise of the Change of Law Call Right, Akerna and/or Callco, as the case may be, shall deposit or cause to be deposited with
the Transfer Agent, on or before the Change of Law Call Date, the Exchangeable Share Consideration representing the aggregate Change
of Law Call Purchase Price less any amounts withheld pursuant to Section 6.3. Provided that such Exchangeable Share Consideration
has been so deposited with the Transfer Agent, the holders of the Exchangeable Shares (other than Akerna and its Affiliates) shall
cease to be holders of the Exchangeable Shares on and after the Change of Law Call Date and, from and after such date, shall not
be entitled to exercise any of the rights of holders in respect thereof (including, without limitation, any rights under the Voting
and Exchange Trust Agreement) other than the right to receive their proportionate part of the aggregate Change of Law Call Purchase
Price, without interest, upon presentation and surrender by the holder of certificates representing the Exchangeable Shares held
by such holder and the holder shall on and after the Change of Law Call Date be considered and deemed for all purposes to be the
holder of the Akerna Shares which such holder is entitled to receive. Upon surrender to the Transfer Agent of a certificate or
certificates representing Exchangeable Shares, together with such other documents and instruments as may be required to effect
a transfer of Exchangeable Shares under the OBCA and the articles of Purchaser, as applicable and such additional documents, instruments
and payments as the Transfer Agent may reasonably require, the holder of such surrendered certificate or certificates shall be
entitled to receive, in exchange therefor, and the Transfer Agent on behalf of Akerna and/or Callco, as the case may be, shall
deliver to such holder the Exchangeable Share Consideration such holder is entitled to receive.

 

ARTICLE
8

AMENDMENTS

 

		8.1	Amendments

 

		(a)	The Parties reserve the right to amend, modify and/or supplement this Plan of Arrangement at any
time and from time to time prior to the Effective Time, provided that any such amendment, modification or supplement must be agreed
to in writing by each of Parties and filed with the Court, and, if made following the Ample Meeting, then: (i) approved by the
Court; and (ii) if the Court directs, approved by the Ample Shareholders and communicated to the Ample Shareholders if and as required
by the Court, and in either case in the manner required by the Court.

 

		(b)	Subject to the provisions of the Interim Order, any amendment, modification or supplement to this
Plan of Arrangement, if agreed to by the Parties, may be proposed by Ample and Akerna at any time prior to or at the Ample Meeting,
with or without any other prior notice or communication, and if so proposed and accepted by the Persons voting at the Ample Meeting
shall become part of this Plan of Arrangement for all purposes.

 

		(c)	Any amendment, modification or supplement to this Plan of Arrangement that is approved or directed
by the Court following the Ample Meeting will be effective only if it is agreed to in writing by each of the Parties and, if required
by the Court, by some or all of the Ample Shareholders voting in the manner directed by the Court.

 

		(d)	Any amendment, modification or supplement to this Plan of Arrangement may be made by the Parties
without the approval of or communication to the Court or the Ample Shareholders, provided that it concerns a matter which, in the
reasonable opinion of Ample and Akerna is of an administrative or ministerial nature required to better give effect to the implementation
of this Plan of Arrangement and is not materially adverse to the financial or economic interests of any of the Ample Shareholders.

 

		(e)	This Plan of Arrangement may be withdrawn prior to the Effective Time in accordance with the Arrangement
Agreement.

 

ARTICLE
9

FURTHER ASSURANCES

 

		9.1	Further Assurances

 

Notwithstanding that
the transactions and events set out in this Plan of Arrangement shall occur and shall be deemed to occur in the order set out in
this Plan of Arrangement without any further act or formality, each of the Parties shall make, do and execute, or cause to be made,
done and executed, all such further acts, deeds, agreements, transfers, assurances, instruments or documents as may reasonably
be required by any of them in order further to document or evidence any of the transactions or events set out in this Plan of Arrangement.

 

    B-21

     

    

 

ANNEX “A”

TO THE PLAN OF ARRANGEMENT

 

EXCHANGEABLE SHARE PROVISIONS

 

Please see attached.

 

    B-22

     

    

  

SCHEDULE “C”

FORM OF

EXCHANGEABLE SHARE SUPPORT AGREEMENT

 

THIS EXCHANGEABLE
SHARE SUPPORT AGREEMENT made as of ● among Akerna Corp., a corporation existing under the laws of the State of Delaware
(“Akerna”), 2732804 Ontario Inc., a corporation existing under the laws of the Province of Ontario (“Callco”),
and 2732805 Ontario Inc., a corporation existing under the laws of the Province of Ontario (“Exchangeco”).

 

RECITALS:

 

		A.	In connection with an arrangement agreement (the “Arrangement Agreement”) dated
December 18, 2019 among Akerna, Exchangeco and Ample Organics Inc. (“Ample”), Exchangeco is to issue exchangeable
shares (the “Exchangeable Shares”) to certain holders of common shares of Ample pursuant to an arrangement under
the Business Corporations Act (Ontario) (the “Arrangement”) on the terms and conditions set out in the
Plan of Arrangement (as defined in the Arrangement Agreement).

 

		B.	Pursuant to the Arrangement Agreement, Akerna, Callco and Exchangeco are required to enter into
an exchangeable share support agreement (the “Agreement”) substantially in the form of this Agreement.

 

In consideration of the foregoing and the
mutual agreements contained herein and for other good and valuable consideration (the receipt and sufficiency of which are acknowledged),
the parties hereby agree as follows:

 

Article
1

AND INTERPRETATION

 

		1.1	Defined Terms

 

In this Agreement, each capitalized term
used and not otherwise defined herein shall have the meaning ascribed thereto in the rights, privileges, restrictions and conditions
(collectively, the “Exchangeable Share Provisions”) attaching to the Exchangeable Shares as set out in the articles
of Exchangeco, unless the context requires otherwise.

 

		1.2	Interpretation Not Affected by Headings

 

The division of this Agreement into Articles,
Sections, subsections and paragraphs and the insertion of headings are for convenience of reference only and shall not affect in
any way the meaning or interpretation of this Agreement. Unless the contrary intention appears, references in this Agreement to
an Article, Section, subsection, paragraph or Schedule by number or letter or both refer to the Article, Section, subsection, paragraph
or Schedule, respectively, bearing that designation in this Agreement.

 

		1.3	Number and Gender

 

In this Agreement, unless the contrary
intention appears, words importing the singular include the plural and vice versa, and words importing gender shall include all
genders.

 

		1.4	Date of any Action

 

If the date on which any action is required
to be taken hereunder by any person is not a Business Day, such action shall be required to be taken on the next succeeding day
which is a Business Day.

 

		1.5	Statutes

 

Any reference to a statute refers to such
statute and all rules and regulations made under it, as it or they may have been or may from time to time be amended or re-enacted,
unless stated otherwise.

 

    C-1

     

    

 

Article
2

COVENANTS OF AKERNA
AND EXCHANGECO

 

		2.1	Covenants Regarding Exchangeable Shares

 

So long as any Exchangeable Shares not
owned by Akerna or its affiliates are outstanding, Akerna shall:

 

		(a)	not take any action that will result in the declaration or payment of any dividend or make any
other distribution on the Akerna Shares unless:

 

		(i)	Exchangeco shall: (A) simultaneously declare or pay, as the case may be, an equivalent dividend
or other distribution economically equivalent thereto (as determined in accordance with the Exchangeable Share Provisions) on the
Exchangeable Shares (an “Equivalent Dividend”); and (B) have sufficient money or other assets or authorized but
unissued securities available to enable the due declaration and the due and punctual payment, in accordance with applicable law
and the Exchangeable Share Provisions, of any such Equivalent Dividend; or

 

		(ii)	if the dividend or other distribution is a stock or share dividend or distribution of stock or
shares, and if Exchangeco so chooses as an alternative to taking the action described in (i), in lieu of such dividend or other
distribution on the Akerna Shares, Exchangeco shall:

 

		(A)	effect a corresponding, contemporaneous and economically equivalent subdivision of the outstanding
Exchangeable Shares (as determined in accordance with the Exchangeable Share Provisions) (an “Equivalent Stock Subdivision”);
and

 

		(B)	have sufficient authorized but unissued securities available to enable the Equivalent Stock Subdivision;

 

		(b)	advise Exchangeco sufficiently in advance of the declaration by Akerna of any dividend or other
distribution on the Akerna Shares and take all such other actions as are reasonably necessary or desirable, in co-operation with
Exchangeco, to ensure that:

 

		(i)	the respective declaration date, record date and payment date for an Equivalent Dividend shall
be the same as the declaration date, record date and payment date for the corresponding dividend or other distribution on the Akerna
Shares; or

 

		(ii)	the record date and effective date for an Equivalent Stock Subdivision shall be the same as the
record date and payment date for the corresponding stock or share dividend or distribution of stock or shares, in lieu of such
a dividend or other distribution on the Akerna Shares and that such Equivalent Stock Subdivision shall comply with the requirements
of the stock exchange on which the Exchangeable Shares are then listed;

 

    C-2

     

    

 

		(c)	take all such actions and do all such things as are reasonably necessary or desirable to enable
and permit Exchangeco, in accordance with applicable law, to pay and otherwise perform its obligations with respect to the satisfaction
of the Liquidation Amount, the Retraction Price or the Redemption Price in respect of each issued and outstanding Exchangeable
Share upon the liquidation, dissolution or winding-up of Exchangeco or any other distribution of the assets of Exchangeco among
its shareholders for the purpose of winding up its affairs, the delivery of a Retraction Request by a holder of Exchangeable Shares
or a redemption of Exchangeable Shares by Exchangeco, as the case may be, including without limitation all such actions and all
such things as are necessary or desirable to enable and permit Exchangeco to deliver or cause to be delivered Akerna Shares or
other property to the holders of Exchangeable Shares in accordance with the provisions of Sections 5,6 or 7, as the case may be,
of the Exchangeable Share Provisions;

 

		(d)	take all such actions and do all such things as are reasonably necessary or desirable to enable
and permit the Trustee in accordance with applicable law to perform its obligations under the Voting and Exchange Trust Agreement,
including, without limitation, all such actions and all such things as are reasonably necessary or desirable to enable and permit
the Trustee in its capacity as trustee under the Voting and Exchange Trust Agreement to exercise such number of votes in respect
of an Akerna Meeting or an Akerna Consent (as such terms are defined in the Voting and Exchange Trust Agreement) as is equal to
the aggregate number of Exchangeable Shares outstanding at the relevant time other than those held by Akerna and its affiliates;

 

		(e)	take all such actions and do all such things as are reasonably necessary or desirable to enable
and permit Akerna or Callco, as the case may be, in accordance with applicable law, to perform its obligations arising upon the
exercise by it of the Liquidation Call Right, the Retraction Call Right, the Change of Law Call Right (as defined in the Plan of
Arrangement) or the Redemption Call Right, including without limitation all such actions and all such things as are necessary or
desirable to enable and permit Akerna or Callco, as the case may be, to deliver or cause to be delivered Akerna Shares or other
property to the holders of Exchangeable Shares in accordance with the provisions of the Liquidation Call Right, the Retraction
Call Right, the Change of Law Call Right or the Redemption Call Right, as the case may be; and

 

		(f)	not exercise its vote as a shareholder of Exchangeco to initiate the voluntary liquidation, dissolution
or winding up of Exchangeco or any other distribution of the assets of Exchangeco among its shareholders for the purpose of winding
up its affairs, nor take any action or omit to take any action that is designed to result in the liquidation, dissolution or winding
up of Exchangeco or any other distribution of the assets of Exchangeco among its shareholders for the purpose of winding up its
affairs.

 

		2.2	Segregation of Funds

 

Akerna will cause Exchangeco to deposit
a sufficient amount of funds in a separate account of Exchangeco and segregate a sufficient amount of such other assets and property
as is necessary to enable Exchangeco to pay or otherwise satisfy its obligations with respect to the applicable dividend, Liquidation
Amount, Retraction Price or Redemption Price, in each case once such amounts become payable under the terms of this Agreement or
the Exchangeable Share Provisions. Exchangeco will use such funds, assets and property so segregated exclusively for the payment
of dividends and the payment or other satisfaction of the Liquidation Amount, the Retraction Price or the Redemption Price, as
applicable net of any corresponding withholding tax obligations and for the remittance of such withholding tax obligations.

 

    C-3

     

    

 

		2.3	Reservation of Akerna Shares

 

Akerna hereby represents, warrants and
covenants in favour of Exchangeco and Callco that Akerna has reserved for issuance and shall, at all times while any Exchangeable
Shares are outstanding, keep available, free from pre-emptive and other rights, out of its authorized and unissued capital stock
such number of Akerna Shares (or other shares or securities into which Akerna Shares may be reclassified or changed as contemplated
by Section 2.7):

 

		(a)	as is equal to the sum of: (i) the number of Exchangeable Shares issued and outstanding from time
to time; and (ii) the number of Exchangeable Shares issuable upon the exercise of all rights to acquire Exchangeable Shares outstanding
from time to time; and

 

		(b)	as are now and may hereafter be required to enable and permit each of Akerna, Callco and Exchangeco
to meet its obligations under the Voting and Exchange Trust Agreement, the Exchangeable Share Provisions and any other security
or commitment relating to the Arrangement pursuant to which Akerna may now or hereafter be required to issue or cause to be issued
Akerna Shares.

 

		2.4	Notification of Certain Events

 

In order to assist Akerna to comply with
its obligations hereunder and to permit Akerna or Callco to exercise, as the case may be, the Liquidation Call Right, the Retraction
Call Right, the Change of Law Call Right or the Redemption Call Right, as applicable, Exchangeco shall notify Akerna and Callco
of each of the following events at the time set forth below:

 

		(a)	in the event of any determination by the board of directors of Exchangeco to institute voluntary
liquidation, dissolution or winding-up proceedings with respect to Exchangeco or to effect any other distribution of the assets
of Exchangeco among its shareholders for the purpose of winding up its affairs, at least 60 days prior to the proposed effective
date of such liquidation, dissolution, winding-up or other distribution;

 

		(b)	promptly upon the earlier of: (i) receipt by Exchangeco of notice of; and (ii) Exchangeco otherwise
becoming aware of, any threatened or instituted claim, suit, petition or other proceedings with respect to the involuntary liquidation,
dissolution or winding-up of Exchangeco or to effect any other distribution of the assets of Exchangeco among its shareholders
for the purpose of winding up its affairs;

 

		(c)	immediately, upon receipt by Exchangeco of a Retraction Request;

 

		(d)	on the same date on which notice of redemption is given to holders of Exchangeable Shares, upon
the determination of a Redemption Date in accordance with the Exchangeable Share Provisions;

 

		(e)	as soon as practicable upon the issuance by Exchangeco of any Exchangeable Shares or rights to
acquire Exchangeable Shares (other than the issuance of Exchangeable Shares and rights to acquire Exchangeable Shares pursuant
to the Arrangement); and

 

		(f)	promptly, upon receiving notice of a Change of Law (as such term is defined in the Plan of Arrangement).

 

		2.5	Delivery of Akerna Shares

 

Upon notice from Callco or Exchangeco of
any event that requires Callco or Exchangeco to deliver or cause to be delivered Akerna Shares to any holder of Exchangeable Shares,
Akerna shall forthwith issue and deliver or cause to be delivered the requisite number of shares of Akerna Shares for the benefit
of Callco or Exchangeco, as appropriate, and Callco or Exchangeco, as the case may be, shall forthwith cause to be delivered the
requisite number of Akerna Shares to be received by or for the benefit of the former holder of the surrendered Exchangeable Shares.
All such Akerna Shares shall be duly authorized and validly issued as fully paid, non-assessable, free of preemptive rights and
shall be free and clear of any lien, claim or encumbrance.

 

    C-4

     

    

 

		2.6	Qualification of Akerna Shares

 

		(1)	Akerna covenants and agrees that it shall: (a) file a registration statement (the “Registration
Statement”) under the U.S. Securities Act of 1933, as amended (the “1933 Act”) to register any and all
of the Akerna Shares to be issued or delivered to holders of the Exchangeable Shares by Akerna or Callco (including, for greater
certainty, pursuant to the Exchange Right or the Automatic Exchange Right); (b) cause the Registration Statement to become effective
prior to the time that any Exchangeable Shares are first issued; and (c) cause the Registration Statement (or a successor registration
statement) to remain effective at all times that any Exchangeable Shares remain outstanding, in each case unless the issuance of
such securities is exempt from any requirement for registration under the 1933 Act and all applicable state securities laws. Without
limiting the generality of the foregoing, Akerna and Callco each covenant and agree that it will to make such filings and seek
such regulatory consents and approvals as are necessary so that the Akerna Shares to be issued or delivered to holders of Exchangeable
Shares by Akerna or Callco pursuant to the terms of the Exchangeable Share Provisions, the Voting and Exchange Trust Agreement
and this Agreement will be offered, sold, issued and delivered in compliance with the 1933 Act and all applicable state securities
laws, and applicable securities laws in Canada and shall ensure that the Akerna Shares will not be “restricted securities”
within the meaning of Rule 144 under the 1933 Act. Akerna will in good faith expeditiously take all such actions and do
all such things as are reasonably necessary or desirable to cause all Akerna Shares to be delivered to holders of Exchangeable
Shares pursuant to the terms of the Exchangeable Share Provisions, the Voting and Exchange Trust Agreement and this Agreement to
be listed, quoted and posted for trading on all stock exchanges and quotation systems on which outstanding Akerna Shares have been
listed by Akerna and remain listed and are quoted or posted for trading at such time.

 

		(2)	Notwithstanding any other provision of the Exchangeable Share Provisions, or any term of this Agreement,
the Voting and Exchange Trust Agreement or the Plan of Arrangement, no Akerna Shares shall be issued (and Akerna will not be required
to issue any Akerna Shares) in connection with any liquidation, dissolution or winding-up of Exchangeco, or any retraction, redemption
or any other exchange, direct or indirect, of Exchangeable Shares, if such issuance of Akerna Shares would not be permitted by
applicable laws.

 

		2.7	Economic Equivalence

 

		(1)	So long as any Exchangeable Shares not owned by Akerna or its affiliates are outstanding:

 

		(a)	Akerna shall not without the prior approval of Exchangeco and the prior approval of the holders
of the Exchangeable Shares given in accordance with Section 11(b) of the Exchangeable Share Provisions:

 

		(i)	issue or distribute Akerna Shares (or securities exchangeable for or convertible into or carrying
rights to acquire Akerna Shares) to the holders of all or substantially all of the then outstanding Akerna Shares by way of stock
or share dividend or other distribution, other than an issue of Akerna Shares (or securities exchangeable for or convertible into
or carrying rights to acquire Akerna Shares) to holders of Akerna Shares: (A) who exercise an option to receive dividends in Akerna
Shares (or securities exchangeable for or convertible into or carrying rights to acquire Akerna Shares) in lieu of receiving cash
dividends; or (B) pursuant to any dividend reinvestment plan or scrip dividend or similar arrangement; or

 

		(ii)	issue or distribute rights, options or warrants to the holders of all or substantially all of the
then outstanding Akerna Shares entitling them to subscribe for or to purchase Akerna Shares (or securities exchangeable for or
convertible into or carrying rights to acquire Akerna Shares); or

 

    C-5

     

    

 

		(iii)	issue or distribute to the holders of all or substantially all of the then outstanding Akerna Shares:
(A) shares or securities of Akerna of any class other than Akerna Shares (or securities convertible into or exchangeable for or
carrying rights to acquire Akerna Shares); (B) rights, options, warrants or other assets other than those referred to in Section
2.7(1)(a)(ii); (C) evidence of indebtedness of Akerna; or (D) assets of Akerna;

 

unless, in each case, Exchangeco
issues or distributes the economic equivalent of such rights, options, warrants, securities, shares, evidences of indebtedness
or other assets simultaneously to holders of the Exchangeable Shares; provided, however, that, for greater certainty, the above
restrictions shall not apply to any securities issued or distributed by Akerna in order to give effect to and to consummate the
transactions contemplated by, and in accordance with, the Arrangement Agreement and the Plan of Arrangement.

 

		(b)	Akerna shall not without the prior approval of Exchangeco and the prior approval of the holders
of the Exchangeable Shares given in accordance with Section 11(b) of the Exchangeable Share Provisions:

 

		(i)	subdivide, redivide or change the then outstanding Akerna Shares into a greater number of Akerna
Shares; or

 

		(ii)	reduce, combine, consolidate or change the then outstanding Akerna Shares into a lesser number
of Akerna Shares; or

 

		(iii)	reclassify or otherwise change the Akerna Shares or effect an amalgamation, merger, reorganization
or other transaction affecting the Akerna Shares;

 

unless, in each case, the same
or an economically equivalent change is made simultaneously to, or in the rights of the holders of, the Exchangeable Shares; provided,
however, that, for greater certainty, the above restrictions shall not apply to any securities issued or distributed by Akerna
in order to give effect to and to consummate the transactions contemplated by, and in accordance with the Arrangement Agreement
and the Plan of Arrangement.

 

		(2)	The board of directors of Exchangeco shall determine, in good faith and in its sole discretion
(with the assistance of such financial or other advisors as the board of may determine), “economic equivalence” for the
purposes of any event referred to in Section 2.7(1)(a) or Section 2.7(1)(b) and each such determination shall be conclusive and
binding on Akerna. In making each such determination, the following factors shall, without excluding other factors determined by
the board of directors of Exchangeco to be relevant, be considered by the board of directors of Exchangeco:

 

		(a)	in the case of any stock or share dividend or other distribution payable in Akerna Shares, the
number of such shares issued as a result of such stock or share dividend or other distribution in proportion to the number of Akerna
Shares previously outstanding;

 

		(b)	in the case of the issuance or distribution of any rights, options or warrants to subscribe for
or purchase Akerna Shares (or securities exchangeable for or convertible into or carrying rights to acquire Akerna Shares), the
relationship between the exercise price of each such right, option or warrant, the number of such rights, options or warrants to
be issued or distributed in respect of each Akerna Share and the Current Market Price of an Akerna Share, the price volatility
of the Akerna Shares and the terms of any such instrument;

 

		(c)	in the case of the issuance or distribution of any other form of property (including without limitation
any shares or securities of Akerna of any class other than Akerna Shares, any rights, options or warrants other than those referred
to in Section 2.7(2)(b), any evidences of indebtedness of Akerna or any assets of Akerna), the relationship between the fair market
value (as determined by the board of directors of Exchangeco in the manner above contemplated) of such property to be issued or
distributed with respect to each outstanding Akerna Share and the Current Market Price of an Akerna Share;

 

    C-6

     

    

 

		(d)	in the case of any subdivision, redivision or change of the then outstanding Akerna Shares into
a greater number of Akerna Shares or the reduction, combination, consolidation or change of the then outstanding Akerna Shares
into a lesser number of Akerna Shares or any amalgamation, merger, arrangement, reorganization or other transaction affecting Akerna
Shares, the effect thereof upon the then outstanding Akerna Shares; and

 

		(e)	in all such cases, the general taxation consequences of the relevant event to holders of Exchangeable
Shares to the extent that such consequences may differ from the taxation consequences to holders of Akerna Shares as a result of
differences between taxation laws of Canada and the United States (except for any differing consequences arising as a result of
differing marginal taxation rates and without regard to the individual circumstances of holders of Exchangeable Shares).

 

		(3)	Exchangeco agrees that, to the extent required, upon due notice from Akerna, Exchangeco shall use
its best efforts to take or cause to be taken such steps as may be necessary for the purposes of ensuring that appropriate dividends
are paid or other distributions are made by Exchangeco, or subdivisions, redivisions or changes are made to the Exchangeable Shares,
in order to implement the required economic equivalence with respect to the Akerna Shares and Exchangeable Shares as provided for
in this Section 2.7.

 

		2.8	Tender Offers

 

In the event that a tender offer, share
exchange offer, issuer bid, take-over bid or similar transaction with respect to Akerna Shares (an “Offer”) is
proposed by Akerna or is proposed to Akerna or its shareholders and is recommended by the board of directors of Akerna, or is otherwise
effected or to be effected with the consent or approval of the board of directors of Akerna, and the Exchangeable Shares are not
redeemed by Exchangeco or purchased by Akerna or Callco pursuant to the Redemption Call Right, Akerna and Exchangeco will use reasonable
efforts to take all such actions and do all such things as are necessary or desirable to enable and permit holders of Exchangeable
Shares (other than Akerna and its affiliates) to participate in such Offer to the same extent and on an economically equivalent
basis as the holders of Akerna Shares, without discrimination. Without limiting the generality of the foregoing, Akerna and Exchangeco
will use reasonable efforts in good faith to ensure that holders of Exchangeable Shares may participate in each such Offer without
being required to retract Exchangeable Shares as against Exchangeco (or, if so required, to ensure that any such retraction shall
be effective only upon, and shall be conditional upon, the closing of such Offer and only to the extent necessary to tender or
deposit to the Offer). Nothing herein shall affect the rights of Exchangeco to redeem, or Akerna or Callco to purchase pursuant
to the Redemption Call Right, Exchangeable Shares in the event of an Akerna Control Transaction.

 

		2.9	Akerna and Affiliates Not to Vote Exchangeable Shares

 

Each of Akerna and Callco covenants and
agrees that it shall appoint and cause to be appointed proxyholders with respect to all Exchangeable Shares held by it and its
affiliates for the sole purpose of attending each meeting of holders of Exchangeable Shares in order to be counted as part of the
quorum for each such meeting. Each of Akerna and Callco further covenants and agrees that it shall not, and shall cause its affiliates
not to, exercise any voting rights which may be exercisable by holders of Exchangeable Shares from time to time pursuant to the
Exchangeable Share Provisions or pursuant to the provisions of the Business Corporations Act (Ontario) (or any successor
or other corporate statute by which Exchangeco may in the future be governed) with respect to any Exchangeable Shares held by it
or by its affiliates in respect of any matter considered at any meeting of holders of Exchangeable Shares; provided however, for
further clarity, that this Section 2.9 shall not in any way restrict the right of Akerna or any of its affiliates to vote their
common shares of Exchangeco in accordance with the Exchangeable Share Provisions.

 

    C-7

     

    

 

		2.10	Ordinary Market Purchases

 

For greater certainty, nothing contained
in this Agreement, including without limitation the obligations of Akerna contained in Section 2.8, shall limit the ability of
Akerna (or any of its affiliates) to make ordinary market or other voluntary purchases of Akerna Shares in accordance with applicable
laws and regulatory or stock exchange requirements.

 

		2.11	Ownership of Outstanding Shares

 

Without the prior approval of Exchangeco
and the prior approval of the holders of the Exchangeable Shares given in accordance with Section 11(b) of the Exchangeable Share
Provisions, Akerna covenants and agrees in favour of Exchangeco that, as long as any outstanding Exchangeable Shares not owned
by Akerna or its affiliates are outstanding, Akerna will be and remain the direct or indirect beneficial owner of all issued and
outstanding common shares in the capital of Exchangeco and Callco. Notwithstanding the foregoing, Akerna shall not be in violation
of this Section 2.11 if any person or group of persons acting jointly or in concert acquires all or substantially all of the assets
of Akerna or the Akerna Shares pursuant to any merger or similar transaction involving Akerna pursuant to which Akerna is not the
surviving corporation.

 

Article
3

AKERNA SUCCESSORS

 

		3.1	Certain Requirements in Respect of Combination, etc.

 

So long as any Exchangeable Shares not
owned by Akerna or its affiliates are outstanding, Akerna shall not enter into any transaction (whether by way of reorganization,
consolidation, arrangement, amalgamation, merger, transfer, sale, lease or otherwise) whereby all or substantially all of its undertaking,
property and assets would become the property of any other person or, in the case of an amalgamation or merger, of the continuing
corporation resulting therefrom, provided that it may do so if:

 

		(a)	such other person or continuing corporation (the “Akerna Successor”) by operation
of law, becomes, without more, bound by the terms and provisions of this Agreement or, if not so bound, executes, prior to or contemporaneously
with the consummation of such transaction, an agreement supplemental hereto and such other instruments (if any) as are necessary
or advisable to evidence the assumption by the Akerna Successor of liability for all moneys payable and property deliverable hereunder
and the covenant of such Akerna Successor to pay and deliver or cause to be paid and delivered the same and its agreement to observe
and perform all the covenants and obligations of Akerna under this Agreement; and

 

		(b)	such transaction shall be upon such terms and conditions as to preserve and not to impair any of
the rights, duties, powers and authorities of the other parties hereunder or the holders of the Exchangeable Shares.

 

		3.2	Vesting of Powers in Successor

 

Whenever the conditions of Section 3.1
have been duly observed and performed, the parties, if required by Section 3.1, shall execute and deliver the supplemental agreement
provided for in Section 3.1(a) and thereupon the Akerna Successor and such other person that may then be the issuer of the Akerna
Shares shall possess and from time to time may exercise each and every right and power of Akerna under this Agreement in the name
of Akerna or otherwise and any act or proceeding by any provision of this Agreement required to be done or performed by the board
of directors of Akerna or any officers of Akerna may be done and performed with like force and effect by the directors or officers
of such Akerna Successor.

 

    C-8

     

    

 

		3.3	Wholly-Owned Subsidiaries

 

Nothing herein shall be construed as preventing:
(a) the amalgamation or merger of any wholly-owned direct or indirect subsidiary of Akerna (other than Exchangeco or Callco) with
or into Akerna; (b) the winding-up, liquidation or dissolution of any wholly-owned direct or indirect subsidiary of Akerna (other
than Exchangeco or Callco), provided that all of the assets of such subsidiary are transferred to Akerna or another wholly-owned
direct or indirect subsidiary of Akerna; (c) any other distribution of the assets of any wholly-owned direct or indirect subsidiary
of Akerna among the shareholders of such subsidiary for the purpose of winding up its affairs; and (d) any such transactions are
expressly permitted by this Article 3.

 

		3.4	Successorship Transaction

 

Notwithstanding the foregoing provisions
of this Article 3, in the event of an Akerna Control Transaction:

 

		(a)	in which Akerna merges or amalgamates with, or in which all or substantially all of the then outstanding
Akerna Shares are acquired by, one or more other corporations to which Akerna is, immediately before such merger, amalgamation
or acquisition, “related” within the meaning of the Income Tax Act (Canada) (otherwise than by virtue of a right
referred to in paragraph 251(5)(b) thereof);

 

		(b)	which does not result in an acceleration of the Redemption Date in accordance with paragraph (ii)
of the definition of Redemption Date in the Exchangeable Share Provisions; and

 

		(c)	in which all or substantially all of the then outstanding Akerna Shares are converted into or exchanged
for shares or rights to receive such shares (the “Other Shares”) or another corporation (the “Other Corporation”)
that, immediately after such Akerna Control Transaction, owns or controls, directly or indirectly, Akerna;

 

then all references herein to “Akerna”
shall thereafter be and be deemed to be references to “Other Corporation” and all references herein to “Akerna Shares”
shall thereafter be and be deemed to be references to “Other Shares” (with appropriate adjustments if any, as are required
to result in a holder of Exchangeable Shares on the exchange, redemption or retraction of such shares pursuant to the Exchangeable
Share Provisions or the Plan of Arrangement or the exchange of such shares pursuant to the Voting and Exchange Trust Agreement
immediately subsequent to the Akerna Control Transaction being entitled to receive that number of Other Shares equal to the number
of Other Shares such holder of Exchangeable Shares would have received if the exchange, redemption or retraction of such shares
pursuant to the Exchangeable Share Provisions or the Plan of Arrangement, or the exchange of such shares pursuant to the Voting
and Exchange Trust Agreement had occurred immediately prior to the Akerna Control Transaction and the Akerna Control Transaction
was completed) but subject to subsequent adjustments to reflect any subsequent changes in the share capital of the issuer of the
Other Shares, including without limitation, any subdivision, consolidation or reduction of share capital, without any need to amend
the terms and conditions of the Exchangeable Shares and without any further action required.

 

Article
4

GENERAL

 

		4.1	Term

 

This Agreement shall come into force and
be effective as of the date hereof and shall terminate and be of no further force and effect at such time as no Exchangeable Shares
(or securities or rights convertible into or exchangeable for or carrying rights to acquire Exchangeable Shares) are held by any
person other than Akerna and any of its affiliates.

 

    C-9

     

    

 

		4.2	Changes in Capital of Akerna and Exchangeco

 

Notwithstanding the provisions of Section
4.4, at all times after the occurrence of any event contemplated pursuant to Section 2.7 and Section 2.8 or otherwise, as a result
of which either Akerna Shares or the Exchangeable Shares or both are in any way changed, this Agreement shall forthwith be amended
and modified as necessary in order that it shall apply with full force and effect, mutatis mutandis, to all new securities
into which Akerna Shares or the Exchangeable Shares or both are so changed and the parties hereto shall execute and deliver an
agreement in writing giving effect to and evidencing such necessary amendments and modifications.

 

		4.3	Severability

 

If any term or other provision of this
Agreement is invalid, illegal or incapable of being enforced by any rule or law, or public policy, all other conditions and provisions
of this Agreement shall nevertheless remain in full force and effect so long as the economic or legal substance of the transactions
contemplated hereby is not affected in any manner materially adverse to any party. Upon such determination that any term or other
provision is invalid, illegal or incapable of being enforced, the parties hereto shall negotiate in good faith to modify this Agreement
so as to effect the original intent of the parties as closely as possible in an acceptable manner to the end that the transactions
contemplated hereby are fulfilled to the fullest extent possible.

 

		4.4	Amendments, Modifications

 

Subject to Section 4.2, Section 4.3 and
Section 4.5 this Agreement may not be amended or modified except by an agreement in writing executed by Akerna, Callco and Exchangeco
and approved by the holders of the Exchangeable Shares in accordance with Section 11(b) of the Exchangeable Share Provisions. No
amendment or modification or waiver of any of the provisions of this Agreement otherwise permitted hereunder shall be effective
unless made in writing and signed by all of the parties hereto.

 

		4.5	Ministerial Amendments

 

Notwithstanding the provisions of Section
4.4, the parties to this Agreement may in writing at any time and from time to time, without the approval of the holders of the
Exchangeable Shares, amend or modify this Agreement for the purposes of:

 

		(a)	adding to the covenants of any or all of the parties hereto if the board of directors of each of
Akerna, Callco and Exchangeco shall be of the good faith opinion that such additions will not be prejudicial to the rights or interests
of the holders of the Exchangeable Shares;

 

		(b)	evidencing the succession of Akerna Successors and the covenants of and obligations assumed by
each such Akerna Successor in accordance with the provisions of Article 3;

 

		(c)	making such amendments or modifications not inconsistent with this Agreement as may be necessary
or desirable with respect to matters or questions arising hereunder which, in the good faith opinion of the board of directors
of each of Akerna, Callco and Exchangeco, it may be expedient to make, provided that each such board of directors shall be of the
good faith opinion, after consultation with counsel, that such amendments or modifications will not be prejudicial to the rights
or interests of the holders of the Exchangeable Shares; or

 

		(d)	making such changes or corrections hereto which, on the advice of counsel to Akerna, Callco and
Exchangeco, are required for the purpose of curing or correcting any ambiguity or defect or inconsistent provision or clerical
omission or mistake or manifest error contained herein, provided that the boards of directors of each of Akerna, Callco and Exchangeco
shall be of the good faith opinion that such changes or corrections will not be prejudicial to the rights or interests of the holders
of the Exchangeable Shares.

 

    C-10

     

    

 

		4.6	Meeting to Consider Amendments

 

Exchangeco, at the request of Akerna, shall
call a meeting or meetings of the holders of the Exchangeable Shares for the purpose of considering any proposed amendment or modification
requiring approval pursuant to Section 4.4. Any such meeting or meetings shall be called and held in accordance with the articles
of Exchangeco, the Exchangeable Share Provisions and all applicable laws.

 

		4.7	Escrow Agreement

 

Notwithstanding any other provision hereof,
the parties hereto acknowledge and agree that the Exchangeable Shares and Akerna Shares are, as at the date hereof, subject to
the terms and conditions of the Escrow Agreement (as defined in the Arrangement Agreement), and for so long as such shares continue
to be subject to the Escrow Agreement, any transfer or exchange of Exchangeable Shares pursuant to this Agreement will be made
subject to the Escrow Agreement and any Exchangeable Share consideration issued in respect of Exchangeable Shares will be subject
to the Escrow Agreement.

 

		4.8	Enurement

 

This Agreement shall be binding upon and
enure to the benefit of the parties hereto and their respective successors and assigns.

 

		4.9	Notices to Parties

 

Any notice and other communications required
or permitted to be given pursuant to this Agreement shall be sufficiently given if delivered in person or if sent by facsimile
transmission (provided such transmission is recorded as being transmitted successfully) to the parties at the following addresses:

 

		(a)	In the case of Akerna, at the following address:

 

Akerna Corp.

1601 Arapahoe Street

Denver, CO 80202

 

	Attention:	Scott Sozio, President
	Email:	scott.sozio@akerna.com

 

with copies (which shall not constitute notice) to:

 

Dentons Canada LLP

15th Floor, Bankers Court, 850 – 2nd
Street S.W.

Calgary, Alberta T2P 0R8

 

	Attention:	Courtney Burton
	Email:	courtney.burton@dentons.com

 

		(b)	In the case of Callco or Exchangeco, at the following address:

 

Akerna Corp.

1601 Arapahoe Street

Denver, CO 80202

 

	Attention:	Scott Sozio, President
	Email:	scott.sozio@akerna.com

 

    C-11

     

    

 

with copies (which shall not constitute notice) to:

 

Dentons Canada LLP

15th Floor, Bankers Court, 850 – 2nd
Street S.W.

Calgary, Alberta T2P 0R8

 

	Attention:	Courtney Burton
	Email:	courtney.burton@dentons.com

 

and such notice or other communication
shall be deemed to have been given and received: (x) if delivered on a Business Day prior to 5:00 p.m. (local time in the place
where the notice or other communication is received), on the date of delivery; or (y) otherwise, on the next Business Day. Either
party may change its address for notice by giving notice to the other parties in accordance with the foregoing provisions.

 

		4.10	Counterparts

 

This Agreement may be executed in counterparts,
each of which shall be deemed an original, and all of which taken together shall constitute one and the same instrument.

 

		4.11	Jurisdiction

 

This Agreement shall be construed and enforced
in accordance with the laws of the Province of Ontario and the laws of Canada applicable therein. Each party hereto irrevocably
submits to the exclusive jurisdiction of the courts of the Province of Ontario with respect to any matter arising hereunder or
related hereto.

 

[Remainder of this page left intentionally
blank]

 

    C-12

     

    

 

IN WITNESS WHEREOF, the parties hereto
have caused this Agreement to be duly executed as of the date first above written.

 

	 	AKERNA CORP.
	 	 	 	 
	 	By:	 
	 	 	Name: 	 
	 	 	Title:	 
	 	 	 	 
	 	2732804 ONTARIO INC.
	 	 	 	 
	 	By:	 
	 	 	Name: 	 
	 	 	Title:	 
	 	 	 	 
	 	2732805 ONTARIO INC. 
	 	 	 	 
	 	By:	 
	 	 	Name: 	 
	 	 	Title:	 

 

    C-13

     

    

 

SCHEDULE “D”

ESCROW
AGREEMENT

  

THIS
ESCROW AGREEMENT (the “Agreement”) is made as of [●], 2020,

 

	AMONG:	 
	 	 
	 	AKERNA CORP.,
    a company existing under the laws of the State of Delaware (“Akerna”);
	 	 
	AND	 
	 	 
	 	2732805 ONTARIO
    INC., a company existing under the laws of the Province of Ontario (“Exchangeco”);
	 	 
	AND	 
	 	 
	 	JOHN PRENTICE,
    an individual resident in the Province of Ontario (hereinafter referred to as the “Shareholder Representative”);
	 	 
	AND	 
	 	 
	 	CONTINENTAL STOCK
    TRANSFER & TRUST COMPANY, INC., a trust company licensed to carry on business in all Provinces of Canada (the “Escrow
    Agent”).

 

WHEREAS
pursuant to an arrangement agreement dated December 18, 2019 (the “Arrangement Agreement”) entered into
among Akerna, Exchangeco, Ample Organics Inc. (“Ample”) and the Shareholder Representative, the parties thereto
have agreed that Akerna will purchase, through its wholly-owned subsidiary, Exchangeco, all of the issued and outstanding common
and preferred shares in the capital of Ample (the “Ample Shares”) by way of an arrangement under section 182
of the OBCA;

 

AND
WHEREAS pursuant to the Arrangement Agreement, Akerna and Exchangeco have agreed to pay to the shareholders of Ample as a
portion of the consideration for the Ample Shares, redeemable preferred shares in the capital of Exchangeco (“Exchangeable
Shares”);

 

AND
WHEREAS pursuant to the Arrangement, the Shareholder Representative has been appointed as the true, exclusive and lawful representative,
attorney-in-fact and agent for the Ample Shareholders in connection with this Agreement and is thereby authorized to make all
decisions, take all actions or do any and all thing necessary on their behalf relating to the matters contained herein;

 

AND
WHEREAS the Arrangement Agreement contemplates that Akerna and Exchangeco will deposit in escrow certain Exchangeable Shares
with the Escrow Agent, to be contributed, held and distributed by the Escrow Agent subject to the terms and conditions hereof;

 

AND
WHEREAS the foregoing recitals are representations and statements of fact made by the parties hereto and not by the Escrow
Agent.

 

    D-1

     

    

 

NOW,
THEREFORE, THIS AGREEMENT WITNESSETH THAT, in consideration of the foregoing recitals, the covenants and agreements hereinafter
contained and other good and valuable consideration (the receipt and sufficiency of which are hereby acknowledged), the parties
hereto agree as follows:

 

		1.	Definitions.
    For the purposes of this Agreement, the following terms shall have the following meanings:

 

		(a)	“Affiliate”
has the meaning ascribed thereto under the Securities Act (Ontario) and the rules, regulations and published policies made
thereunder.

 

	 	(b)	“Akerna
    Shares” means the shares in the common stock in the share capital of Akerna.

 

	 	(c)	“Ample
    Shareholders” means the holders of issued and outstanding shares in the capital of Ample immediately prior to the
    Closing Time that are entitled to receive Exchangeable Shares in accordance with the Arrangement Agreement and the Plan of
    Arrangement.

 

		(d)	“Arrangement”
means an arrangement under the OBCA on the terms and subject to the conditions set out in the Plan of Arrangement, subject to
any amendments or any variations to the Plan of Arrangement made in accordance with the terms of the Arrangement Agreement.

 

		(e)	“Business
Day” means a day on which banks are generally open for the transaction of commercial business in Toronto, Ontario, or
Denver, Colorado but does not in any event include a Saturday or Sunday or statutory holiday in Ontario or Colorado.

 

		(f)	“Callco”
means 2732804 Ontario Inc..

 

		(g)	“Claim
Notice” means written notification of a Claim pursuant to the Arrangement Agreement containing:

 

		(i)	a
description and the amount of Damages incurred or reasonably expected to be incurred by Akerna or Exchangeco, as applicable; and

 

		(ii)	a
statement that Akerna or Exchangeco, as applicable, is entitled to indemnification under Article 6 of the Arrangement Agreement
for such Damages and a reasonable explanation of the basis therefor.

 

		(h)	“Claims”
means any claim by Akerna or Exchangeco for indemnification in accordance with the Arrangement Agreement.

 

		(i)	“Closing
Date” means [●], 2020.

 

		(j)	“Closing
Shares” means [●] Exchangeable Shares deposited into escrow pursuant to this Agreement on the date hereof.

 

		(k)	“Closing
Time” means the time at which the Arrangement becomes effective on the Closing Date pursuant to the OBCA.

 

		(l)	“Court”
means the Ontario Superior Court of Justice.

 

		(m)	“Damages”
means any and all claims, debts, obligations and other liabilities (whether absolute, accrued, contingent, fixed or otherwise,
or whether known or unknown, or due to become due or otherwise), diminution in value, monetary damages, fines, fees, penalties,
interest obligations, deficiencies, losses and expenses (including amounts paid in settlement, interest, court costs, reasonable
fees and expenses of attorneys, accountants, financial advisors, investigators, and other experts, and other reasonable expenses
of litigation, arbitration or other dispute resolution procedures).

 

		(n)	“Deposited
Shares” means, collectively, the Closing Shares and the Escrowed Shares.

 

    D-2

     

    

 

		(o)	“Escrowed
Shares” means [●] Exchangeable Shares deposited into escrow pursuant to this Agreement on the date hereof.

 

		(p)	“Exchangeco
Articles” means the articles of incorporation of Exchangeco, as may be amended by any articles of amendment.

 

		(q)	“Final
Order” means an order issued by a court of competent jurisdiction, accompanied by a written certification from counsel
for the instructing party attesting that such order is final and not subject to further proceedings or appeal along with a written
instruction from an authorized representative of such instructing party given to effectuate such order and the Escrow Agent shall
be entitled to conclusively rely upon any such certification and instruction and shall have no responsibility to review the order
to which such certification and instruction refers or to make any determination as to whether such order is final;

 

		(r)	“Final
Release Date” has the meaning specified in Section 7(b);

 

		(s)	“Joint
Instructions” means joint, written instructions executed by each of Akerna and the Shareholder Representative substantially
in the formed attached as Schedule “A”.

 

		(t)	“OBCA”
means the Business Corporations Act, R.S.O. 1900, c. B.16, as amended, including the regulations promulgated thereunder.

 

		(u)	“Person”
means any individual, firm, partnership, joint venture, venture capital fund, association, trust, trustee, executor, administrator,
legal personal representative, estate group, body corporate, corporation, unincorporated association or organization, governmental
entity, syndicate or other entity, whether or not having legal status.

 

		(v)	“Plan
of Arrangement” means the plan of arrangement set forth in Schedule “B” to the Arrangement Agreement, as
such plan of arrangement may be amended or supplemented from time to time.

 

		(w)	“Resignation
Date” has the meaning specified in Section 16(a).

 

		(x)	“Shareholder
Correspondence” has the meaning specified in Section 6(b).

 

		(y)	“Trustee”
means Continental Stock Transfer & Trust Company, Inc., acting in its capacity as trustee pursuant to the Voting and Exchange
Trust Agreement.

 

		(z)	“Unresolved
Claims” means all Claims asserted against an Ample Shareholder pursuant to the delivery of a Claim Notice in accordance
with this Agreement and the Arrangement Agreement prior to the Final Release Date and that are not resolved as of the Final Release
Date.

 

		(aa)	“Voting
and Exchange Trust Agreement” means the Voting and Exchange Trust Agreement entered into by Akerna, Exchangeco, Callco,
the Trustee and the Shareholder Representative as of the date hereof.

 

		2.	Appointment
of Escrow Agent. Akerna, Exchangeco and the Shareholder Representative hereby appoint the Escrow Agent to act as agent
on their behalf pursuant to this Agreement, and the Escrow Agent hereby accepts such appointment on the terms and conditions of
this Agreement.

 

    D-3

     

    

 

		3.	Delivery
of the Escrowed Shares. Akerna and Exchangeco hereby deposit with the Escrow Agent a total of [•] Exchangeable Shares,
representing in the aggregate the Deposited Shares. The Deposited Shares shall be registered in the name of the Escrow Agent and
shall be held and retained by the Escrow Agent until released from escrow solely in accordance with the terms and conditions of
this Agreement.

 

		4.	Retention
in Escrow. The Deposited Shares and all cash and all other securities and property as may be held by the Escrow Agent
from time to time in accordance with the terms hereof, including, any securities or other property that may be issued in connection
with share splits, share dividends, distributions, combinations, exchanges and like transactions affecting the Deposited Shares
(or any of them) shall be held by the Escrow Agent in escrow pursuant to the terms hereof and for the limited purposes specified
herein. Unless otherwise expressly stated herein, the Deposited Shares shall not be sold, assigned, hypothecated, alienated, released
from escrow, transferred within escrow, or otherwise in any manner dealt with, without the prior written consent of the Shareholder
Representative and Akerna being given to the Escrow Agent.

 

		5.	Reorganizations,
Dividends etc.

 

		(a)	If,
during the period in which any of the Deposited Shares are held in escrow pursuant to this Agreement, a share split or consolidation,
share dividend, recapitalization, exchange or similar transaction affecting the share capital of Exchangeco occurs, then
in each such event, the Deposited Shares so affected and that are then held in escrow pursuant to this Agreement shall be released
and remitted by the Escrow Agent to such Person(s) in order to give effect to such share split or consolidation, share dividend,
recapitalization, exchange or similar transaction.

 

		(b)	Subject
to Section 10, any cash, securities or other property that is issued from time to time with respect to any Deposited Shares or
other property then held in escrow pursuant to this Agreement shall be deposited in escrow with the Escrow Agent and shall be
held on the same terms as the Deposited Shares or other property with respect to which such cash, securities or other property
shall have been delivered.

 

		6.	Voting
of Deposited Shares

  

		(a)	Grant
of Power of Attorney and Proxy. The Escrow Agent, as holder of record of the Deposited Shares, to the extent that such shares
are held in escrow pursuant to this Agreement, hereby irrevocably appoints the Shareholder Representative as its true, exclusive
and lawful representative, attorney-in-fact, agent and proxy:

 

		(i)	to
exercise any and all voting rights held by the Escrow Agent in its capacity as a Beneficiary (as such term is defined in the Voting
and Exchange Trust Agreement) under the Voting and Exchange Trust Agreement, including, without limitation, to direct and instruct
the Trustee with respect to the voting of the Special Voting Share (as such term is defined in the Voting and Exchange Trust Agreement)
in accordance with the Voting and Exchange Trust Agreement and with respect to all rights granted to Beneficiaries under the Voting
and Exchange Trust Agreement respecting (A) the attendance at meetings of the shareholders of Akerna and the voting of the Special
Voting Share thereat, and (B) the provision of any consents in writing that are sought by Akerna from holders of Akerna Shares;
and

 

		(ii)	to
attend any meeting of the holders of Exchangeable Shares, including any adjournment or postponement thereof, on behalf of the
Escrow Agent, and to exercise any and all rights with respect to the voting of the Deposited Shares registered in the name of
the Escrow Agent and held in escrow pursuant to this Agreement, including the right to vote the Deposited Shares in respect of
any matter, question, proposal or proposition whatsoever that may properly come before the holders of Exchangeable Shares at any
meeting of Exchangeco or in any consent sought by Exchangeco, as applicable, for such time as any Deposited Shares remain in escrow
pursuant to this Agreement.

 

    D-4

     

    

 

		(b)	Delivery
of Meeting Materials. Akerna and Exchangeco shall deliver to the Shareholder Representative and each Ample Shareholder any
notice or correspondence (“Shareholder Correspondence”) required to be delivered to the registered holders
of Exchangeable Shares at the same time, in the same form and on the same basis as Akerna, Exchangeco or the Trustee are required
under applicable law, by contract, or otherwise, to deliver such notice or other correspondence to registered holders of Exchangeable
Shares. Concurrently with the delivery of any Shareholder Correspondence in respect of which any voting rights (including any
right to direct the voting of the Special Voting Share) or consent rights attaching to the Exchangeable Shares shall arise, Akerna
and Exchangeco shall deliver to each Ample Shareholder:

 

		(i)	a
statement that such Ample Shareholder is entitled to instruct the Shareholder Representative as to the exercise of voting rights
(including any right to direct the voting of the Special Voting Share) or consent rights attaching to such portion of the Deposited
Shares as the Shareholder Representative shall determine in accordance with the Arrangement Agreement and Plan of Arrangement;

 

		(ii)	a
form of direction whereby the Ample Shareholder may so direct and instruct the Shareholder Representative; and

 

		(iii)	a
statement of the time by which such instructions must be received by the Shareholder Representative in order to be binding upon
them and the method for revoking or amending any such instructions.

 

		(c)	Exercise
of Voting Rights. The Shareholder Representative has been granted the authority under the Arrangement Agreement and the Plan
of Arrangement, in its capacity as the representative, attorney-in-fact and agent for each Ample Shareholder, to determine from
time to time while the Deposited Shares (or any of them) are held in escrow pursuant to this Agreement, the number (if any) of
all Deposited Shares in respect of which each Ample Shareholder shall be entitled to provide instructions with respect to the
exercise of any voting rights (including any right to direct the voting of the Special Voting Share) or any consent rights. The
Shareholder Representative hereby agrees and covenants that it shall exercise any voting rights (including any right to direct
the voting of the Special Voting Share) or consent rights attaching to each Deposited Shares exclusively in accordance with the
written instructions of the Ample Shareholder that the Shareholder Representative has determined, in accordance with the Arrangement
Agreement and the Plan of Arrangement, is entitled to provide instructions with respect to such Deposited Share.

 

		7.	Release
of Deposited Shares.

  

		(a)	On
the Business Day that is six (6) months following the Closing Date, provided that any Closing Shares remain subject to escrow
at such times, Akerna and the Shareholder Representative shall deliver Joint Instructions to the Escrow Agent directing the release
from escrow to the Ample Shareholders of that number of Closing Shares equal to the lesser of (i) fifty percent (50%) of the Closing
Shares first deposited into escrow pursuant to this Agreement, and (ii) the number of Closing Shares then held in escrow pursuant
to this Agreement and are not then subject to an Unresolved Claim in respect of fraud.

 

    D-5

     

    

 

		(b)	On
the Business Day that is nine (9) months following the Closing Date, provided that any Closing Shares remain subject to escrow
at such times, Akerna and the Shareholder Representative shall deliver Joint Instructions to the Escrow Agent directing the release
from escrow to the Ample Shareholders of that number of Closing Shares equal to the lesser of (i) thirty percent (30%) of the
Closing Shares first deposited into escrow pursuant to this Agreement, and (ii) the number of Closing Shares then held in escrow
pursuant to this Agreement and are not then subject to an Unresolved Claim in respect of fraud.

 

		(c)	On
the Business Day that is twelve (12) months following the Closing Date (the “Final Release Date”), provided
that any Closing Shares or Escrowed Shares, as the case may be, remain subject to escrow at such time, Akerna and the Shareholder
Representative shall deliver Joint Instructions to the Escrow Agent directing the release from escrow to the Ample Shareholders
of:

 

		(i)	All,
but not less than all, of the Closing Shares that are held in escrow pursuant to this Agreement and are not then subject to an
Unresolved Claim in respect of fraud; and

 

		(ii)	all,
but not less than all, of the Escrowed Shares held in escrow pursuant to this Agreement and are not then subject to an Unresolved
Claim.

 

		(d)	Upon
receipt by the Escrow Agent of Joint Instructions from time to time directing the release from escrow of Deposited Shares in accordance
with Sections 7(a), 7(b) or 7(c), the Escrow Agent is hereby irrevocably authorized and directed, in each case, to release, transfer
and deliver such Deposited Shares in accordance with Section 9(a).

  

		8.	Indemnification
Claims.

 

		(a)	If
Akerna or Exchangeco provides to the Shareholder Representative a Claim Notice on or before the Final Release Date and otherwise
in accordance with Section 6.3(a) of the Arrangement Agreement, Akerna or Exchangeco, as applicable, shall concurrently provide
a copy of the same Claim Notice to the Escrow Agent.

 

		(b)	If
in respect of any Claim Notice that has been received by the Escrow Agent on or before 5:00 p.m. (Eastern Standard Time) on the
Final Release Date, then the Escrow Agent shall hold the portion of the Deposited Shares that are subject to such Claim Notice
until the Escrow Agent receives either (i) Joint Instructions authorizing the release to Akerna and/or Exchangeco of all or any
portion of the Deposited Shares that are subject to such Claim Notice, or (ii) a Final Order directing the release to Akerna and/or
Exchangeco of all or any portion of the portion of the Deposited Shares that are subject to such Claim Notice. Within five (5)
Business Days after the Escrow Agent’s receipt of such Joint Instructions or Final Order, as the case may be, the Escrow
Agent shall release from escrow the portion of the Deposited Shares required to be released in accordance with such Joint Instructions
or Final Order.

 

		(c)	On
the Final Release Date, the Shareholder Representative and Akerna shall jointly provide a certificate to the Escrow Agent setting
forth the aggregate amount of all Unresolved Claims as of the Final Release Date based on all Claim Notices submitted in accordance
with this Agreement and the Arrangement Agreement prior to the Final Release Date.

 

    D-6

     

    

 

		(d)	Following
the Final Release Date, within five (5) Business Days after the Escrow Agent’s receipt of Joint Instructions or Final Order,
in either case, containing the final determination of any Unresolved Claims, the Escrow Agent shall (i) first, distribute from
the Deposited Shares to Akerna and/or Exchangeco an amount equal to the lesser of (A) such portion of the Deposited Shares to
be released to Akerna and/or Exchangeco pursuant to such Joint Instructions or Final Order, as the case may be, and (B) the portion
of the Deposited Shares remaining in escrow pursuant to this Agreement and available to satisfy such Claim at such time, and (ii)
second, after distributing any Deposited Shares pursuant to Section 8(d)(i), distribute from the Deposited Shares to the Ample
Shareholders the remaining amount of any Deposited Shares then held by the Escrow Agent.

 

		9.	Allocation
of Released Shares.

 

		(a)	All
Deposited Shares released by the Escrow Agent to the Ample Shareholders in accordance with the terms of this Agreement shall be
transferred to such Ample Shareholders in such proportions as the Shareholder Representative shall direct in writing, which direction
shall be provided by the Shareholder Representative to the Escrow Agent within two (2) Business Days of the date on which any
Deposited Shares are directed to be released to the Ample Shareholders pursuant to any Joint Instructions or Final Order.

 

		(b)	Upon
the release and transfer of Deposited Shares to Ample Shareholders pursuant to this Agreement, each of Akerna and Exchangeco shall
take all steps reasonably required to facilitate such transfer, including obtaining all approvals and consents, and executing
all such documents and instruments, as may be reasonably required to complete the release and transfer of Deposited Shares to
the Ample Shareholders (or any of them) in accordance with this Agreement.

 

		10.	Exchange
of Exchangeable Shares.

  

		(a)	During
such time as any Deposited Shares are held in escrow pursuant to this Agreement, neither the Escrow Agent nor the Shareholder
Representative shall be required to act upon or otherwise give effect to any request by any Ample Shareholder that the Escrow
Agent or Shareholder Representative request or otherwise cause the exchange of any Deposited Shares at the option or election
of the registered holder thereof for any shares in the capital of Akerna, whether pursuant to the Voting and Exchange Trust Agreement
or in accordance with the terms of Exchangeco Articles.

 

		(b)	If
at any time, Exchangeable Shares comprising part of the Deposited Shares subject to escrow hereunder are to be exchanged pursuant
to a call right granted to Akerna or any of its Affiliates pursuant to the Voting and Exchange Trust Agreement, the Plan of Arrangement
or the terms of Exchangeco Articles, Akerna shall notify the Escrow Agent in writing with a simultaneously delivered notice from
Akerna or its Affiliates with respect to the exercise of such call right. Subject to Section 10(c), the Escrow Agent shall deliver
the Akerna Shares to be issued in exchange for the Exchangeable Shares to the Person designated in the notice in the manner and
at the time and place specified in the notice. The terms and procedures for any such exchange shall be as set forth in the Plan
of Arrangement, the Exchangeco Articles and the Voting and Exchange Trust Agreement (copies of which have been delivered to the
Escrow Agent), as applicable.

 

		(c)	Within
five (5) Business Days following the exchange of any Deposited Shares for shares in the capital of Akerna (or any other Person)
pursuant to the exercise by Akerna or any of its Affiliates of any call right provided for the Plan of Arrangement, the Exchangeco
Articles or the Voting and Exchange Trust Agreement, Akerna and the Shareholder Representative shall deliver Joint Instructions
to the Escrow Agent instructing the Escrow Agent to release to the Ample Shareholders all but not less than all of the Deposited
Shares that are then held in escrow pursuant to this Agreement and are not then subject to an Unresolved Claim.

 

    D-7

     

    

 

		11.	Termination
of Escrow. Upon release and distribution by the Escrow Agent of all Deposited Shares and any other property subject to
escrow and/or distribution pursuant to this Agreement, this Agreement shall terminate, provided, however, that the termination
of this Agreement shall be without prejudice to any rights and obligations accrued prior to such termination and shall not in
any way limit the indemnification obligations of the Ample Shareholders as set out in the Arrangement Agreement.

 

		12.	Shareholder
Representative. The Shareholder Representative, or any successor hereafter appointed, shall be discharged of its duties
hereunder upon appointment of a successor Shareholder Representative appointed in accordance with applicable law. Each such successor
Shareholder Representative shall have all the power, authority, rights and privileges conferred upon the original Shareholder
Representative, and the term “Shareholder Representative” as used herein shall be deemed to include such successor
Shareholder Representative.

 

		13.	Responsibility
of the Escrow Agent; Indemnification.

 

		(a)	The
parties hereto acknowledge and agree that the Escrow Agent acts hereunder as a depositary only and (i) shall not be responsible
or liable in any manner whatsoever for the sufficiency, correctness, genuineness or validity of any instrument, statement, certificate,
request or other document deposited with it (including, without limitation, the Arrangement Agreement), for the form or execution
of such documents, for the identity, authority or right of any Person or party executing or depositing such instruments or for
determining or compelling compliance therewith, and shall not otherwise be bound thereby; (ii) shall be obligated only for
the performance of such duties as are expressly and specifically set forth in this Agreement on its part to be performed, and
no implied duties or obligations of any kind shall be read into this Agreement against or on the part of the Escrow Agent; (iii) shall
not be required to take notice of any default or to take any action with respect to such default; (iv) may rely on and shall
be protected in acting or refraining from acting upon any written notice, instruction (including, without limitation, wire transfer
instructions, whether incorporated herein or provided in a separate written instruction), instrument, statement, certificate,
request or other document furnished to it hereunder and believed by it to be genuine and to have been signed or presented by the
proper Person, and shall have no responsibility for determining the accuracy thereof; and, (v) may employ and consult counsel
satisfactory to it, including in-house counsel for any of the parties hereto, and the opinion of such counsel shall be full and
complete authorization and protection in respect of any action taken, suffered or omitted by it hereunder in good faith and in
accordance with the opinion of such counsel.

 

		(b)	The
Escrow Agent may employ such counsel, accountants, engineers, appraisers, other experts, agents, agencies and advisors as it may
reasonably require for the purpose of discharging its duties under this Agreement, and the Escrow Agent may act and shall be protected
in acting or not acting in good faith on the opinion or advice or on information obtained from any such parties and shall not
be responsible for any misconduct on the part of any of them. The reasonable costs of such services shall be added to and be part
of the Escrow Agent’s fee hereunder.

 

		(c)	The
Escrow Agent retains the right not to act and shall not be held liable for refusing to act unless it has received clear and reasonable
documentation which complies with the terms of this Agreement. Such documentation must not require the exercise of any discretion
or independent judgment.

 

		(d)	No
provision of this Agreement shall require the Escrow Agent to expend or risk its own funds or otherwise incur financial liability
in the performance of its duties or the exercise of any of its rights or powers unless indemnified and funded as provided for
herein, other than as a result of its own gross negligence or bad faith.

 

		(e)	The
Escrow Agent shall not be liable for any error of judgment, or for any act done or step taken or omitted by it in good faith,
or for any mistake of fact or law, or for anything which it may do or refrain from doing in connection herewith, except for its
own gross negligence or wilful misconduct.

 

    D-8

     

    

 

		(f)	The
Escrow Agent shall incur no liability with respect to the delivery or non-delivery of any cash or securities whether delivered
by hand, wire transfer, registered mail or bonded courier.

 

		(g)	The
forwarding of a cheque by the Escrow Agent will satisfy and discharge the liability for any cash amounts due to the extent of
the sum or sums represented thereby (plus the amount of any tax deducted or withheld as required by law) unless such cheque is
not honoured on presentation; provided that in the event of non-receipt of such cheque by the payee, or loss or destruction thereof,
the Escrow Agent upon being furnished with reasonable evidence of such non-receipt, loss or destruction and indemnity reasonably
satisfactory to it, will issue to such payee a replacement cheque for the amount of such cheque.

 

		(h)	Akerna
shall pay the costs and expenses reasonably incurred by the Escrow Agent’s services hereunder, in connection with the administration
of the escrow created hereby or the performance or observance of its duties hereunder; covered by the remuneration are included,
without limitation, all out-of-pocket expenses and disbursements incurred or made by the Escrow Agent in the administration of
its services and duties created hereby, in excess of its compensation for normal services or not (including the reasonable fees
and disbursements of its outside counsel and other outside advisors required for discharge of its duties hereunder). Any amount
owing under this Section 13(h) and unpaid thirty (30) days after request for such payment will bear interest from the expiration
of such thirty (30) days at a rate per annum equal to the then current rate charged by the Escrow Agent, payable on demand. The
Escrow Agent is not required to effect any partial or full release unless its fees and expenses are paid in full. The parties
hereto further agree that any residual fees or expenses incurred by the Escrow Agent after termination of the Agreement will be
reimbursed by Akerna.

 

		(i)	Akerna
agrees to indemnify the Escrow Agent and its officers, directors, employees, agents, successors and assigns and hold it and them
harmless from and against any loss, fee, claim, demand, penalty, liability, damage, cost and expense of any nature incurred by
the Escrow Agent and its officers, directors, employees, agents, successors and assigns arising out of or in connection with this
Agreement or with the administration of its duties hereunder, including but not limited to, reasonable attorneys’ fees and
other costs and expenses of defending or preparing to defend against any claim of liability, unless and except to the extent such
loss, liability, damage, cost and expense shall be caused by the Escrow Agent’s or its officers’, directors’,
employees’ agents’, successors’ or assigns’ gross negligence or wilful misconduct. The foregoing indemnification
and agreement to hold harmless shall survive the release of all property held in escrow pursuant to this Agreement, the resignation
or removal of the Escrow Agent or the termination of this Agreement. Notwithstanding the foregoing or any other provision of this
Agreement, any liability of the Escrow Agent shall be limited, in the aggregate, to the amount of annual retainer fees paid by
Akerna to the Escrow Agent under this Agreement in the twelve (12) months immediately prior to the Escrow Agent receiving the
first notice of the claim.

 

		(j)	Notwithstanding
any other provision of this Agreement, and whether such losses or damages are foreseeable or unforeseeable, the Escrow Agent shall
not be liable under any circumstances whatsoever for any: (i) breach by any other party of securities law or other rule of any
securities regulatory authority; (ii) lost profits; or (iii) special, indirect, incidental, consequential, exemplary, aggravated
or punitive losses or damages.

 

		(k)	The
Escrow Agent does not have any interest in the Deposited Shares but is serving as escrow agent only and having only possession
thereof.

 

    D-9

     

    

 

		(l)	The
Escrow Agent shall have no duties except those which are expressly set forth herein, and it shall not be bound by any notice of
a claim or demand with respect to, or any waiver, modification, amendment, termination or rescission of this Agreement, unless
received by it in writing, and signed by the parties hereto and if its duties herein are affected, unless it shall have given
its prior written consent thereto.

 

		(m)	The
Escrow Agent accepts the duties and responsibilities under this Agreement as agent and no trust is intended to be, or is or will
be, created hereby and the Escrow Agent shall owe no duties hereunder as trustee.

 

		(n)	The
Escrow Agent shall have no responsibility for seeking, obtaining, compiling, preparing or determining the accuracy of any information
or document, including the representative capacity in which a party purports to act, that the Escrow Agent receives as a condition
to a release from escrow or a transfer of the Deposited Shares or any other property subject to escrow.

 

		(o)	The
Escrow Agent shall have no responsibility for escrow securities that it has released to a securityholder or at a securityholder’s
direction according to this Agreement.

 

		(p)	The
Escrow Agent is authorized to hold such escrow securities in electronic or uncertificated form only, pending release of such
securities from escrow.

 

		(q)	The
Escrow Agent shall have no responsibility with respect to any escrow securities in respect of which no share certificate or other
evidence or electronic or uncertificated form of these securities has been delivered to it, or otherwise received by it.

 

		(r)	The
Escrow Agent shall have no responsibility or liability for any diminution in the value of any of the Deposited Shares or any securities
which may be deposited with it hereunder.

 

		(s)	This
Section 13 shall survive notwithstanding any termination of the Agreement or the resignation or removal of the Escrow Agent.

 

		14.	Dispute
Resolution. It is understood and agreed that should any dispute arise with respect to the delivery, ownership, right of
possession and/or disposition of the Deposited Shares or any other property subject to escrow hereunder, or should any claim be
made against the Escrow Agent or upon such shares by a third party, the Escrow Agent, upon receipt of notice of such dispute or
claim, is authorized and shall be entitled (at its sole option and election) to retain in its possession without liability, all
or any of said escrowed shares, until such dispute shall have been settled either by the mutual written agreement of the parties
involved, or by a final order, decree or judgment of a court or arbitrator of competent jurisdiction, the time for perfection
of an appeal of such order, decree or judgment having expired. A copy of any such settlement or final order, decree or judgment
of a court or arbitrator of competent jurisdiction shall be delivered to the Escrow Agent by Akerna and the Shareholder Representative
forthwith upon receipt thereof. The Escrow Agent may, but shall be under no duty whatsoever to, institute or defend any legal
proceedings which relate to the Deposited Shares or any other property subject to escrow hereunder. In the event that the Escrow
Agent shall become involved in any arbitration or litigation relating to the Deposited Shares or any other property subject to
escrow hereunder, the Escrow Agent is authorized to comply with any decision reached through such arbitration or litigation.

 

    D-10

     

    

 

		15.	Arbitration.
Any disputes with respect to this Agreement shall be resolved by arbitration and any party may demand by written notice to the
other party that the matter be submitted to arbitration. The notice shall set out the reasons for the dispute and reasonable details
to support the dispute. The parties hereto shall cooperate in completing any arbitration as expeditiously as possible, the procedure
to commence no later than thirty (30) days from the date the notice was sent, and the arbitrator may hire such experts as
may appear to be appropriate. All of the costs and expenses of the arbitration shall be borne equally by Akerna and the Shareholder
Representative. Any award rendered by the arbitrator shall be final and binding on the parties.

 

		16.	Resignation
of Escrow Agent; Successor by Merger.

 

		(a)	The
Escrow Agent may at any time resign as such, subject to this Section 16, by delivering written notice of resignation to the other
parties to this Agreement and by delivering all Deposited Shares subject to escrow (less any portion thereof previously distributed
in accordance with this Agreement) to any successor escrow agent designated by Akerna and the Shareholder Representative, jointly,
or by a court of competent jurisdiction, whereupon the Escrow Agent shall be discharged of and from any and all further obligations
arising in connection with this Agreement. The resignation of the Escrow Agent will take effect on the earlier to occur of (the
“Resignation Date”): (i) the appointment of a successor escrow agent as aforesaid or by a court of competent
jurisdiction; or (ii) the day which is thirty (30) days after the date of delivery of the Escrow Agent’s written notice
of resignation to the other parties hereto, or such shorter notice as the parties accept as sufficient. If the Escrow Agent has
not received written notice of the designation of a successor escrow agent by the Resignation Date, the Escrow Agent’s sole
responsibility after such time shall be to retain and safeguard the Deposited Shares and all other property subject to escrow
until receipt of written notice of the designation of a successor escrow agent hereunder or pursuant to a final non-appealable
order of a court of competent jurisdiction. If a successor escrow agent has not been appointed within ninety (90) days of the
date of the delivery of its written notice of resignation, the Escrow Agent shall deliver the Deposited Shares and all other property
subject to escrow (less any portion thereof previously distributed in accordance with this Agreement) to the legal counsel designated
by Akerna and the Shareholder Representative, jointly, and all of the Escrow Agent’s duties and obligations under this Agreement
shall thereupon cease immediately. Failing such designation by Akerna and the Shareholder Representative, jointly, the Escrow
Agent shall deliver such Deposited Shares to a court of competent jurisdiction directed to hold such shares for the benefit of
Akerna and the Shareholder Representative, whereupon this Agreement shall terminate and the Escrow Agent shall have no further
duties and obligations under this Agreement. Akerna and the Shareholder Representative, acting together, shall have power at any
time to remove the existing Escrow Agent and to appoint a successor escrow agent.

 

		(b)	If
any Deposited Shares and all other property subject to escrow or other property is to be released hereunder to a party who has
become bankrupt, has gone into liquidation or has otherwise become incapable of performing their rights and responsibilities under
this Agreement, the Escrow Agent shall forthwith deliver such shares to the estate and other representatives of such party. If
all of the parties hereunder have become bankrupt, have gone into liquidation or have otherwise become incapable of performing
their rights and responsibilities under this Agreement, the Escrow Agent shall forthwith deliver the Deposited Shares and all
other property subject to escrow to the estate and other representatives of such party, and provide written notice to all of the
other parties to this Agreement of the disposition of such shares. Upon such delivery of shares, this Agreement shall terminate
and the Escrow Agent shall have no further duties and obligations.

 

		(c)	In
the event of the Escrow Agent resigning or being removed as aforesaid or being dissolved, becoming bankrupt, going into liquidation
or otherwise becoming incapable of acting hereunder, Akerna and the Shareholder Representative, jointly, shall forthwith appoint
a successor escrow agent; failing such appointment by Akerna and the Shareholder Representative, the retiring Escrow Agent, acting
alone, may apply, at the expense of Akerna and the Shareholder Representative, jointly, to a justice of the Court on such notice
as such justice may direct, for the appointment of a successor escrow agent; but any successor escrow agent so appointed by the
Court shall be subject to removal as aforesaid.

 

    D-11

     

    

 

		(d)	Any
successor escrow agent appointed under any provision of this Section 16 shall be a corporation authorized to carry on the business
of a trust company in the Province of Ontario and, if required by the applicable legislation for any other jurisdiction, in such
other jurisdictions. On any such appointment, the successor escrow agent shall be vested with the same powers, rights, duties
and responsibilities as if it had been originally named herein as Escrow Agent hereunder. At the request of Akerna and the Shareholder
Representative, or the successor escrow agent, the retiring Escrow Agent, upon payment of the amounts, if any, due to it pursuant
to this Agreement, including any amounts owing to it in respect to outstanding fees, disbursements and interest thereon, shall
duly assign, transfer and deliver to the successor escrow agent all property and money held, and all records kept, by the retiring
Escrow Agent hereunder or in connection herewith.

 

		(e)	Any
corporation into or with which the Escrow Agent may be merged or consolidated or amalgamated, or any corporation resulting therefrom
to which the Escrow Agent shall be a party, or any corporation succeeding to all or substantially all of the corporate trust business
of the Escrow Agent shall be the successor to the Escrow Agent hereunder without any further act on its part or any of the parties
hereto, provided that such corporation would be eligible for appointment as a successor escrow agent hereunder.

 

		17.	Anti-money
Laundering.

 

		(a)	Each
party to this Agreement (in this paragraph referred to as a “representing party”), other than the Escrow Agent,
hereby represents to the Escrow Agent that any account to be opened by, or interest to held by, the Escrow Agent in connection
with this Agreement, for or to the credit of such representing party, either: (i) is not intended to be used by or on behalf of
any third party (other than an Ample Shareholder); or (ii) is intended to be used by or on behalf of a third party, in which case
such representing party hereby agrees to complete, execute and deliver forthwith to the Escrow Agent a declaration, in the Escrow
Agent’s prescribed form or in such other form as may be satisfactory to it, as to the particulars of such third party (other
than an Ample Shareholder).

 

		(b)	The
Escrow Agent shall retain the right not to act and shall not be liable for refusing to act if, due to a lack of information or
for any other reason whatsoever, the Escrow Agent, in its sole judgment, determines that such act might cause it to be in non-compliance
with any applicable anti-money laundering, anti-terrorist or economic sanctions legislation, regulation or guideline. Further,
should the Escrow Agent, in its sole judgment, determine at any time that its acting under this Agreement has resulted in its
being in non-compliance with any applicable anti-money laundering, anti-terrorist or economic sanctions legislation, regulation
or guideline, then it shall have the right to resign on ten (10) days written notice to the other parties to this Agreement, provided:
(i) that the Escrow Agent’s written notice shall describe the circumstances of such non-compliance; and (ii) that if such
circumstances are rectified to the Escrow Agent’s satisfaction within such ten (10) day period, then such resignation shall
not be effective.

 

		18.	Privacy.
The parties acknowledge that the Escrow Agent may, in the course of providing services hereunder, collect or receive financial
and other personal information about such parties and/or their representatives, as individuals, or about other individuals related
to the subject matter hereof, and use such information for the following purposes:

 

		(a)	to
provide the services required under this Agreement and other services that may be requested from time to time;

  

		(b)	to
help the Escrow Agent manage its servicing relationships with such individuals;

 

    D-12

     

    

 

		(c)	to
meet the Escrow Agent’s legal and regulatory requirements; and

 

		(d)	if
Social Insurance Numbers are collected by the Escrow Agent, to perform tax reporting and to assist in verification of an individual’s
identity for security purposes.

 

		(e)	Each
party acknowledges and agrees that the Escrow Agent may receive, collect, use and disclose personal information provided to it
or acquired by it in the course of this Agreement for the purposes described above and, generally, in the manner and on the terms
described in its privacy policies, which the Escrow Agent shall make available on its website, [•], or upon request, including
revisions thereto. The Escrow Agent may transfer personal information to other companies in or outside of Canada that provide
data processing and storage or other support in order to facilitate the services it provides.

 

		19.	Notices.
Any notice, direction or other communication given under this Agreement shall be in writing and given by delivering it or sending
it by personal delivery, nationally recognized overnight courier (with all fees prepaid), email (with confirmation of transmission)
or certified or registered mail (in each case, return receipt requested, postage prepaid), addressed:

 

	 	to Akerna and Exchangeco at:	 
	 	 	 
	 	Akerna Corp.
	 	1601 Arapahoe Street 
	 	Denver, CO 80202
	 	 	 
	 	Attention:	Scott Sozio, President
	 	Email:	Scott.sozio@akerna.com
	 	 	 
	 	With a copy to Dentons Canada LLP (which copy shall not constitute notice hereunder) at:
	 	 
	 	Dentons Canada LLP 
	 	15th Floor, Bankers Court, 850 – 2nd Street S.W. 
	 	Calgary, Alberta T2P 0R8
	 	 	 
	 	Attention:	Courtney Burton
	 	Email:	courtney.burton@dentons.com
	 	 	 
	 	to the Shareholder Representative at:	 
	 	 	 
	 	John Prentice
	 	14A Bingham Ave.
	 	Toronto, ON M4E 3P9
	 	 	 
	 	Attention:	John Prentice
	 	Email:	john.prentice@ampleorganics.com

 

    D-13

     

    

 

	 	 
	With a copy to Dentons Canada LLP (which copy shall not constitute notice hereunder) at:
	 
	Dentons Canada LLP
	77 King Street West, Suite 400
	Toronto-Dominion Centre
	Toronto, Ontario M5K 0A1
	 	 
	Attention:	Eric Foster
	Email:	Eric.foster@dentons.com
	 	 
	to the Escrow Agent at:	 
	 	 
	Continental Stock Transfer & Trust Company, Inc.
	[Address]
	 	 
	Attention:	[l]
	Email:	[l]

 

Any
such communication shall be deemed to have been validly and effectively given and received (a) if sent by personal delivery or
by courier (all fees prepaid) on the date of actual receipt by the receiving party; (b) if sent by email on the date of transmission
if a Business Day or if not a Business Day or after 5:00 p.m. (Eastern Standard Time) on the date of transmission, on the
next following Business Day; or (c) if sent by certified or registered mail (postage prepaid) on the date indicated in the return
receipt. Any party to this Agreement may change its address for service from time to time by notice given in accordance with the
foregoing and any subsequent notice shall be sent to such party at its changed address.

 

		20.	Miscellaneous.

 

		(a)	This
Agreement may be executed in any number of counterparts and any party hereto may execute any such counterpart by facsimile (followed
by the originally executed document forwarded promptly thereafter to the other party hereto), each of which when executed and
delivered shall be deemed to be an original and all of which counterparts taken together shall constitute but one and the same
instrument. This Agreement shall become binding when one or more counterparts taken together shall have been executed and delivered
by all of the parties. It shall not be necessary in making proof of this Agreement or any counterpart hereof to produce or account
for any of the other counterparts.

 

		(b)	This
Agreement or any provision hereof may be amended or waived only by written instrument duly signed by the party against whom such
amendment or waiver is sought to be enforced.

 

		(c)	No
waiver of any of the provisions of this Agreement shall be deemed to constitute a waiver of any other provision (whether or not
similar), nor shall such waiver be binding unless executed in writing by the party to be bound by the waiver.

 

		(d)	No
failure on the part of Akerna, Exchangeco or the Shareholder Representative to exercise, and no delay in exercising, any right
under this Agreement shall operate as a waiver of such right; nor shall any single or partial exercise of any such right preclude
any other or further exercise of such right or the exercise of any other right.

 

		(e)	If
one or more of the provisions hereof shall for any reason be held to be invalid, illegal or unenforceable in any respect under
applicable law, such invalidity, illegality or unenforceability shall not affect any other provision hereof, and this Agreement
shall be construed as if such invalid, illegal or unenforceable provision had never been contained herein, and the remaining provisions
hereof shall remain in full force and effect.

 

    D-14

     

    

 

		(f)	This
Agreement is for the sole and exclusive benefit of the parties hereto, and nothing in this Agreement, express or implied, is intended
to confer or shall be construed as conferring upon any other Person any rights, remedies or any other type or types of benefits.

 

		(g)	No
party may assign its rights hereunder without the prior written consent of the other parties.

 

		(h)	This
Agreement shall enure to the benefit of, and be binding upon, the parties hereto and their respective successors and permitted
assigns.

 

		(i)	This
Agreement shall be governed by and interpreted and enforced in accordance with the laws of the Province of Ontario and the federal
laws of Canada applicable therein.

 

		(j)	The
Schedules attached to this Agreement shall, for all purposes of this Agreement, form an integral part of it. This Agreement shall
override the Schedules attached hereto to the extent of any inconsistency.

 

		(k)	Any
reference to time of day or date means the local time or date in Toronto, Ontario, Canada.

 

		21.	Force
Majeure. Except for the payment obligations of Akerna contained herein, none of the parties shall be liable to the other,
or held in breach of this Agreement, if prevented, hindered, or delayed in the performance or observance of any provision contained
herein by reason of act of God, strikes, lockouts, riots, terrorism, acts of war, epidemics, governmental action or judicial order,
earthquakes, or any other similar causes (including, but not limited to, mechanical, electronic or communication interruptions,
disruptions or failures). Performance times under this Agreement shall be extended for a period of time equivalent to the time
lost because of any delay that is excusable under this Section 21.

 

		22.	Interpretation.

 

		(a)	The
division of this Agreement into Sections, subsections and other portions and the insertion of headings are for convenience of
reference only and will not affect the construction or interpretation hereof. Unless otherwise indicated, all references to a
“Section” followed by a number and/or a letter refer to the specified Section or subsection of this Agreement.

 

		(b)	Unless
the context otherwise requires, in this Agreement, words importing the singular number include the plural and vice versa,
and words importing the use of any gender include all genders. If a word is defined in this Agreement a grammatical derivative
of that word will have a corresponding meaning. The words “include”, “includes” and “including”
shall be deemed to be followed by the words “without limitation”.

 

		(c)	Whenever
any payment shall be due, any period of time shall begin or end, any calculation is to be made or any other action is to be taken
on, or as of, or from a period ending on, a day other than a Business Day, such payment shall be made, such period of time shall
begin or end, and such other actions shall be taken, as the case may be, on, or as of, or from a period ending on, the next succeeding
Business Day.

 

		(d)	All
sums of money that are referred to in this Agreement are expressed in lawful money of Canada unless otherwise noted.

 

    D-15

     

    

 

IN
WITNESS WHEREOF, the parties hereto have executed this Agreement to be effective as of the date first above written.

 

	 	AKERNA
    CORP.
	 	 	 
	 	By:	 
	 	 	Authorized Signing Officer
	 	 	 
	 	2732805
    ONTARIO INC.
	 	 	 
	 	By:	 
	 	 	Authorized Signing Officer
	 	 	 
	 	 
	 	John Prentice, in his capacity as Shareholder Representative
	 	 	 
	 	CONTINENTAL STOCK TRANSFER & TRUST COMPANY, INC.
	 	 	 
	 	By:	 
	 	 	Authorized Signing Officer

 

[Share Escrow Agreement]

    D-16

     

    

 

SCHEDULE A

 

Form of Joint Instruction

 

 

 

 

Date:
●, 200●

 

		TO:	Continental
Stock Transfer & Trust Company, Inc. (“Escrow Agent”)

 

Pursuant
to the Escrow Agreement entered into as of l, 2020 by and among Akerna Corp. (“Akerna”), 2732805 Ontario Inc.
(“Exchangeco”), John Prentice (“Shareholder Representative”) and the Escrow Agent (the “Escrow
Agreement”), you are hereby instructed to release out of the Deposited Shares (as defined in the Escrow Agreement),
the following amount of shares: ____________________________.

 

	 	AKERNA CORP.
	 	 	 
	 	By:	 
	 	 	Authorized Signing Officer
	 	 	 
	 	2732805 ONTARIO INC.
	 	 	 
	 	By:	 
	 	 	Authorized Signing Officer
	 	 	 
	 	 
	 	John Prentice, in his capacity as Shareholder Representative

 

    D-17

     

    

  

SCHEDULE “E”

FORM
OF

VOTING AND EXCHANGE TRUST AGREEMENT

 

THIS
VOTING AND EXCHANGE TRUST AGREEMENT made as of [●] among Akerna Corp., a corporation existing under the laws of the
State of Delaware (“Akerna”), 2732804 Ontario Inc., a corporation existing under the laws of the Province of
Ontario (“Callco”), 2732805 Ontario Inc., a corporation existing under the laws of the Province of Ontario (“Exchangeco”),
and Continental Stock Transfer & Trust Company (the “Trustee”).

 

RECITALS:

 

		A.	In connection with an arrangement agreement (the “Arrangement Agreement”) dated
December 18, 2019 among Akerna, Exchangeco and Ample Organics Inc. (“Ample”), Exchangeco is to issue exchangeable
shares (the “Exchangeable Shares”) to certain holders of common shares and Class A Preferred Shares of Ample pursuant
to an arrangement under the Business Corporations Act (Ontario) on the terms and conditions set out in the Plan of Arrangement
(as defined in the Arrangement Agreement).

 

		B.	Pursuant to the Arrangement Agreement, Akerna, Callco and Exchangeco are required to enter into
a voting and exchange trust agreement (the “Agreement”) substantially in the form of this Agreement.

 

		C.	These recitals and any statements of fact in this Agreement are made by Akerna, Callco and Exchangeco
and not by the Trustee.

 

In consideration of the foregoing and the
mutual agreements contained herein and for other good and valuable consideration (the receipt and sufficiency of which are hereby
acknowledged), the parties agree as follows:

 

Article
1

DEFINITIONS AND INTERPRETATION

 

		1.1	Definitions

 

In this Agreement, each capitalized term
used and not otherwise defined herein shall have the meaning ascribed thereto in the rights, privileges, restrictions and conditions
(collectively, the “Exchangeable Share Provisions”) attaching to the Exchangeable Shares as set out in the articles
of Exchangeco and the following terms shall have the following meanings:

 

“1933 Act” has
the meaning ascribed thereto in Section 5.10;

 

“Agreement”
has the meaning ascribed thereto in Recital B;

 

“Akerna” has
the meaning ascribed thereto in the introductory paragraph;

 

“Akerna Consent”
has the meaning ascribed thereto in Section 4.2;

 

“Akerna Meeting”
has the meaning ascribed thereto in Section 4.2;

 

“Akerna Successor”
has the meaning ascribed thereto in Section 10.1(a);

 

“Ample” has
the meaning ascribed thereto in the introductory paragraph;

 

“Arrangement Agreement”
has the meaning ascribed thereto in Recital A;

 

    E-1

     

    

 

“Automatic Exchange Right”
has the meaning ascribed thereto in Section 5.12(2);

 

“Beneficiaries”
means the registered holders from time to time of Exchangeable Shares, other than Akerna and its affiliates;

 

“Beneficiary Votes”
has the meaning ascribed thereto in Section 4.2;

 

“Callco” has
the meaning ascribed thereto in the introductory paragraph;

 

“Change of Law Call Right”
has the meaning ascribed thereto in the Plan of Arrangement;

 

“Equivalent Vote Amount”
means, with respect to any matter, proposition, proposal or question on which holders of Akerna Shares are entitled to vote, consent
or otherwise act, the number of votes to which a holder of one Akerna Share is entitled with respect to such matter, proposition
or question;

 

“Escrow Agreement”
means the escrow agreement substantially in the form of Schedule D of the Arrangement Agreement;

 

“Exchange Right”
has the meaning ascribed thereto in Section 5.1;

 

“Exchangeable Shares”
has the meaning ascribed thereto in Recital A;

 

“Exchangeco”
has the meaning ascribed thereto in the introductory paragraph;

 

“Indemnified Parties”
has the meaning ascribed thereto in Section 8.1;

 

“Insolvency Event”
means: (i) the institution by Exchangeco of any proceeding to be adjudicated a bankrupt or insolvent or to be dissolved or wound
up, or the consent of Exchangeco to the institution of bankruptcy, insolvency, dissolution or winding-up proceedings against it;
(ii) the filing by Exchangeco of a petition, answer or consent seeking dissolution or winding-up under any bankruptcy, insolvency
or analogous laws, including the Companies Creditors’ Arrangement Act (Canada) and the Bankruptcy and Insolvency Act
(Canada), or the failure by Exchangeco to contest in good faith any such proceedings commenced in respect of Exchangeco within
30 days of becoming aware thereof, or the consent by Exchangeco to the filing of any such petition or to the appointment of a receiver;
(iii) the making by Exchangeco of a general assignment for the benefit of creditors, or the admission in writing by Exchangeco
of its inability to pay its debts generally as they become due; or (iv) Exchangeco not being permitted, pursuant to solvency requirements
of applicable law, to redeem any Retracted Shares pursuant to Section 6(a)(iii) of the Exchangeable Share Provisions specified
in a retraction request delivered to Exchangeco in accordance with Section 6 of the Exchangeable Share Provisions;

 

“Liquidation Event”
has the meaning ascribed thereto in Section 5.12(1)(a);

 

“Liquidation Event Effective
Date” has the meaning ascribed thereto in Section 5.12(2);

 

“List” has the
meaning ascribed thereto in Section 4.6;

 

“Officer’s Certificate”
means, with respect to Akerna, Callco or Exchangeco, a certificate signed by any one of the respective directors or officers of
Akerna, Callco or Exchangeco;

 

“Other Corporation”
has the meaning ascribed thereto in Section 10.4(c);

 

“Other Shares”
has the meaning ascribed thereto in Section 10.4(c);

 

    E-2

     

    

 

“Privacy Laws”
has the meaning ascribed thereto in Section 6.18;

 

“Put Right”
has the meaning ascribed thereto in Section 5.1(1).

 

“Registration Statement”
has the meaning ascribed thereto in Section 5.10;

 

“Retracted Shares”
has the meaning ascribed thereto in Section 5.7;

 

“Special Voting Share”
means the special voting share in the capital of Akerna, issued by Akerna to and deposited with the Trustee, which, at any time,
entitles the holder of record to that number of votes at meetings of holders of Akerna Shares equal to the number of Exchangeable
Shares outstanding at such time (excluding Exchangeable Shares held by Akerna and its affiliates);

 

“Support Agreement”
means the support agreement dated the date hereof between Akerna, Callco and Exchangeco, substantially in the form of Schedule
E to the Arrangement Agreement;

 

“Trust” means
the trust created by this Agreement under the laws of the Province of Ontario;

 

“Trust Estate”
means the Special Voting Share, any other securities, the Exchange Right, the Put Right, the Automatic Exchange Right and any money
or other property which may be held by the Trustee from time to time pursuant to this Agreement;

 

“Trustee” has
the meaning ascribed thereto in the introductory paragraph; and

 

“Voting Rights”
means the voting rights attached to the Special Voting Share.

 

		1.2	Interpretation Not Affected by Headings

 

The division of this Agreement into Articles,
Sections, subsections and paragraphs and the insertion of headings are for convenience of reference only and shall not affect in
any way the meaning or interpretation of this Agreement. Unless the contrary intention appears, references in this Agreement to
an Article, Section, subsection, paragraph or Schedule by number or letter or both refer to the Article, Section, subsection, paragraph
or Schedule, respectively, bearing that designation in this Agreement.

 

		1.3	Number, Gender, etc.

 

In this Agreement, unless the contrary
intention appears, words importing the singular include the plural and vice versa, and words importing gender shall include all
genders.

 

		1.4	Date for any Action

 

If the date on which any action is required
to be taken hereunder by any person is not a Business Day, such action shall be required to be taken on the next succeeding day
which is a Business Day.

 

		1.5	Currency

 

Unless otherwise stated, all references
in this Agreement to sums of money are expressed in lawful money of Canada and “$” refers to Canadian dollars.

 

		1.6	Statutes

 

Any reference to a statute refers to such
statute and all rules and regulations made under it, as it or they may have been or may from time to time be amended or re-enacted,
unless stated otherwise.

 

    E-3

     

    

 

Article
2

PURPOSE OF AGREEMENT

 

		2.1	Establishment of Trust

 

The purpose of this Agreement is to create
the Trust for the benefit of the Beneficiaries as herein provided. Akerna, as the settlor of the Trust, hereby appoints the Trustee
as trustee of the Trust. The Trustee shall hold the Special Voting Share in order to enable the Trustee to exercise the Voting
Rights and shall hold the Exchange Right, the Put Right and the Automatic Exchange Right in order to enable the Trustee to exercise
or enforce such rights, in each case as trustee for and on behalf of the Beneficiaries as provided in this Agreement.

 

Article
3

SPECIAL VOTING SHARE

 

		3.1	Issue and Ownership of the Special Voting Share

 

Immediately following execution and delivery
of this Agreement, Akerna shall issue to and deposit with the Trustee the Special Voting Share (and shall deliver the certificate
representing such share to the Trustee) to be hereafter held of record by the Trustee as trustee for and on behalf of, and for
the use and benefit of, the Beneficiaries and in accordance with the provisions of this Agreement. Akerna hereby acknowledges receipt
from the Trustee, as trustee for and on behalf of the Beneficiaries, of $1.00 and other good and valuable consideration (and the
adequacy thereof) for the issuance of the Special Voting Share by Akerna to the Trustee. During the term of the Trust, and subject
to the terms and conditions of this Agreement, the Trustee shall possess and be vested with full legal ownership of the Special
Voting Share and shall be entitled to exercise all of the rights and powers of an owner with respect to the Special Voting Share;
provided, however, that:

 

		(a)	the Trustee shall hold the Special Voting Share and the legal title thereto as trustee solely for
the use and benefit of the Beneficiaries in accordance with the provisions of this Agreement; and

 

		(b)	except as specifically authorized by this Agreement, the Trustee shall have no power or authority
to sell, transfer, vote or otherwise deal in or with the Special Voting Share and the Special Voting Share shall not be used or
disposed of by the Trustee for any purpose (including for exercising dissent or appraisal rights relating to the Special Voting
Share) other than the purposes for which this Trust is created pursuant to this Agreement.

 

		3.2	Legended Share Certificates

 

Exchangeco shall cause each certificate
representing Exchangeable Shares to bear a legend notifying the Beneficiary of such shares of his, her or its right to instruct
the Trustee with respect to the exercise of that portion of the Voting Rights which corresponds to the number of Exchangeable Shares
held by each such Beneficiary.

 

		3.3	Safe Keeping of Certificate

 

The certificate representing the Special
Voting Share shall at all times be held in safe keeping by the Trustee or its duly authorized agent.

 

    E-4

     

    

 

Article
4

EXERCISE OF VOTING RIGHTS

 

		4.1	Voting Rights

 

The Trustee, as the holder of record of
the Special Voting Share, shall be entitled to exercise all of the Voting Rights, including the right to consent to or vote in
person or by proxy the Special Voting Share, on any matter, question, proposal or proposition whatsoever that may properly come
before the shareholders of Akerna at an Akerna Meeting or in connection with an Akerna Consent. The Voting Rights shall be and
remain vested in and exercisable by the Trustee on behalf of the Beneficiaries as provided in this Agreement. Subject to Section
6.15:

 

		(a)	the Trustee shall exercise the Voting Rights only on the basis of instructions received pursuant
to this Article 4 from Beneficiaries on the record date established by Akerna or by applicable law for such Akerna Meeting or Akerna
Consent who are entitled to instruct the Trustee as to the voting thereof;

 

		(b)	to the extent that no instructions are received from a Beneficiary with respect to the Voting Rights
in respect of which such Beneficiary is entitled to instruct the Trustee, the Trustee shall not exercise or permit the exercise
of such Voting Rights; and

 

		(c)	without prejudice to paragraph (b) above, under no circumstances shall the Trustee exercise or
permit the exercise of a number of Voting Rights which is greater than the number of Exchangeable Shares outstanding at the relevant
time.

 

		4.2	Number of Votes

 

With respect to all meetings of shareholders
of Akerna at which holders of Akerna Shares are entitled to vote (each, an “Akerna Meeting”) and with respect
to all written consents sought by Akerna from holders of Akerna Shares (each, an “Akerna Consent”), each Beneficiary
shall be entitled to instruct the Trustee to cast and exercise, in the manner instructed, that number of votes equal to the Equivalent
Vote Amount for each Exchangeable Share owned of record by such Beneficiary at the close of business on the record date established
by Akerna or by applicable law for such Akerna Meeting or Akerna Consent, as the case may be (collectively, the “Beneficiary
Votes”), in respect of each matter, question, proposal or proposition to be voted on at such Akerna Meeting or consented
to in connection with such Akerna Consent.

 

		4.3	Mailings to Shareholders

 

		(1)	With respect to each Akerna Meeting or Akerna Consent, the Trustee will mail or cause to be mailed
(or otherwise communicate in the same manner as Akerna utilizes in communications to holders of Akerna Shares, subject to applicable
regulatory requirements and to the Trustee being advised in writing of such manner of communications and provided that such manner
of communications is reasonably available to the Trustee) to each Beneficiary named in the applicable List on the same day as the
mailing (or other communication) with respect thereto is commenced by Akerna to its shareholders:

 

		(a)	a copy of such mailing, together with any related materials, including, without limitation, any
proxy circular or information statement or listing particulars, to be provided to shareholders of Akerna;

 

		(b)	a statement that such Beneficiary is entitled to instruct the Trustee as to the exercise of the
Beneficiary Votes with respect to such Akerna Meeting or Akerna Consent or, pursuant to Section 4.7, to attend such Akerna Meeting
and to exercise personally the Beneficiary Votes thereat;

 

		(c)	a statement as to the manner in which such instructions may be given to the Trustee, including
an express indication that instructions may be given to the Trustee to give: (A) a proxy to such Beneficiary or his, her or its
designee to exercise personally such holder’s Beneficiary Votes; or (B) a proxy to a designated agent or other representative of
Akerna to exercise such holder’s Beneficiary Votes;

 

    E-5

     

    

 

		(d)	a statement that if no such instructions are received from such Beneficiary, the Beneficiary Votes
to which the Beneficiary is entitled will not be exercised;

 

		(e)	a form of direction such Beneficiary may use to direct and instruct the Trustee as contemplated
herein; and

 

		(f)	a statement of: (A) the time and date by which such instructions must be received by the Trustee
in order for such instructions to be binding upon the Trustee, which in the case of an Akerna Meeting shall not be earlier than
the close of business on the Business Day immediately prior to the date by which Akerna has required proxies to be deposited for
such meeting; and (B) of the method for revoking or amending such instructions.

 

		(2)	The materials referred to in this Section 4.3 shall be provided to the Trustee by Akerna, and the
materials referred to in Sections 4.3(1)(b), 4.3(1)(c), 4.3(1)(d), 4.3(1)(e) and 4.3(1)(f) shall (if reasonably practicable to
do so) be subject to reasonable comment by the Trustee in a timely manner. Subject to the foregoing, Akerna shall ensure that the
materials to be provided to the Trustee are provided in sufficient time to permit the Trustee to comment as aforesaid and to send
all materials to each Beneficiary at the same time as such materials are first sent to holders of Akerna Shares. Akerna agrees
not to communicate with holders of Akerna Shares with respect to the materials referred to in this Section 4.3 otherwise than by
mail unless such method of communication is also reasonably available to the Trustee for communication with the Beneficiaries.
Notwithstanding the foregoing, Akerna may, at its option, exercise the duties of the Trustee to deliver copies of all materials
to all Beneficiaries as required by this Section 4.3 so long as, in each case, Akerna delivers a certificate to the Trustee stating
that Akerna has undertaken to perform the obligations of the Trustee set forth in this Section 4.3.

 

		(3)	For the purpose of determining the number of Beneficiary Votes to which a Beneficiary is entitled
in respect of any Akerna Meeting or Akerna Consent, the number of Exchangeable Shares owned of record by the Beneficiary shall
be determined at the close of business on the record date established by Akerna or by applicable law for purposes of determining
shareholders entitled to vote at such Akerna Meeting or in respect of such Akerna Consent. Akerna shall notify the Trustee of any
decision of the board of directors of Akerna with respect to the calling of any Akerna Meeting or any Akerna Consent and shall
provide all necessary information and materials to the Trustee in each case promptly and, in any event, in sufficient time to enable
the Trustee to perform the obligations of the Trustee set forth in this Section 4.3.

 

		4.4	Copies of Shareholder Information

 

Akerna
shall deliver to the Trustee copies of all proxy materials (including, without limitation, notices of Akerna Meetings but excluding
proxies to vote Akerna Shares), information statements, reports (including, without limitation, all interim and annual financial
statements) and other written communications that, in each case, are to be distributed by Akerna from time to time to holders of
Akerna Shares in sufficient quantities and in sufficient time so as to enable the Trustee to send or cause to send those materials
to each Beneficiary at the same time as such materials are first sent to holders of Akerna Shares. The Trustee shall mail or otherwise
send to each Beneficiary, at the expense of Akerna, copies of all such materials (and all materials specifically directed to the
Beneficiaries or to the Trustee for the benefit of the Beneficiaries by Akerna) received by the Trustee from Akerna contemporaneously
with the sending of such materials to holders of Akerna Shares. The Trustee shall also make available for inspection during regular
business hours by any Beneficiary at the Trustee’s principal office in [●]
all proxy materials, information statements, reports and other written communications that are:

 

		(a)	received by the Trustee as the registered holder of the Special Voting Share and made available
by Akerna generally to the holders of Akerna Shares; or

 

    E-6

     

    

 

		(b)	specifically directed to the Beneficiaries or to the Trustee for the benefit of the Beneficiaries
by Akerna.

 

Notwithstanding the foregoing, Akerna may,
at its option, exercise the duties of the Trustee to deliver copies of all such materials to all Beneficiaries as required by this
Section 4.4 so long as, in each case, Akerna delivers a certificate to the Trustee stating that Akerna has undertaken to perform
the obligations of the Trustee set forth in this Section 4.4.

 

		4.5	Other Materials

 

As
soon as reasonably practicable after receipt by Akerna or shareholders of Akerna (if such receipt is known by Akerna) of any material
sent or given by or on behalf of a third party to holders of Akerna Shares generally, including dissident proxy and information
circulars (and related information and material) and take-over bid and securities exchange take-over bid circulars (and related
information and material), provided such material has not been sent to the Beneficiaries by or on behalf of such third party, Akerna
shall obtain and deliver to the Trustee copies thereof in sufficient quantities so as to enable the Trustee to forward such material
(unless the same has been provided directly to Beneficiaries by such third party) to each Beneficiary as soon as possible thereafter.
As soon as reasonably practicable after receipt thereof, the Trustee shall mail or otherwise send to each Beneficiary, at the expense
of Akerna, copies of all such materials received by the Trustee from Akerna. The Trustee shall also make available for inspection
during regular business hours by any Beneficiary at the Trustee’s principal office in [●]
copies of all such materials. Notwithstanding the foregoing, Akerna may, at its option, exercise the duties of the Trustee to deliver
copies of all such materials to all Beneficiaries as required by this Section 4.5 so long as, in each case, Akerna delivers a certificate
to the Trustee stating that Akerna has undertaken to perform the obligations of the Trustee set forth in this Section 4.5.

 

		4.6	List of Persons Entitled to Vote

 

Exchangeco shall: (a) prior to each annual
or other Akerna Meeting or the seeking of any Akerna Consent; and (b) forthwith upon each request made at any time by the Trustee
in writing, prepare or cause to be prepared a list (a “List”) of the names and addresses of the Beneficiaries
arranged in alphabetical order and showing the number of Exchangeable Shares held of record by each such Beneficiary, in each case
at the close of business on the date specified by the Trustee in such request or, in the case of a List prepared in connection
with an Akerna Meeting or Akerna Consent, at the close of business on the record date established by Akerna or pursuant to applicable
law for determining the holders of Akerna Shares entitled to receive notice of and/or to vote at such Akerna Meeting or to give
consent in connection with an Akerna Consent. Each such List shall be delivered to the Trustee promptly after receipt by Exchangeco
of such request or the record date for such meeting or seeking of consent, as the case may be, and, in any event, within sufficient
time as to permit the Trustee to perform its obligations under this Agreement. Akerna agrees to give Exchangeco notice (with a
copy to the Trustee) of the calling of any Akerna Meeting or the seeking of any Akerna Consent, together with the record date therefor,
sufficiently prior to the date of the calling of such meeting or seeking of such consent, so as to enable Exchangeco to perform
its obligations under this Section 4.6.

 

		4.7	Entitlement to Direct Votes

 

Subject to Section 4.8 and Section 4.11,
any Beneficiary named in a List prepared in connection with any Akerna Meeting or Akerna Consent shall be entitled to: (a) instruct
the Trustee in the manner described in Section 4.2 with respect to the exercise of the Beneficiary Votes to which such Beneficiary
is entitled; (b) attend such meeting and personally exercise thereat (or to exercise with respect to any written consent), as the
proxy of the Trustee, the Beneficiary Votes to which such Beneficiary is entitled; or (c) appoint a third party as the proxy of
the Trustee to attend such meeting and exercise thereat the Beneficiary Votes to which such Beneficiary is entitled except, in
each case, to the extent that such Beneficiary has transferred the ownership of any Exchangeable Shares in respect of which such
Beneficiary is entitled to Beneficiary Votes after the close of business on the record date for such meeting or seeking of consent.

 

    E-7

     

    

 

		4.8	Voting by Trustee and Attendance of Trustee Representative at Meeting

 

		(1)	In connection with each Akerna Meeting and Akerna Consent, the Trustee shall exercise, either in
person or by proxy, in accordance with the instructions received from a Beneficiary pursuant to Section 4.2, the Beneficiary Votes
as to which such Beneficiary is entitled to direct the vote (or any lesser number thereof as may be set forth in the instructions)
other than any Beneficiary Votes that are the subject of Section 4.8(2); provided, however, that such written instructions are
received by the Trustee from the Beneficiary prior to the time and date fixed by the Trustee for receipt of such instruction in
the notice given by the Trustee to the Beneficiary pursuant to Section 4.3.

 

		(2)	To the extent so instructed in accordance with the terms of this Agreement, the Trustee shall cause
a representative who is empowered by it to sign and deliver, on behalf of the Trustee, proxies for Voting Rights enabling a Beneficiary
to attend an Akerna Meeting. Upon submission by a Beneficiary (or its designee) named in the List prepared in connection with the
relevant meeting of identification satisfactory to the Trustee’s representative, and at the Beneficiary’s request, such representative
shall sign and deliver to such Beneficiary (or its designee) a proxy to exercise personally the Beneficiary Votes as to which such
Beneficiary is otherwise entitled hereunder to direct the vote, if such Beneficiary either: (i) has not previously given the Trustee
instructions pursuant to Section 4.3 in respect of such meeting; or (ii) submits to such representative written revocation of any
such previous instructions. At such meeting, the Beneficiary (or its designee) exercising such Beneficiary Votes in accordance
with such proxy shall have the same rights in respect of such Beneficiary Votes as the Trustee to speak at the meeting in favour
of any matter, question, proposal or proposition, to vote by way of ballot at the meeting in respect of any matter, question, proposal
or proposition, and to vote at such meeting by way of a show of hands in respect of any matter, question, proposal or proposition.

 

		4.9	Distribution of Written Materials

 

Any written materials distributed by the
Trustee to the Beneficiaries pursuant to this Agreement shall be sent by mail (or otherwise communicated in the same manner as
Akerna utilizes in communications to holders of Akerna Shares subject to applicable regulatory requirements and to the Trustee
being advised in writing of such manner and provided such manner of communications is reasonably available to the Trustee) to each
Beneficiary at its address as shown on the register of holders of Exchangeable Shares maintained by the registrar. In connection
with each such distribution, Exchangeco shall provide or cause to be provided to the Trustee for purposes of communication, on
a timely basis and without charge or other expense, a current List, and upon the request of the Trustee, mailing labels to enable
the Trustee to carry out its duties under this Agreement. Exchangeco’s obligations under this Section 4.9 shall be deemed satisfied
to the extent Akerna exercises its option to perform the duties of the Trustee to deliver copies of materials to each Beneficiary
and Exchangeco provides the required information and materials to Akerna.

 

		4.10	Termination of Voting Rights

 

Except as otherwise provided in the Exchangeable
Share Provisions, all of the rights of a Beneficiary with respect to the Beneficiary Votes exercisable in respect of each Exchangeable
Share held by such Beneficiary, including the right to instruct the Trustee as to the voting of or to vote personally such Beneficiary
Votes, shall lapse and be deemed to be surrendered by the Beneficiary to Akerna or Callco, as the case may be, and such Beneficiary
Votes and the Voting Rights represented thereby shall cease immediately upon:

 

		(a)	the surrender of the Exchangeable Shares to Akerna for cancellation pursuant to the Escrow Agreement;

 

		(b)	the delivery by such holder to the Trustee of the certificates representing such Exchangeable Shares
in connection with the exercise by the Beneficiary of the Exchange Right or the Put Right;

 

    E-8

     

    

 

		(c)	the occurrence of the automatic exchange of the Exchangeable Shares for Akerna Shares, as specified
in Article 5 (unless Akerna shall not have delivered the requisite Akerna Shares deliverable in exchange therefor to the Trustee
pending delivery to the Beneficiaries);

 

		(d)	the retraction or redemption of the Exchangeable Shares pursuant to Section 6 or 7 of the Exchangeable
Share Provisions;

 

		(e)	the effective date of the liquidation, dissolution or winding-up of Exchangeco or any other distribution
of the assets of Exchangeco among its shareholders for the purpose of winding up its affairs pursuant to Section 5 of the Exchangeable
Share Provisions; or

 

		(f)	upon the purchase of the Exchangeable Shares from the holder thereof by Akerna or Callco, as the
case may be, pursuant to the exercise by Akerna or Callco of the Liquidation Call Right, the Redemption Call Right, the Change
of Law Call Right or the Retraction Call Right (unless, in any case, Akerna or Callco, as the case may be, shall not have delivered
the requisite consideration deliverable in exchange therefor).

 

		4.11	Disclosure of Interest in Exchangeable Shares

 

The Trustee or Exchangeco shall be entitled
to require any Beneficiary or any person whom the Trustee or Exchangeco, as the case may be, knows or has reasonable cause to believe
holds any interest whatsoever in an Exchangeable Share to: (a) confirm that fact; or (b) give such details as to whom has an interest
in such Exchangeable Share, in each case as would be required (if the Exchangeable Shares were a class of “equity securities”
of Exchangeco) under Section 5.2 of National Instrument 62-104 – Take-Over Bids and Issuer Bids or as would be required
under the articles of Akerna or any laws or regulations, or pursuant to the rules or regulations of any regulatory agency, if and
only to the extent that the Exchangeable Shares were Akerna Shares. If a Beneficiary does not provide the information required
to be provided by such Beneficiary pursuant to this Section 4.11, the board of directors of Akerna may take any action permitted
under the articles or by-laws of Akerna or any laws or regulations, or pursuant to the rules or regulations of any regulatory agency,
with respect to the Voting Rights relating to the Exchangeable Shares held by such Beneficiary as if, and only to that the extent
that, the Exchangeable Shares were Akerna Shares.

 

Article
5

EXCHANGE AND AUTOMATIC EXCHANGE

 

		5.1	Grant and Ownership of the Exchange Right, Automatic Exchange Right and Put Right

 

		(1)	Akerna and, in the case of the Exchange Right and Put Right, Callco hereby grant to the Trustee
as trustee for and on behalf of, and for the use and benefit of, the Beneficiaries: (i) the right (the “Exchange Right”),
upon the occurrence and during the continuance of an Insolvency Event, to require Akerna or Callco to purchase from each or any
Beneficiary all or any part of the Exchangeable Shares held by such Beneficiary, all in accordance with the provisions of this
Agreement; (ii) the Automatic Exchange Right; and (iii) at any other time on not less than fifteen (15) days’ written notice
by the Trustee requiring Callco or Akerna to purchase from any Beneficiary all or any part of the Exchangeable Shares held by such
Beneficiary, all in accordance with the provisions of this Agreement (the “Put Right”). Each of Akerna and Callco
hereby acknowledges receipt from the Trustee as trustee for and on behalf of the Beneficiaries of good and valuable consideration
(and the adequacy thereof) for the grant of the Exchange Right, the Automatic Exchange Right and the Put Right by Akerna or Callco,
as the case may be, to the Trustee.

 

    E-9

     

    

 

		(2)	During the term of the Trust, and subject to the terms and conditions of this Agreement, the Trustee
shall possess and be vested with full legal ownership of the Exchange Right, the Put Right and the Automatic Exchange Right and
shall be entitled to exercise all of the rights and powers of an owner with respect to the Exchange Right, the Automatic Exchange
Right and the Put Right, provided that the Trustee shall:

 

		(a)	hold the Exchange Right, the Automatic Exchange Right, the Put Right and the legal title thereto
as trustee solely for the use and benefit of the Beneficiaries in accordance with the provisions of this Agreement; and

 

		(b)	except as specifically authorized by this Agreement, have no power or authority to exercise or
otherwise deal in or with the Exchange Right, the Automatic Exchange Right or the Put Right, and the Trustee shall not exercise
any such rights for any purpose other than the purposes for which the Trust is created pursuant to this Agreement.

 

		5.2	Legended Share Certificates

 

Exchangeco shall cause each certificate
representing Exchangeable Shares to bear a legend notifying the Beneficiary in respect of the Exchangeable Shares represented by
such certificate of: (a) his, her or its right to instruct the Trustee with respect to the exercise of the Exchange Right in respect
of the Exchangeable Shares held by such Beneficiary; (b) the Automatic Exchange Right; and (c) his, her or its right to instruct
the Trustee with respect to the exercise of the Put Right in respect of the Exchangeable Shares held by such Beneficiary;

 

		5.3	General Exercise of Exchange Right

 

The Exchange Right and the Put Right shall
be and remain vested in and exercisable by the Trustee. Subject to Section 6.15, the Trustee shall exercise the Exchange Right
and the Put Right only on the basis of instructions received pursuant to this Article 5 from Beneficiaries entitled to instruct
the Trustee as to the exercise thereof. To the extent that no instructions are received from any Beneficiary with respect to the
Exchange Right or the Put Right, the Trustee shall not exercise or permit the exercise of the Exchange Right or the Put Right.

 

		5.4	Purchase Price

 

The purchase price payable by Akerna or
Callco, as the case may be, for each Exchangeable Share to be purchased by Akerna or Callco, as the case may be, pursuant to the
exercise of the Exchange Right or the Put Right shall be an amount per share equal to the Exchangeable Share Price on the last
Business Day prior to the day of the closing of the purchase and sale of such Exchangeable Share pursuant to such exercise of the
Exchange Right or the Put Right, as the case may be, which price may be satisfied only by Akerna or Callco, as the case may be,
delivering or causing to be delivered to the Trustee, on behalf of the relevant Beneficiary, the Exchangeable Share Consideration
representing such Exchangeable Share Price. In connection with each exercise of the Exchange Right or the Put Right, Akerna or
Callco, as the case may be, shall provide to the Trustee an Officer’s Certificate setting forth the calculation of the Exchangeable
Share Price. Upon payment by Akerna or Callco, as the case may be, of the Exchangeable Share Price, the relevant Beneficiary shall
cease to have any right to be paid any amount in respect of declared and unpaid dividends on each such Exchangeable Share by Exchangeco
and Exchangeco shall cease to be obligated to pay any amount in respect of such dividends.

 

    E-10

     

    

 

		5.5	Exercise Instructions

 

Subject
to the terms and conditions set forth herein, a Beneficiary shall be entitled upon the occurrence and during the continuance of
an Insolvency Event and in respect of the Put Right, at any time, to instruct the Trustee to exercise the Exchange Right or the
Put Right, as the case may be, with respect to all or any part of the Exchangeable Shares registered in the name of such Beneficiary.
In order to cause the Trustee to exercise the Exchange Right or the Put Right with respect to all or any part of the Exchangeable
Shares registered in the name of a Beneficiary, such Beneficiary shall deliver to the Trustee, in person or by certified or registered
mail, at its principal office in [●]
or at such other place as the Trustee may from time to time designate by written notice to the Beneficiaries, the certificates
representing the Exchangeable Shares which such Beneficiary desires Akerna or Callco to purchase, duly endorsed in blank for transfer,
and accompanied by such other documents and instruments as may be required to effect a transfer of the Exchangeable Shares under
the Business Corporations Act (Ontario), the articles of Exchangeco and such additional documents and instruments as Akerna,
Exchangeco or the Trustee may reasonably require together with:

 

		(a)	a duly completed form of notice of exercise of the Exchange Right or the Put Right, as the case
may be, contained on the reverse of or attached to the Exchangeable Share certificates, stating: (i) that the Beneficiary thereby
instructs the Trustee to exercise the Exchange Right or the Put Right, as the case may be, so as to require Akerna or Callco to
purchase from the Beneficiary the number of Exchangeable Shares specified therein; (ii) that such Beneficiary has good title to
and owns all such Exchangeable Shares to be acquired by Akerna or Callco free and clear of all liens, claims, security interests
and encumbrances; (iii) the names in which the certificates representing Akerna Shares issuable in connection with the exercise
of the Exchange Right or the Put Right, as the case may be, are to be issued; and (iv) the names and addresses of the persons to
whom such new certificates should be delivered; and

 

		(b)	payment (or evidence satisfactory to Akerna, Exchangeco and the Trustee of payment) of the taxes
(if any) payable as contemplated by Section 5.8 of this Agreement;

 

provided that if only a part of the Exchangeable
Shares represented by any certificate or certificates delivered to the Trustee are to be purchased by Akerna or Callco pursuant
to the exercise of the Exchange Right or the Put Right, as the case may be, a new certificate for the balance of such Exchangeable
Shares shall be issued to the holder at the expense of Exchangeco.

 

		5.6	Delivery of Akerna Shares; Effect of Exercise

 

Promptly after the receipt by the Trustee
of the certificates representing the Exchangeable Shares which a Beneficiary desires Akerna or Callco to purchase pursuant to the
exercise of the Exchange Right or the Put Right, as the case may be, together with a notice of exercise and such other documents
and instruments specified by Section 5.5, the Trustee shall notify Akerna, Callco and Exchangeco of its receipt of the same, which
notice to Akerna, Callco and Exchangeco shall constitute exercise of the Exchange Right or the Put Right, as the case may be, by
the Trustee on behalf of such Beneficiary in respect of such Exchangeable Shares, and Akerna or Callco, as the case may be, shall
promptly thereafter deliver or cause to be delivered to the Trustee, for delivery to such Beneficiary (or to such other persons,
if any, properly designated by such Beneficiary) the Exchangeable Share Consideration (as defined in the Exchangeable Share terms)
deliverable in connection with such exercise of the Exchange Right or the Put Right, as the case may be; provided, however, that
no such delivery shall be made unless and until the Beneficiary requesting the same shall have paid (or provided evidence satisfactory
to Akerna, Callco, Exchangeco and the Trustee of the payment of) the taxes (if any) payable as contemplated by Section 5.7 of this
Agreement. Immediately upon the giving of notice by the Trustee to Akerna, Callco and Exchangeco of any exercise of the Exchange
Right or the Put Right, as the case may be, as provided in this Section 5.6, the closing of the transaction of purchase and sale
contemplated by the Exchange Right or the Put Right, as the case may be, shall be deemed to have occurred, and the Beneficiary
in respect of such Exchangeable Shares shall be deemed to have transferred to Akerna or Callco, as the case may be, all of such
Beneficiary’s right, title and interest in and to such Exchangeable Shares and in the related interest in the Trust Estate and
shall cease to be a holder of such Exchangeable Shares and shall not be entitled to exercise any of the rights of a holder in respect
thereof, other than the right to receive the total Exchangeable Share Consideration in respect of such Exchangeable Shares, unless
such Exchangeable Share Consideration is not delivered by Akerna or Callco, as the case may be, to the Trustee for delivery to
such Beneficiary (or to such other person, if any, properly designated by such Beneficiary) within five (5) Business Days of the
date of the giving of such notice by the Trustee, in which case the rights of the Beneficiary shall remain unaffected until such
Exchangeable Share Consideration is so delivered. Upon delivery of such Exchangeable Share Consideration to the Trustee, the Trustee
shall promptly deliver such Exchangeable Share Consideration to such Beneficiary (or to such other person, if any, properly designated
by such Beneficiary). Concurrently with the closing of the transaction of purchase and sale contemplated by such exercise of the
Exchange Right or the Put Right, as the case may be, the Beneficiary shall be considered and deemed for all purposes to be the
holder of the Akerna Shares delivered to it pursuant to such exercise of the Exchange Right or the Put Right, as the case may be.

 

    E-11

     

    

 

		5.7	Exercise of Exchange Right Subsequent to Retraction

 

In the event that a Beneficiary has exercised
its retraction right under Section 6 of the Exchangeable Share Provisions to require Exchangeco to redeem any or all of the Exchangeable
Shares held by the Beneficiary (the “Retracted Shares”) and is notified by Exchangeco pursuant to Section 6(a)(iii)
of the Exchangeable Share Provisions that Exchangeco will not be permitted as a result of solvency requirements of applicable law
to redeem all such Retracted Shares, subject to receipt by the Trustee of written notice to that effect from Exchangeco, and provided
that neither Akerna nor Callco shall have exercised its Retraction Call Right with respect to the Retracted Shares and that the
Beneficiary shall not have revoked the retraction request delivered by the Beneficiary to Exchangeco pursuant to Section 6(a)(iv)
of the Exchangeable Share Provisions, the retraction request will constitute and will be deemed to constitute notice from the Beneficiary
to the Trustee instructing the Trustee to exercise the Exchange Right with respect to those Retracted Shares that Exchangeco is
unable to redeem. In any such event, Exchangeco hereby agrees with the Trustee, and in favour of the Beneficiary, promptly to notify
the Trustee of such prohibition against Exchangeco and to forward or cause to be forwarded to the Trustee all relevant materials
delivered by the Beneficiary to Exchangeco or to the Transfer Agent in connection with such proposed redemption of the Retracted
Shares and the Trustee will thereupon exercise the Exchange Right with respect to the Retracted Shares that Exchangeco is not permitted
to redeem and will require Akerna or, at the option of Akerna, Callco to purchase such shares in accordance with the provisions
of this Article 5.

 

		5.8	Stamp or Other Transfer Taxes

 

Upon any sale or transfer of Exchangeable
Shares to Akerna pursuant to the exercise of the Exchange Right, the Put Right or the Automatic Exchange Right, the share certificate
or certificates representing the Akerna Shares to be delivered in connection with the payment of the purchase price therefor shall
be issued in the name of the Beneficiary in respect of the Exchangeable Shares so sold or transferred or in such names as such
Beneficiary may otherwise direct in writing without charge to the holder of the Exchangeable Shares so sold or transferred; provided,
however, that such Beneficiary: (a) shall pay (and none of Akerna, Callco, Exchangeco or the Trustee shall be required to pay)
any documentary, stamp, transfer of other taxes or duties that may be payable in respect of any sale or transfer involved in the
issuance or delivery of such shares to a person other than such Beneficiary including, without limitation, in the event that Exchangeable
Shares are being delivered, sold or transferred in the name of a clearing service or depositary or a nominee thereof; or (b) shall
have evidenced to the satisfaction of Akerna, Callco, Exchangeco and the Trustee that such taxes or duties (if any) have been paid.

 

		5.9	Notice of Insolvency Event

 

As soon as practicable following the occurrence
of an Insolvency Event or any event that with the giving of notice or the passage of time or both would be an Insolvency Event,
Akerna and Exchangeco shall give written notice thereof to the Trustee. As soon as practicable after receiving notice from Akerna
or Exchangeco of the occurrence of an Insolvency Event, or upon the Trustee otherwise becoming aware of an Insolvency Event, the
Trustee shall mail to each Beneficiary, at the expense of Akerna (such funds to be received in advance), a notice of such Insolvency
Event in the form provided by Akerna, which notice shall contain a brief statement of the rights of the Beneficiaries with respect
to the Exchange Right.

 

    E-12

     

    

 

		5.10	U.S. Securities Law Compliance and Listing of Akerna Shares

 

Akerna covenants and agrees that it shall:
(a) file a registration statement (the “Registration Statement”) under the U.S. Securities Act of 1933, as amended
(the “1933 Act”) to register any and all of the Akerna Shares to be issued or delivered to holders of the Exchangeable
Shares by Akerna or Callco (including, for greater certainty, pursuant to the Exchange Right, the Put Right or the Automatic Exchange
Right); (b) cause the Registration Statement to become effective prior to the time that any Exchangeable Shares are first issued;
and (c) cause the Registration Statement (or a successor registration statement) to remain effective at all times that any Exchangeable
Shares remain outstanding, in each case unless the issuance of such securities is exempt from any requirement for registration
under the 1933 Act and all applicable state securities laws. Without limiting the generality of the foregoing, Akerna and Callco
each covenant and agree that it shall make such filings and seek such regulatory consents and approvals as are necessary so that
the Akerna Shares to be issued or delivered to holders of Exchangeable Shares by Akerna or Callco pursuant to the terms of the
Exchangeable Share Provisions, the Support Agreement and this Agreement will be offered, sold, issued and delivered in compliance
with the 1933 Act and all applicable state securities laws, and applicable securities laws in Canada and shall ensure that the
Akerna Shares will not be “restricted securities” within the meaning of Rule 144 under the 1933 Act. Akerna will
in good faith expeditiously take all such actions and do all such things as are reasonably necessary or desirable to cause all
Akerna Shares to be delivered to holders of Exchangeable Shares pursuant to the terms of the Exchangeable Share Provisions, the
Support Agreement and this Agreement to be listed, quoted and posted for trading on all stock exchanges and quotation systems on
which outstanding Akerna Shares have been listed by Akerna and remain listed and are quoted or posted for trading at such time.

 

		5.11	Akerna Shares

 

Akerna hereby represents, warrants and
covenants that the Akerna Shares deliverable as described herein will be duly authorized and validly issued as fully paid and non-assessable
and shall be free and clear of any lien, claim or encumbrance.

 

		5.12	Automatic Exchange on Liquidation of Akerna

 

		(1)	Akerna shall give the Trustee written notice of each of the following events (each, a “Liquidation
Event”) at the time set forth below:

 

		(a)	in the event of any determination by the board of directors of Akerna to institute voluntary liquidation,
dissolution or winding-up proceedings with respect to Akerna or to effect any other distribution of assets of Akerna among its
shareholders for the purpose of winding up its affairs, at least 30 days prior to the proposed effective date of such liquidation,
dissolution, winding-up or other distribution; and

 

		(b)	as soon as practicable following the earlier of: (A) receipt by Akerna of notice of; and (B) Akerna
otherwise becoming aware of any instituted claim, suit, petition or other proceedings with respect to the involuntary liquidation,
dissolution or winding-up of Akerna or to effect any other distribution of assets of Akerna among its shareholders for the purpose
of winding up its affairs, in each case where Akerna has failed to contest in good faith any such proceeding commenced in respect
of Akerna within 30 days of becoming aware thereof; and

 

		(c)	definitive documents
respecting any Akerna Control Transaction (other than a transaction contemplated by Section 10.4) are entered into by Akerna and
the board of directors of Akerna determines in good faith that it is not practicable to substantially replicate the terms and conditions
of the Exchangeable Shares in connection with such Akerna Control Transaction.

 

		(2)	As soon as practicable following receipt by the Trustee from Akerna of notice of a Liquidation
Event, the Trustee shall give notice thereof to the Beneficiaries. Such notice shall be provided by Akerna to the Trustee and shall
include a brief description of the automatic exchange of Exchangeable Shares for Akerna Shares provided for in Section 5.12(3)
(the “Automatic Exchange Right”).

 

    E-13

     

    

 

		(3)	In order that the Beneficiaries will be able to participate on a pro rata basis with the holders
of Akerna Shares in the distribution of assets of Akerna in connection with a Liquidation Event, immediately prior to the effective
date (the “Liquidation Event Effective Date”) of a Liquidation Event, each of the then outstanding Exchangeable
Shares (other than Exchangeable Shares held by Akerna and its affiliates) shall be automatically exchanged for Akerna Shares. To
effect such automatic exchange, Akerna shall purchase each such Exchangeable Share outstanding immediately prior to the Liquidation
Event Effective Date, and each Beneficiary shall sell each Exchangeable Shares held by it at such time, free and clear of any lien,
claim or encumbrance, for a purchase price per share equal to the Exchangeable Share Price immediately prior to the Liquidation
Event Effective Date, which price shall be satisfied in full by Akerna delivering to such holder the Exchangeable Share Consideration
representing such Exchangeable Share Price. For greater certainty, the Beneficiary shall upon delivery of the Exchangeable Share
Consideration cease to have any rights to be paid by Exchangeco any amount in respect of declared and unpaid dividends on the Exchangeable
Shares.

 

		(4)	The closing of the transaction of purchase and sale contemplated by any exercise of the Automatic
Exchange Right shall be deemed to have occurred at the close of business on the Business Day immediately prior to the Liquidation
Event Effective Date, and each Beneficiary shall be deemed to have transferred to Akerna all of such Beneficiary’s right, title
and interest in and to the Exchangeable Shares held by such Beneficiary free and clear of any lien, claim or encumbrance and the
related interest in the Trust Estate, any right of each such Beneficiary to receive declared and unpaid dividends from Exchangeco
shall be deemed to be satisfied and discharged, and each such Beneficiary shall cease to be a holder of such Exchangeable Shares
and Akerna shall deliver or cause to be delivered to the Trustee, for delivery to such Beneficiary, the Exchangeable Share Consideration
deliverable to such Beneficiary upon such exercise of the Automatic Exchange Right. Concurrently with each such Beneficiary ceasing
to be a holder of Exchangeable Shares, such Beneficiary shall be considered and deemed for all purposes to be the holder of the
Akerna Shares included in the Exchangeable Share Consideration to be delivered to such Beneficiary and the certificates held by
such Beneficiary previously representing the Exchangeable Shares exchanged by the Beneficiary with Akerna pursuant to the exercise
of the Automatic Exchange Right shall thereafter be deemed to represent the Akerna Shares issued to such Beneficiary by Akerna
pursuant to the exercise of the Automatic Exchange Right. Upon the request of any Beneficiary and the surrender by such Beneficiary
of Exchangeable Share certificates deemed to represent Akerna Shares, duly endorsed in blank and accompanied by such instruments
of transfer as Akerna may reasonably require, Akerna shall deliver or cause to be delivered to such Beneficiary certificates representing
the Akerna Shares of which the Beneficiary is the holder.

 

		5.13	Withholding Rights

 

Akerna, Callco, Exchangeco and the Trustee
shall be entitled to deduct and withhold from any dividend, distribution, price or other consideration otherwise payable under
this Agreement to any holder of Exchangeable Shares or Akerna Shares such amounts as Akerna, Callco, Exchangeco or the Trustee
is required to deduct and withhold with respect to such payment under the Income Tax Act (Canada) or United States tax laws
or any provision of federal, provincial, territorial, state, local or foreign tax Law, in each case as amended or succeeded. The
Trustee may act and rely on the advice of counsel with respect to such matters. To the extent that amounts are so deducted and
withheld, such amounts shall be treated for all purposes as having been paid to the holder of the shares in respect of which such
deduction and withholding was made, provided that such withheld amounts are actually remitted to the appropriate taxing agency.
To the extent that the amount so required to be deducted or withheld from any payment to a holder exceeds the cash portion of the
consideration otherwise payable to the holder, Akerna, Callco, Exchangeco and the Trustee are hereby authorized to sell or otherwise
dispose of such portion of the consideration as is necessary to provide sufficient funds to Akerna, Callco, Exchangeco or the Trustee,
as the case may be, to enable it to comply with such deduction or withholding requirement and Akerna, Callco, Exchangeco or the
Trustee, as the case may be, shall notify the holder thereof and remit to such holder any unapplied balance of the net proceeds
of such sale.

 

    E-14

     

    

 

		5.14	No Fractional Shares

 

A holder of an Exchangeable Share shall
not be entitled to any fraction of an Akerna Share upon the exercise of the Exchange Right, the Put Right or Automatic Exchange
Right hereunder and no certificates representing any such fractional interest shall be issued and the number of Akerna Shares to
be received by any such holder otherwise entitled to a fractional interest shall be rounded to the nearest whole Akerna Share (with
fractions equal to or greater than 0.5 being rounded up).

 

Article
6

CONCERNING THE TRUSTEE

 

		6.1	Powers and Duties of the Trustee

 

		(1)	The rights, powers, duties and authorities of the Trustee under this Agreement, in its capacity
as Trustee of the Trust, shall include:

 

		(a)	receipt and deposit of the Special Voting Share from Akerna as trustee for and on behalf of the
Beneficiaries in accordance with the provisions of this Agreement;

 

		(b)	granting proxies and distributing materials to Beneficiaries as provided in this Agreement;

 

		(c)	voting the Beneficiary Votes on the direction and behalf of the Beneficiaries in accordance with
the provisions of this Agreement;

 

		(d)	receiving the grant of the Exchange Right and Put Right from Akerna and Callco, and the Automatic
Exchange Right from Akerna, as trustee for and on behalf of the Beneficiaries in accordance with the provisions of this Agreement;

 

		(e)	exercising the Exchange Right and Put Right and enforcing the benefit of the Automatic Exchange
Right, in each case in accordance with the provisions of this Agreement, and in connection therewith receiving from Beneficiaries
any requisite documents and distributing to such Beneficiaries the Exchangeable Share Consideration to which such Beneficiaries
are entitled pursuant to the exercise of the Exchange Right, the Put Right or the Automatic Exchange Right, as the case may be;

 

		(f)	holding title to the Trust Estate;

 

		(g)	investing any moneys forming, from time to time, a part of the Trust Estate as provided in this
Agreement;

 

		(h)	taking action at the direction of a Beneficiary or Beneficiaries to enforce the obligations of
Akerna, Callco and Exchangeco under this Agreement; and

 

		(i)	taking such other actions and doing such other things as are specifically provided in this Agreement
to be carried out by the Trustee.

 

		(2)	In the exercise of such rights, powers, duties and authorities, the Trustee shall have (and is
granted) such incidental and additional rights, powers, duties and authority not in conflict with any of the provisions of this
Agreement as the Trustee, acting in good faith and in the reasonable exercise of its discretion, may deem necessary, appropriate
or desirable to effect the purpose of the Trust. Any exercise of such discretionary rights, powers, duties and authorities by the
Trustee shall be final, conclusive and binding upon all persons. For greater certainty, the Trustee shall have only those duties
as are set out specifically in this Agreement.

 

    E-15

     

    

 

		(3)	The Trustee, in exercising its rights, powers, duties and authorities hereunder, shall act honestly
and in good faith and with a view to the best interests of the Beneficiaries and shall exercise the care, diligence and skill that
a reasonably prudent trustee would exercise in comparable circumstances.

 

		(4)	The Trustee shall not be bound to give notice or do or take any act, action or proceeding by virtue
of the powers conferred on it hereby unless and until it shall be specifically required to do so under the terms hereof; nor shall
the Trustee be required to take any notice of, or to do, or to take any act, action or proceeding as a result of any default or
breach of any provision hereunder, unless and until notified in writing of such default or breach, which notices shall distinctly
specify the default or breach desired to be brought to the attention of the Trustee, and in the absence of such notice the Trustee
may for all purposes of this Agreement conclusively assume that no default or breach has been made in the observance or performance
of any of the representations, warranties, covenants, agreements or conditions contained herein.

 

		6.2	No Conflict of Interest

 

The Trustee represents to Akerna, Callco
and Exchangeco that, at the date of execution and delivery of this Agreement, there exists no material conflict of interest in
the role of the Trustee as a fiduciary hereunder and the role of the Trustee in any other capacity. The Trustee shall, within 90
days after it becomes aware that such material conflict of interest exists, either eliminate such material conflict of interest
or resign in the manner and with the effect specified in Article 9. If, notwithstanding the foregoing provisions of this Section
6.2, the Trustee has such a material conflict of interest, the validity and enforceability of this Agreement shall not be affected
in any manner whatsoever by reason only of the existence of such material conflict of interest. If the Trustee contravenes the
foregoing provisions of this Section 6.2, any interested party may apply to the courts of Ontario for an order that the Trustee
be replaced as Trustee hereunder.

 

		6.3	Dealings with Transfer Agents, Registrars, etc.

 

		(1)	(a) Each of Akerna, Callco and Exchangeco irrevocably authorizes the Trustee, from time to time,
to:

 

		(a)	consult, communicate and otherwise deal with the respective registrars and transfer agents, and
with any such subsequent registrar or transfer agent, of the Exchangeable Shares and Akerna Shares; and

 

		(b)	requisition, from time to time, from any such registrar or transfer agent, any information readily
available from the records maintained by it which the Trustee may reasonably require for the discharge of its duties and responsibilities
under this Agreement.

 

		(2)	Each of Akerna and Callco irrevocably authorizes its respective registrar and Transfer Agent to
comply with all such requests and covenants that it shall supply the Trustee or its transfer agent, as the case may be, in a timely
manner with duly executed share certificates for the purpose of completing the exercise from time to time of all rights to acquire
Akerna Shares hereunder, under the Exchangeable Share Provisions and under any other security or commitment given to the Beneficiaries
pursuant thereto, in each case pursuant to the provisions hereof or of the Exchangeable Share Provisions or otherwise.

 

    E-16

     

    

 

		6.4	Books and Records

 

The
Trustee shall keep available for inspection during regular business hours by Akerna, Callco and Exchangeco at the Trustee’s principal
office in [●] correct
and complete books and records of account relating to the Trust created by, and Trustee’s actions under, this Agreement, including
all relevant data relating to mailings and instructions to and from Beneficiaries and all transactions pursuant to the Exchange
Right, the Put Right and the Automatic Exchange Right. On or before [●],
and on or before [●]
in every year thereafter, so long as the Special Voting Share is registered in the name of the Trustee, the Trustee shall transmit
to Akerna, Callco and Exchangeco a brief report, dated as of the preceding December 31, with respect to:

 

		(a)	the property and funds comprising the Trust Estate as of that date;

 

		(b)	the number of exercises of any Exchange Right or Put Right, as the case may be, and the aggregate
number of Exchangeable Shares received by the Trustee on behalf of Beneficiaries in consideration of the issuance and delivery
by Akerna or Callco of Akerna Shares in connection with the Exchange Right or Put Right, as the case may be, during the calendar
year ended on such December 31; and

 

		(c)	any action taken by the Trustee in the performance of its duties under this Agreement which it
had not previously reported.

 

		6.5	Income Tax Returns and Reports

 

The Trustee shall, to the extent necessary,
prepare and file, or cause to be prepared and filed, on behalf of the Trust appropriate Canadian income tax returns and any other
returns or reports as may be required by applicable law, by any court, tribunal, government, governmental or regulatory agency
or public official, or pursuant to the rules and regulations of any securities exchange or other trading system through which the
Exchangeable Shares are traded. In connection therewith, the Trustee may obtain the advice and assistance of such experts or advisors
(who may be experts or advisors to Akerna, Callco and/or Exchangeco) as the Trustee considers necessary or advisable. If requested
by the Trustee, Akerna shall retain or caused to be retained qualified experts or advisors for the purpose of providing such tax
advice or assistance.

 

		6.6	Indemnification Prior to Certain Actions by Trustee

 

		(1)	The Trustee shall exercise any or all of the rights, duties, powers or authorities vested in it
by this Agreement at the request, order or direction of any Beneficiary upon such Beneficiary furnishing to the Trustee reasonable
funding, security or indemnity against the costs, expenses and liabilities which may be incurred by the Trustee therein or thereby,
provided that no Beneficiary shall be obligated to furnish to the Trustee any such funding, security or indemnity in connection
with the exercise by the Trustee of any of its rights, duties, powers and authorities with respect to the Special Voting Share
pursuant to Article 4, subject to Section 6.15, and with respect to the Exchange Right and the Automatic Exchange Right pursuant
to Article 5.

 

		(2)	None of the provisions contained in this Agreement shall require the Trustee to expend or risk
its own funds or otherwise incur financial liability in the exercise of any of its rights, powers, duties, or authorities unless
funded, given security and indemnified as aforesaid.

 

		6.7	Action of Beneficiaries

 

No Beneficiary shall have the right to
institute any action, suit or proceeding or to exercise any other remedy authorized by this Agreement for the purpose of enforcing
any of its rights or for the execution of any trust or power hereunder unless the Beneficiary has requested the Trustee to take
or institute such action, suit or proceeding and furnished the Trustee with the funding, security or indemnity referred to in Section
6.6 and the Trustee shall have failed to act within a reasonable time thereafter. In such case, but not otherwise, the Beneficiary
shall be entitled to take proceedings in any court of competent jurisdiction such as the Trustee might have taken; it being understood
and intended that no one or more Beneficiaries shall have any right in any manner whatsoever to affect, disturb or prejudice the
rights hereby created by any such action, or to enforce any right hereunder or the Voting Rights, the Exchange Right, the Put Right
or the Automatic Exchange Right except subject to the conditions and in the manner herein provided, and that all powers and trusts
hereunder shall be exercised and all proceedings at law shall be instituted, had and maintained by the Trustee, except only as
herein provided, and in any event for the equal benefit of all Beneficiaries.

 

    E-17

     

    

 

		6.8	Reliance Upon Declarations

 

The Trustee shall not be considered to
be in contravention of any of its rights, powers, duties and authorities hereunder if, when required, it acts and relies in good
faith upon statutory declarations, certificates, opinions or reports furnished pursuant to the provisions hereof or required by
the Trustee to be furnished to it in the exercise of its rights, powers, duties and authorities hereunder if such statutory declarations,
certificates, opinions or reports comply with the provisions of Section 6.9, if applicable, and with any other applicable provisions
of this Agreement.

 

		6.9	Evidence and Authority to Trustee

 

		(1)	Akerna, Callco and/or Exchangeco shall furnish to the Trustee evidence of compliance with the conditions
provided for in this Agreement relating to any action or step required or permitted to be taken by Akerna, Callco and/or Exchangeco
or the Trustee under this Agreement or as a result of any obligation imposed under this Agreement, including in respect of the
Voting Rights, the Exchange Right, the Put Right or the Automatic Exchange Right and the taking of any other action to be taken
by the Trustee at the request of or on the application of Akerna, Callco and/or Exchangeco promptly if and when:

 

		(a)	such evidence is required by any other Section of this Agreement to be furnished to the Trustee
in accordance with the terms of this Section 6.9; or

 

		(b)	the Trustee, in the exercise of its rights, powers, duties and authorities under this Agreement,
gives Akerna, Callco and/or Exchangeco written notice requiring it to furnish such evidence in relation to any particular action
or obligation specified in such notice.

 

		(2)	Such evidence shall consist of an Officer’s Certificate of Akerna, Callco and/or Exchangeco or
a statutory declaration or a certificate made by persons entitled to sign an Officer’s Certificate stating that any such condition
has been complied with in accordance with the terms of this Agreement.

 

		(3)	Whenever such evidence relates to a matter other than the Voting Rights, the Exchange Right, the
Put Right or the Automatic Exchange Right or the taking of any other action to be taken by the Trustee at the request or on the
application of Akerna, Callco and/or Exchangeco, and except as otherwise specifically provided herein, such evidence may consist
of a report or opinion of any solicitor, attorney, auditor, accountant, appraiser, valuer or other expert or any other person whose
qualifications give authority to a statement made by such person; provided, however, that if such report or opinion is furnished
by a director, officer or employee of Akerna, Callco and/or Exchangeco it shall be in the form of an Officer’s Certificate or a
statutory declaration.

 

		(4)	Each statutory declaration, Officer’s Certificate, opinion or report furnished to the Trustee as
evidence of compliance with a condition provided for in this Agreement shall include a statement by the person giving the evidence:

 

		(a)	declaring that such person has read and understands the provisions of this Agreement relating to
the condition in question;

 

		(b)	describing the nature and scope of the examination or investigation upon which such person based
the statutory declaration, certificate, statement or opinion; and

 

		(c)	declaring that such person has made such examination or investigation as such person believes is
necessary to enable such person to make the statements or give the opinions contained or expressed therein.

 

    E-18

     

    

 

		6.10	Experts, Advisers and Agents

 

The Trustee may:

 

		(a)	in relation to these presents act and rely on the opinion or advice of or information obtained
from any solicitor, attorney, auditor, accountant, appraiser, valuer or other expert, whether retained by the Trustee or by Akerna,
Callco and/or Exchangeco or otherwise, and may retain or employ such assistants as may be necessary to the proper discharge of
its powers and duties and determination of its rights hereunder and may pay proper and reasonable compensation for all such legal
and other advice or assistance as aforesaid;

 

		(b)	employ such agents and other assistants as it may reasonably require for the proper determination
and discharge of its powers and duties hereunder; and

 

		(c)	pay reasonable remuneration for all services performed for it (and shall be entitled to receive
reasonable remuneration for all services performed by it) in the discharge of the trusts hereof and compensation for all reasonable
disbursements, costs and expenses made or incurred by it in the discharge of its duties hereunder and in the management of the
Trust.

 

		6.11	Investment of Moneys Held by Trustee

 

Unless otherwise provided in this Agreement,
any moneys held by or on behalf of the Trustee which under the terms of this Agreement may or ought to be invested or which may
be on deposit with the Trustee or which may be in the hands of the Trustee may be invested or reinvested in the name or under the
control of the Trustee in securities in which, under the laws of the Province of Ontario, trustees are authorized to invest trust
moneys or as otherwise agreed upon in writing by the Trustee and Exchangeco, provided that such securities are stated to mature
within two years after their purchase by the Trustee and the Trustee shall so invest such money on the written direction of Exchangeco.
Pending the investment of any money as herein provided, such moneys may be deposited in the name of the Trustee in any chartered
bank in Canada or, with the consent of Exchangeco, in the deposit department of the Trustee or any other specified loan or trust
company authorized to accept deposits under the laws of Canada or any province thereof at the rate of interest then current on
similar deposits. The Trustee shall not be held liable for any losses incurred in the investment of any funds as herein provided
and all interest on monies held by or on behalf of the Trustee shall be for the account of Exchangeco and held by the Trustee for
the benefit of Exchangeco.

 

		6.12	Trustee Not Required to Give Security

 

The Trustee shall not be required to give
any bond or security in respect of the execution of the trusts, rights, duties, powers and authorities of this Agreement or otherwise
in respect of the premises.

 

		6.13	Trustee Not Bound to Act on Request

 

Except as in this Agreement otherwise specifically
provided, the Trustee shall not be bound to act in accordance with any direction or request of Akerna, Callco and/or Exchangeco
or of the respective directors thereof until a duly authenticated copy of the instrument or resolution containing such direction
or request shall have been delivered to the Trustee, and the Trustee shall be empowered to act upon any such copy purporting to
be authenticated and believed by the Trustee to be genuine. The Trustee shall have the right not to act and shall not be liable
for refusing to act if, due to a lack of information or for any other reason whatsoever, the Trustee, in its sole judgment, determines
that such act might cause it to be in non-compliance with any applicable anti-money laundering or anti-terrorist legislation or
regulation. Further, should the Trustee, in its sole judgment, determine at any time that its acting under this Agreement has resulted
in its being in non-compliance with any applicable anti-money laundering or anti-terrorist legislation or regulation, then it shall
have the right to resign on fifteen days written notice to the other parties to this Agreement, provided that: (a) the Trustee’s
written notice shall describe the circumstances of such non-compliance; and (b) if such circumstances are rectified to the Trustee’s
satisfaction within such fifteen day period, such resignation shall not be effective.

 

    E-19

     

    

 

		6.14	Authority to Carry on Business

 

The Trustee represents to Akerna, Callco
and Exchangeco that, at the date of execution and delivery by it of this Agreement, it is authorized to carry on the business of
a trust company in each of the provinces and territories of Canada but if, notwithstanding the provisions of this Section 6.14,
it ceases to be so authorized to carry on business, the validity and enforceability of this Agreement and the Voting Rights, the
Exchange Right, the Put Right and the Automatic Exchange Right and the other rights granted in or resulting from the Trustee being
a party to this Agreement shall not be affected in any manner whatsoever by reason only of such event but the Trustee shall, within
90 days after ceasing to be authorized to carry on the business of a trust company in any province or territory of Canada, either
become so authorized or resign in the manner and with the effect specified in Article 9.

 

		6.15	Conflicting Claims

 

		(1)	If conflicting claims or demands are made or asserted with respect to any interest of any Beneficiary
in any Exchangeable Shares, including any disagreement between the heirs, representatives, successors or assigns succeeding to
all or any part of the interest of any Beneficiary in any Exchangeable Shares, resulting in conflicting claims or demands being
made in connection with such interest, then the Trustee shall be entitled, in its sole discretion, to refuse to recognize or to
comply with any such claims or demands. In so refusing, the Trustee may elect not to exercise any Voting Rights, Exchange Right,
the Put Right, Automatic Exchange Right or other rights subject to such conflicting claims or demands and, in so doing, the Trustee
shall not be or become liable to any person on account of such election or its failure or refusal to comply with any such conflicting
claims or demands. The Trustee shall be entitled to continue to refrain from acting and to refuse to act until:

 

		(a)	the rights of all adverse claimants with respect to the Voting Rights, Put Right, Exchange Right,
Automatic Exchange Right or other rights subject to such conflicting claims or demands have been adjudicated by a final judgement
of a court of competent jurisdiction and all rights of appeal have expired; or

 

		(b)	all differences with respect to the Voting Rights, Exchange Right, Put Right, Automatic Exchange
Right or other rights subject to such conflicting claims or demands have been conclusively settled by a valid written agreement
binding on all such adverse claimants, and the Trustee shall have been furnished with an executed copy of such agreement certified
to be in full force and effect.

 

		(2)	If the Trustee elects to recognize any claim or comply with any demand made by any such adverse
claimant, it may in its discretion require such claimant to furnish such surety bond or other security satisfactory to the Trustee
as it shall deem appropriate to fully indemnify it as between all conflicting claims or demands.

 

		6.16	Acceptance of Trust

 

The Trustee hereby accepts the Trust created
and provided for, by and in this Agreement and agrees to perform the same upon the terms and conditions herein set forth and to
hold all rights, privileges and benefits conferred hereby and by law in trust for the various persons who shall from time to time
be Beneficiaries, subject to all the terms and conditions herein set forth.

 

    E-20

     

    

 

		6.17	Third Party Interests

 

Each party to this Agreement hereby represents
to the Trustee that any account to be opened by, or interest to be held by the Trustee in connection with this Agreement, for or
to the credit of such party, either: (a) is not intended to be used by or on behalf of any third party; or (b) is intended to be
used by or on behalf of a third party, in which case such party hereto agrees to complete and execute forthwith a declaration in
the Trustee’s prescribed form as to the particulars of such third party.

 

		6.18	Privacy

 

The parties acknowledge that Canadian federal
and/or provincial legislation that addresses the protection of individuals’ personal information (collectively, “Privacy
Laws”) applies to obligations and activities under this Agreement. Despite any other provision of this Agreement, no party
shall take or direct any action that would contravene, or cause the others to contravene, applicable Privacy Laws. The parties
shall, prior to transferring or causing to be transferred personal information to the Trustee, obtain and retain required consents
of the relevant individuals to the collection, use and disclosure of their personal information, or shall have determined that
such consents either have previously been given upon which the parties can rely or are not required under the Privacy Laws. Specifically,
the Trustee agrees: (a) to have a designated chief privacy officer; (b) to maintain policies and procedures to protect personal
information and to receive and respond to any privacy complaint or inquiry; (c) to use personal information solely for the purposes
of providing its services under or ancillary to this Agreement and not to use it for any purpose except with the consent of or
direction from the other parties or the individual involved; (d) not to sell or otherwise improperly disclose personal information
to any third party; and (e) to employ administrative, physical and technological safeguards to reasonably secure and protect personal
information against loss, theft, or unauthorized access, use or modification.

 

Article
7

COMPENSATION

 

		7.1	Fees and Expenses of the Trustee

 

Akerna, Callco and Exchangeco jointly and
severally agree to pay the Trustee reasonable compensation for all of the services rendered by it under this Agreement and shall
reimburse the Trustee for all reasonable expenses (including, but not limited to, taxes (other than taxes based on the net income
or capital of the Trustee), fees paid to legal counsel and other experts and advisors and agents and travel expenses) and disbursements,
including the reasonable cost and expense of any suit or litigation of any character and any proceedings before any governmental
agency, in each case reasonably incurred by the Trustee in connection with its duties under this Agreement; provided, however,
that Akerna, Callco and Exchangeco shall have no obligation to reimburse the Trustee for any expenses or disbursements paid, incurred
or suffered by the Trustee in any suit or litigation or any such proceedings in which the Trustee is determined to have acted in
bad faith or with fraud, gross negligence, recklessness or wilful misconduct.

 

Article
8

INDEMNIFICATION AND LIMITATION OF LIABILITY

 

		8.1	Indemnification of the Trustee

 

		(1)	Akerna, Callco and Exchangeco jointly and severally agree to indemnify and hold harmless the Trustee
and each of its directors, officers, employees and agents appointed and acting in accordance with this Agreement (collectively,
the “Indemnified Parties”) against all claims, losses, damages, reasonable costs, penalties, fines and reasonable
expenses (including reasonable expenses of the Trustee’s legal counsel) which, without bad faith, fraud, gross negligence, recklessness
or wilful misconduct on the part of such Indemnified Party, may be paid, incurred or suffered by the Indemnified Party by reason
or as a result of the Trustee’s acceptance or administration of the Trust, its compliance with its duties set forth in this Agreement,
or any written or oral instruction delivered to the Trustee by Akerna, Callco or Exchangeco pursuant hereto.

 

    E-21

     

    

 

		(2)	The Trustee shall promptly notify Akerna, Callco and Exchangeco of a claim or of any action commenced
against any Indemnified Parties promptly after the Trustee or any of the Indemnified Parties shall have received written assertion
of such a claim or action or have been served with a summons or other first legal process giving information as to the nature and
basis of the claim or action; provided, however, that the omission to so notify Akerna, Callco or Exchangeco shall not relieve
Akerna, Callco or Exchangeco of any liability which any of them may have to any Indemnified Party except to the extent that any
such delay prejudices the defence of any such claim or action or results in any increase in the liability which Akerna, Callco
or Exchangeco have under this indemnity. Subject to (ii) below, Akerna, Callco and Exchangeco shall be entitled to participate
at their own expense in the defence and, if Akerna, Callco and Exchangeco so elect at any time after receipt of such notice, either
of them may assume the defence of any suit brought to enforce any such claim. The Trustee shall have the right to employ separate
counsel in any such suit and participate in the defence thereof, but the fees and expenses of such counsel shall be at the expense
of the Trustee unless: (i) the employment of such counsel has been authorized by Akerna, Callco or Exchangeco; or (ii) the named
parties to any such suit include both the Trustee and Akerna, Callco or Exchangeco and the Trustee shall have been advised by counsel
acceptable to Akerna, Callco and Exchangeco that there may be one or more legal defences available to the Trustee that are different
from or in addition to those available to Akerna, Callco or Exchangeco and that, in the judgement of such counsel, would present
a conflict of interest were a joint representation to be undertaken (in which case Akerna, Callco and Exchangeco shall not have
the right to assume the defence of such suit on behalf of the Trustee but shall be liable to pay the reasonable fees and expenses
of counsel for the Trustee). This indemnity shall survive the termination of the Trust and the resignation or removal of the Trustee.

 

		8.2	Limitation of Liability

 

The Trustee shall not be held liable for
any loss which may occur by reason of depreciation of the value of any part of the Trust Estate or any loss incurred on any investment
of funds pursuant to this Agreement, except to the extent that such loss is attributable to the bad faith, fraud, gross negligence,
recklessness or willful misconduct on the part of the Trustee.

 

Article
9

CHANGE OF TRUSTEE

 

		9.1	Resignation

 

The Trustee, or any trustee hereafter appointed,
may at any time resign by giving written notice of such resignation to Akerna, Callco and Exchangeco specifying the date on which
it desires to resign, provided that such notice shall not be given less than 30 days before such desired resignation date unless
Akerna, Callco and Exchangeco otherwise agree and provided further that such resignation shall not take effect until the date of
the appointment of a successor trustee and the acceptance of such appointment by the successor trustee. Upon receiving such notice
of resignation, Akerna, Callco and Exchangeco shall promptly appoint a successor trustee, which successor trustee shall be a corporation
organized and existing under the laws of Canada and authorized to carry on the business of a trust company in all provinces and
territories of Canada, by written instrument in duplicate, one copy of which shall be delivered to the resigning trustee and one
copy to the successor trustee. Failing the appointment and acceptance of a successor trustee, a successor trustee may be appointed
by order of a court of competent jurisdiction upon application of one or more of the parties to this Agreement. If the retiring
trustee is the party initiating an application for the appointment of a successor trustee by order of a court of competent jurisdiction,
Akerna, Callco and Exchangeco shall be jointly and severally liable to reimburse the retiring trustee for its legal costs and expenses
in connection with same.

 

    E-22

     

    

 

		9.2	Removal

 

The Trustee, or any trustee hereafter appointed,
may (provided a successor trustee is appointed) be removed at any time on not less than 30 days’ prior notice by written instrument
executed by Akerna, Callco and Exchangeco, in duplicate, one copy of which shall be delivered to the trustee so removed and one
copy to the successor trustee, provided that such removal shall not take effect until the date of acceptance of appointment by
the successor trustee.

 

		9.3	Successor Trustee

 

Any successor trustee appointed as provided
under this Agreement shall execute, acknowledge and deliver to Akerna, Callco and Exchangeco and to its predecessor trustee an
instrument accepting such appointment. Thereupon the resignation or removal of the predecessor trustee shall become effective and
such successor trustee, without any further act, deed or conveyance, shall become vested with all the rights, powers, duties and
obligations of its predecessor under this Agreement, with the like effect as if originally named as trustee in this Agreement.
However, on the written request of Akerna, Callco and Exchangeco or of the successor trustee, the trustee ceasing to act shall,
upon payment of any amounts then due to it pursuant to the provisions of this Agreement, execute and deliver an instrument transferring
to such successor trustee all the rights and powers of the trustee so ceasing to act. Upon the request of any such successor trustee,
Akerna, Callco, Exchangeco and such predecessor trustee shall execute any and all instruments in writing for more fully and certainly
vesting in and confirming to such successor trustee all such rights and powers.

 

		9.4	Notice of Successor Trustee

 

Upon acceptance of appointment by a successor
trustee as provided herein, Akerna, Callco and Exchangeco shall cause to be mailed notice of the succession of such trustee hereunder
to each Beneficiary specified in a List. If Akerna, Callco or Exchangeco shall fail to cause such notice to be mailed within ten
days after acceptance of appointment by the successor trustee, the successor trustee shall cause such notice to be mailed at the
expense of Akerna, Callco and Exchangeco.

 

Article
10

AKERNA SUCCESSORS

 

		10.1	Certain Requirements in Respect of Combination, etc.

 

So long as any Exchangeable Shares not
owned by Akerna or its affiliates are outstanding, Akerna shall not enter into any transaction (whether by way of reorganization,
consolidation, arrangement, amalgamation, merger, transfer, sale for otherwise) whereby all or substantially all of its undertaking,
property and assets would become the property of any other person or, in the case of an amalgamation or merger, of the continuing
corporation resulting therefrom, provided that it may do so if:

 

		(a)	such other person or continuing corporation (the “Akerna Successor”), by operation
of law, becomes, without more, bound by the terms and provisions of this Agreement or, if not so bound, executes, prior to or contemporaneously
with the consummation of such transaction, a trust agreement supplemental hereto and such other instruments (if any) as are necessary
or advisable to evidence the assumption by the Akerna Successor of liability for all moneys payable and property deliverable hereunder
and the covenant of such Akerna Successor to pay and deliver or cause to be paid and delivered the same and its agreement to observe
and perform all the covenants and obligations of Akerna under this Agreement; and

 

		(b)	such transaction shall be upon such terms and conditions as to substantially preserve and not impair
any of the rights, duties, powers and authorities of the Trustee or the holders of the Exchangeable Shares.

 

    E-23

     

    

 

		10.2	Vesting of Powers in Successor

 

Whenever the conditions of Section 10.1
have been duly observed and performed, the parties, if required by Section 10.1, shall execute and deliver the supplemental trust
agreement provided for in Section 10.1(a) and thereupon the Akerna Successor and such other person that may then be the issuer
of the Akerna Shares shall possess and from time to time may exercise each and every right and power of Akerna under this Agreement
in the name of Akerna or otherwise and any act or proceeding by any provision of this Agreement required to be done or performed
by the board of directors of Akerna or any officers of Akerna may be done and performed with like force and effect by the directors
or officers of such Akerna Successor.

 

		10.3	Wholly-Owned Subsidiaries

 

Nothing herein shall be construed as preventing:
(a) the amalgamation or merger of any wholly-owned direct or indirect subsidiary of Akerna (other than Exchangeco or Callco) with
or into Akerna; (b) the winding-up, liquidation or dissolution of any wholly-owned direct or indirect subsidiary of Akerna (other
than Exchangeco or Callco), provided that all of the assets of such subsidiary are transferred to Akerna or another wholly-owned
direct or indirect subsidiary of Akerna; (c) any other distribution of the assets of any wholly-owned direct or indirect subsidiary
of Akerna among the shareholders of such subsidiary for the purpose of winding up its affairs; and (d) any such transactions which
are expressly permitted by this Article 10.

 

		10.4	Successor Transactions

 

Notwithstanding the foregoing provisions
of this Article 10, in the event of an Akerna Control Transaction:

 

		(a)	in which Akerna merges or amalgamates with, or in which all or substantially all of the then outstanding
Akerna Shares are acquired by, one or more other corporations to which Akerna is, immediately before such merger, amalgamation
or acquisition, “related” within the meaning of the Income Tax Act (Canada) (otherwise than by virtue of a right
referred to in paragraph 251(5)(b) thereof);

 

		(b)	which does not result in an acceleration of the Redemption Date in accordance with paragraph (ii)
of the definition of Redemption Date in the Exchangeable Share Provisions; and

 

		(c)	in which all or substantially all of the then outstanding Akerna Shares are converted into or exchanged
for shares or rights to receive such shares (the “Other Shares”) of another corporation (the “Other Corporation”)
that, immediately after such Akerna Control Transaction, owns or controls, directly or indirectly, Akerna;

 

then: (i) all references herein to “Akerna”
shall thereafter be and be deemed to be references to “Other Corporation” and all references herein to “Akerna Shares”
shall thereafter be and be deemed to be references to “Other Shares” (with appropriate adjustments, if any, as are required
to result in a holder of Exchangeable Shares on the exchange, redemption or retraction of such shares pursuant to the Exchangeable
Share Provisions or the Plan of Arrangement or the exchange of such shares pursuant to this Agreement immediately subsequent to
the Akerna Control Transaction being entitled to receive that number of Other Shares equal to the number of Other Shares such holder
of Exchangeable Shares would have received if the exchange, redemption or retraction of such shares pursuant to the Exchangeable
Share Provisions or the Plan of Arrangement, or the exchange of such shares pursuant to this Agreement had occurred immediately
prior to the Akerna Control Transaction and the Akerna Control Transaction was completed) but subject to subsequent adjustments
to reflect any subsequent changes in the share capital of the issuer of the Other Shares, including without limitation, any subdivision,
consolidation or reduction of share capital, without any need to amend the terms and conditions of this Agreement and without any
further action required; and (ii) Akerna shall cause the Other Corporation to deposit one or more voting securities of such Other
Corporation to allow Beneficiaries to exercise voting rights in respect of the Other Corporation substantially similar to those
provided for in this Agreement.

 

    E-24

     

    

 

Article
11

AMENDMENTS AND SUPPLEMENTAL TRUST AGREEMENTS

 

		11.1	Amendments, Modifications, etc.

 

Subject to Section 11.2, 11.4 and 13.1
this Agreement may not be amended or modified except by an agreement in writing executed by Akerna, Callco, Exchangeco and the
Trustee and approved by the Beneficiaries in accordance with Section 11(b) of the Exchangeable Share Provisions.

 

		11.2	Ministerial Amendments

 

Notwithstanding the provisions of Section
11.1, the parties to this Agreement may in writing, at any time and from time to time, without the approval of the Beneficiaries,
amend or modify this Agreement for the purposes of:

 

		(a)	adding to the covenants of any or all parties hereto for the protection of the Beneficiaries hereunder
provided that the board of directors of each of Akerna, Callco and Exchangeco shall be of the good faith opinion that such additions
will not be prejudicial to the rights or interests of the Beneficiaries;

 

		(b)	evidencing the succession of Akerna Successors and the covenants of and obligations assumed by
each such Akerna Successor in accordance with the provisions of Article 10;

 

		(c)	making such amendments or modifications not inconsistent with this Agreement as may be necessary
or desirable with respect to matters or questions arising hereunder which, in the good faith opinion of the board of directors
of each of Akerna, Callco and Exchangeco and in the opinion of the Trustee it may be expedient to make, provided that each such
board of directors and the Trustee shall be of the good faith opinion, after consultation with counsel, that such amendments or
modifications will not be prejudicial to the rights or interests of the Beneficiaries; or

 

		(d)	making such changes or corrections which, on the advice of counsel to Akerna, Callco, Exchangeco
and the Trustee, are required for the purpose of curing or correcting any ambiguity or defect or inconsistent provision or clerical
omission or mistake or manifest error, provided that each such board of directors and the Trustee shall be of the good faith opinion
that such changes or corrections will not be prejudicial to the rights or interests of the Beneficiaries.

 

		11.3	Meeting to Consider Amendments

 

Exchangeco, at the request of Akerna, shall
call a meeting or meetings of the Beneficiaries for the purpose of considering any proposed amendment or modification requiring
approval pursuant hereto. Any such meeting or meetings shall be called and held in accordance with the articles of Exchangeco,
the Exchangeable Share Provisions and all applicable laws.

 

		11.4	Changes in Capital of Akerna and Exchangeco

 

Notwithstanding the provisions of Section
11.1, at all times after the occurrence of any event contemplated pursuant to Sections 2.7 or 2.8 of the Support Agreement or otherwise,
as a result of which either Akerna Shares or the Exchangeable Shares or both are in any way changed, this Agreement shall forthwith
be amended and modified as necessary in order that it shall apply with full force and effect, mutatis mutandis, to all new
securities into which Akerna Shares or the Exchangeable Shares or both are so changed and the parties hereto shall execute and
deliver a supplemental trust agreement giving effect to and evidencing such necessary amendments and modifications.

 

    E-25

     

    

 

		11.5	Execution of Supplemental Trust Agreements

 

No amendment to or modification or waiver
of any of the provisions of this Agreement otherwise permitted hereunder shall be effective unless made in writing and signed by
all of the parties hereto. Notwithstanding the provisions of Section 11.1, from time to time Akerna, Callco and Exchangeco (in
each case, when authorized by a resolution of its board of directors) and the Trustee may, subject to the provisions of these presents,
and they shall, when so directed by these presents, execute and deliver by their proper officers, trust agreements or other instruments
supplemental hereto, which thereafter shall form part hereof, for any one or more of the following purposes:

 

		(a)	evidencing the succession of Akerna Successors and the covenants of and obligations assumed by
each such Akerna Successor in accordance with the provisions of Article 10 and the successors of the Trustee or any successor trustee
in accordance with the provisions of Article 9;

 

		(b)	making any additions to, deletions from or alterations of the provisions of this Agreement or the
Voting Rights, the Exchange Right, the Put Right or the Automatic Exchange Right which, in the opinion of the Trustee, will not
be prejudicial to the interests of the Beneficiaries or are, in the opinion of counsel to the Trustee, necessary or advisable in
order to incorporate, reflect or comply with any legislation the provisions of which apply to Akerna, Callco, Exchangeco, the Trustee
or this Agreement; and

 

		(c)	for any other purposes not inconsistent with the provisions of this Agreement, including without
limitation to make or evidence any amendment or modification to this Agreement as contemplated hereby; provided that, in the opinion
of the Trustee, the rights of the Trustee and Beneficiaries will not be prejudiced thereby.

 

Article
12

TERMINATION

 

		12.1	Term

 

The Trust created by this Agreement shall
continue until the earliest to occur of the following events:

 

		(a)	no outstanding Exchangeable Shares are held by a Beneficiary;

 

		(b)	each of Akerna, Callco and Exchangeco elects in writing to terminate the Trust and such termination
is approved by the Beneficiaries in accordance with Section 11(b) of the Exchangeable Share Provisions; and

 

		(c)	21 years after the death of the last survivor of the descendants of His Majesty King George VI
of Canada and the United Kingdom of Great Britain and Northern Ireland living on the date of the creation of the Trust.

 

		12.2	Survival of Agreement

 

This Agreement shall survive any termination
of the Trust and shall continue until there are no Exchangeable Shares outstanding held by a Beneficiary; provided, however, that
the provisions of Article 7 and Article 8 shall survive any such termination of this Agreement.

 

    E-26

     

    

 

Article
13

GENERAL

 

		13.1	Severability

 

If any term or other provision of this
Agreement is invalid, illegal or incapable of being enforced by any rule or law, or public policy, all other conditions and provisions
of this Agreement shall nevertheless remain in full force and effect so long as the economic or legal substance of the transactions
contemplated hereby is not affected in any manner materially adverse to any party. Upon such determination that any term or other
provision is invalid, illegal or incapable of being enforced, the parties hereto shall negotiate in good faith to modify this Agreement
so as to effect the original intent of the parties as closely as possible in an acceptable manner to the end that the transactions
contemplated hereby are fulfilled to the fullest extent possible.

 

		13.2	Escrow Agreement

 

Notwithstanding any other provision hereof,
the parties hereto acknowledge and agree that the Exchangeable Shares and Akerna Shares are, as at the date hereof, subject to
the terms and conditions of the Escrow Agreement (as defined in the Arrangement Agreement), and for so long as such shares continue
to be subject to the Escrow Agreement, any transfer or exchange of Exchangeable Shares pursuant to this Agreement will be made
subject to the Escrow Agreement and any Exchangeable Share Consideration issued in respect of Exchangeable Shares will be subject
to the Escrow Agreement.

 

		13.3	Enurement

 

This Agreement shall be binding upon and
enure to the benefit of the parties hereto and their respective successors and assigns and, subject to the terms hereof, to the
benefit of the Beneficiaries.

 

		13.4	Notices to Parties

 

Any notice and other communications required
or permitted to be given pursuant to this Agreement shall be sufficiently given if delivered in person or if sent by facsimile
transmission (provided such transmission is recorded as being transmitted successfully) to the parties at the following addresses:

 

		(a)	In the case of Akerna, at the following address:

 

Akerna Corp.

1601 Arapahoe Street

Denver, CO 80202

 

	Attention:	Scott Sozio, President
	Email:	scott.sozio@akerna.com

 

with copies (which shall not constitute notice) to:

 

Dentons Canada LLP

15th Floor, Bankers Court, 850 – 2nd Street S.W.

Calgary, Alberta T2P 0R8

 

	Attention:	Courtney Burton
	Email:	courtney.burton@dentons.com

 

    E-27

     

    

 

		(b)	In the case of Callco or Exchangeco, at the following addresses:

 

Akerna Corp.

1601 Arapahoe Street

Denver, CO 80202

 

	Attention:	Scott Sozio, President
	Email:	scott.sozio@akerna.com

 

with copies (which shall not constitute notice) to:

 

Dentons Canada LLP

15th Floor, Bankers Court, 850 – 2nd Street S.W.

Calgary, Alberta T2P 0R8

 

	Attention:	Courtney Burton
	Email:	courtney.burton@dentons.com

 

		(c)	In the case of Trustee, at the following addresses:

 

●

 

	Attention:	●
	Facsimile:	●

  

and such notice or other communication
shall be deemed to have been given and received: (x) if delivered on a Business Day prior to 5:00 p.m. (local time in the place
where the notice or other communication is received), on the date of delivery; or (y) otherwise, on the next Business Day. Either
party may change its address for notice by giving notice to the other parties in accordance with the foregoing provisions.

 

		13.5	Notice to Beneficiaries

 

Any notice, request or other communication
to be given to a Beneficiary shall be given or sent to the address of the holder recorded in the securities register of Exchangeco
or, in the event of the address of any such holder not being so recorded, then at the last known address of such holder, in any
manner permitted by the articles of Exchangeco, and shall be deemed received at the time specified by such articles. Accidental
failure or omission to give any notice, request or other communication to one or more holders of Exchangeable Shares, or any defect
in such notice, shall not invalidate or otherwise alter or affect any action or proceeding to be taken pursuant thereto.

 

		13.6	Counterparts

 

This Agreement may be executed in counterparts,
each of which shall be deemed an original, but all of which taken together shall constitute one and the same instrument.

 

		13.7	Jurisdiction

 

This Agreement shall be construed and enforced
in accordance with the laws of the Province of Ontario and the laws of Canada applicable therein.

 

		13.8	Attornment

 

Each of Akerna, Callco, Exchangeco and
the Trustee agrees that any action or proceeding arising out of or relating to this Agreement may be instituted in the courts of
Ontario, waives any objection which it may have now or hereafter to the venue of any such action or proceeding, irrevocably submits
to the non-exclusive jurisdiction of the said courts in any such action or proceeding, agrees to be bound by any judgement of the
said courts and not to seek, and hereby waives, any review of the merits of any such judgement by the courts of any other jurisdiction,
and Akerna hereby appoints Exchangeco at its registered office in the Province of Ontario as attorney for service of process.

 

[Remainder of this page left intentionally
blank]

 

    E-28

     

    

 

IN WITNESS WHEREOF, the parties hereto
have caused this Agreement to be duly executed as of the date first above written.

 

	 	AKERNA CORP.
	 	 	 
	 	By:	
	 	 	Name: 
	 	 	Title:
	 	 	 
	 	2732804 ONTARIO INC.
	 	 	 
	 	By:	
	 	 	Name: 
	 	 	Title:
	 	 	 
	 	2732805 ONTARIO INC.
	 	 	 
	 	By:	
	 	 	Name: 
	 	 	Title:
	 	 	 
	 	CONTINENTAL STOCK TRANSFER &
    TRUST COMPANY, INC.
	 	 	 
	 	By:	
	 	 	Name: 
	 	 	Title:
	 	 	 
	 	By:	
	 	 	Name: 
	 	 	Title:

 

    E-29

     

    

  

SCHEDULE “F”

Form
of Rights Indenture

 

 

 

 

 

 

 

 

AKERNA CORP.

 

– and –

 

2732805 ONTARIO INC.

 

– and –

 

JOHN PRENTICE

 

– and –

 

CONTINENTAL STOCK TRANSFER & TRUST
COMPANY, INC.

 

RIGHTS INDENTURE

 

Providing for the Issue of Certain Contingent
Value Rights

 

 

 

 

 

 

 

 

     

     

    

 

TABLE OF CONTENTS

 

	 	Page
	 	 
	ARTICLE 1 INTERPRETATION	2
	 	 	 
	1.1	DEFINITIONS	2
	1.2	MEANING OF “OUTSTANDING” FOR CERTAIN PURPOSES	5
	1.3	CERTAIN RULES OF INTERPRETATION	5
	1.4	INTERPRETATION NOT AFFECTED BY HEADINGS, ETC.	6
	1.5	APPLICABLE LAW	6
	1.6	DAY NOT A BUSINESS DAY	6
	1.7	CONFLICT	6
	1.8	TIME OF THE ESSENCE	6
	1.9	CURRENCY	6
	1.10	SCHEDULES	6
	 	 	 
	ARTICLE 2 ISSUE OF RIGHTS	6
	 	 	 
	2.1	CREATION AND ISSUE OF RIGHTS	6
	2.2	TERMS OF RIGHTS	7
	2.3	RIGHTS CERTIFICATES	7
	2.4	SIGNING OF RIGHTS CERTIFICATES	8
	2.5	CERTIFICATION BY THE RIGHTS AGENT	8
	2.6	HOLDER NOT A SHAREHOLDER	8
	2.7	ISSUE IN SUBSTITUTION FOR LOST RIGHTS CERTIFICATE	9
	2.8	REGISTER FOR RIGHTS	9
	2.9	TRANSFER OF RIGHTS	9
	2.10	TRANSFEREE ENTITLED TO REGISTRATION	10
	2.11	REGISTERS OPEN FOR INSPECTION	11
	2.12	OWNERSHIP OF RIGHTS	11
	2.13	EXCHANGE OF RIGHTS CERTIFICATES	11
	2.14	PRINCIPAL OFFICE	12
	 	 	 
	ARTICLE 3 DELIVERY OF DEFERRED CONSIDERATION	12
	 	 	 
	3.1	METHOD OF DELIVERY OF DEFERRED CONSIDERATION	12
	3.2	PAYMENT MECHANISM	12
	3.3	CANCELLATION OF RIGHTS	13
	3.4	RIGHTS VOID	13
	3.5	ACCOUNTING AND RECORDING	13
	 	 	 
	ARTICLE 4 COVENANTS OF AKERNA AND EXCHANGECO	13
	 	 	 
	4.1	MAINTENANCE	13
	4.2	TO PAY RIGHTS AGENT REMUNERATION AND EXPENSES	13
	4.3	TO PERFORM COVENANTS	14
	4.4	RIGHTS AGENT MAY PERFORM COVENANTS	14
	4.5	CREATION AND ISSUE OF THE RIGHTS	14

 

    i

     

    

 

	ARTICLE 5 ROLE OF RIGHTS AGENT	14
	 	 	 
	5.1	ROLE AS RIGHTS AGENT	14
	 	 	 
	ARTICLE 6 ENFORCEMENT	15
	 	 	 
	6.1	SUITS BY HOLDERS OF RIGHTS	15
	6.2	WAIVER OF DEFAULT	15
	 	 	 
	ARTICLE 7 SUCCESSOR ENTITIES	15
	 	 	 
	7.1	CERTAIN REQUIREMENTS	15
	7.2	VESTING OF POWERS IN SUCCESSOR ENTITY	15
	 	 	 
	ARTICLE 8 NOTICES	16
	 	 	 
	8.1	NOTICE TO AKERNA AND THE RIGHTS AGENT	16
	 	 	 
	ARTICLE 9 CONCERNING THE RIGHTS AGENT	17
	 	 	 
	9.1	NO CONFLICT OF INTEREST	17
	9.2	REPLACEMENT OF RIGHTS AGENT	17
	9.3	EVIDENCE, EXPERTS AND ADVISERS	17
	9.4	RIGHTS AGENT MAY DEAL IN SECURITIES	18
	9.5	RIGHTS AGENT NOT ORDINARILY BOUND	18
	9.6	RIGHTS AGENT NOT REQUIRED TO GIVE SECURITY	18
	9.7	RIGHTS AGENT NOT REQUIRED TO GIVE NOTICE OF DEFAULT	18
	9.8	ACCEPTANCE OF APPOINTMENT	19
	9.9	DUTIES OF RIGHTS AGENT	19
	9.10	ACTIONS BY RIGHTS AGENT	19
	9.11	PROTECTION OF RIGHTS AGENT	20
	9.12	INDEMNIFICATION OF THE RIGHTS AGENT	20
	9.13	THIRD PARTY INTERESTS	20
	9.14	NOT BOUND TO ACT / ANTI-MONEY LAUNDERING	20
	9.15	PRIVACY LAWS	21
	9.16	FORCE MAJEURE	21
	 	 	 
	ARTICLE 10 SUPPLEMENTAL INDENTURES	21
	 	 	 
	10.1	SUPPLEMENTAL INDENTURES	21
	 	 	 
	ARTICLE 11 GENERAL PROVISIONS	22
	 	 	 
	11.1	EXECUTION	22
	11.2	AMENDMENT	22
	11.3	FORMAL DATE	22
	11.4	SATISFACTION AND DISCHARGE OF INDENTURE	22
	11.5	PROVISIONS OF INDENTURE AND RIGHTS FOR THE SOLE BENEFIT OF PARTIES AND HOLDERS	22
	11.6	WITHHOLDING	22

 

	SCHEDULE “A” – FORM OF RIGHTS CERTIFICATE

 

    ii

     

    

 

THIS RIGHTS INDENTURE dated as of [l],
2020

 

BETWEEN:

 

AKERNA CORP.,

 

a corporation existing under the laws
of the State of Delaware

(“Akerna”)

 

- AND –

 

2732805 ONTARIO INC.

 

a corporation existing under the laws
of the Province of Ontario

(“Exchangeco”)

 

- AND –

 

JOHN PRENTICE,

 

an individual resident in the Province
of Ontario

(the “Shareholder Representative”)

 

- AND –

 

CONTINENTAL STOCK TRANSFER & TRUST
COMPANY, INC.,

 

a trust company existing under the federal
laws of Canada

(the “Rights Agent”)

 

WHEREAS:

 

		A.	All capitalized terms used in these recitals have the meanings ascribed to them in Section 1.1
below;

 

		B.	Akerna, Ample, Exchangeco and the Shareholder Representative have entered into the Arrangement
Agreement;

 

		C.	Pursuant to the terms of the Arrangement Agreement and the Plan of Arrangement, Akerna and Exchangeco
proposes to issue to the Ample Shareholders the Rights on the terms and conditions herein set forth;

 

		D.	Each Right shall entitle the Holder to receive, without payment of any further consideration and
without further action on the part of the holder thereof, a portion of the Deferred Consideration, which portion shall be determined
in accordance with the Arrangement Agreement and the terms and conditions herein set forth;

 

     

     

    

 

		E.	Akerna and Exchangeco are each duly authorized to create and issue the Rights to be issued as herein
provided;

 

		F.	All things necessary have been done and performed to make the Rights, when issued as provided in
this Indenture, legal, valid and binding upon Akerna and Exchangeco with the benefits of and subject to the terms of this Indenture;

 

		G.	The foregoing recitals are made as representations and statements of fact by Akerna and Exchangeco
and not by the Rights Agent; and

 

		H.	The Rights Agent has agreed to act as the rights agent in respect of the Rights on behalf of the
Holders on the terms and conditions herein set forth;

 

NOW THEREFORE THIS INDENTURE WITNESSES
that for good and valuable consideration mutually given and received, the receipt and sufficiency of which are hereby acknowledged,
it is hereby agreed and declared as follows:

 

ARTICLE
1

INTERPRETATION

 

		1.1	DEFINITIONS

 

In this Indenture, including the recitals
and schedules hereto, the following words and phrases shall have the following meanings:

 

		(a)	“Akerna Shares” means the shares in the common stock in the share capital of
Akerna;

 

		(b)	“Allocation Notice” has the meaning ascribed thereto in Section 3.2(a);

 

		(c)	“Ample” means Ample Organics Inc.;

 

		(d)	“Ample Common Shareholders” means the holders of Ample Common Shares immediately
prior to the Closing Time;

 

		(e)	“Ample Common Shares” means the Common Shares in the authorized capital of Ample;

 

		(f)	“Ample Preferred Shareholders” means the holders of Ample Preferred Shares immediately
prior to the Closing Time;

 

		(g)	“Ample Preferred Shares” means each issued and outstanding Class A Preferred
Share in the capital of Ample, being all issued and outstanding Class A-1 Preferred Shares, Class A-2 Preferred Shares and Class
A-3 Preferred Shares;

 

		(h)	“Ample Shareholders” means collectively the Ample Common Shareholders and the
Ample Preferred Shareholders;

 

		(i)	“Arrangement” means an arrangement under the Business Corporations Act
(Ontario) on the terms and subject to the conditions set out in the Plan of Arrangement, subject to any amendments or any variations
to the Plan of Arrangement made in accordance with the terms of the Arrangement Agreement;

 

    F-2

     

    

 

		(j)	“Arrangement Agreement” means the arrangement agreement dated December 18, 2019
between Akerna, Ample, Exchangeco and the Shareholder Representative in respect of the Arrangement, as such agreement may be amended
from time to time;

 

		(k)	“Articles” means the certificate and articles of amendment of Ample dated October
1, 2019;

 

		(l)	“Business Day” means any day, other than Saturday, Sunday or a statutory holiday
in the Province of Alberta;

 

		(m)	“Closing Date” means the date hereof;

 

		(n)	“Closing Time” means the time at which the Arrangement becomes effective on
the Closing Date pursuant to the Business Corporations Act (Ontario);

 

		(o)	“Counsel” means a barrister or solicitor or firm of barristers or solicitors
retained by the Rights Agent or retained or employed by Akerna and acceptable to the Rights Agent, acting reasonably;

 

		(p)	“Court” means the Ontario Superior Court of Justice;

 

		(q)	“Deferred Consideration” means $10,000,000, payable in Exchangeable Shares;
provided that in the event the Recurring Revenue recognized during the Deferred Consideration Period is less than $9,000,000, the
Deferred Consideration amount of $10,000,000 shall be reduced by an amount equal to the product of $6.67 multiplied by the difference
between $9,000,000 and the amount of Recurring Revenue realized during the Deferred Consideration Period (up to a maximum reduction
of $10,000,000), all as calculated in the Deferred Consideration Statement finally determined in accordance with the Arrangement
Agreement;

 

		(r)	“Deferred Consideration Payment Date” means the date that the Deferred Consideration
is payable by Akerna and Exchangeco to the Rights Agent in accordance with Section 2.19 of the Arrangement Agreement;

 

		(s)	“Deferred Consideration Period” means the period of time beginning on the Closing
Date, and ending on the date that is 12 months after the Closing Date;

 

		(t)	“Deferred Consideration Statement” has the meaning ascribed thereto in the Arrangement
Agreement;

 

		(u)	“Director” means a director of Akerna and “Directors” or
“Board of Directors” means the board of directors of Akerna or, whenever duly empowered, a committee of the
board of directors of Akerna, and reference to “action by the directors” means action by the directors of Akerna
as a board or action by a committee as a committee;

 

		(v)	“distributions” means distributions (payable in cash or in securities, property
or assets of equivalent value) declared payable on Exchangeable Shares;

 

		(w)	“Exchange Rate” means, on any date of determination, the CAD/USD daily exchange
rate quoted by the Bank of Canada three Business Days prior to such date;

 

    F-3

     

    

 

		(x)	“Exchangeable Shares” means the redeemable preferred shares in the capital of
Exchangeco;

 

		(y)	“Exchangeco” means 2732805 Ontario Inc.;

 

		(z)	“Holder” means a Person for the time being who is the registered holder of a
Right;

 

		(aa)	“Indenture” or “this Indenture” and “hereto”,
“herein”, “hereby”, “hereunder”, “hereof” and similar
expressions refer to this instrument and not to any particular Article, Section, clause, subdivision or other portion hereof, and
include each instrument supplemental or ancillary hereto or required to implement this instrument;

 

		(bb)	“NASDAQ” means the National Association of Securities Dealers Automated Quotations
exchange;

 

		(cc)	“Permitted Transfer” means a transfer of Rights (i) upon death of a Holder by
will or intestacy; (b) pursuant to a court order; or (c) by operation of law (including any consolidation or merger) or without
consideration in connection with the dissolution, liquidation or termination of any corporation, limited liability company, partnership
or other entity;

 

		(dd)	“Person” includes any individual, corporation, company, partnership, association,
joint venture, trust, unincorporated association, government or governmental authority;

 

		(ee)	“Plan of Arrangement” means the plan of arrangement attached as Schedule “C”
to the Arrangement Agreement, as amended from time to time;

 

		(ff)	“Recurring Revenue” means all revenue that is derived from or that is associated
with license revenue from Ample’s core seed-to-sale, AmpleCentral and “Last Call Analytics” products;

 

		(gg)	“Regulatory Authorities” means securities regulatory authorities in Canada, the United States and/or a jurisdiction
outside Canada and the United States where a Holder is resident;

 

		(hh)	“Rights” mean the contingent value rights issued and certified hereunder and
for the time being outstanding, entitling Holders thereof to receive Exchangeable Shares, in accordance with the terms hereof,
and “Right” means any one of them;

 

		(ii)	“Rights Agency” means the transfer office of the Rights Agent in [l]
and such other locations as Akerna may designate, with the approval of the Rights Agent;

 

		(jj)	“Rights Agent” means Continental Stock Transfer & Trust Company, Inc. or its successor or successors
for the time being as rights agent hereunder, at its offices in [l];

 

		(kk)	“Rights Certificate” means a certificate in substantially the form set out in
Schedule “A” hereto, issued and certified hereunder to evidence a Right;

 

		(ll)	“Successor Entity” has the meaning ascribed thereto in Section 7.1;

 

    F-4

     

    

 

		(mm)	“Termination Date” means the date that Akerna and/or Exchangeco fully pays to
the Holders all Deferred Consideration to which such holders are entitled;

 

		(nn)	“United States” means the United States of America, its territories and possessions,
any State of the United States, and the District of Columbia;

 

		(oo)	“U.S. Person” means a “U.S. person” as that term is defined in Rule
902(k) of Regulation S of the U.S. Securities Act;

 

		(pp)	“U.S. Securities Act” means the United States Securities Act of 1933, as
amended;

 

		(qq)	“U.S. Securities Exchange Act” means the United States Securities Exchange
Act of 1934;

 

		(rr)	“written request of Akerna” and “certificate of Akerna” mean,
respectively, a written order, request, consent and certificate signed in the name of Akerna by any one or more of the officers
or Directors of Akerna and may consist of one or more instruments so executed and any other documents referred to herein which
is required or contemplated to be provided or given by Akerna is a document signed on behalf of Akerna by any one or more of such
officers or Directors;

 

and a derivative of any defined word or
phrase has the meaning appropriate to the derivation of the word or phrase.

 

		1.2	MEANING OF “OUTSTANDING” FOR CERTAIN PURPOSES

 

Except as provided in Section 3.4, every
Rights Certificate countersigned and delivered by the Rights Agent under this Indenture shall be deemed to be outstanding until
the Termination Date, provided however that where a Rights Certificate has been issued in substitution for a Rights Certificate
that has been lost, stolen or destroyed, only one of them shall be counted for the purpose of determining the Rights outstanding.

 

		1.3	CERTAIN RULES OF INTERPRETATION

 

Unless otherwise specified in this Indenture:

 

		(a)	words importing the singular number include the plural and vice versa;

 

		(b)	words importing gender include both genders and vice versa and words importing individuals
include firms and corporations and vice versa;

 

		(c)	“in writing” or “written” includes printing, typewriting
or any electronic means of communication capable of being visibly reproduced at the point of reception, including facsimile;

 

		(d)	“including” is used for illustration only and not to limit the generality of
any preceding words, whether or not non-limiting language (such as, “without limitation”, “but not
limited to” and similar expressions) is used with reference thereto; and

 

		(e)	reference to any statute, regulation or by-law includes amendments, consolidations, re-enactments
and replacements thereof and instruments and legislation thereunder.

 

    F-5

     

    

 

		1.4	INTERPRETATION NOT AFFECTED BY HEADINGS, ETC.

 

The division of this Indenture into Articles,
Sections and other subdivisions, the inclusion of a table of contents and the insertion of headings are for convenience of reference
only and do not affect the construction or interpretation of this Indenture.

 

		1.5	APPLICABLE LAW

 

This Indenture, the Rights and the Rights
Certificates shall be governed by and construed in accordance with the laws of the Province of Ontario and the federal laws of
Canada applicable therein. Any and all disputes arising under this Indenture, the Rights and the Rights Certificates, whether as
to interpretation, performance or otherwise, shall be subject to the non-exclusive jurisdiction of the courts of the Province of
Ontario and each of the parties hereto irrevocably attorns to the jurisdiction of the courts of such province.

 

		1.6	DAY NOT A BUSINESS DAY

 

Whenever any payment is due or required
to be made or any other action is required to be taken under this Indenture or the Rights Certificates on or as of a day that is
not a Business Day, that payment must be made and the other action must be taken on or as of the next day that is a Business Day.

 

		1.7	CONFLICT

 

In the event of a conflict or inconsistency
between a provision of this Indenture and in the Rights Certificates issued hereunder, the relevant provision in this Indenture
shall prevail to the extent of the inconsistency.

 

		1.8	TIME OF THE ESSENCE

 

Time shall be of the essence of this Indenture,
the Rights and the Rights Certificates.

 

		1.9	CURRENCY

 

Except as otherwise stated, all dollar
amounts herein are expressed in Canadian dollars.

 

		1.10	SCHEDULES

 

Schedule “A” to this Indenture
is incorporated into this Indenture by reference.

 

ARTICLE
2

ISSUE OF RIGHTS

 

		2.1	CREATION AND ISSUE OF RIGHTS

 

		(a)	The Rights Agent is hereby appointed rights agent in respect of the Rights.

 

		(b)	Pursuant to the Arrangement Agreement and the Plan of Arrangement, each Ample Shareholder immediately
prior to the Closing Time (other than any Ample Shareholder that validly exercised dissent rights in connection with the Arrangement
and which dissent right remains valid immediately prior to the Closing Time) shall be entitled to a Right upon the Closing Time.

 

    F-6

     

    

 

		(c)	Pursuant to the Arrangement Agreement and the Plan of Arrangement, to the extent that an Ample
Shareholder who has validly exercised dissent rights in connection with the Arrangement is ultimately deemed to have participated
in the Arrangement on the same basis as a non-dissenting Ample Shareholder, Akerna and Exchangeco shall cause the Rights Agent
to forward the Rights to such Holder, pursuant to the Arrangement Agreement and the Plan of Arrangement and upon the written request
of Akerna.

 

		2.2	TERMS OF RIGHTS

 

		A.	Each Right shall entitle the Holder thereof to receive that portion of the Deferred Consideration
that the initial Holder of such Right is entitled to receive in its capacity as an Ample Shareholder pursuant to the Articles.
The amount of the entitlement attaching to each Right shall be determined in accordance with the Articles and the Plan of Arrangement
by the Shareholder Representative acting reasonably and with reference to the shareholder register of Ample delivered by Ample
as of the Effective Time in accordance with the Arrangement Agreement.

 

		(b)	Akerna and Exchangeco shall remit any Deferred Consideration accruing to a Holder on or before
the Deferred Consideration Payment Date by delivery of Exchangeable Shares in accordance with Section 3.2.

 

		(c)	Subject to the terms and conditions of this Indenture, all Rights shall rank pari passu, whatever
may be the actual date of issue thereof.

 

		(d)	The Rights shall terminate in accordance with the provisions of Section 3.4 and the Plan of Arrangement.

 

		2.3	RIGHTS CERTIFICATES

 

		(a)	The Rights Certificates to be issued to evidence the Rights authorized for issuance pursuant to
Section 2.1 shall be issuable in registered form only and shall be substantially in the form set out in Schedule “A”.

 

		(b)	All Rights Certificates shall be dated as of the date of their issuance, and shall bear such distinguishing
letters and numbers as Akerna may, with the approval of the Rights Agent, prescribe.

 

		(c)	Rights Certificates shall continue to be in the form set out in Schedule “A” and shall
continue to express the Deferred Consideration deliverable thereunder.

 

		(d)	Akerna covenants that (i) the Rights and the Exchangeable Shares issuable pursuant to the Rights
shall be registered or qualified for distribution, or exempt from or not subject to any requirement for registration or qualification
for distribution, under the U.S. Securities Act and the applicable securities laws of U.S. states and (ii) such securities shall
not be “restricted securities” within the meaning of Rule 144 under the U.S. Securities Act or under any other U.S.
federal or state securities laws.

 

    F-7

     

    

 

		(e)	Any certificates representing Rights, and, if applicable, any certificates representing Exchangeable
Shares issued pursuant to the Rights, and any certificates issued in replacement thereof or in substitution therefor, shall, until
such time as the same is no longer required under applicable requirements of the U.S. Securities Act or applicable state securities
laws, bear a legend in substantially the following form:

 

THE SECURITIES
REPRESENTED HEREBY [For Rights Include: AND THE SECURITIES ISSUABLE PURSUANT THERETO] ARE SUBJECT TO THE TERMS AND CONDITIONS OF
(I) AN ARRANGEMENT AGREEMENT DATED AS OF [●], 2019 AND (II) A RIGHTS INDENTURE DATED AS OF [●], 2020, INCLUDING TERMS
AND CONDITIONS THAT RESTRICT THE SALE, ASSIGNMENT, PLEDGE, ENCUMBRANCE, TRANSFER, OR DISPOSITION OF SUCH SECURITIES.

 

		2.4	SIGNING OF RIGHTS CERTIFICATES

 

The Rights Certificates shall be signed
by any Director or officer of each of Akerna and Exchangeco at or prior to the date of issue of such Rights Certificate and the
date of certification or delivery thereof. The signature of such signing officer may be mechanically reproduced in facsimile or
electronically and Rights Certificates bearing such facsimile or electronic signature shall be binding upon Akerna and Exchangeco
as if they had been manually signed by such signing officer. Notwithstanding that any individual whose manual, facsimile or electronic
signature appears on any Rights Certificate as a signing officer may no longer hold office or a trusteeship, as applicable, at
the date of issue of such Rights Certificate or at the date of certification or delivery thereof, any Rights Certificate signed
as aforesaid shall, subject to Section 2.5, be valid and binding upon Akerna, Exchangeco and the Holder thereof shall be entitled
to the benefits of this Indenture.

 

		2.5	CERTIFICATION BY THE RIGHTS AGENT

 

		(a)	Rights Certificates evidencing the Rights shall be certified by or on behalf of the Rights Agent
on written direction of Akerna.

 

		(b)	No Rights Certificate shall be issued or, if issued, shall be valid for any purpose or entitle
the Holder to the benefits hereof until it has been certified by manual signature by or on behalf of the Rights Agent substantially
in the form of the certificate set out in Schedule “A”, and such certification by the Rights Agent upon any Rights
Certificate shall be conclusive evidence as against Akerna and Exchangeco that the Rights Certificate so certified has been duly
issued hereunder and that the Holder is entitled to the benefits hereof.

 

		(c)	The certification of the Rights Agent on Rights Certificates issued hereunder shall not be construed
as a representation or warranty by the Rights Agent as to the validity of this Indenture or the Rights Certificates (except the
due certification thereof) and the Rights Agent shall in no respect be liable or answerable for the use made of the Rights Certificates
or any of them or of the consideration therefor except as otherwise specified herein.

 

		2.6	HOLDER NOT A SHAREHOLDER

 

Nothing in this Indenture or in the holding
of a Right itself evidenced by a Rights Certificate, or otherwise, shall be construed as conferring upon a Holder any right or
interest whatsoever as a shareholder of Akerna or Exchangeco, including, but not limited to, the right to vote at, to receive notice
of, or to attend, meetings of shareholders or any other proceedings of Akerna or Exchangeco, or the right to receive distributions,
except as may be provided herein or in the Rights Certificates.

 

    F-8

     

    

 

		2.7	ISSUE IN SUBSTITUTION FOR LOST RIGHTS CERTIFICATE

 

		(a)	If any of the Rights Certificates shall become mutilated or lost, destroyed or stolen, Akerna and
Exchangeco, subject to applicable law and to Subsection 2.7(b), shall issue and thereupon the Rights Agent shall certify and deliver
a new Rights Certificate of like date and tenor as the one mutilated, lost, destroyed or stolen upon surrender and in place of
and upon cancellation of such mutilated Rights Certificate, or in lieu of and in substitution for such lost, destroyed or stolen
Rights Certificate, and the substituted Rights Certificate shall be in a form approved by the Rights Agent and shall be entitled
to the benefits hereof and shall rank equally in accordance with its terms with all other Rights Certificates issued or to be issued
hereunder.

 

		(b)	The applicant for the issue of a new Rights Certificate pursuant to this Section 2.7 shall bear
the cost of the issue thereof and in case of loss, destruction or theft shall, as a condition precedent to the issue thereof, furnish
to Akerna and to the Rights Agent evidence of ownership and of the loss, destruction or theft of the Rights Certificate so lost,
destroyed or stolen satisfactory to Akerna and to the Rights Agent in their sole discretion, in each case acting reasonably, and
such applicant may also be required to furnish an indemnity or surety bond in amount and form satisfactory to Akerna and the Rights
Agent in their sole discretion, in each case acting reasonably, and shall pay the reasonable charges of Akerna and the Rights Agent
in connection therewith.

 

		2.8	REGISTER FOR RIGHTS

 

Akerna and Exchangeco shall cause to be
kept by and at the Rights Agency which is the transfer office of the Rights Agent in [l]
and in such other place or places as Akerna with the approval of the Rights Agent may designate, a securities register in which
shall be entered the names and addresses of Holders and the other particulars, prescribed by law, of the Rights held by them. Akerna
and Exchangeco shall also cause to be kept by and at such office the register of transfers, and may also cause to be kept by the
Rights Agent or such other registrar or registrars and at such other place or places as Akerna may designate with the approval
of the Rights Agent, branch registers of transfers (including, without limitation, branch registers of transfers at each of the
other Rights Agencies) in which shall be recorded the particulars of the transfers of Rights registered in that branch register
of transfers.

 

		2.9	TRANSFER OF RIGHTS

 

		(a)	The Rights may not be sold, assigned, transferred, pledged, encumbered or in any other manner transferred
or disposed of, in whole or in part, other than through a Permitted Transfer. Any attempted sale, assignment, transfer, pledge,
encumbrance or disposition of Rights, in whole or in part, in violation of this Section 2.9(a) shall be void ab initio and
of no effect.

 

		(b)	Subject to Sections 2.8, 2.9(a) and 2.9(c) and such reasonable requirements as the Rights Agent
may prescribe and all applicable securities laws and requirements of Regulatory Authorities, the Rights may be transferred on the
register kept at the Rights Agency pursuant to a Permitted Transfer by the Holder or its legal representatives or its attorney
duly appointed by an instrument in writing in form and manner of execution satisfactory to the Rights Agent only upon the surrendering
of the relevant Rights Certificate with a written instrument of transfer in form reasonably satisfactory to the Rights Agent. After
receiving the surrendered Rights Certificate and upon the Holder surrendering the same meeting the requirements set forth above,
the Rights Agent shall issue to the transferee a Rights Certificate representing the Rights transferred pursuant to the Permitted
Transfer.

 

    F-9

     

    

 

		(c)	No transfer of a Right shall be effective or shall be entered on the register kept by the Rights
Agent unless the transferee thereof certifies in writing to Akerna’s satisfaction that the transfer is a Permitted Transfer
and:

 

		(i)	the Rights may be transferred in the manner contemplated pursuant to an applicable exemption from
the registration requirements of the U.S. Securities Act and applicable state securities laws; or

 

		(ii)	(A) it is not a U.S. Person; (B) at the time of transfer it is not within the United States; and
(C) it is not acquiring such Right for the account or benefit of a U.S. Person or a Person within the United States.

 

The transferee
shall also be required to acknowledge that it shall notify Akerna prior to the Termination Date if the representations, warranties
and certifications contained in the written instrument of transfer attached to the Rights Certificate, as applicable, are no longer
true and correct.

 

		(d)	No transfer of a Right shall be valid:

 

		(i)	unless made in accordance with the provisions hereof;

 

		(ii)	until, upon compliance with such reasonable requirements as the Rights Agent may prescribe, such
transfer is recorded on the register maintained by the Rights Agent pursuant to Subsection 2.8; and

 

		(iii)	until all governmental or other charges arising by reason of such transfer have been paid.

 

		(e)	The Rights Agent will promptly advise Akerna of any requested transfer of the Rights. Akerna and
Exchangeco will be entitled, and Akerna may direct the Rights Agent, to refuse to recognize any transfer, or enter the name of
any transferee, of any Rights on the register kept by the Rights Agent, if such transfer is not a Permitted Transfer and/or would
constitute a violation of the securities laws of any jurisdiction or the rules, regulations or policies or any Regulatory Authority
having jurisdiction.

 

		(f)	The transfer register for the Rights shall be closed as of the close on business on the last Business
Day immediately preceding the Termination Date.

 

		2.10	TRANSFEREE ENTITLED TO REGISTRATION

 

The transferee of a Right in accordance
with Sections 2.8 and 2.9 shall, after the written instrument of transfer attached to the Rights Certificate is duly completed
and the Rights Certificate and written instrument of transfer are lodged with the Rights Agent, and upon compliance with all other
conditions in that regard required by this Indenture and by all applicable securities laws and requirements of Regulatory Authorities,
be entitled to have its name entered on the register as the owner of such Right free from all equities or rights of set-off or
counterclaim between Akerna or Exchangeco and its transferor or any previous Holder of such Right, save in respect of equities
of which Akerna or Exchangeco or the transferee is required to take notice by statute or by order of a court of competent jurisdiction.

 

    F-10

     

    

 

No duty shall rest with the Rights Agent
to determine compliance of the transferee or transferor of any Rights with applicable securities laws. The Rights Agent may assume
for the purposes of this Indenture that the address on the register of Holders of any Holder is the actual address of such Holder
and is also determinative of the residence of such Holder and that the address of any transferee to whom any Rights or other securities
deliverable in connection with any Rights are to be registered, as shown on the transfer document, is the actual address of the
transferee and is also determinative of the residency of the transferee.

 

		2.11	REGISTERS OPEN FOR INSPECTION

 

The registers hereinbefore referred to
shall be open at all reasonable times and upon reasonable notice for inspection by Akerna, Exchangeco, the Rights Agent, the Shareholder
Representative or any Holder. The Rights Agent shall, from time to time when requested to do so in writing by Akerna, furnish Akerna
and/or Exchangeco, upon payment of the Rights Agent’s reasonable charges, with a list of the names and addresses of Holders
entered in the register kept by the Rights Agent and showing the number of Rights held by each such Holder.

 

		2.12	OWNERSHIP OF RIGHTS

 

		(a)	Akerna, Exchangeco and the Rights Agent may deem and treat the registered Holder of any Rights
Certificate as the absolute owner of the Right represented thereby for all purposes and Akerna, Exchangeco and the Rights Agent
shall not be affected by any notice or knowledge to the contrary, except where Akerna, Exchangeco or the Rights Agent is required
to take notice by statute or by order of a court of competent jurisdiction. For greater certainty, subject to applicable law, none
of Akerna, Exchangeco nor the Rights Agent shall be bound to take notice of or see to the execution of any trust, whether express,
implied or constructive, in respect of any Right, and may transfer any Right in accordance with Section 2.9 on the direction of
the Person registered as Holder thereof, whether named as rights agent or otherwise, as though that Person were the beneficial
owner thereof.

 

		(b)	Subject to the provisions of this Indenture and applicable law, each Holder shall be entitled to
the rights and privileges attaching to the Rights held thereby.

 

		2.13	EXCHANGE OF RIGHTS CERTIFICATES

 

		(a)	Rights Certificates, representing Rights entitling the Holders to receive Deferred Consideration
may, prior to the Termination Date and upon compliance with the reasonable requirements of the Rights Agent, be exchanged for another
Rights Certificate or Rights Certificates entitling the Holder thereof to receive any Deferred Consideration payable under the
Rights Certificate or Rights Certificates so exchanged of equal aggregate amount.

 

    F-11

     

    

 

		(b)	Rights Certificates may be exchanged only at the Rights Agency or at any other place that is designated
by Akerna with the approval of the Rights Agent. Any Rights Certificates tendered for exchange shall be surrendered to the Rights
Agent and shall be cancelled.

 

		(c)	Except as otherwise herein provided, the Rights Agent shall charge to the Holder requesting an
exchange a reasonable sum for each new Rights Certificate issued in exchange for a surrendered Rights Certificate(s).

 

		2.14	PRINCIPAL OFFICE

 

If the principal transfer office of the
Rights Agent in the city where the Rights Agency is situated is for any reason not available to act in connection with the exchange
of Rights Certificates as contemplated by this Indenture, Akerna and the Rights Agent shall arrange for another office in such
city to act in connection with the exchange of Rights Certificates and shall give notice of the change of such office to the Shareholder
Representative.

 

ARTICLE
3

DELIVERY OF DEFERRED CONSIDERATION

 

		3.1	METHOD OF DELIVERY OF DEFERRED CONSIDERATION

 

At least three (3) Business Days prior
to the Deferred Consideration Payment Date determined in accordance with the Arrangement Agreement, Akerna shall provide the Rights
Agent with a written notice setting out the Deferred Consideration Payment Date, the amount and kind of Deferred Consideration
to be issued to the Holders in accordance with the Deferred Consideration Statement finally determined in accordance with the Arrangement
Agreement, together with a detailed description of the calculation thereof in accordance with Section 3.2.

 

		3.2	PAYMENT MECHANISM

 

		(a)	The aggregate number of Exchangeable Shares to be issued in respect of all Rights held by the Holders
shall be equal to the quotient obtained by dividing: (i) the amount of the Deferred Consideration payable in accordance with Section
2.2, divided by (ii) the 20 day volume weighted average price of the Akerna Shares (converted to Canadian dollars from US dollars
using the Exchange Rate as of the Deferred Consideration Payment Date) as quoted on the NASDAQ on the last trading day immediately
preceding the Deferred Consideration Payment Date.

 

		(b)	Following the determination of the aggregate number of Exchangeable Shares to be issued in accordance
with Section 3.2(a), the Shareholder Representative shall provide written notice (the “Allocation Notice”) to
the Rights Agent, Akerna and Exchangeco setting forth the Seller Representative’s final determination with respect to number
of Exchangeable Shares payable in respect of each Right, together with instructions for the issuance of Exchangeable Shares to
each Holder of a Right in satisfaction of the obligations of Akerna and Exchangeco thereunder.

 

		(c)	On the Deferred Consideration Payment Date, Akerna and Exchangeco shall cause the Rights Agent
to deliver Exchangeable Shares to the Holders in accordance with the instructions set forth in the Allocation Notice.

 

    F-12

     

    

 

		(d)	No certificates or other entitlements to fractional Exchangeable Shares shall be issued to any
Holder, and any Holder otherwise entitled to a fractional interest in an Exchangeable Share will receive the nearest whole number
of Exchangeable Shares (with fractions equal to or greater than 0.5 being rounded up and fractions less than 0.5 being rounded
down).

 

		3.3	CANCELLATION OF RIGHTS

 

At the Termination Date, all Rights Certificates
shall be cancelled.

 

		3.4	RIGHTS VOID

 

The Rights shall, as at the Termination
Date, be null, void and of no effect.

 

		3.5	ACCOUNTING AND RECORDING

 

Exchangeco shall cause its registrar and
transfer agent to account to the Rights Agent with respect to the issuance of Exchangeable Shares as soon as reasonably practicable
upon such issuance. Such accounting will include the particulars of the issuance of Exchangeable Shares pursuant to the Rights,
including the names and addresses of the Persons who become holders of Exchangeable Shares pursuant to the Rights and the certificate
numbers. The Rights Agent shall rely, and shall be protected in so doing, upon the certificate of Exchangeco or of its registrar
and transfer agent and any other document filed by Exchangeco pursuant to this Section for all purposes.

 

Any instruments, from time to time received
by the Rights Agent, shall be received in trust for, and shall be segregated and kept apart by the Rights Agent in trust for, Akerna.

 

ARTICLE
4

COVENANTS OF AKERNA AND EXCHANGECO

 

		4.1	MAINTENANCE

 

So long as any Rights are outstanding,
each of Akerna and Exchangeco shall use its commercially reasonable efforts to at all times maintain its existence, carry on and
conduct its business, and that of its material subsidiaries, in accordance with good business practice.

 

		4.2	TO PAY RIGHTS AGENT REMUNERATION AND EXPENSES

 

Akerna covenants that it shall pay to the
Rights Agent from time to time reasonable remuneration for its services hereunder and shall pay or reimburse the Rights Agent upon
its request for all expenses, disbursements and advances incurred or made by the Rights Agent in the administration or execution
of its duties hereunder (including the reasonable compensation and the disbursements of its Counsel and all other advisors and
assistants not regularly in its employ) both before any default hereunder and thereafter until all duties of the Rights Agent hereunder
shall be finally and fully performed and even after the termination of this Indenture, except any such expenses, disbursement or
advance as may arise out of or result from the Rights Agent’s gross negligence, wilful misconduct or bad faith. Such remuneration
which shall remain unpaid for a period of 30 Business Days after invoicing shall incur interest at the rate then charged by the
Rights Agent to its corporate clients. The Rights Agent shall not have any recourse against the securities or any other property
held by it pursuant to this Indenture for payment of its fees. This Section 4.2 shall survive the resignation or removal of the
Rights Agent and the termination and discharge of this Indenture. The Rights Agent shall have no obligation to take any action
under this Indenture so long as any payment remains due to the Rights Agent for any reasonable fees, expenses and disbursements.

 

    F-13

     

    

 

		4.3	TO PERFORM COVENANTS

 

Each of Akerna and Exchangeco shall perform
and carry out all of the acts or things to be done by it as provided in this Indenture and shall promptly advise the Rights Agent
in writing of any material default by Akerna or Exchangeco in the performance of its covenants hereunder.

 

		4.4	RIGHTS AGENT MAY PERFORM COVENANTS

 

If Akerna or Exchangeco fails to perform
any of its covenants contained in this Indenture, the Rights Agent, upon receipt of written notice from Akerna or Exchangeco of
such failure to perform, shall notify the Shareholder Representative of such failure on the part of Akerna or may itself perform
any of the covenants capable of being performed by it but, subject to ARTICLE 9, shall be under no obligation to perform said covenants
or to notify the Shareholder Representative that it is doing so. All sums expended or advanced by the Rights Agent in so doing
shall be repayable as provided in Section 4.2, but the Rights Agent shall not be required to expend or risk its own funds. No such
performance, expenditure or advance by the Rights Agent shall relieve Akerna of any default hereunder or of its continuing obligations
under the covenants herein contained.

 

		4.5	CREATION AND ISSUE OF THE RIGHTS

 

Akerna and Exchangeco are each duly authorized
to create and issue the Rights and, the Rights, when issued and countersigned as herein provided, shall be valid and enforceable
against Akerna and Exchangeco and, subject to the provisions of this Indenture, Akerna and Exchangeco shall cause the Exchangeable
Shares, to be issued pursuant to Error! Reference source not found. under this Indenture and cause the certificates representing
such Exchangeable Shares to be duly issued and delivered in accordance with the Right Certificates and the terms hereof. At all
times prior to and as at the Termination Date, while any of the Rights are outstanding, Exchangeco shall reserve, and Akerna shall
cause Exchangeco to reserve, and there shall be conditionally allotted but unissued out of Exchangeco’s authorized capital
that number of Exchangeable Shares sufficient to enable Akerna and Exchangeco to meet their respective obligations hereunder. All
Exchangeable Shares issued pursuant to the Rights shall be issued as fully paid and non-assessable. Akerna and Exchangeco shall
make or cause to be made all requisite filings, and pay all applicable fees, under applicable securities laws to report the issuance
of Exchangeable Shares pursuant to the Rights.

 

ARTICLE
5

ROLE OF RIGHTS AGENT

 

		5.1	ROLE AS RIGHTS AGENT

 

The Rights Agent accepts its duties and
responsibilities under this Indenture solely as a custodian, bailee and agent, and no trust is intended to be, or is or shall be,
created hereby, except as otherwise expressly stated herein, and the Rights Agent shall owe no duty hereunder as a trustee, except
as otherwise expressly stated herein.

 

    F-14

     

    

 

ARTICLE
6

ENFORCEMENT

 

		6.1	SUITS BY HOLDERS OF RIGHTS

 

All or any of the rights conferred upon
any Holder by any of the terms of the Rights Certificates or this Indenture may be enforced on behalf of the Holders (or any of
them) by the Shareholder Representative by appropriate legal proceedings but without prejudice to the right which is hereby conferred
upon the Rights Agent to proceed in its own name to enforce each and all of the provisions herein contained for the benefit of
the Holders.

 

		6.2	WAIVER OF DEFAULT

 

Upon the happening of any default hereunder,
the Shareholder Representative shall have the power by requisition in writing to instruct the Rights Agent to waive any default
hereunder and the Rights Agent shall thereupon waive the default upon such terms and conditions as shall be prescribed in such
requisition, provided that no delay or omission of the Rights Agent or of the Shareholder Representative, as applicable, to exercise
any right or power accruing upon any default shall impair any such right or power or shall be construed to be a waiver of any such
default or acquiescence therein and provided further that no act or omission either of the Rights Agent or the Shareholder Representative
in the premises shall extend to or be taken in any manner whatsoever to affect any subsequent default hereunder or the rights resulting
therefrom.

 

ARTICLE
7

SUCCESSOR ENTITIES

 

		7.1	CERTAIN REQUIREMENTS

 

Prior to the Termination Date, neither
Akerna nor Exchangeco shall, directly or indirectly, sell, transfer or otherwise dispose of all or substantially all of their respective
properties and assets as an entirety to any other Person and shall not amalgamate or merge with or into any other Person (any such
other Person being herein referred to as a “Successor Entity”) unless:

 

		(a)	the Successor Entity executes, before or contemporaneously with the consummation of any such transaction,
an indenture supplemental hereto together with such other instruments as are satisfactory to the Rights Agent and in the opinion
of Counsel are necessary or advisable to evidence the assumption by the Successor Entity of the due and punctual observance and
performance of all the covenants and obligations of Akerna under this Indenture; and

 

		(b)	such transaction shall be to the satisfaction of the Rights Agent, acting reasonably, and in the
opinion of Counsel, be upon such terms so as to substantially preserve and not impair or reduce in any material respect the rights,
and powers of the Rights Agent or of the Holders hereunder, including, for certainty, the economic rights, entitlements and interests
of the Holders (or any of them) hereunder.

 

		7.2	VESTING OF POWERS IN SUCCESSOR ENTITY

 

Whenever the conditions of Section 7.1
have been duly observed and performed, a Successor Entity shall possess and from time to time may exercise each and every right
and power of Akerna and/or Exchangeco under this Indenture in the name of Akerna and/or Exchangeco or otherwise and any act or
proceeding by any provision of this Indenture required to be done or performed by any Directors or officers of Akerna and/or Exchangeco
may be done and performed with like force and effect by the Directors or officers of such Successor Entity.

 

    F-15

     

    

 

ARTICLE
8

NOTICES

 

		8.1	NOTICE TO AKERNA AND THE RIGHTS AGENT

 

		(a)	Unless herein otherwise expressly provided,
any notice to be given hereunder to Akerna, the Rights Agent and/or the Shareholder Representative (for and on behalf of the Holders)
shall be deemed to be validly given if delivered or if sent by registered letter, postage prepaid, or by electronic transmission:

 

	if to Akerna or Exchangeco:	 	Akerna Corp.
	 	 	1601 Arapahoe Street
	 	 	Denver, CO 80202
	 	 	Email: scott.sozio@akerna.com
	 	 	 
	Attention:	 	Scott Sozio, President
	 	 	 
	with a copy to:	 	Dentons Canada LLP
	 	 	15th Floor, Bankers Court, 850 – 2nd Street S.W.
	 	 	Calgary, Alberta T2P 0R8
	 	 	Email: courtney.burton@dentons.com
	 	 	 
	Attention:	 	Courtney Burton
	 	 	 
	if to the Rights Agent:	 	Continental Stock Transfer & Trust Company, Inc.
	 	 	Email: [l]
	 	 	 
	Attention:	 	[l]
	 	 	 
	if to the Shareholder	 	 
	Representative:	 	John Prentice
	 	 	629 Eastern Avenue, Building B
	 	 	Toronto, Ontario M4M 1E4
	 	 	Email: john.prentice@ampleorganics.com

 

and any such notice delivered in
accordance with the foregoing shall be deemed to have been received on the date of delivery or if sent by electronic transmission,
on the first Business Day following such transmission or, if mailed, on the fifth Business Day following the date of the postmark
on such notice.

 

		(b)	Akerna, the Shareholder Representative or the Rights Agent, as the case may be, may from time to
time notify the others in the manner provided in Subsection 8.1(a) of a change of address which, from the effective date of such
notice and until changed by like notice, shall be the address of Akerna or the Rights Agent, as the case may be, for all purposes
of this Indenture.

 

    F-16

     

    

 

ARTICLE
9

CONCERNING THE RIGHTS AGENT

 

		9.1	NO CONFLICT OF INTEREST

 

The Rights Agent represents to Akerna that
to the best of its knowledge, at the date of the execution and delivery of this Indenture there exists no material conflict of
interest in its role as a fiduciary hereunder. In the event of a material conflict of interest arising in the Rights Agent’s
role as fiduciary hereunder the Rights Agent shall, as soon as practicable but in any case within 20 days after ascertaining that
it has such material conflict of interest, either eliminate the same or assign its trust hereunder to a successor rights agent
approved by Akerna. Notwithstanding the foregoing provisions of this section, if any such material conflict of interest exists
or hereafter shall exist, the validity and enforceability of this Indenture and the Rights Certificate(s) shall not be affected
in any manner whatsoever by reason hereof.

 

		9.2	REPLACEMENT OF RIGHTS AGENT

 

		(a)	The Rights Agent may resign its trust and be discharged from all further duties and liabilities
hereunder by giving to Akerna at least 45 days’ notice in writing or such shorter notice as Akerna may accept as sufficient.
The Shareholder Representative shall have the power at any time to remove the existing Rights Agent and to appoint a new rights
agent. If the Rights Agent resigns or is removed by the Shareholder Representative or is dissolved, becomes bankrupt, goes into
liquidation or otherwise becomes incapable of acting hereunder, Akerna shall forthwith appoint a new rights agent unless a new
rights agent has already been appointed by the Shareholder Representative; failing such appointment by Akerna, the retiring Rights
Agent or the Shareholder Representative may apply to a court of competent jurisdiction, on such notice as such court may direct,
for the appointment of a new rights agent; but any new rights agent so appointed by Akerna or by such court shall be subject to
removal as aforesaid by the Shareholder Representative. Any new rights agent appointed under any provision of this section must
be a corporation authorized to carry on the business of a trust company in the Province of Ontario and, if required by the applicable
trust indenture legislation of any other province or territory, in that other province or territory, and must be a corporation
which is independent of Akerna and has no material conflict of interest. On any new appointment the new rights agent shall be vested
with the same powers, rights, duties and responsibilities as if it had been originally named herein as Rights Agent.

 

		(b)	Any entity into which the Rights Agent may be merged or with which it may be consolidated or amalgamated
or any entity resulting from any merger, consolidation or amalgamation to which the Rights Agent shall be a party or any entity
succeeding to the trust business of the Rights Agent, shall be the successor rights agent under this Indenture without the execution
of any instrument or any further act.

 

		9.3	EVIDENCE, EXPERTS AND ADVISERS

 

		(a)	In addition to the reports, certificates, opinions and other evidence required by this Indenture,
Akerna and Exchangeco shall furnish to the Rights Agent such additional evidence of compliance with any provision hereof, and in
such form, as may be prescribed by any trust indenture legislation or as the Rights Agent may reasonably require by written notice
to Akerna.

 

    F-17

     

    

 

		(b)	In the exercise of its rights and duties hereunder, the Rights Agent may, if it is acting in good
faith, rely as to the truth of the statements and the accuracy of the opinions expressed in statutory declarations, opinions, reports,
written requests, consents, or orders of Akerna, certificates of Akerna or other evidence furnished to the Rights Agent pursuant
to any provision hereof or any trust indenture legislation or pursuant to a request of the Rights Agent, not only as to its due execution
and the validity and effectiveness of its provisions, but also to the truth and acceptability of any information therein contained
which the Rights Agent in good faith believes to be genuine.

 

		(c)	Proof of the execution of an instrument in writing, including a Holders’ Request, by any
Holder may be made by the certificate of a notary public, or other officer with similar powers, that the Person signing such instrument
acknowledged to it the execution thereof, or by an affidavit of a witness to such execution or in any other manner which the Rights
Agent may consider adequate.

 

		(d)	The Rights Agent may, at the expense of Akerna employ or retain such counsel, accountants, appraisers
or other experts or advisers as it may reasonably require for the purpose of discharging its duties hereunder and may pay reasonable
remuneration for all services so performed by any of them, without taxation of costs of any counsel, and shall not be responsible
for any misconduct or negligence on the part of any such experts or advisers who have been appointed with due care by the Rights
Agent.

 

		9.4	RIGHTS AGENT MAY DEAL IN SECURITIES

 

Subject to Section 9.1, the Rights Agent
may buy, sell, lend upon and deal in securities of Akerna and generally contract and enter into financial transactions with Akerna
or otherwise, without being liable to account for any profits made thereby.

 

		9.5	RIGHTS AGENT NOT ORDINARILY BOUND

 

Except as otherwise specifically provided
herein, the Rights Agent shall not be bound to give notice to any Person of the execution hereof, nor to do, observe or perform
or see to the observance or performance by Akerna of any of the obligations herein imposed upon Akerna or of the covenants on the
part of Akerna herein contained.

 

		9.6	RIGHTS AGENT NOT REQUIRED TO GIVE SECURITY

 

The Rights Agent shall not be required
to give any bond or security in respect of the execution of the trusts and powers of this Indenture or otherwise in respect of
the premises.

 

		9.7	RIGHTS AGENT NOT REQUIRED TO GIVE NOTICE OF DEFAULT

 

The Rights Agent shall not be bound to
give any notice or do or take any act, action or proceeding by virtue of the powers conferred on it hereby unless and until it
shall have been required to do so under the terms hereof; nor shall the Rights Agent be required to take notice of any default
hereunder, unless and until notified in writing of such default, which notice shall distinctly specify the default desired to be
brought to the attention of the Rights Agent and in the absence of any such notice the Rights Agent may for all purposes of this
Indenture conclusively assume that no default has been made in the observance or performance of any of the representations, warranties,
covenants, agreements or conditions contained herein. Any such notice shall in no way limit any discretion herein given to the
Rights Agent to determine whether or not the Rights Agent shall take action with respect to any default.

 

    F-18

     

    

 

		9.8	ACCEPTANCE OF APPOINTMENT

 

The Rights Agent hereby accepts its appointment
as Rights Agent and its duties and obligations in this Indenture declared and provided for and agrees to perform them upon the
terms and conditions herein set forth and to hold and exercise the rights, privileges and benefits conferred upon it hereby, subject
to all the terms and conditions herein set forth, until discharged therefrom by resignation or other lawful removal.

 

		9.9	DUTIES OF RIGHTS AGENT

 

The Rights Agent, in exercising its powers
and discharging its duties hereunder, shall:

 

		(a)	act honestly and in good faith with a view to the best interests of the Holders; and

 

		(b)	exercise the care, diligence and skill that a reasonably prudent rights agent would exercise in comparable circumstances.

 

		9.10	ACTIONS BY RIGHTS AGENT

 

		(a)	Subject only to Section 9.9, the obligation of the Rights Agent to commence or continue any act,
action or proceeding for the purpose of enforcing any rights of the Rights Agent or the Holders hereunder shall be conditional
upon the Holders delivering to the Rights Agent:

 

		(i)	a written request by the Shareholder Representative directing the Rights Agent to take such act,
action, or proceeding;

 

		(ii)	sufficient funds to commence or continue such act, action or proceeding; and

 

		(iii)	an indemnity reasonably satisfactory to the Rights Agent to protect and hold harmless the Rights
Agent against the costs, charges and expenses and liabilities to be incurred thereby and any loss and damages it may suffer by
reason thereof.

 

		(b)	None of the provisions contained in this Indenture shall require the Rights Agent to expend or
risk its own funds or otherwise incur financial liability in the performance of any of its duties or in the exercise of any of
its rights or powers unless indemnified and funded as aforesaid.

 

		(c)	The Rights Agent may, before commencing or at any time during the continuance of any such act,
action or proceeding, require the Shareholder Representative (for and on behalf of the Holders), at whose instance it is acting,
to deposit with the Rights Agent the Rights held by them, for which Rights the Rights Agent shall issue receipts.

 

    F-19

     

    

 

		9.11	PROTECTION OF RIGHTS AGENT

 

By way of supplement to the provisions
of any law for the time being relating to trustees it is expressly declared and agreed as follows:

 

		(a)	the Rights Agent shall not be liable for or by reason of any statements of fact or recitals in
this Indenture or in the Rights Certificates (except the representation contained in Section 9.1 or in the certificate of the Rights
Agent on the Rights Certificates) or be required to verify the same, but all such statements or recitals are and shall be deemed
to be made by Akerna;

 

		(b)	nothing herein contained shall impose any obligation on the Rights Agent to see to or to require
evidence of the registration or filing (or renewal thereof) of this Indenture or any instrument ancillary or supplemental hereto;
and

 

		(c)	the Rights Agent shall not be bound to give notice to any Person or Persons of the execution hereof.

 

		9.12	INDEMNIFICATION OF THE RIGHTS AGENT

 

The Rights Agent, its officers, directors,
agents and employees shall at all times be indemnified and saved harmless by Akerna from and against all claims, demands, losses,
actions, causes of action, suits, proceedings, costs, charges, expenses, assessments, judgements, damages and liabilities whatsoever
arising in connection with this Indenture, including, without limitation, those arising out of or related to actions taken or
omitted to be taken by the Rights Agent contemplated hereby, reasonable expert consultant and legal fees and disbursements on
a solicitor and client basis and reasonable costs and expenses incurred in connection with the enforcement of this indemnity,
which the Rights Agent may suffer or incur, whether at law or in equity, in any way caused by or arising, directly or indirectly,
in respect of any act, deed, matter or thing whatsoever made, done, acquiesced in or omitted in or about or in relation to the
execution of its duties as Rights Agent. The foregoing provisions of this section do not apply to the extent that in any circumstance
there have been acts of gross negligence, wilful misconduct, or bad faith by the Rights Agent. This indemnity shall survive the
termination or discharge of this Indenture and the resignation or removal of the Rights Agent.

 

		9.13	THIRD PARTY INTERESTS

 

Each party to this Indenture hereby represents
to the Rights Agent that any account to be opened by, or interest to held by the Rights Agent in connection with this Indenture,
for or to the credit of such party, either: (a) is not intended to be used by or on behalf of any third party; or (b) is intended
to be used by or on behalf of a third party, in which case such party hereto agrees to complete and execute forthwith a declaration
in the Rights Agent’s prescribed form as to the particulars of such third party.

 

		9.14	NOT BOUND TO ACT / ANTI-MONEY LAUNDERING

 

The Rights Agent shall retain the right
not to act and shall not be liable for refusing to act if, due to a lack of information or for any other reason whatsoever, the
Rights Agent, in its sole judgment, determines that such act might cause it to be in non-compliance with any applicable anti-money
laundering, anti-terrorist or economic sanctions legislation, regulation or guideline. Further, should the Rights Agent, in its
sole judgment, determine at any time that its acting under this Indenture has resulted in its being in non-compliance with any
applicable anti-money laundering, antiterrorist or economic sanctions legislation, regulation or guideline, then it shall have
the right to resign on 10 days written notice to Akerna, provided: (a) that the Rights Agent’s written notice shall describe
the circumstances of such non-compliance; and (b) that if such circumstances are rectified to the Rights Agent’s satisfaction
within such 10 day period, then such resignation shall not be effective.

 

    F-20

     

    

 

		9.15	PRIVACY LAWS

 

The parties acknowledge that the Rights
Agent may, in the course of providing services hereunder, collect or receive financial and other personal information about such
parties and/or their representatives, as individuals, or about other individuals related to the subject matter hereof, and use
such information for the following purposes: (a) to provide the services required under this Indenture and other services that
may be requested from time to time; (b) to help the Rights Agent manage its servicing relationships with such individuals; (c)
to meet the Rights Agent’s legal and regulatory requirements; and (d) if Social Insurance Numbers are collected by the Rights
Agent, to perform tax reporting and to assist in verification of an individual’s identity for security purposes.

 

Each party acknowledges and agrees that
the Rights Agent may receive, collect, use and disclose personal information provided to it or acquired by it in the course of
its acting as agent hereunder this Indenture for the purposes described above and, generally, in the manner and on the terms described
in its Privacy Code, which the Rights Agent shall make available on its website, [l],
or upon request, including revisions thereto. The Rights Agent may transfer personal information to other companies in or outside
of Canada that provide data processing and storage or other support in order to facilitate the services it provides.

 

Further, each party agrees that it shall
not provide or cause to be provided to the Rights Agent any personal information relating to an individual who is not a party to
this Indenture unless the that party has assured itself that such individual understands and has consented to the aforementioned
uses and disclosures.

 

		9.16	FORCE MAJEURE

 

Except for the payment obligations of
Akerna contained herein, neither party shall be liable to the other, or held in breach of this Indenture, if prevented, hindered,
or delayed in the performance or observance of any provisions contained herein by reason of act of God, riots, terrorism, acts
of war, epidemics, governmental action or judicial order, earthquakes, economic sanctions or any other similar causes (including,
but not limited to, mechanical, electronic or communication interruptions, disruptions or failures). Performance times under this
Indenture shall be extended for a period of time equivalent to the time lost because of any delay that is excusable under this
section.

 

ARTICLE
10

SUPPLEMENTAL INDENTURES

 

		10.1	SUPPLEMENTAL INDENTURES

 

The Rights Agent may,
without the consent or concurrence of the Holders, by supplemental Indenture or otherwise, concur with Akerna in making any changes
or corrections in this Indenture which it has been advised by Counsel are required for the purpose of curing or correcting any
ambiguity or defective or inconsistent provision or clerical omission or mistake or manifest error contained herein or in any deed
or indenture supplemental or ancillary hereto, provided that the Rights Agent, relying on the opinion of Counsel, the rights of
the Rights Agent and of the Holders are in no way prejudiced thereby.

 

    F-21

     

    

 

ARTICLE
11

GENERAL PROVISIONS

 

		11.1	EXECUTION

 

This Indenture may be simultaneously executed
in several counterparts, and may be executed by facsimile or other means of electronic communication producing a printed copy,
each of which when so executed shall be deemed to be an original and such counterparts together shall constitute one and the same
instrument and notwithstanding their date of execution they shall be deemed to be dated as of the date hereof.

 

		11.2	AMENDMENT

 

This provisions of this
Indenture may be waived, altered, amended or supplemented, in whole or in part, only by a writing signed by Akerna, the Shareholder
Representative and the Rights Agent.

 

		11.3	FORMAL DATE

 

This Indenture may be referred to as bearing
the formal date [l] irrespective of the actual date of execution hereof.

 

		11.4	SATISFACTION AND DISCHARGE OF INDENTURE

 

Upon the Termination Date, this Indenture
shall cease to be of any force and effect and the Rights Agent, on demand of and at the cost and expense of Akerna and upon delivery
to the Rights Agent of a certificate of Akerna stating that all conditions precedent to the satisfaction and discharge of this
Indenture have been complied with, shall execute instruments as requested by Akerna acknowledging satisfaction of and discharging
this Indenture. Notwithstanding the foregoing, the indemnities provided to the Rights Agent by Akerna hereunder shall remain in
full force and effect and survive the termination of this Indenture.

 

		11.5	PROVISIONS OF INDENTURE AND RIGHTS FOR THE SOLE BENEFIT OF PARTIES AND HOLDERS

 

Nothing in this Indenture or in the Rights
Certificates, expressed or implied, shall give or be construed to give to any Person other than the parties thereto and the Holders,
as the case may be, any legal or equitable right, remedy or claim under this Indenture, or under any covenant or provision herein
or therein contained, all such covenants and provisions being for the sole benefit of the parties hereto and the Holders.

 

		11.6	WITHHOLDING

 

Each of Akerna, Exchangeco and the Rights
Agent shall be entitled to deduct and withhold from any amounts or property to be issued, paid, assigned or conveyed hereunder,
such amounts as Akerna, Exchangeco or the Rights Agent, as the case may be, is required to deduct and withhold with respect to
such payment or transfer under the Income Tax Act (Canada) or any provision of federal, provincial, state, local or foreign
tax law. In lieu of withholding such amounts Akerna, Exchangeco and the Rights Agent shall be entitled to otherwise recover or
to require a Holder to provide for such applicable taxes. To the extent that amounts are so withheld, such withheld amounts shall
be treated for all purposes hereof as having been paid to the relevant Holder, provided that such withheld amounts are actually
remitted to the appropriate taxing authority.

 

[The remainder of this page is intentionally
blank; signature page follows.]

 

 

 

 

    F-22

     

    

 

IN WITNESS WHEREOF the parties hereto have executed this
Indenture under the hands of their proper officers in that behalf.

 

	 	By:	 
	 	 	Name:   John Prentice, exclusively in his capacity as Shareholder Representative

 

	 	2732805 ONTARIO INC.
	 	 
	 	By:	 
	 	 	Name:
	 	 	Title:

 

	 	AKERNA CORP.
	 	 
	 	By:	 
	 	 	Name:  Scott Sozio
	 	 	Title:    President

 

	 	CONTINENTAL STOCK TRANSFER & TRUST COMPANY, INC.
	 	 
	 	By:	 
	 	 	Name:
	 	 	Title:

 

	 	By:	 
	 	 	Name:
	 	 	Title:

 

[Rights Indenture]

 

    F-23

     

    

 

SCHEDULE
“A”

 

FORM OF
RIGHTS CERTIFICATE

 

(see attached)

 

    F-24

     

    

 

THIS IS SCHEDULE “A”
to the Rights Indenture made as of [l] between Akerna Corp., 2732805 Ontario
Inc., John Prentice, as Shareholder Representative, and Continental Stock Transfer & Trust Company, Inc., as Rights Agent.

 

RIGHTS CERTIFICATE

 

AKERNA CORP.

(a corporation existing under the laws of
Delaware)

(“Akerna”)

 

	RIGHTS CERTIFICATE NO. ____________________________

 

	ONE RIGHT, entitling the holder to acquire such share of the Deferred Consideration as specified in Section 2.2 of the Rights Indenture (as defined below).

 

THIS IS TO CERTIFY THAT ____________________________________________________________

 

(the “holder”) is the
registered holder of a right (the “Right”) entitling the holder to receive Exchangeable Shares all on the terms
and conditions set out in a rights indenture (the “Rights Indenture”) between Akerna, Exchangeco, John Prentice,
as Shareholder Representative, and Continental Stock Transfer & Trust Company, Inc. dated [l].

 

The Right represented by this certificate
is issued under and pursuant to the Rights Indenture. Reference is made to the Rights Indenture and any instruments supplemental
thereto for a full description of the rights of the holders of the Rights and the terms and conditions upon which the Rights are,
or are to be, issued and held, with the same effect as if the provisions of the Rights Indenture and all instruments supplemental
thereto were herein set forth. By acceptance hereof, the holder assents to all provisions of the Rights Indenture. In the event
of a conflict between the provisions of this Rights Certificate and the Rights Indenture, the provisions of the Rights Indenture
shall govern. Capitalized terms used in the Rights Indenture have the same meaning herein as therein, unless otherwise defined.

 

The registered holder of this Rights Certificate
may, at any time prior to the close of business on the last Business Day immediately preceding the Termination Date, upon surrender
hereof to the Rights Agent at its offices in the city of [l], exchange this Rights
Certificate for other Rights Certificates entitling the holder to acquire, in the aggregate, the same Deferred Consideration as
may be acquired under this Rights Certificate.

 

The holding of the Right evidenced by this
Rights Certificate shall not constitute the holder hereof a shareholder of Akerna or Exchangeco or entitle the holder to any right
or interest in respect thereof except as expressly provided in the Rights Indenture and in this Rights Certificate.

 

The Right evidenced by this Rights Certificate
may only be transferred in accordance with the terms of the Rights Indenture and upon compliance with such reasonable requirements
as the Rights Agent may prescribe.

 

This Rights Certificate shall not be valid
for any purpose whatever unless and until it has been certified by or on behalf of the Rights Agent.

 

Time shall be of the essence hereof.

 

    F-25

     

    

 

IN WITNESS WHEREOF Akerna has caused this
Rights Certificate to be signed by its duly authorized officer as of [l].

 

	 	AKERNA CORP.
	 	 
	 	Per:	            
	 	 	(Authorized Signatory)

 

	 	2732805 ONTARIO INC.
	 	 
	 	Per:	 
	 	 	(Authorized Signatory)

 

	Certified by:	 
	 	 
	CONTINENTAL STOCK TRANSFER & TRUST COMPANY, INC.	 
	Rights Agent	 
	 	 
	Per:	 	 
	 	(Authorized Signatory)	 

 

    F-26

     

    

  

SCHEDULE “G”

Form
of Ample Shareholder Support Agreement

 

●, 2019

 

Akerna Corp.

1601 Arapahoe Street

Denver, CO

80202

 

and

 

Ample Organics Inc.

629 Eastern Avenue, Building B,

Toronto, ON

M4M 1E4

 

Dear Sirs/Mesdames:

 

		Re:	Support Agreement

 

_____________________________ (the “Shareholder”)
understands that Akerna Corp. (“Company”) and Ample Organics Inc. (the “Ample”) have entered
into an arrangement agreement (the “Arrangement Agreement”) dated as of the date of this letter agreement (the
“Support Agreement”) contemplating a plan of arrangement under the provisions of the Business Corporations
Act (Ontario), the result of which will be the indirect acquisition of all of the issued and outstanding shares in the capital
of Ample by the Company (the “Arrangement”). The completion of the Arrangement is conditional upon, among other
conditions, the approval by resolution of the shareholders of the Company of the Akerna Shareholder Matters (as such term is defined
in the Arrangement Agreement). The Arrangement Agreement contemplates that certain shareholders of the Company, including the Shareholder,
will agree to vote the common shares in the capital of the Company beneficially owned or controlled by them in favour of the Akerna
Shareholder Matters, and to otherwise support the Arrangement as contemplated by the Arrangement Agreement. The Shareholder is
the beneficial owner of the number and class of shares of the Company and options and warrants to purchase shares of the Company,
in each case as listed in Schedule “A” (the “Shareholder’s Securities”). The name of the registered
holder of the Shareholder’s Securities is also set out in Schedule “A” (if different from the Shareholder).

 

The Shareholder hereby agrees, in its capacity
as securityholder of the Company (and not in its capacity as an officer or director of the Company) to vote or to cause to be voted
the Shareholder’s Securities, and any other securities directly or indirectly acquired by or issued to the undersigned after
the date hereof (including without limitation any shares issued upon any exercise of options to purchase shares of the Company
or purchase warrants of the Company), if any: (i) in favour of the Akerna Shareholder Matters; and (ii) against any acquisition
proposal that could reasonably be expected to delay, prevent or frustrate the successful completion of the Arrangement or any of
the transactions contemplated by the Arrangement Agreement.

 

The Shareholder hereby represents and warrants
that (a) it is the sole beneficial owner of the Shareholder’s Securities, and, to the extent the Shareholder’s Securities
are voting securities, the Shareholder has the sole right to vote all of the Shareholder’s Securities; and (b) the only securities
of the Company beneficially owned, directly or indirectly, by the Shareholder on the date hereof are the Shareholder’s Securities.

 

    G-1

     

    

 

The Shareholder hereby represents and warrants
that this Support Agreement has been duly executed and delivered and is a valid and binding agreement, enforceable against the
Shareholder in accordance with its terms, and the performance by the Shareholder of his, her or its obligations hereunder will
not constitute a violation or breach of or default under, or conflict with, any contract, commitment, agreement, understanding
or arrangement of any kind to which the Shareholder will be a party and by which the Shareholder will be bound, in each case at
the time of such performance.

 

The Shareholder hereby agrees that the
details of this Support Agreement may be described in any press release, information circular or other communication prepared by
the Company or Ample in connection with the Arrangement and in any material change report prepared by Ample or similar document
prepared by the Company in connection with the execution and delivery of this Support Agreement and the Shareholder further agrees
to this Support Agreement being made publicly available in accordance with any applicable securities laws.

 

This Support Agreement shall be deemed
to terminate, and the respective rights and obligations of the parties hereunder shall cease, immediately upon the earliest to
occur of any of the following: (a) the completion of the Arrangement in accordance with its terms; and (b) upon the termination
of the Arrangement Agreement in accordance with its terms.

 

The provisions of this Support Agreement
shall be binding upon and enure to the benefit of the parties hereto and their respective successors, permitted assigns and legal
personal representatives, provided that no party may assign, delegate or otherwise transfer any of its rights, interests or obligations
under this Support Agreement without the prior written consent of the other parties hereto, except that Ample may assign, delegate
or otherwise transfer any of its rights, interests or obligations under this Support Agreement to an affiliate, without reducing
its own obligations hereunder.

 

This Support Agreement may be executed
in any number of counterparts (including counterparts by facsimile or electronic mail) and all such counterparts taken together
shall be deemed to constitute one and the same instrument. The parties shall be entitled to rely upon delivery of an executed facsimile
or similar executed electronic copy of this Support Agreement, and such facsimile or similar executed electronic copy shall be
legally effective to create a valid and binding agreement between the parties.

 

This Support Agreement shall be governed
by the laws of the Province of Ontario and the federal laws of Canada applicable therein.

 

[Signature Page Follows]

 

    G-2

     

    

 

If the foregoing is in accordance with
your understanding and is agreed to by you, please signify your acceptance by executing the enclosed copies of this letter agreement
where indicated below and returning the same to the undersigned, upon which this letter agreement as so accepted shall constitute
an agreement among the Shareholder, Ample and the Company.

 

Yours truly,

 

___________________________

[SHAREHOLDER]

 

Accepted and agreed on this _____ day of
2019.

 

	Akerna corp.	 
	 	 
	By:	 	 
	 	Name:	 
	Title:	 

 

	ample organics INC.	 
	 	 
	By:	 	 
	 	Name:	 
	Title:	 

 

 

 

[Signature Page to Akerna Support Agreement]

 

    G-3

     

    

 

Schedule “A”

 

Shareholder’s Securities

 

	Number of Securities	 	Name of Beneficial Owner	 	Name of Registered Holder

(e.g. Broker or Custodian)
	__________ common shares 	 		 	
	__________ options 	 	 	 	 
	__________ warrants	 	 	 	 

 

    G-4

     

    

  

SCHEDULE “H”

Form
of Akerna Shareholder Support Agreement

 

 

December 18, 2019

 

Akerna Corp.

1601 Arapahoe Street

Denver, CO

80202

 

and

 

Ample Organics Inc.

629 Eastern Avenue, Building B,

Toronto, ON

M4M 1E4

 

Dear Sirs/Mesdames:

 

		Re:	Support Agreement

 

_____________________________ (the “Shareholder”)
understands that Akerna Corp. (“Company”) and Ample Organics Inc. (the “Ample”) have entered
into an arrangement agreement (the “Arrangement Agreement”) dated as of the date of this letter agreement (the
“Support Agreement”) contemplating a plan of arrangement under the provisions of the Business Corporations
Act (Ontario), the result of which will be the indirect acquisition of all of the issued and outstanding shares in the capital
of Ample by the Company (the “Arrangement”). The completion of the Arrangement is conditional upon, among other
conditions, the approval by resolution of the shareholders of the Company of the Akerna Shareholder Matters (as such term is defined
in the Arrangement Agreement). The Arrangement Agreement contemplates that certain shareholders of the Company, including the Shareholder,
will agree to vote the common shares in the capital of the Company beneficially owned or controlled by them in favour of the Akerna
Shareholder Matters, and to otherwise support the Arrangement as contemplated by the Arrangement Agreement. The Shareholder is
the beneficial owner of the number and class of shares of the Company and options and warrants to purchase shares of the Company,
in each case as listed in Schedule “A” (the “Shareholder’s Securities”). The name of the registered
holder of the Shareholder’s Securities is also set out in Schedule “A” (if different from the Shareholder).

 

The Shareholder hereby agrees, in its capacity
as securityholder of the Company (and not in its capacity as an officer or director of the Company) to vote or to cause to be voted
the Shareholder’s Securities, and any other securities directly or indirectly acquired by or issued to the undersigned after the
date hereof (including without limitation any shares issued upon any exercise of options to purchase shares of the Company or purchase
warrants of the Company), if any: (i) in favour of the Akerna Shareholder Matters; and (ii) against any acquisition proposal that
could reasonably be expected to delay, prevent or frustrate the successful completion of the Arrangement or any of the transactions
contemplated by the Arrangement Agreement.

 

    H-1

     

    

 

The Shareholder hereby represents and warrants
that (a) it is the sole beneficial owner of the Shareholder’s Securities, and, to the extent the Shareholder’s Securities are voting
securities, the Shareholder has the sole right to vote all of the Shareholder’s Securities; and (b) the only securities of the
Company beneficially owned, directly or indirectly, by the Shareholder on the date hereof are the Shareholder’s Securities.

 

The Shareholder hereby represents and warrants
that this Support Agreement has been duly executed and delivered and is a valid and binding agreement, enforceable against the
Shareholder in accordance with its terms, and the performance by the Shareholder of his, her or its obligations hereunder will
not constitute a violation or breach of or default under, or conflict with, any contract, commitment, agreement, understanding
or arrangement of any kind to which the Shareholder will be a party and by which the Shareholder will be bound, in each case at
the time of such performance.

 

The Shareholder hereby agrees that the
details of this Support Agreement may be described in any press release, information circular or other communication prepared by
the Company or Ample in connection with the Arrangement and in any material change report prepared by Ample or similar document
prepared by the Company in connection with the execution and delivery of this Support Agreement and the Shareholder further agrees
to this Support Agreement being made publicly available in accordance with any applicable securities laws.

 

This Support Agreement shall be deemed
to terminate, and the respective rights and obligations of the parties hereunder shall cease, immediately upon the earliest to
occur of any of the following: (a) the completion of the Arrangement in accordance with its terms; and (b) upon the termination
of the Arrangement Agreement in accordance with its terms.

 

The provisions of this Support Agreement
shall be binding upon and enure to the benefit of the parties hereto and their respective successors, permitted assigns and legal
personal representatives, provided that no party may assign, delegate or otherwise transfer any of its rights, interests or obligations
under this Support Agreement without the prior written consent of the other parties hereto, except that Ample may assign, delegate
or otherwise transfer any of its rights, interests or obligations under this Support Agreement to an affiliate, without reducing
its own obligations hereunder.

 

This Support Agreement may be executed
in any number of counterparts (including counterparts by facsimile or electronic mail) and all such counterparts taken together
shall be deemed to constitute one and the same instrument. The parties shall be entitled to rely upon delivery of an executed facsimile
or similar executed electronic copy of this Support Agreement, and such facsimile or similar executed electronic copy shall be
legally effective to create a valid and binding agreement between the parties.

 

This Support Agreement shall be governed
by the laws of the Province of Ontario and the federal laws of Canada applicable therein.

 

[Signature Page Follows]

 

    H-2

     

    

 

If the foregoing is in accordance with
your understanding and is agreed to by you, please signify your acceptance by executing the enclosed copies of this letter agreement
where indicated below and returning the same to the undersigned, upon which this letter agreement as so accepted shall constitute
an agreement among the Shareholder, Ample and the Company.

 

	Yours truly,	 
	 	 
	 	 
	Name:	 

 

Accepted and agreed on this _____ day of
2019.

 

	Akerna corp.	 
	 	 	 	 
	By:	 	 
	 	Name:	 	 
	 	 	 	 
	 	Title:	 	 
	 	 	 	 
	ample organics INC.	 
	 	 	 	 
	By:	 	 
	 	Name:	 	 
	 	 	 	 
	 	Title:	 	 

 

[Signature Page to Akerna Support Agreement]

 

    H-3

     

    

 

Schedule “A” 

Shareholder’s Securities

 

	Number of Securities	 	Name of Beneficial Owner	 	 	Name of Registered Holder
 (e.g. Broker or Custodian)	 
	__________ common shares	 		              	 	 		                 	 
	__________ options	 	 	 	 	 	 	 	 
	__________ warrants	 	 	 	 	 	 	 	 

 

    H-4

     

    

 

SCHEDULE “I” 

PROVISIONS
ATTACHING TO THE EXCHANGEABLE SHARES

 

The
Exchangeable Shares shall have the following rights, privileges, restrictions and conditions (it being understood that all references
to the “Company” in this Schedule I shall be a reference to 2732805 Ontario Inc.):

 

		1.	Interpretation

 

		(a)	Definitions.
                                         For the purposes of these Exchangeable Share Provisions:

 

“affiliate”
has the meaning ascribed thereto National Instrument 45-106 Prospectus Exemptions;

 

“Akerna”
means Akerna Corp., a corporation existing under the laws of Delaware;

 

“Akerna
Control Transaction” shall be deemed to have occurred if:

 

		(i)	except
                                         in connection with the Arrangement Agreement, Plan of Arrangement or Akerna Transactions,
                                         any person acquires, directly or indirectly, any voting security of Akerna and, immediately
                                         after such acquisition, directly or indirectly owns, or exercises control and direction
                                         over, voting securities representing more than 50% of the total voting power of all of
                                         the then outstanding voting securities of Akerna;

 

		(ii)	except
                                         in connection with the Arrangement Agreement, Plan of Arrangement or Akerna Transactions,
                                         the shareholders of Akerna approve a merger, consolidation, recapitalization or reorganization
                                         of Akerna, other than any such transaction which would result in the holders of outstanding
                                         voting securities of Akerna immediately prior to such transaction directly or indirectly
                                         owning, or exercising control and direction over, voting securities representing more
                                         than 50% of the total voting power of all of the voting securities of the surviving entity
                                         outstanding immediately after such transaction;

 

		(iii)	the
                                         shareholders of Akerna approve a liquidation of Akerna; or

 

		(iv)	Akerna
                                         sells or disposes of all or substantially all of its assets;

 

“Akerna
Dividend Declaration Date” means the date on which the board of directors of Akerna declares any dividend or other distribution
on the Akerna Shares;

 

“Akerna
Shares” means shares of common stock of Akerna;

 

“Akerna
Transactions” has the meaning ascribed thereto in the Arrangement Agreement;

 

“Ample”
means Ample Organics Inc., a corporation existing under the laws of the Province of Ontario;

 

“Ample”
has the meaning ascribed thereto in the Arrangement Agreement;

 

“Arrangement
Agreement” means the arrangement agreement dated December 18, 2019 among Akerna, Ample, the Company and John Prentice
as amended, supplemented or otherwise modified from time to time in accordance with its terms;

  

    I-1

     

    

 

“Automatic
Exchange Right” has the meaning ascribed thereto in the Voting and Exchange Trust Agreement;

 

“Board
of Directors” means the board of directors of the Company;

 

“Business
Day” means any day, other than a Saturday, a Sunday or a statutory or civic holiday in the Province of Ontario or in
the State of Colorado;

 

“Callco”
means 2732804 Ontario Inc., a wholly-owned subsidiary of Akerna incorporated under the laws of the Province of Ontario;

 

“Canadian
Dollar Equivalent” means, at any date, in respect of any amount expressed in a currency other than Canadian dollars (the
“Foreign Currency Amount”) as of such date, the product obtained by multiplying: (i) the Foreign Currency Amount,
by (ii) the daily exchange rate on such date for such foreign currency expressed in Canadian dollars as reported by the Bank of
Canada or, in the event such daily exchange rate is not available, the average daily exchange rate during the period of 20 consecutive
Business Days ending on the third Business Day immediately before such date for such foreign currency expressed in Canadian dollars;

 

“Change
of Law Call Right” has the meaning ascribed thereto in the Plan of Arrangement;

 

“Common
Shares” means the common shares in the capital of the Company;

 

“Current
Market Price” means, in respect of an Akerna Share on any date, the Canadian Dollar Equivalent of the average closing
price of an Akerna Share on the NASDAQ during the period of 20 consecutive trading days ending on the third trading day immediately
before such date or, if the Akerna Shares are not then listed on the NASDAQ, on such other stock exchange or automated quotation
system on which the Akerna Shares are listed or quoted, as the case may be, as may be selected by the Board of Directors for such
purpose; provided, however, that if in the opinion of the Board of Directors the public distribution or trading activity of Akerna
Shares during such period does not reflect the fair market value of an Akerna Share, then the Current Market Price of an Akerna
Share shall be determined by the Board of Directors, based upon the advice of such qualified independent financial advisors as
the Board of Directors may deem to be appropriate; and provided further that any such selection, opinion or determination by the
Board of Directors shall be conclusive and binding, absent manifest error;

 

“Effective
Date” has the meaning ascribed thereto in the Plan of Arrangement;

 

“Exchangeable
Share Consideration” means, with respect to each Exchangeable Share, for any acquisition of, redemption of or distribution
of assets of the Company in respect of such Exchangeable Share, or purchase of such Exchangeable Share pursuant to these Exchangeable
Share Provisions, the Plan of Arrangement, the Support Agreement or the Voting and Exchange Trust Agreement:

 

		(i)	the
                                         Current Market Price of one Akerna Share deliverable in connection with such action;
                                         plus

 

		(ii)	a
                                         cheque or cheques payable at par at any branch of the bankers of the payor in the amount
                                         of all declared, payable and unpaid, and all undeclared but payable, cash dividends deliverable
                                         in connection with such action; plus

  

    I-2

     

    

 

		(iii)	such
                                         stock or other property constituting any declared, payable and unpaid non-cash dividends,
                                         and all undeclared but payable stock or property constituting any undeclared but payable
                                         non-cash dividends, in either case, deliverable on the Exchangeable Shares;

 

provided
that: (A) the part of the consideration which represents (i) above shall be fully paid and satisfied by the delivery of one Akerna
Share, such share to be duly issued, fully paid and nonassessable; (B) the part of the consideration which represents (iii) above
shall be fully paid and satisfied by delivery of such non-cash items; (C) in each case, any such consideration shall be delivered
free and clear of any lien, claim, encumbrance, security interest or adverse claim or interest; and (D) in each case, any such
consideration shall be paid without interest and less any tax required to be deducted and withheld therefrom;

 

“Exchangeable
Share Price” means, at any time, for each Exchangeable Share, an amount equal to the aggregate of:

 

		(i)	the
                                         Current Market Price of one Akerna Share at such time;

 

		(ii)	the
                                         full amount of all cash dividends declared, payable and unpaid, at such time, on such
                                         Exchangeable Share;

 

		(iii)	the
                                         full amount of all non-cash dividends declared, payable and unpaid, at such time, on
                                         such Exchangeable Share; and

 

		(iv)	the
                                         full amount of all dividends declared and payable or paid in respect of each Akerna Share
                                         which have not, at such time, been declared or paid on such Exchangeable Share in accordance
                                         herewith;

 

“Exchangeable
Share Provisions” means the rights, privileges, restrictions and conditions set out herein;

 

“Exchangeable
Share Voting Event” means any matter in respect of which holders of Exchangeable Shares are entitled to vote as shareholders
of the Company, other than an Exempt Exchangeable Share Voting Event, and, for greater certainty, excluding any matter in respect
of which holders of Exchangeable Shares are entitled to vote (or instruct the Trustee to vote) in their capacity as Beneficiaries
under (and as that term is defined in) the Voting and Exchange Trust Agreement;

 

“Exempt
Exchangeable Share Voting Event” means any matter in respect of which holders of Exchangeable Shares are entitled to
vote as shareholders of the Company to approve or disapprove, as applicable, any change to, or in the rights of the holders of,
the Exchangeable Shares, where the approval or disapproval, as applicable, of such change is required to maintain the economic
equivalence of the Exchangeable Shares and the Akerna Shares;

 

“Exchangeable
Shares” means the exchangeable shares in the capital of the Company, having the rights, privileges, restrictions and
conditions set forth herein;

 

“Liquidation
Amount” has the meaning ascribed thereto in Section 5(a);

 

“Liquidation
Call Right” has the meaning ascribed thereto in the Plan of Arrangement;

 

“Liquidation
Date” has the meaning ascribed thereto in Section 5(a);

  

    I-3

     

    

 

“NASDAQ”
means the National Association of Securities Dealers Automated Quotations exchange;

 

“OBCA”
means the Business Corporations Act (Ontario) and the regulations made thereunder, as now in effect and as they may be
promulgated or amended from time to time;

 

“person”
includes an individual, partnership, association, body corporate, trustee, executor, administrator, legal representative, government
or any other entity, whether or not having legal status;

 

“Plan
of Arrangement” means the plan of arrangement substantially in the form and content of Schedule A to the Arrangement
Agreement, including any appendices thereto, and any amendments, modifications or supplements thereto made from time to time in
accordance with its terms;

 

“Redemption
Call Purchase Price” has the meaning ascribed thereto in the Plan of Arrangement;

 

“Redemption
Call Right” has the meaning ascribed thereto in the Plan of Arrangement;

 

“Redemption
Date” means the date, if any, established by the Board of Directors for the redemption by the Company of all but not
less than all of the outstanding Exchangeable Shares, which date shall be no earlier than the seventh anniversary of the Effective
Date, unless:

 

		(i)	the
                                         aggregate number of Exchangeable Shares issued and outstanding (other than Exchangeable
                                         Shares held by Akerna and its subsidiaries) is less than 2% of the number of Exchangeable
                                         Shares issued on the Effective Date (as such number of shares may be adjusted as deemed
                                         appropriate by the Board of Directors to give effect to any subdivision, combination
                                         or consolidation of or stock or share dividend on the Exchangeable Shares, any issue
                                         or distribution of rights to acquire Exchangeable Shares or securities exchangeable for
                                         or convertible into Exchangeable Shares, any issue or distribution of other securities
                                         or rights or evidences of indebtedness or assets, or any other capital reorganization
                                         or other transaction affecting the Exchangeable Shares), in which case the Board of Directors
                                         may accelerate such redemption date to such date prior to the seventh anniversary of
                                         the Effective Date as it may determine, upon at least 30 days’ prior written notice to
                                         the holders of the Exchangeable Shares and the Trustee;

 

		(ii)	an
                                         Akerna Control Transaction is proposed, in which case, provided the Board of Directors
                                         determines in good faith that it is not practicable to substantially replicate the terms
                                         and conditions of the Exchangeable Shares in connection with such Akerna Control Transaction
                                         or that the redemption of all but not less than all of the outstanding Exchangeable Shares
                                         (other than Exchangeable Shares held by Akerna and its affiliates) is necessary to enable
                                         the completion of such Akerna Control Transaction in accordance with its terms, the Board
                                         of Directors may accelerate such redemption date to such date as it may determine, upon
                                         such number of days prior written notice to the holders of the Exchangeable Shares and
                                         the Trustee as the Board of Directors may determine to be reasonably practicable in such
                                         circumstances;

  

    I-4

     

    

 

		(iii)	an
                                         Exchangeable Share Voting Event is proposed and (A) the holders of the Exchangeable Shares
                                         fail to take the necessary action at a meeting or other vote of holders of Exchangeable
                                         Shares to approve or disapprove, as applicable, the Exchangeable Share Voting Event,
                                         and (B) the Board of Directors has determined, in good faith and in its sole discretion,
                                         that it is not reasonably practicable to accomplish the business purpose (which business
                                         purpose must be bona fide and not for the primary purpose of causing the occurrence of
                                         the Redemption Date) intended by the Exchangeable Share Voting Event in a commercially
                                         reasonable manner that does not result in an Exchangeable Share Voting Event, in which
                                         case the Redemption Date shall be the Business Day following the day on which the later
                                         of the events described in (A) and (B) above occurs; or

 

		(iv)	an
                                         Exempt Exchangeable Share Voting Event is proposed and the holders of the Exchangeable
                                         Shares fail to take the necessary action at a meeting or other vote of holders of Exchangeable
                                         Shares to approve or disapprove, as applicable, the Exempt Exchangeable Share Voting
                                         Event, in which case the Redemption Date shall be the Business Day following the day
                                         on which the holders of the Exchangeable Shares fail to take such action;

 

provided,
however, that the accidental failure or omission to give any notice of redemption under clauses (i), (ii), (iii) or (iv) above
to any of the holders of Exchangeable Shares shall not affect the validity of any such redemption;

 

“Redemption
Price” has the meaning ascribed thereto in Section 7(a);

 

“Retracted
Shares” has the meaning ascribed thereto in Section 6(a)(i);

 

“Retraction
Call Notice” has the meaning ascribed thereto in Section 6(b)(ii);

 

“Retraction
Call Right” has the meaning ascribed thereto in Section 6(a)(i)(C);

 

“Retraction
Call Right Purchase Price” has the meaning ascribed thereto in Section 6(b)(i);

 

“Retraction
Date” has the meaning ascribed thereto in Section 6(a)(i);

 

“Retraction
Price” has the meaning ascribed thereto in Section 6(a)(i);

 

“Retraction
Request” has the meaning ascribed thereto in Section 6(a)(i);

 

“Support
Agreement” means the support agreement to be entered into at or prior to the issuance by the Company of any Exchangeable
Shares among Akerna, Callco and the Company substantially in the form of Schedule D to the Arrangement Agreement, as may be amended,
supplemented or otherwise modified from time to time in accordance with its terms;

 

“Transfer
Agent” means Continental Stock Transfer & Trust Company, Inc. or such other person as may from time to time be appointed
by the Company as the registrar and transfer agent for the Exchangeable Shares;

 

“Trustee”
means the trustee chosen by Akerna and Ample, each acting reasonably, to act as trustee under the Voting and Exchange Trust Agreement
and any successor trustee appointed under the Voting and Exchange Trust Agreement; and

  

    I-5

     

    

 

“Voting
and Exchange Trust Agreement” means the voting and exchange trust agreement to be made among Akerna, Callco, the Company
and the Trustee in connection with the Plan of Arrangement substantially in the form of Schedule G to the Arrangement Agreement,
as may be amended, supplemented or otherwise modified from time to time in accordance with its terms.

 

		(b)	Interpretation
                                         Not Affected by Headings. The division of these Exchangeable Share Provisions into
                                         sections and other portions and the insertion of headings are for convenience of reference
                                         only and shall not affect the construction or interpretation hereof. Unless otherwise
                                         indicated, all references to a “Section” followed by a number and/or a letter
                                         refer to the specified section of these Exchangeable Share Provisions.

 

		(c)	Number
                                         and Gender. In these Exchangeable Share Provision, unless the context otherwise clearly
                                         requires, words used herein importing the singular include the plural and vice versa
                                         and words imparting any gender shall include all genders.

 

		(d)	Date
                                         of Any Action. If any date on which any action is required to be taken hereunder
                                         by any person is not a Business Day, then such action shall be required to be taken on
                                         the next succeeding day which is a Business Day.

 

		(e)	Currency.
                                         In these Exchangeable Share Provision, unless stated otherwise, all cash payments provided
                                         for herein shall be made in Canadian dollars.

 

		2.	Ranking
of Exchangeable Shares

 

The
Exchangeable Shares shall be entitled to a preference over the Common Shares and any other shares ranking junior to the Exchangeable
Shares: (a) with respect to the payment of dividends or other distributions as and to the extent provided in Section 3; and (b)
with respect to the distribution of assets in the event of the liquidation, dissolution or winding-up of the Company, whether
voluntary or involuntary, or any other distribution of the assets of the Company among its shareholders for the purpose of winding
up its affairs as and to the extent provided in Section 5.

 

		3.	Dividends
and Distributions

 

		(a)	Dividends
                                         and Distributions. A holder of an Exchangeable Share shall be entitled to receive
                                         and the Board of Directors shall, subject to applicable law, on each Akerna Dividend
                                         Declaration Date, declare a dividend or other distribution on each Exchangeable Share:

 

		(i)	in
                                         the case of a cash dividend or other distribution declared on the Akerna Shares, in an
                                         amount in cash for each Exchangeable Share equal to the Canadian Dollar Equivalent of
                                         the cash dividend or other distribution declared on each Akerna Share on the Akerna Dividend
                                         Declaration Date;

 

		(ii)	in
                                         the case of a stock or share dividend or other distribution declared on the Akerna Shares
                                         to be paid in Akerna Shares, by the issue or transfer by the Company of such number of
                                         Exchangeable Shares for each Exchangeable Share as is equal to the number of Akerna Shares
                                         to be paid on each Akerna Share; provided, however, that the Company may, in lieu of
                                         such stock or share dividend or other distribution, elect to effect a corresponding,
                                         contemporaneous and economically equivalent (as determined by the Board of Directors
                                         in accordance with Sections 3(e) and 3(f)) subdivision of the outstanding Exchangeable
                                         Shares; or

 

		(iii)	in
                                         the case of a dividend or other distribution declared on the Akerna Shares in property
                                         other than cash or Akerna Shares, in such type and amount of property for each Exchangeable
                                         Share as is the same as or economically equivalent (as determined by the Board of Directors
                                         in accordance with Section 3(e)) to the type and amount of property declared as a dividend
                                         or other distribution on each Akerna Share; and

  

    I-6

     

    

 

such
dividends or other distributions shall be paid out of money, assets or property of the Company properly applicable to the payment
of dividends or other distributions, out of authorized but unissued shares of the Company or through the subdivision of outstanding
Exchangeable Shares, as applicable. The holders of Exchangeable Shares shall not be entitled to any dividends or other distributions
other than or in excess of the dividends or other distributions referred to in this Section 3(a).

 

		(b)	Payments
                                         of Dividends and Distributions. Cheques of the Company payable at par at any branch
                                         of the bankers of the Company shall be issued in respect of any cash dividends or other
                                         distributions contemplated by Section 3(a)(i) and the sending of such cheque to each
                                         holder of an Exchangeable Share shall satisfy the cash dividend or other distribution
                                         represented thereby unless the cheque is not paid on presentation. Certificates registered
                                         in the name of the registered holder of Exchangeable Shares or written evidence of the
                                         book entry issuance or transfer to the registered holder of Exchangeable Shares shall
                                         be delivered in respect of any stock or share dividends or other distributions contemplated
                                         by Section 3(a)(ii) or any subdivision of the Exchangeable Shares under Sections 3(a)(ii)
                                         and 3(f), and the sending of such certificates or written evidence to each holder of
                                         an Exchangeable Share shall satisfy the stock or share dividend or other distribution
                                         represented thereby. Such other type and amount of property in respect of any dividends
                                         or other distributions contemplated by Section 3(a)(iii) shall be issued, distributed
                                         or transferred by the Company in such manner as it shall determine, and the issuance,
                                         distribution or transfer thereof by the Company to each holder of an Exchangeable Share
                                         shall satisfy the dividend or other distribution represented thereby. Subject to the
                                         requirements of applicable law with respect to unclaimed property, no holder of an Exchangeable
                                         Share shall be entitled to recover by action or other legal process against the Company
                                         any dividend or other distribution that is represented by a cheque that has not been
                                         duly presented to the Company’s bankers for payment or that otherwise remains unclaimed
                                         for a period of six years from the date on which such dividend was payable.

 

		(c)	Record
                                         and Payment Dates. The record date for the determination of the holders of Exchangeable
                                         Shares entitled to receive payment of, and the payment date for, any dividend or other
                                         distribution declared on the Exchangeable Shares under Section 3(a) shall be the same
                                         dates as the record date and payment date, respectively, for the corresponding dividend
                                         or other distribution declared on the Akerna Shares. The record date for the determination
                                         of the holders of Exchangeable Shares entitled to receive Exchangeable Shares in connection
                                         with any subdivision of the Exchangeable Shares under Sections 3(a)(ii) and 3(f), and
                                         the effective date of such subdivision, shall be the same dates as the record and payment
                                         date, respectively, for the corresponding stock or share dividend or other distribution
                                         declared on the Akerna Shares.

 

		(d)	Partial
                                         Payment. If on any payment date for any dividends or other distributions declared
                                         on the Exchangeable Shares under Section 3(a) the dividends or other distributions are
                                         not paid in full on all of the Exchangeable Shares then outstanding, any such dividends
                                         or other distributions that remain unpaid shall be paid on a subsequent date or dates
                                         determined by the Board of Directors on which the Company shall have sufficient moneys,
                                         assets or property properly applicable to the payment of such dividends or other distributions.

  

    I-7

     

    

 

		(e)	Economic
                                         Equivalence. The Board of Directors shall determine, in good faith and in its sole
                                         discretion (with the assistance of such financial or other advisors as the Board of Directors
                                         may determine), “economic equivalence” for the purposes of the Exchangeable
                                         Share Provisions and each such determination shall be conclusive and binding on the Company
                                         and its shareholders. In making each such determination, the following factors shall,
                                         without excluding other factors determined by the Board of Directors to be relevant,
                                         be considered by the Board of Directors:

 

		(i)	in
                                         the case of any stock or share dividend or other distribution payable in Akerna Shares,
                                         the number of such shares issued as a result of such stock or share dividend or other
                                         distribution in proportion to the number of Akerna Shares previously outstanding;

 

		(ii)	in
                                         the case of the issuance or distribution of any rights, options or warrants to subscribe
                                         for or purchase Akerna Shares (or securities exchangeable for or convertible into or
                                         carrying rights to acquire Akerna Shares), the relationship between the exercise price
                                         of each such right, option or warrant, the number of such rights, options or warrants
                                         to be issued or distributed in respect of each Akerna Share and the Current Market Price
                                         of an Akerna Share, the price volatility of the Akerna Shares and the terms of any such
                                         instrument;

 

		(iii)	in
                                         the case of the issuance or distribution of any other form of property (including without
                                         limitation any shares or securities of Akerna of any class other than Akerna Shares,
                                         any rights, options or warrants other than those referred to in Section 3(e)(ii), any
                                         evidences of indebtedness of Akerna or any assets of Akerna), the relationship between
                                         the fair market value (as determined by the Board of Directors in the manner above contemplated)
                                         of such property to be issued or distributed with respect to each outstanding Akerna
                                         Share and the Current Market Price of an Akerna Share;

 

		(iv)	in
                                         the case of any subdivision, redivision or change of the then outstanding Akerna Shares
                                         into a greater number of Akerna Shares or the reduction, combination, consolidation or
                                         change of the then outstanding Akerna Shares into a lesser number of Akerna Shares or
                                         any amalgamation, merger, arrangement, reorganization or other transaction affecting
                                         the Akerna Shares, the effect thereof upon the then outstanding Akerna Shares; and

 

		(v)	in
                                         all such cases, the general taxation consequences of the relevant event to holders of
                                         Exchangeable Shares to the extent that such consequences may differ from the taxation
                                         consequences to holders of Akerna Shares as a result of differences between taxation
                                         laws of Canada and the United States (except for any differing consequences arising as
                                         a result of differing marginal taxation rates and without regard to the individual circumstances
                                         of holders of Exchangeable Shares).

 

		(f)	Subdivision
                                         on Stock or Share Dividend. In the case of a stock or share dividend declared on
                                         Akerna Shares to be paid in Akerna Shares, in lieu of declaring the stock or share dividend
                                         contemplated by Section 3(a)(ii) on the Exchangeable Shares, the Board of Directors may,
                                         in good faith and in its discretion and subject to applicable law and to obtaining all
                                         required regulatory approvals, subdivide, redivide or change each issued and unissued
                                         Exchangeable Share on the basis that each Exchangeable Share before such subdivision
                                         becomes a number of Exchangeable Shares equal to the sum of: (i) one Akerna Share; and
                                         (ii) the number of Akerna Shares to be paid as a share dividend on each Akerna Share.

  

    I-8

     

    

 

		4.	Certain
Restrictions

 

So
long as any of the Exchangeable Shares are outstanding, the Company shall not at any time without, but may at any time with, the
approval of the holders of the Exchangeable Shares given as specified in Section 11(a):

 

		(a)	pay
                                         any dividends or other distributions on the Common Shares or any other shares ranking
                                         junior to the Exchangeable Shares with respect to the payment of dividends or other distributions,
                                         other than stock or share dividends payable in Common Shares or any such other shares
                                         ranking junior to the Exchangeable Shares, as the case may be;

 

		(b)	redeem
                                         or purchase or make any capital distribution in respect of Common Shares or any other
                                         shares ranking junior to the Exchangeable Shares with respect to the payment of dividends
                                         or the distribution of the assets in the event of the liquidation, dissolution or winding
                                         up of the Company, whether voluntary or involuntary, or any other distribution of the
                                         assets of the Company among its shareholders for the purpose of winding up its affairs;

 

		(c)	redeem
                                         or purchase or make any capital distribution in respect of any other shares of the Company
                                         ranking equally with the Exchangeable Shares with respect to the payment of dividends
                                         or the distribution of assets in the event of the liquidation, dissolution or winding-up
                                         of the Company, whether voluntary or involuntary, or any other distribution of the assets
                                         of the Company among its shareholders for the purpose of winding up its affairs; or

 

		(d)	issue
                                         any Exchangeable Share or any other shares ranking equally with, or superior to, the
                                         Exchangeable Shares, other than, in each case, by way of stock or share dividends to
                                         the holders of such Exchangeable Shares or pursuant to a shareholders rights plan adopted
                                         by the Company;

 

provided,
however, that the restrictions in this Section 4 shall not apply if all dividends or other distributions on the outstanding Exchangeable
Shares corresponding to dividends or other distributions declared and paid on the Akerna Shares shall have been declared and paid
in full on the Exchangeable Shares prior to or as at the date of any such event referred to in this Section 4.

 

		5.	Liquidation

 

		(a)	Liquidation
                                         Amount. Subject to applicable laws and the due exercise by Akerna or Callco of the
                                         Liquidation Call Right (which shall itself be subject to the sale and purchase contemplated
                                         by the Automatic Exchange Right), in the event of the liquidation, dissolution or winding-up
                                         of the Company or any other distribution of the assets of the Company among its shareholders
                                         for the purpose of winding up its affairs, a holder of Exchangeable Shares shall be entitled
                                         to receive from the assets of the Company in respect of each Exchangeable Share held
                                         by such holder on the effective date of such liquidation, dissolution, winding-up or
                                         other distribution (the “Liquidation Date”), before any distribution
                                         of any part of the assets of the Company among the holders of the Common Shares or any
                                         other shares ranking junior to the Exchangeable Shares with respect to dividends or other
                                         distributions an amount per share (the “Liquidation Amount”) equal to
                                         the Exchangeable Share Price applicable on the last Business Day prior to the Liquidation
                                         Date, which price shall be satisfied in full by the Company delivering or causing to
                                         be delivered to such holder the Exchangeable Share Consideration representing the Liquidation
                                         Amount.

  

    I-9

     

    

 

		(b)	Payment
                                         of Liquidation Amount. In the case of a distribution pursuant to Section 5(a), and
                                         provided that the sale and purchase contemplated by the Automatic Exchange Right has
                                         not occurred and that the Liquidation Call Right has not been exercised by Akerna or
                                         Callco, on or promptly after the Liquidation Date, the Company shall deliver or cause
                                         to be delivered to the holders of the Exchangeable Shares the Liquidation Amount for
                                         each such Exchangeable Share upon presentation and surrender of the certificates representing
                                         such Exchangeable Shares, together with such other documents and instruments as may be
                                         required to effect a transfer of Exchangeable Shares under the OBCA and the articles
                                         of the Company, as applicable, together with such additional documents, instruments and
                                         payments as the Transfer Agent and the Company may reasonably require, at the registered
                                         office of the Company or at any office of the Transfer Agent as may be specified by the
                                         Company by notice to the holders of the Exchangeable Shares. Payment of the Liquidation
                                         Amount for such Exchangeable Shares shall be made by delivery to each holder, at the
                                         address of such holder recorded in the securities register of the Company for the Exchangeable
                                         Shares or by holding for pick-up by such holder at the registered office of the Company
                                         or at any office of the Transfer Agent as may be specified by the Company by notice to
                                         the holders of the Exchangeable Shares, the Exchangeable Share Consideration such holder
                                         is entitled to receive pursuant to Section 5(a). On and after the Liquidation Date, the
                                         holders of the Exchangeable Shares shall cease to be holders of such Exchangeable Shares
                                         and shall not be entitled to exercise any of the rights of holders in respect thereof
                                         (including, without limitation, any rights under the Voting and Exchange Trust Agreement)
                                         other than the right to receive, without interest, their proportionate part of the aggregate
                                         Liquidation Amount, unless payment of the aggregate Liquidation Amount for such Exchangeable
                                         Shares shall not be made upon presentation and surrender of share certificates and other
                                         required documents in accordance with the foregoing provisions, in which case the rights
                                         of the holders shall remain unaffected until the Liquidation Amount has been paid in
                                         the manner hereinbefore provided. The Company shall have the right at any time after
                                         the Liquidation Date to transfer or cause to be issued or transferred to, and deposited
                                         in a custodial account with, any chartered bank or trust company the Liquidation Amount
                                         in respect of the Exchangeable Shares represented by certificates that have not at the
                                         Liquidation Date been surrendered by the holders thereof, such Liquidation Amount to
                                         be held by such bank or trust company as trustee for and on behalf of, and for the use
                                         and benefit of, such holders. Upon such deposit being made, the rights of a holder of
                                         Exchangeable Shares as of the date of such deposit shall be limited to receiving its
                                         proportionate part of the aggregate Liquidation Amount for such Exchangeable Shares so
                                         deposited, without interest, and all dividends and other distributions with respect to
                                         the Akerna Shares to which such holder is entitled with a record date on or after the
                                         date of such deposit and before the date of transfer of such Akerna Shares to such holder
                                         (in each case less any amounts withheld on account of tax required to be deducted and
                                         withheld therefrom) against presentation and surrender of the certificates for the Exchangeable
                                         Shares held by them in accordance with the foregoing provisions. Upon such payment or
                                         deposit of the Liquidation Amount, the holders of the Exchangeable Shares shall thereafter
                                         be considered and deemed for all purposes to be holders of the Akerna Shares delivered
                                         to them or the custodian on their behalf.

 

		(c)	No
                                         Right to Participate in Further Distributions. After the Company has satisfied its
                                         obligations to pay the holders of the Exchangeable Shares the aggregate Liquidation Amount
                                         per Exchangeable Share pursuant to this Section 5, such holders shall not be entitled
                                         to share in any further distribution of the assets of the Company.

  

    I-10

     

    

 

		6.	Retraction
of Exchangeable Shares

 

		(a)	Retraction
                                         at Option of Holder

 

		(i)	Subject
                                         to applicable laws and the due exercise by Akerna or Callco of the Retraction Call Right,
                                         a holder of Exchangeable Shares shall be entitled at any time to require the Company
                                         to redeem any or all of the Exchangeable Shares registered in the name of such holder
                                         for an amount per share equal to the Exchangeable Share Price applicable on the last
                                         Business Day prior to the Retraction Date (the “Retraction Price”),
                                         which price shall be satisfied in full by the Company delivering or causing to be delivered
                                         to such holder the Exchangeable Share Consideration representing the Retraction Price.
                                         A holder of Exchangeable Shares must give notice of a request to redeem by presenting
                                         and surrendering to the Company, at the registered office of the Company or at any office
                                         of the Transfer Agent as may be specified by the Company by notice to the holders of
                                         the Exchangeable Shares, the certificate or certificates representing the Exchangeable
                                         Shares that such holder desires to have the Company redeem, together with: (A) such other
                                         documents and instruments as may be required to effect a transfer of Exchangeable Shares
                                         under the OBCA and the articles of the Company, as applicable, together with such additional
                                         documents, instruments and payments as the Transfer Agent and the Company may reasonably
                                         require; and (B) a duly executed request (the “Retraction Request”)
                                         in the form of Appendix I hereto or in such other form as may be acceptable to the Company:

 

		(A)	specifying
                                         that such holder desires to have all or any number specified therein of the Exchangeable
                                         Shares represented by such certificate or certificates (the “Retracted Shares”)
                                         redeemed by the Company;

 

		(B)	stating
                                         the Business Day on which the holder desires to have the Company redeem the Retracted
                                         Shares (the “Retraction Date”), provided that the Retraction Date shall
                                         not be less than 10 Business Days nor more than 15 Business Days after the date on which
                                         the Retraction Request is received by the Company and further provided that, in the event
                                         that no such Business Day is specified by the holder in the Retraction Request, the Retraction
                                         Date shall be deemed to be the 15th Business Day after the date on which the
                                         Retraction Request is received by the Company, subject to Section 6(a)(v); and

 

		(C)	acknowledging
                                         the overriding right (the “Retraction Call Right”) of Akerna and Callco
                                         to purchase all but not less than all the Retracted Shares directly from the holder and
                                         that the Retraction Request shall be deemed to be a revocable offer by the holder to
                                         sell the Retracted Shares to Akerna or Callco in accordance with the Retraction Call
                                         Right on the Retraction Date for the Retraction Call Right Purchase Price and on the
                                         other terms and conditions set out in Section 6(b).

 

		(ii)	In
                                         the case of a redemption of Exchangeable Shares pursuant to this Section 6(a), upon receipt
                                         by the Company or the Transfer Agent in the manner specified in Section 6(a)(i) of a
                                         certificate or certificates representing the number of Exchangeable Shares which the
                                         holder desires to have the Company redeem, together with a duly executed Retraction Request
                                         and such additional documents and instruments specified in Section 6(a)(i) or that the
                                         Company may reasonably require, and provided that: (A) the Retraction Request has not
                                         been revoked by the holder of such Retracted Shares in the manner specified in Section
                                         6(a)(iv); and (B) neither Akerna nor Callco has exercised the Retraction Call Right,
                                         the Company shall redeem the Retracted Shares effective at the close of business on the
                                         Retraction Date. On the Retraction Date, the Company shall deliver or cause to be delivered
                                         to such holder, at the address of the holder recorded in the securities register of the
                                         Company for the Exchangeable Shares or at the address specified in the Retraction Request
                                         or by holding for pick-up by the holder at the registered office of the Company or at
                                         any office of the Transfer Agent as may be specified by the Company by notice to the
                                         holders of the Exchangeable Shares, the Exchangeable Share Consideration representing
                                         the Retraction Price and such delivery of such Exchangeable Share Consideration by or
                                         on behalf of the Company by the Transfer Agent shall be deemed to be payment of and shall
                                         satisfy and discharge all liability for the Retraction Price to the extent that the same
                                         is represented by such Exchangeable Share Consideration, unless any cheque comprising
                                         part of such Exchangeable Share Consideration is not paid on due presentation. If only
                                         a part of the Exchangeable Shares represented by any certificate is redeemed, a new certificate
                                         for the balance of such Exchangeable Shares shall be issued to the holder at the expense
                                         of the Company. On and after the close of business on the Retraction Date, the holder
                                         of the Retracted Shares shall cease to be a holder of such Retracted Shares and shall
                                         not be entitled to exercise any of the rights of a holder in respect thereof (including,
                                         without limitation, any rights under the Voting and Exchange Trust Agreement), other
                                         than the right to receive the aggregate Retraction Price in respect thereof, unless payment
                                         of the aggregate Retraction Price payable to such holder shall not be made upon presentation
                                         and surrender of share certificates and other required documents in accordance with the
                                         foregoing provisions, in which case the rights of such holder shall remain unaffected
                                         until such aggregate Retraction Price has been paid in the manner hereinbefore provided.
                                         On and after the close of business on the Retraction Date, provided that presentation
                                         and surrender of the certificates and payment of such aggregate Retraction Price has
                                         been made in accordance with the foregoing provisions, the holder of the Retracted Shares
                                         so redeemed by the Company shall thereafter be considered and deemed for all purposes
                                         to be a holder of the Akerna Shares delivered to such holder.

 

    I-11

     

    

 

		(iii)	Notwithstanding
                                         any other provision of this Section 6, the Company shall not be obligated to redeem Retracted
                                         Shares specified by a holder in a Retraction Request if and to the extent that such redemption
                                         of Retracted Shares would be contrary to solvency requirements or other provisions of
                                         applicable laws. If the Company believes, after due enquiry, that on any Retraction Date
                                         it would not be permitted by any of such provisions to redeem the Retracted Shares tendered
                                         for redemption on such date, and provided that neither Akerna nor Callco has exercised
                                         the Retraction Call Right with respect to such Retracted Shares, the Company shall only
                                         be obligated to redeem Retracted Shares specified by a holder in a Retraction Request
                                         to the extent of the maximum number that may be so redeemed (rounded down to a whole
                                         number of shares) as would not be contrary to such provisions and shall notify the holder
                                         and the Trustee at least two Business Days prior to the Retraction Date as to the number
                                         of Retracted Shares which will not be redeemed by the Company. In any case in which the
                                         redemption by the Company of Retracted Shares would be contrary to solvency requirements
                                         or other provisions of applicable laws, the Company shall redeem Retracted Shares in
                                         accordance with Section 6(a)(ii) on a pro rata basis in proportion to the total number
                                         of Exchangeable Shares tendered for retraction and shall issue to each holder of Retracted
                                         Shares a new certificate, at the expense of the Company, representing the Retracted Shares
                                         not redeemed by the Company pursuant to Section 6(a)(ii). If the Company would otherwise
                                         be obligated to redeem Retracted Shares pursuant to Section 6(a)(ii) but is not obligated
                                         to do so as a result of solvency requirements or other provisions of applicable laws,
                                         the holder of any such Retracted Shares not redeemed by the Company pursuant to Section
                                         6(a)(ii) as a result of solvency requirements or other provisions of applicable laws
                                         shall be deemed, by delivery of the Retraction Request, to have instructed the Transfer
                                         Agent to require Akerna or Callco to purchase such Retracted Shares from such holder
                                         on the Retraction Date or as soon as practicable thereafter on payment by Akerna or Callco
                                         to such holder of the aggregate Retraction Price in respect of such Retracted Shares,
                                         all as more specifically provided for in the Voting and Exchange Trust Agreement.

  

    I-12

     

    

 

		(iv)	A
                                         holder of Retracted Shares may, by notice in writing given by the holder to the Company
                                         before the close of business on the Business Day immediately preceding the Retraction
                                         Date, withdraw its Retraction Request, in which event such Retraction Request shall be
                                         null and void and, for greater certainty, the revocable offer constituted by the Retraction
                                         Request to sell the Retracted Shares to Akerna or Callco shall be deemed to have been
                                         revoked.

 

		(v)	Notwithstanding
                                         any other provision of this Section 6(a), if:

 

		(A)	exercise
                                         of the rights of the holders of the Exchangeable Shares, or any of them, to require the
                                         Company to redeem any Exchangeable Shares pursuant to this Section 6(a) on any Retraction
                                         Date would require listing particulars or any similar document to be issued in order
                                         to obtain the approval of the NASDAQ to the listing and trading (subject to official
                                         notice of issuance) of the Akerna Shares that would be required to be delivered to such
                                         holders of Exchangeable Shares in connection with the exercise of such rights; and

 

		(B)	as
                                         a result of (A) above, it would not be practicable (notwithstanding the reasonable endeavours
                                         of Akerna) to obtain such approvals in time to enable all or any of such Akerna Shares
                                         to be admitted to listing and trading by the NASDAQ (subject to official notice of issuance)
                                         when so delivered; the Retraction Date shall, notwithstanding any other date specified
                                         or otherwise deemed to be specified in any relevant Retraction Request, be deemed for
                                         all purposes to be the earlier of: (i) the second Business Day immediately following
                                         the date the approvals referred to in Section 6(a)(v)(A) are obtained; and (ii) the date
                                         which is 30 Business Days after the date on which the relevant Retraction Request is
                                         received by the Company, and references in these Exchangeable Share Provisions to such
                                         Retraction Date shall be construed accordingly.

 

		(b)	Retraction
                                         Call Rights

 

		(i)	In
                                         the event that a holder of Exchangeable Shares delivers a Retraction Request pursuant
                                         to Section 6(a), and subject to the limitations set forth in Section 6(a)(ii) (including
                                         that Callco shall only be entitled to exercise its Retraction Call Right with respect
                                         to those holders of Exchangeable Shares, if any, in respect of which Akerna has not exercised
                                         its Retraction Call Right), the Retraction Call Right will be available to each of Akerna
                                         and Callco, notwithstanding the proposed redemption of the Exchangeable Shares by the
                                         Company pursuant to Section 6(a), to purchase from such holder on the Retraction Date
                                         all but not less than all of the Retracted Shares held by such holder on payment by Akerna
                                         or Callco, as the case may be, of an amount per share equal to the Exchangeable Share
                                         Price applicable on the last Business Day prior to the Retraction Date (the “Retraction
                                         Call Right Purchase Price”), which price shall be satisfied in full by Akerna
                                         or Callco, as the case may, delivering or causing to be delivered to such holder the
                                         Exchangeable Share Consideration representing the Retraction Call Right Purchase Price.
                                         Upon the exercise of the Retraction Call Right in respect of Retracted Shares, the holder
                                         of such Retracted Shares shall be obligated to sell all of such Retracted Shares to Akerna
                                         or Callco, as the case may be, on the Retraction Date on payment by Akerna or Callco,
                                         as the case may be, of the aggregate Retraction Call Right Purchase Price in respect
                                         of such Retracted Shares as set forth in this Section 6(b)(i).

  

    I-13

     

    

 

		(ii)	Upon
                                         receipt by the Company of a Retraction Request, the Company shall immediately notify
                                         Akerna and Callco thereof and shall provide Akerna and Callco with a copy of the Retraction
                                         Request. Callco shall only be entitled to exercise its Retraction Call Right with respect
                                         to those holders of Retracted Shares, if any, in respect of which Akerna has not exercised
                                         its Retraction Call Right. In order to exercise its Retraction Call Right, Akerna or
                                         Callco, as the case may be, must notify the Company in writing of its determination to
                                         do so (a “Retraction Call Notice”) within five Business Days after the
                                         Company notifies Akerna and Callco of the Retraction Request. If neither Akerna nor Callco
                                         so notifies the Company within such five Business Day period, the Company shall notify
                                         the holder as soon as possible thereafter that neither Akerna nor Callco will exercise
                                         the Retraction Call Right. If one or both of Akerna and Callco delivers a Retraction
                                         Call Notice within such five Business Day period and duly exercises its Retraction Call
                                         Right in accordance with this Section 6(b)(ii), the obligation of the Company to redeem
                                         the Retracted Shares shall terminate and, provided that the Retraction Request is not
                                         revoked by the holder of such Retracted Shares in the manner specified in Section 6(a)(iv),
                                         Akerna or Callco, as the case may be, shall purchase from such holder and such holder
                                         shall sell to Akerna or Callco, as the case may be, on the Retraction Date the Retracted
                                         Shares for an amount per share equal to the Retraction Call Right Purchase Price. Provided
                                         that the aggregate Retraction Call Right Purchase Price has been so deposited with the
                                         Transfer Agent as provided in Section 6(b)(iii), the closing of the purchase and sale
                                         of the Retracted Shares pursuant to the Retraction Call Right shall be deemed to have
                                         occurred as at the close of business on the Retraction Date and, for greater certainty,
                                         no redemption by the Company of such Retracted Shares shall take place on the Retraction
                                         Date.

 

		(iii)	For
                                         the purpose of completing a purchase of Retracted Shares pursuant to the exercise of
                                         the Retraction Call Right, Akerna or Callco, as the case may be, shall deliver or cause
                                         to be delivered to the holder of such Retracted Shares, at the address of the holder
                                         recorded in the securities register of the Company for the Exchangeable Shares or at
                                         the address specified in the holder’s Retraction Request or by holding for pick-up by
                                         the holder at the registered office of the Company or at any office of the Transfer Agent
                                         as may be specified by the Company by notice to the holders of Exchangeable Shares, the
                                         Exchangeable Share Consideration representing the Retraction Call Right Purchase Price
                                         to which such holder is entitled and such delivery of Exchangeable Share Consideration
                                         on behalf of Akerna or Callco, as the case may be, shall be deemed to be payment of and
                                         shall satisfy and discharge all liability for the Retraction Call Right Purchase Price
                                         to the extent that the same is represented by such Exchangeable Share Consideration,
                                         unless any cheque comprising part of such Exchangeable Share Consideration is not paid
                                         on due presentation.

 

		(iv)	On
                                         and after the close of business on the Retraction Date, the holder of the

                                         Retracted Shares shall cease to be a holder of such Retracted Shares and shall not be
                                         entitled to exercise any of the rights of a holder in respect thereof (including, without
                                         limitation, any rights under the Voting and Exchange Trust Agreement), other than the
                                         right to receive the aggregate Retraction Call Right Purchase Price in respect thereof,
                                         unless payment of the aggregate Retraction Call Right Purchase Price payable to such
                                         holder shall not be made upon presentation and surrender of share certificates and other
                                         required documents in accordance with the foregoing provisions, in which case the rights
                                         of such holder shall remain unaffected until such aggregate Retraction Call Right Purchase
                                         Price has been paid in the manner hereinbefore provided. On and after the close of business
                                         on the Retraction Date, provided that presentation and surrender of certificates and
                                         payment of such aggregate Retraction Call Right Purchase Price has been made in accordance
                                         with the foregoing provisions, the holder of the Retracted Shares so purchased by Akerna
                                         or Callco, as the case may be, shall thereafter be considered and deemed for all purposes
                                         to be a holder of the Akerna Shares delivered to such holder.

  

    I-14

     

    

 

		7.	Redemption
of Exchangeable Shares by the Company

 

		(a)	Redemption
                                         Amount. Subject to applicable laws and the due exercise by Akerna or Callco of the
                                         Redemption Call Right, the Company shall on the Redemption Date redeem all but not less
                                         than all of the then outstanding Exchangeable Shares (other than Exchangeable Shares
                                         held by Akerna and its affiliates) for an amount per share (the “Redemption Price”)
                                         equal to the Exchangeable Share Price on the last Business Day prior to the Redemption
                                         Date, which price shall be satisfied in full by the Company delivering or causing to
                                         be delivered to each holder of Exchangeable Shares the Exchangeable Share Consideration
                                         for each Exchangeable Share held by such holder.

 

		(b)	Notice
                                         of Redemption. In the case of a redemption of Exchangeable Shares pursuant to Section
                                         7(a), the Company shall, at least 30 days before the Redemption Date (other than a Redemption
                                         Date established in connection with an Akerna Control Transaction, an Exchangeable Share
                                         Voting Event or an Exempt Exchangeable Share Voting Event), send or cause to be sent
                                         to each holder of Exchangeable Shares a notice in writing of the redemption by the Company
                                         or the purchase by Akerna or Callco under the Redemption Call Right, as the case may
                                         be, of the Exchangeable Shares held by such holder. In the case of a Redemption Date
                                         established in connection with an Akerna Control Transaction, an Exchangeable Share Voting
                                         Event or an Exempt Exchangeable Share Voting Event, the written notice of the redemption
                                         by the Company or the purchase by Akerna or Callco, as the case may be, of the Exchangeable
                                         Shares under the Redemption Call Right will be sent on or before the Redemption Date,
                                         on as many days’ prior written notice as may be determined by the Board of Directors
                                         to be reasonably practicable in the circumstances. In any such case, such notice shall
                                         set out the formula for determining the Redemption Price or the Redemption Call Purchase
                                         Price, as the case may be, the Redemption Date and, if applicable, particulars of the
                                         Redemption Call Right. In the case of any notice given in connection with a possible
                                         Redemption Date, such notice will be given contingently and will be withdrawn if the
                                         contingency does not occur.

 

		(c)	Payment
                                         of Redemption Price. On or promptly after the Redemption Date, and provided that
                                         the Redemption Call Right has not been exercised by Akerna or Callco, the Company shall
                                         deliver or cause to be delivered to the holders of the Exchangeable Shares to be redeemed
                                         the Redemption Price for each such Exchangeable Share, upon presentation and surrender
                                         of the certificates representing such Exchangeable Shares, together with such other documents
                                         and instruments as may be required to effect a transfer of Exchangeable Shares under
                                         the OBCA and the articles of the Company, as applicable, together with such additional
                                         documents, instruments and payments as the Transfer Agent and the Company may reasonably
                                         require, at the registered office of the Company or at any office of the Transfer Agent
                                         as may be specified by notice to the holders of the Exchangeable Shares. Payment of the
                                         Redemption Price for such Exchangeable Shares shall be made by delivery to each holder,
                                         at the address of the holder recorded in the securities register of the Company for the
                                         Exchangeable Shares or by holding for pick-up by the holder at the registered office
                                         of the Transfer Agent as may be specified by the Company by notice to the holders of
                                         Exchangeable Shares, the Exchangeable Share Consideration representing the Redemption
                                         Price. On and after the Redemption Date, the holders of the Exchangeable Shares called
                                         for redemption shall cease to be holders of such Exchangeable Shares and shall not be
                                         entitled to exercise any of the rights of holders in respect thereof (including, without
                                         limitation, any rights under the Voting and Exchange Trust Agreement) other than the
                                         right to receive, without interest, their proportionate part of the aggregate Redemption
                                         Price, unless payment of the aggregate Redemption Price for such Exchangeable Shares
                                         shall not be made upon presentation and surrender of certificates in accordance with
                                         the foregoing provisions, in which case the rights of the holders shall remain unaffected
                                         until the Redemption Price has been paid in the manner hereinbefore provided. The Company
                                         shall have the right at any time after the sending of notice of its intention to redeem
                                         the Exchangeable Shares as aforesaid to deposit or cause to be deposited the aggregate
                                         Redemption Price (in the form of Exchangeable Share Consideration) of the Exchangeable
                                         Shares so called for redemption, or of such of the said Exchangeable Shares represented
                                         by certificates that have not at the date of such deposit been surrendered by the holders
                                         thereof in connection with such redemption, in a custodial account with any chartered
                                         bank or trust company in Canada named in such notice and any interest earned on such
                                         deposit shall belong to the Company. Provided that such aggregate Redemption Price has
                                         been so deposited prior to the Redemption Date, on and after the Redemption Date, the
                                         Exchangeable Shares in respect of which such deposit shall have been made shall be redeemed
                                         and the rights of the holders thereof after the Redemption Date shall be limited to receiving,
                                         without interest, their proportionate part of the aggregate Redemption Price for such
                                         Exchangeable Shares so deposited, against presentation and surrender of the certificates
                                         for the Exchangeable Shares held by them, respectively, in accordance with the foregoing
                                         provisions. Upon such payment or deposit of the Redemption Price, the holders of the
                                         Exchangeable Shares shall thereafter be considered and deemed for all purposes to be
                                         holders of the Akerna Shares delivered to them or the custodian on their behalf.

  

    I-15

     

    

 

		8.	Purchase
for Cancellation

 

		(a)	Private
                                         Agreement. Subject to applicable laws and the articles of the Company, and notwithstanding
                                         Section 8(b), the Company may at any time and from time to time purchase for cancellation
                                         all or any part of the Exchangeable Shares by private agreement with the holder thereof.

 

		(b)	Tender
                                         Offer. Subject to applicable laws and the articles of the Company, the Company may
                                         at any time and from time to time purchase for cancellation all or any part of the outstanding
                                         Exchangeable Shares at any price per share by tender to all the holders of Exchangeable
                                         Shares then outstanding or through the facilities of any stock exchange on which the
                                         Exchangeable Shares are listed or quoted together with an amount equal to all declared
                                         and unpaid dividends thereon for which the record date has occurred prior to the date
                                         of purchase. If in response to an invitation for tenders under the provisions of this
                                         Section 8(b) more Exchangeable Shares are tendered at a price or prices acceptable to
                                         the Company than the Company is prepared to purchase, the Exchangeable Shares to be purchased
                                         by the Company shall be purchased as nearly as may be pro rata according to the number
                                         of shares tendered by each holder who submits a tender to the Company, provided that
                                         when shares are tendered at different prices the pro rating shall be effected (disregarding
                                         fractions) only with respect to the shares tendered at the price at which more shares
                                         were tendered than the Company is prepared to purchase after the Company has purchased
                                         all the shares tendered at lower prices. If only part of the Exchangeable Shares represented
                                         by any certificate are purchased pursuant to this Section 8(b), a new certificate for
                                         the balance of such shares shall be issued at the expense of the Company.

 

		9.	Voting
Rights

 

Except
as required by applicable laws and by Section 11, the holders of the Exchangeable Shares shall not be entitled as such to receive
notice of or to attend any meeting of the shareholders of the Company or to vote at any such meeting. Without limiting the generality
of the foregoing, the holders of the Exchangeable Shares shall not be entitled to class votes except as required by applicable
law.

  

    I-16

     

    

 

		10.	Specified
Amount

 

The
amount specified in respect of each Exchangeable Share for the purposes of subsection 191(4) of the Income Tax Act (Canada)
shall be an amount equal to C$●.

 

		11.	Amendment
and Approval

 

		(a)	Amendment.
                                         The rights, privileges, restrictions and conditions attaching to the Exchangeable Shares
                                         may be added to, changed or removed only with the approval of the holders of the Exchangeable
                                         Shares given as hereinafter specified.

 

		(b)	Approval.
                                         Any approval given by the holders of the Exchangeable Shares to add to, change or remove
                                         any right, privilege, restriction or condition attaching to the Exchangeable Shares or
                                         any other matter requiring the approval or consent of the holders of the Exchangeable
                                         Shares in accordance with applicable laws shall be deemed to have been sufficiently given
                                         if it shall have been given in accordance with applicable laws, subject to a minimum
                                         requirement that such approval be evidenced by resolution passed by not less than two-thirds
                                         of the votes cast on such resolution at a meeting of holders of Exchangeable Shares duly
                                         called and held at which the holders of at least 10% of the outstanding Exchangeable
                                         Shares at that time are present or represented by proxy; provided, however, that if at
                                         any such meeting the holders of at least 10% of the outstanding Exchangeable Shares at
                                         that time are not present or represented by proxy within one-half hour after the time
                                         appointed for such meeting, then the meeting shall be adjourned to such date not less
                                         than five days thereafter and to such time and place as may be designated by the Chairman
                                         of such meeting. At such adjourned meeting, the holders of Exchangeable Shares present
                                         or represented by proxy thereat may transact the business for which the meeting was originally
                                         called and a resolution passed thereat by the affirmative vote of not less than two-thirds
                                         of the votes cast on such resolution at such meeting shall constitute the approval or
                                         consent of the holders of the Exchangeable Shares.

 

		12.	Reciprocal
Changes, etc. in Respect of Akerna Shares

 

		(a)	Acknowledgement
                                         in Respect of Issuances or Distributions. Each holder of an Exchangeable Share acknowledges
                                         that the Support Agreement provides, in part, that Akerna will not, except as provided
                                         in the Support Agreement, without the prior approval of the Company and the prior approval
                                         of the holders of the Exchangeable Shares given in accordance with Section 11(b):

 

		(i)	issue
                                         or distribute Akerna Shares (or securities exchangeable for or convertible into or carrying
                                         rights to acquire Akerna Shares) to the holders of all or substantially all of the then
                                         outstanding Akerna Shares by way of stock or share dividend or other distribution, other
                                         than an issue of Akerna Shares (or securities exchangeable for or convertible into or
                                         carrying rights to acquire Akerna Shares) to holders of Akerna Shares: (i) who exercise
                                         an option to receive dividends in Akerna Shares (or securities exchangeable for or convertible
                                         into or carrying rights to acquire Akerna Shares) in lieu of receiving cash dividends;
                                         or (ii) pursuant to any dividend reinvestment plan or scrip dividend or similar arrangement;

 

		(ii)	issue
                                         or distribute rights, options or warrants to the holders of all or substantially all
                                         of the then outstanding Akerna Shares entitling them to subscribe for or to purchase
                                         Akerna Shares (or securities exchangeable for or convertible into or carrying rights
                                         to acquire Akerna Shares); or

  

    I-17

     

    

 

		(iii)	issue
                                         or distribute to the holders of all or substantially all of the then outstanding Akerna
                                         Shares:

 

		(A)	shares
                                         or securities of Akerna of any class other than Akerna Shares (or securities convertible
                                         into or exchangeable for or carrying rights to acquire Akerna Shares);

 

		(B)	rights,
                                         options or warrants other than those referred to in Section 12(a)(ii) above;

 

		(C)	evidence
                                         of indebtedness of Akerna; or

 

		(D)	assets
                                         of Akerna;

 

unless,
in each case, the Company issues or distributes the economic equivalent of such rights, options, warrants, securities, shares,
evidences of indebtedness or other assets simultaneously to holders of the Exchangeable Shares; provided, however, that, for greater
certainty, the above restrictions shall not apply to any securities issued or distributed by Akerna in order to give effect to
and to consummate the transactions contemplated by, and in accordance with, the Arrangement Agreement and the Plan of Arrangement.

 

		(b)	Acknowledgement
                                         in Respect of Corporate Changes. Each holder of an Exchangeable Share acknowledges
                                         that the Support Agreement further provides, in part, that for so long as any Exchangeable
                                         Shares not owned by Akerna or its affiliates are outstanding, Akerna will not without
                                         the prior approval of the Company and the prior approval of the holders of the Exchangeable
                                         Shares given in accordance with Section 11(b):

 

		(i)	subdivide,
                                         redivide or change the then outstanding Akerna Shares into a greater number of Akerna
                                         Shares;

  

    I-18

     

    

 

		(ii)	reduce,
                                         combine, consolidate or change the then outstanding Akerna Shares into a lesser number
                                         of Akerna Shares; or

 

		(iii)	reclassify
                                         or otherwise change the Akerna Shares or effect an amalgamation, merger, reorganization
                                         or other transaction affecting the Akerna Shares;

 

unless,
in each case, the same or an economically equivalent change is made simultaneously to, or in the rights of the holders of, the
Exchangeable Shares; provided, however, that, for greater certainty, the above restrictions shall not apply to any securities
issued or distributed by Akerna in order to give effect to and to consummate the transactions contemplated by, and in accordance
with the Arrangement Agreement and the Plan of Arrangement. The Support Agreement further provides, in part, that the aforesaid
provisions of the Support Agreement shall not be changed without the approval of the holders of the Exchangeable Shares given
in accordance with Section 11(b).

 

		(c)	Successorship
                                         Transaction. Notwithstanding the foregoing provisions of this Section 12, in the
                                         event of an Akerna Control Transaction:

 

		(i)	in
                                         which Akerna merges or amalgamates with, or in which all or substantially all of the
                                         then outstanding Akerna Shares are acquired by one or more other corporations to which
                                         Akerna is, immediately before such merger, amalgamation or acquisition, related within
                                         the meaning of the Income Tax Act (Canada) (otherwise than virtue of a right referred
                                         to in paragraph 251(5)(b) thereof);

 

		(ii)	which
                                         does not result in an acceleration of the Redemption Date in accordance with paragraph
                                         (ii) of the definition of such term in Section 1(a); and

 

		(iii)	in
                                         which all or substantially all of the then outstanding Akerna Shares are converted into
                                         or exchanged for shares or rights to receive such shares (the “Other Shares”)
                                         of another corporation (the “Other Corporation”) that, immediately after
                                         such Akerna Control Transaction, owns or controls, directly or indirectly, Akerna;

 

then
all references herein to “Akerna” shall thereafter be and be deemed to be references to “Other Corporation”
and all references herein to “Akerna Shares” shall thereafter be and be deemed to be references to “Other Shares”
(with appropriate adjustments, if any, as are required to result in a holder of Exchangeable Shares on the exchange, redemption
or retraction of shares pursuant to these Exchangeable Share Provisions or the Plan of Arrangement or the exchange of shares pursuant
to the Voting and Exchange Trust Agreement immediately subsequent to the Akerna Control Transaction being entitled to receive
that number of Other Shares equal to the number of Other Shares such holder of Exchangeable Shares would have received if the
exchange, redemption or retraction of such shares pursuant to these Exchangeable Share Provisions or the Plan of Arrangement or
the exchange of such shares pursuant to the Voting and Exchange Trust Agreement had occurred immediately prior to the Akerna Control
Transaction and the Akerna Control Transaction was completed) but subject to subsequent adjustments to reflect any subsequent
changes in the share capital of the issuer of the Other Shares, including without limitation, any subdivision, consolidation or
reduction of share capital, without any need to amend the terms and conditions of the Exchangeable Shares and without any further
action required.

 

		13.	Actions
by the Company under Support Agreement

 

		(a)	Actions
                                         by the Company. The Company will take all such actions and do all such things as
                                         shall be necessary or advisable to perform and comply with and to ensure performance
                                         and compliance by Akerna, Callco and the Company with all provisions of the Support Agreement
                                         applicable to Akerna, Callco and the Company, respectively, in accordance with the terms
                                         thereof including taking all such actions and doing all such things as shall be necessary
                                         or advisable to enforce to the fullest extent possible for the direct benefit of the
                                         Company all rights and benefits in favour of the Company under or pursuant to such agreement.

 

		(b)	Changes
                                         to the Support Agreement. The Company shall not propose, agree to or otherwise give
                                         effect to any amendment to, or waiver or forgiveness of its rights or obligations under,
                                         the Support Agreement without the approval of the holders of the Exchangeable Shares
                                         given in accordance with Section 11(b) other than such amendments, waivers and/or forgiveness
                                         as may be necessary or advisable for the purposes of:

 

		(i)	adding
                                         to the covenants of any or all of the other parties to the Support Agreement if the board
                                         of directors of each of Akerna, Callco and the Company shall be of the good faith opinion
                                         that such additions will not be prejudicial to the rights or interests of the holders
                                         of the Exchangeable Shares;

 

		(ii)	evidencing
                                         the succession of successors to Akerna either by operation of law or agreement to the
                                         liabilities and covenants of Akerna under the Support Agreement (“Akerna Successors”)
                                         and the covenants of and obligations assumed by each such Akerna Successor in accordance
                                         with the provisions of Article 3 of the Support Agreement;

  

    I-19

     

    

 

		(iii)	making
                                         such amendments or modifications not inconsistent with the Support Agreement as may be
                                         necessary or desirable with respect to matters or questions arising thereunder which,
                                         in the good faith opinion of the board of directors of each of Akerna, Callco and the
                                         Company, it may be expedient to make, provided that each such board of directors shall
                                         be of the good faith opinion, after consultation with counsel, that such amendments and
                                         modifications will not be prejudicial to the rights or interests of the holders of the
                                         Exchangeable Shares; or

 

		(iv)	making
                                         such changes in or corrections to the Support Agreement which, on the advice of counsel
                                         to Akerna, Callco and the Company, are required for the purpose of curing or correcting
                                         any ambiguity or defect or inconsistent provision or clerical omission or mistake or
                                         manifest error contained therein, provided that the board of directors of each of Akerna,
                                         Callco and the Company shall be of the good faith opinion that such changes or corrections
                                         will not be prejudicial to the rights or interests of the holders of the Exchangeable
                                         Shares.

 

		14.	Legend;
Call Rights; Withholding Rights

 

		(a)	Legend.
                                         The certificates evidencing the Exchangeable Shares shall contain or have affixed thereto
                                         a legend in form and on terms approved by the Board of Directors with respect to the
                                         Support Agreement, the provisions of the Plan of Arrangement relating to the Liquidation
                                         Call Right, the Redemption Call Right and the Change of Law Call Right, the Voting and
                                         Exchange Trust Agreement (including the provisions with respect to the voting rights
                                         and automatic exchange thereunder) and the Retraction Call Right.

 

		(b)	Call
                                         Rights. Each holder of an Exchangeable Share, whether of record or beneficial, by
                                         virtue of becoming and being such a holder shall be deemed to acknowledge each of the
                                         Liquidation Call Right, the Redemption Call Right, the Change of Law Call Right and the
                                         Retraction Call Right, in each case, in favour of Akerna and Callco, and the overriding
                                         nature thereof in connection with the liquidation, dissolution or winding-up of the Company
                                         or any other distribution of the assets of the Company among its shareholders for the
                                         purpose of winding up its affairs, or the retraction or redemption of Exchangeable Shares,
                                         as the case may be, and to be bound thereby in favour of Akerna and Callco as provided
                                         herein and in the Plan of Arrangement.

 

		(c)	Withholding
                                         Rights. Akerna, Callco, the Company and the Transfer Agent shall be entitled to deduct
                                         and withhold from any dividend, distribution or other consideration otherwise payable
                                         to any holder of Exchangeable Shares such amounts as Akerna, Callco, the Company or the
                                         Transfer Agent, as the case may be, is required to deduct and withhold with respect to
                                         such payment under the Income Tax Act (Canada) or United States tax laws or any
                                         provision of provincial, territorial, state, local or foreign tax law, in each case,
                                         as amended. To the extent that amounts are so withheld, such withheld amounts shall be
                                         treated for all purposes hereof as having been paid to the holder of the Exchangeable
                                         Shares in respect of which such deduction and withholding was made. To the extent that
                                         the amount so required to be deducted or withheld from any payment to a holder exceeds
                                         the cash portion of the consideration otherwise payable to the holder, Akerna, Callco,
                                         the Company and the Transfer Agent are hereby authorized to sell or otherwise dispose
                                         of such portion of the consideration as is necessary to provide sufficient funds to Akerna,
                                         Callco, the Company or the Transfer Agent, as the case may be, to enable it to comply
                                         with such deduction or withholding requirement and Akerna, Callco, the Company or the
                                         Transfer Agent, as the case may be, shall notify the holder thereof and remit any unapplied
                                         balance of the net proceeds of such sale.

  

    I-20

     

    

 

		15.	Notices

 

		(a)	Notices.
                                         Subject to applicable laws, any notice, request or other communication to be given to
                                         the Company by a holder of Exchangeable Shares shall be in writing and shall be valid
                                         and effective if given by first class mail (postage prepaid) or by telecopy or by delivery
                                         to the registered office of the Company and addressed to the attention of the Secretary
                                         of the Company. Any such notice, request or other communication, if given by mail, telecopy
                                         or delivery, shall only be deemed to have been given and received upon actual receipt
                                         thereof by the Company.

 

		(b)	Certificates.
                                         Any presentation and surrender by a holder of Exchangeable Shares to the Company or the
                                         Transfer Agent of certificates representing Exchangeable Shares in connection with the
                                         liquidation, dissolution or winding-up of the Company or the retraction or redemption
                                         of Exchangeable Shares shall be made by first class mail (postage prepaid) or by delivery
                                         to the registered office of the Company or to such office of the Transfer Agent as may
                                         be specified by the Company, in each case, addressed to the attention of the Secretary
                                         of the Company. Any such presentation and surrender of certificates shall only be deemed
                                         to have been made and to be effective upon actual receipt thereof by the Company or the
                                         Transfer Agent, as the case may be. Any such presentation and surrender of certificates
                                         made by first class mail (postage prepaid) shall be at the sole risk of the holder mailing
                                         the same.

 

		(c)	Notice
                                         to Shareholders.

 

		(i)	Subject
                                         to applicable laws, any notice, request or other communication to be given to a holder
                                         of Exchangeable Shares by or on behalf of the Company shall be in writing and shall be
                                         valid and effective if given by first class mail (postage prepaid) or by delivery to
                                         the address of the holder recorded in the register of shareholders of the Company or,
                                         in the event of the address of any such holder not being so recorded, then at the last
                                         known address of such holder. Any such notice, request or other communication, if given
                                         by mail, shall be deemed to have been given and received on the third Business Day following
                                         the date of mailing and, if given by delivery, shall be deemed to have been given and
                                         received on the date of delivery. Accidental failure or omission to give any notice,
                                         request or other communication to one or more holders of Exchangeable Shares shall not
                                         invalidate or otherwise alter or affect any action or proceeding to be taken by the Company
                                         pursuant thereto.

 

		(ii)	In
                                         the event of any interruption of mail service immediately prior to a scheduled mailing
                                         or in the period following a mailing during which delivery normally would be expected
                                         to occur, the Company shall make reasonable efforts to disseminate any notice by other
                                         means, such as publication. Except as otherwise required or permitted by law, if post
                                         offices in Canada are not open for the deposit of mail, any notice which the Company
                                         or the Transfer Agent may give or cause to be given hereunder will be deemed to have
                                         been properly given and to have been received by holders of Exchangeable Shares if it
                                         is published once in the national edition of The Globe and Mail, provided that
                                         if the national edition of The Globe and Mail is not being generally circulated,
                                         publication thereof will be made in the National Post or any other daily newspaper of
                                         general circulation published in the City of Toronto.

 

		(iii)	Notwithstanding
                                         any other provisions of these Exchangeable Share Provisions, notices, other communications
                                         and deliveries need not be mailed if the Company determines that delivery thereof by
                                         mail may be delayed. Persons entitled to any deliveries (including certificates and cheques)
                                         which are not mailed for the foregoing reason may take delivery thereof at the office
                                         of the Transfer Agent to which the deliveries were made, upon application to the Transfer
                                         Agent, until such time as the Company has determined that delivery by mail will no longer
                                         be delayed. The Company will provide notice of any such determination not to mail made
                                         hereunder as soon as reasonably practicable after the making of such determination and
                                         in accordance with this Section 15(c). Such deliveries in such circumstances will constitute
                                         delivery to the persons entitled thereto.

  

    I-21

     

    

 

		16.	Disclosure
of Interests in Exchangeable Shares

 

The
Company shall be entitled to require any holder of an Exchangeable Share or any person whom the Company knows or has reasonable
cause to believe holds any interest whatsoever in an Exchangeable Share to: (a) confirm that fact; or (b) give such details as
to whom has an interest in such Exchangeable Share, in each case as would be required (if the Exchangeable Shares were a class
of “equity securities” of the Company) under section 5.2 of National Instrument 62-104 Take-Over Bids and Issuer
Bids or as would be required under the articles of Akerna or any laws or regulations, or pursuant to the rules or regulations
of any regulatory agency, if and only to the extent that the Exchangeable Shares were Akerna Shares.

 

		17.	Fractional
Shares

 

A
holder of an Exchangeable Share shall not be entitled to any fraction of an Akerna Share upon the exchange, redemption or purchase
of such holder’s Exchangeable Share pursuant to Section 5, 6 and 7 and no certificates representing any such fractional interest
shall be issued and the number of Akerna Shares or Exchangeable Shares, as the case may be, to be received by an Ample Shareholder
otherwise entitled to a fractional interest shall be rounded to the nearest whole Akerna Share or Exchangeable Share, as the case
may be (with fractions equal to or greater than 0.5 being rounded up).

  

    I-22

     

    

 

APPENDIX
I

TO SCHEDULE I

 

RETRACTION
REQUEST

 

[TO
BE PRINTED ON EXCHANGEABLE SHARE CERTIFICATES]

 

		To:	Akerna
                                         Corp. (“Akerna”)

                                         2732804 Ontario Inc. (“Callco”)

                                         2732805 Ontario Inc. (the “Company”)

 

This
notice is given pursuant to Section 6 of the share provisions (the “Exchangeable Share Provisions”) attaching
to the Exchangeable Shares of the Company represented by this certificate and all capitalized words and expressions used in this
notice that are defined in the Exchangeable Share Provisions have the meanings ascribed to such words and expressions in such
Exchangeable Share Provisions.

 

The
undersigned hereby notifies the Company that, subject to the Retraction Call Right referred to below, the undersigned desires
to have the Company redeem in accordance with Section 6 of the Exchangeable Share Provisions: (select one)

 

☐       all
Exchangeable Share(s) represented by this certificate

 

☐       ______________
Exchangeable Share(s) only

 

The
undersigned hereby notifies the Company that the Retraction Date shall be __________.

 

NOTE:
The Retraction Date must be a Business Day and must not be less than 10 Business Days nor more than 15 Business Days after the
date upon which this notice is received by the Company. If no such Business Day is specified above, the Retraction Date shall
be deemed to be the 15th Business Day after the date on which this notice is received by the Company.

 

The
undersigned acknowledges the overriding Retraction Call Right of Akerna and Callco to purchase all but not less than all the Retracted
Shares from the undersigned and that this notice is and shall be deemed to be a revocable offer by the undersigned to sell the
Retracted Shares to Akerna or Callco in accordance with the Retraction Call Right on the Retraction Date for the Retraction Call
Right Purchase Price and on the other terms and conditions set out in Section 6(b) of the Exchangeable Share Provisions. If neither
Akerna nor Callco exercise the Retraction Call Right, the Company will notify the undersigned of such fact as soon as possible.
This Retraction Request, and this offer to sell the Retracted Shares to Akerna or Callco, may be revoked and withdrawn by the
undersigned only by notice in writing given to the Company at any time before the close of business on the Business Day immediately
preceding the Retraction Date.

 

The
undersigned acknowledges that if, as a result of solvency provisions of applicable law, the Company is unable to redeem all Retracted
Shares, and provided that neither Akerna nor Callco has exercised the Retraction Call Right with respect to the Retracted Shares,
the Retracted Shares will be automatically exchanged pursuant to the Voting and Exchange Trust Agreement so as to require Akerna
to purchase the unredeemed Retracted Shares.

  

The
undersigned hereby represents and warrants to Akerna, Callco and the Company that the undersigned: (select one)

 

☐       is

 

☐       is
not

  

    I-23

     

    

 

a
resident of Canada for purposes of the Income Tax Act (Canada). THE UNDERSIGNED ACKNOWLEDGES THAT IN THE ABSENCE OF AN
INDICATION THAT THE UNDERSIGNED IS A RESIDENT OF CANADA, WITHHOLDING ON ACCOUNT OF CANADIAN TAX MAY BE MADE FROM AMOUNTS PAYABLE
TO THE UNDERSIGNED ON THE REDEMPTION OR PURCHASE OF THE RETRACTED SHARES.

 

The
undersigned hereby represents and warrants to Akerna, Callco and the Company that the undersigned has good title to, and owns,
the share(s) represented by this certificate to be acquired by Akerna, Callco or the Company, as the case may be, free and clear
of all liens, claims and encumbrances.

  

	 	
	
	
	

	(Date)	
	
        (Signature of Shareholder)
	
	
        (Guarantee of Signature)

 

		☐	Please
                                         check box if the securities and any cheque(s) resulting from the retraction or purchase
                                         of the Retracted Shares are to be held for pick-up by the shareholder from the Transfer
                                         Agent, failing which such certificates and cheque(s) will be mailed to the last address
                                         of the shareholder as it appears on the register.

 

Note:
This panel must be completed and this certificate, together with such additional documents and payments (including, without limitation,
any applicable Stamp Taxes) as the Transfer Agent and the Company may require, must be deposited with the Transfer Agent. The
securities and any cheque(s) resulting from the retraction or purchase of the Retracted Shares will be issued and registered in,
and made payable to, respectively, the name of the shareholder as it appears on the register of the Company and the certificates
for the securities and any cheque(s) resulting from such retraction or purchase will be delivered to such shareholder as indicated
above, unless the form appearing immediately below is duly completed.

 

Date:___________________________________________

 

Name
of Person in Whose Name Securities or Cheque(s)

Are to be Registered, Issued or Delivered (please print): _________________________________________

_________________________________________________________________________________________

_________________________________________________________________________________________

 

	Street
Address or P.O. Box:
	 
	Signature
    of Shareholder:	 
	City,
    Province and Postal Code:	 
	Signature
    Guaranteed by:	 

 

Note:
If this Retraction Request is for less than all of the shares represented by this certificate, a certificate representing the
remaining share(s) of the Company represented by this certificate will be issued and registered in the name of the shareholder
as it appears on the register of the Company, unless the Share Transfer Power on the share certificate is duly completed in respect
of such share(s).

 

 

 

I-24

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00302-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00302-of-00352.parquet"}]]